
<html lang="en"     class="pb-page"  data-request-id="b5fda3ed-15ab-40e0-8256-3c4cdb54a468"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";article:article:10.1021/acs.jmedchem.6b01857;requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text;issue:issue:10.1021/jmcmar.2017.60.issue-7"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Discovery of G Protein-Biased Dopaminergics with a Pyrazolo[1,5-a]pyridine Substructure" /></meta><meta name="dc.Creator" content="Dorothee  Möller" /></meta><meta name="dc.Creator" content="Ashutosh  Banerjee" /></meta><meta name="dc.Creator" content="Taygun C.  Uzuneser" /></meta><meta name="dc.Creator" content="Marika  Skultety" /></meta><meta name="dc.Creator" content="Tobias  Huth" /></meta><meta name="dc.Creator" content="Bianca  Plouffe" /></meta><meta name="dc.Creator" content="Harald  Hübner" /></meta><meta name="dc.Creator" content="Christian  Alzheimer" /></meta><meta name="dc.Creator" content="Kristina  Friedland" /></meta><meta name="dc.Creator" content="Christian P.  Müller" /></meta><meta name="dc.Creator" content="Michel  Bouvier" /></meta><meta name="dc.Creator" content="Peter  Gmeiner" /></meta><meta name="dc.Description" content="1,4-Disubstituted aromatic piperazines are privileged structural motifs recognized by aminergic G protein-coupled receptors. Connection of a lipophilic moiety to the arylpiperazine core by an appro..." /></meta><meta name="Description" content="1,4-Disubstituted aromatic piperazines are privileged structural motifs recognized by aminergic G protein-coupled receptors. Connection of a lipophilic moiety to the arylpiperazine core by an appro..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="March 22, 2017" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.6b01857" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2017 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.6b01857" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.6b01857" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.6b01857" /></link>
        
    
    

<title>Discovery of G Protein-Biased Dopaminergics with a Pyrazolo[1,5-a]pyridine Substructure | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.6b01857" /></meta><meta property="og:title" content="Discovery of G Protein-Biased Dopaminergics with a Pyrazolo[1,5-a]pyridine Substructure" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01857/20170407/images/large/jm-2016-01857v_0011.jpeg" /></meta><meta property="og:description" content="1,4-Disubstituted aromatic piperazines are privileged structural motifs recognized by aminergic G protein-coupled receptors. Connection of a lipophilic moiety to the arylpiperazine core by an appropriate linker represents a promising concept to increase binding affinity and to fine-tune functional properties. In particular, incorporation of a pyrazolo[1,5-a]pyridine heterocyclic appendage led to a series of high-affinity dopamine receptor partial agonists. Comprehensive pharmacological characterization involving BRET biosensors, binding studies, electrophysiology, and complementation-based assays revealed compounds favoring activation of G proteins (preferably Go) over β-arrestin recruitment at dopamine D2 receptors. The feasibility to design G protein-biased partial agonists as putative novel therapeutics was demonstrated for the representative 2-methoxyphenylpiperazine 16c, which unequivocally displayed antipsychotic activity in vivo. Moreover, combination of the pyrazolo[1,5-a]pyridine appendage with a 5-hydroxy-N-propyl-2-aminotetraline unit led to balanced or G protein-biased dopaminergic ligands depending on the stereochemistry of the headgroup, illustrating the complex structure–functional selectivity relationships at dopamine D2 receptors." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.6b01857"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.6b01857">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-14/achre4.2021.54.issue-14/20210720/achre4.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-29/aamick.2021.13.issue-29/20210728/aamick.2021.13.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-14/acncdm.2021.12.issue-14/20210721/acncdm.2021.12.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-7/amlcef.2021.3.issue-7/20210705/amlcef.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-29/acsodf.2021.6.issue-29/20210727/acsodf.2021.6.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-29/ascecg.2021.9.issue-29/20210726/ascecg.2021.9.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-29/ancham.2021.93.issue-29/20210727/ancham.2021.93.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-29/bichaw.2021.60.issue-29/20210727/bichaw.2021.60.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-27/cgeabj.2021.99.issue-27/20210726-01/cgeabj.2021.99.issue-27.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-7/cgdefu.2021.21.issue-7/20210707/cgdefu.2021.21.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-14/esthag.2021.55.issue-14/20210720/esthag.2021.55.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-29/iecred.2021.60.issue-29/20210728/iecred.2021.60.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-14/inocaj.2021.60.issue-14/20210719/inocaj.2021.60.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-29/jafcau.2021.69.issue-29/20210728/jafcau.2021.69.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-29/jacsat.2021.143.issue-29/20210728/jacsat.2021.143.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-7/jamsef.2021.32.issue-7/20210707/jamsef.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-29/langd5.2021.37.issue-29/20210727/langd5.2021.37.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-7/mpohbp.2021.18.issue-7/20210705/mpohbp.2021.18.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.6b01857&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.6b01857&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.6b01857&amp;href=/doi/10.1021/acs.jmedchem.6b01857" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2017</span><span class="cit-fg-volume">, 60</span><span class="cit-fg-issue">, 7</span><span class="cit-fg-pageRange">, 2908-2929</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/60/7" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.6b01875" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.6b01879" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Discovery of G Protein-Biased Dopaminergics with a Pyrazolo[1,5-<i>a</i>]pyridine Substructure</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Dorothee++M%C3%B6ller">Dorothee Möller</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ashutosh++Banerjee">Ashutosh Banerjee</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Taygun+C.++Uzuneser">Taygun C. Uzuneser</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Marika++Skultety">Marika Skultety</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Tobias++Huth">Tobias Huth</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Bianca++Plouffe">Bianca Plouffe</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Harald++H%C3%BCbner">Harald Hübner</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Christian++Alzheimer">Christian Alzheimer</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Kristina++Friedland">Kristina Friedland</a></span><span class="author-xref-symbol author-aff-symbol"><sup>⊥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Christian+P.++M%C3%BCller">Christian P. Müller</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Michel++Bouvier">Michel Bouvier</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Peter++Gmeiner">Peter Gmeiner</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="loa-info-orcid"><a href="http://orcid.org/0000-0002-4127-197X" title="Orcid link"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img></a></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-symbol">†</span> <span class="aff-text">Department of Chemistry and Pharmacy, Medicinal Chemistry, Friedrich-Alexander University Erlangen-Nürnberg, Schuhstraße 19, 91052 Erlangen, Germany</span></div><div class="aff-info" id="aff2"><span class="aff-symbol">‡</span> <span class="aff-text">Department of Psychiatry and Psychotherapy, Friedrich-Alexander University Erlangen-Nürnberg, Schwabachanlage 6, 91054 Erlangen, Germany</span></div><div class="aff-info" id="aff3"><span class="aff-symbol">§</span> <span class="aff-text">Institute of Physiology and Pathophysiology, Friedrich-Alexander University Erlangen-Nürnberg, Universitätsstraße 17, 91054 Erlangen, Germany</span></div><div class="aff-info" id="aff4"><span class="aff-symbol">∥</span> <span class="aff-text">Institute for Research in Immunology and Cancer (IRIC), Department of Biochemistry and Molecular Medicine, University of Montreal, Québec, Canada H3C 1J4</span></div><div class="aff-info" id="aff5"><span class="aff-symbol">⊥</span> <span class="aff-text">Department of Chemistry and Pharmacy, Molecular and Clinical Pharmacy, Friedrich-Alexander University Erlangen-Nürnberg, Cauerstraße 4, 91058 Erlangen, Germany</span></div><div class="corresp-info"><strong>*</strong>Address: Department of Chemistry and Pharmacy, Emil Fischer Center, Friedrich-Alexander University, Schuhstraße 19, 91052 Erlangen, Germany. E-mail: <a href="/cdn-cgi/l/email-protection#5424312031267a3339313d3a3126143235217a3031"><span class="__cf_email__" data-cfemail="5c2c3928392e723b31393532392e1c3a3d29723839">[email protected]</span></a>. Tel: +49 9131 85-29383. Fax: +49 9131 85-22585.</div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.6b01857&amp;href=/doi/10.1021%2Facs.jmedchem.6b01857" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2017</span></span><span class="cit-volume">, 60</span><span class="cit-issue">, 7</span><span class="cit-pageRange">, 2908–2929</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">March 1, 2017</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>21 December 2016</li><li><span class="item_label"><b>Published</b> online</span>22 March 2017</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 13 April 2017</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.6b01857" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b01857</a></div><div class="article_header-article-copyright"><strong>Copyright © 2017 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D2908%26pageCount%3D22%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DDorothee%2BM%25C3%25B6ller%252C%2BAshutosh%2BBanerjee%252C%2BTaygun%2BC.%2BUzuneser%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D60%26issueNum%3D7%26contentID%3Dacs.jmedchem.6b01857%26title%3DDiscovery%2Bof%2BG%2BProtein-Biased%2BDopaminergics%2Bwith%2Ba%2BPyrazolo%255B1%252C5-a%255Dpyridine%2BSubstructure%26numPages%3D22%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D2929%26publicationDate%3DApril%2B2017">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.6b01857"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">1487</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">35</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.6b01857" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Discovery of G Protein-Biased Dopaminergics with a Pyrazolo[1,5-a]pyridine Substructure&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Dorothee&quot;,&quot;last_name&quot;:&quot;Möller&quot;},{&quot;first_name&quot;:&quot;Ashutosh&quot;,&quot;last_name&quot;:&quot;Banerjee&quot;},{&quot;first_name&quot;:&quot;Taygun&quot;,&quot;last_name&quot;:&quot;C. Uzuneser&quot;},{&quot;first_name&quot;:&quot;Marika&quot;,&quot;last_name&quot;:&quot;Skultety&quot;},{&quot;first_name&quot;:&quot;Tobias&quot;,&quot;last_name&quot;:&quot;Huth&quot;},{&quot;first_name&quot;:&quot;Bianca&quot;,&quot;last_name&quot;:&quot;Plouffe&quot;},{&quot;first_name&quot;:&quot;Harald&quot;,&quot;last_name&quot;:&quot;Hübner&quot;},{&quot;first_name&quot;:&quot;Christian&quot;,&quot;last_name&quot;:&quot;Alzheimer&quot;},{&quot;first_name&quot;:&quot;Kristina&quot;,&quot;last_name&quot;:&quot;Friedland&quot;},{&quot;first_name&quot;:&quot;Christian&quot;,&quot;last_name&quot;:&quot;P. Müller&quot;},{&quot;first_name&quot;:&quot;Michel&quot;,&quot;last_name&quot;:&quot;Bouvier&quot;},{&quot;first_name&quot;:&quot;Peter&quot;,&quot;last_name&quot;:&quot;Gmeiner&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2017&quot;,&quot;month&quot;:&quot;03&quot;,&quot;day&quot;:&quot;22&quot;,&quot;issue&quot;:&quot;7&quot;,&quot;volume&quot;:&quot;60&quot;,&quot;pages&quot;:&quot;2908-2929&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.6b01857&quot;},&quot;abstract&quot;:&quot;1,4-Disubstituted aromatic piperazines are privileged structural motifs recognized by aminergic G protein-coupled receptors. Connection of a lipophilic moiety to the arylpiperazine core by an appropriate linker represents a promising concept to increase binding affinity and to fine-tune functional properties. In particular, incorporation of a pyrazolo[1,5-a]pyridine heterocyclic appendage led to a series of high-affinity dopamine receptor partial agonists. Comprehensive pharmacological characterization involving BRET biosensors, binding studies, electrophysiology, and complementation-based assays revealed compounds favoring activation of G proteins (preferably Go) over β-arrestin recruitment at dopamine D2 receptors. The feasibility to design G protein-biased partial agonists as putative novel therapeutics was demonstrated for the representative 2-methoxyphenylpiperazine 16c, which unequivocally displayed antipsychotic activity in vivo. Moreover, combination of the pyrazolo[1,5-a]pyridine appendage with a 5-h&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.6b01857&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.6b01857" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.6b01857&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.6b01857" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.6b01857&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.6b01857" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.6b01857&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.6b01857&amp;href=/doi/10.1021/acs.jmedchem.6b01857" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.6b01857" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.6b01857" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (2 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b01857&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.6b01857%26sid%3Dliteratum%253Aachs%26pmid%3D28248104%26genre%3Darticle%26aulast%3DM%25C3%25B6ller%26date%3D2017%26atitle%3DDiscovery%2Bof%2BG%2BProtein-Biased%2BDopaminergics%2Bwith%2Ba%2BPyrazolo%255B1%252C5-a%255Dpyridine%2BSubstructure%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D60%26issue%3D7%26spage%3D2908%26epage%3D2929%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291181" title="Amines">Amines</a>,</li><li><a href="/action/doSearch?ConceptID=292589" title="Agonists">Agonists</a>,</li><li><a href="/action/doSearch?ConceptID=292366" title="Ligands">Ligands</a>,</li><li><a href="/action/doSearch?ConceptID=291352" title="Screening assays">Screening assays</a>,</li><li><a href="/action/doSearch?ConceptID=292186" title="Receptors">Receptors</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/60/7" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/jmcmar.2017.60.issue-7/20170413/jmcmar.2017.60.issue-7.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01857/20170407/images/medium/jm-2016-01857v_0011.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01857/20170407/images/large/jm-2016-01857v_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01857&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">1,4-Disubstituted aromatic piperazines are privileged structural motifs recognized by aminergic G protein-coupled receptors. Connection of a lipophilic moiety to the arylpiperazine core by an appropriate linker represents a promising concept to increase binding affinity and to fine-tune functional properties. In particular, incorporation of a pyrazolo[1,5-<i>a</i>]pyridine heterocyclic appendage led to a series of high-affinity dopamine receptor partial agonists. Comprehensive pharmacological characterization involving BRET biosensors, binding studies, electrophysiology, and complementation-based assays revealed compounds favoring activation of G proteins (preferably G<sub>o</sub>) over β-arrestin recruitment at dopamine D<sub>2</sub> receptors. The feasibility to design G protein-biased partial agonists as putative novel therapeutics was demonstrated for the representative 2-methoxyphenylpiperazine <b>16c</b>, which unequivocally displayed antipsychotic activity in vivo. Moreover, combination of the pyrazolo[1,5-<i>a</i>]pyridine appendage with a 5-hydroxy-<i>N</i>-propyl-2-aminotetraline unit led to balanced or G protein-biased dopaminergic ligands depending on the stereochemistry of the headgroup, illustrating the complex structure–functional selectivity relationships at dopamine D<sub>2</sub> receptors.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_38125" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_38125" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">In recent years, a number of studies have identified 1,4-disubstituted aromatic piperazines (1,4-DAPs) as privileged scaffolds<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> interacting with aminergic G protein-coupled receptors (GPCRs), especially those belonging to the serotonergic, α-adrenergic, and dopamine D<sub>2</sub> receptor (D<sub>2</sub>R) family.<a onclick="showRef(event, 'ref2 ref3'); return false;" href="javascript:void(0);" class="ref ref2 ref3">(2, 3)</a> Consisting of an aromatic headgroup in vicinity to a basic amine, they are able to recognize a three-dimensional pattern of highly conserved amino acids in the orthosteric binding pocket, a cavity formed within the helix bundle of the 7-transmembrane receptor (7-TM). 1,4-DAPs are able to mimic the crucial interactions between dopamine and the receptor and can therefore serve as surrogates for the endogenous agonist. Although the core region of the aromatic piperazines is sufficient to allow binding to D<sub>2</sub>R and the closely related D<sub>3</sub>R subtype,<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> enlargement of the chemical structures by addition of a flexible linker and a second, mostly lipophilic system (type I compounds, <a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>) has been found to promote enhanced affinity and subtype selectivity.<a onclick="showRef(event, 'ref2 ref4 ref5'); return false;" href="javascript:void(0);" class="ref ref2 ref4 ref5">(2, 4, 5)</a></div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01857/20170407/images/medium/jm-2016-01857v_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01857/20170407/images/large/jm-2016-01857v_0001.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Chemical structure of type I compounds (1,4-DAP) consisting of an aromatic core structure (π<sub>1</sub>), a basic amine unit, a linker region, and a second, mostly lipophilic system (π<sub>2</sub>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01857/20170407/images/large/jm-2016-01857v_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01857&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The relevance of type I compounds is best illustrated by the growing number of antipsychotic drugs with antagonist/partial agonist activity at D<sub>2</sub>R and D<sub>3</sub>R. Besides aripiprazole<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> (<b>1a</b>), cariprazine<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> (<b>1b</b>) and brexiprazole<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> (<b>1c</b>) have recently received FDA-approval for the treatment of schizophrenia and bipolar I manic/mixed episodes or major depressive disorders, respectively (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>).<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a></div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01857/20170407/images/medium/jm-2016-01857v_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01857/20170407/images/large/jm-2016-01857v_0002.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Chemical structures of approved antipsychotics drugs <b>1a</b>–<b>1c</b> and recently described functionally selective dopamine receptor partial agonists (<b>2a</b>–<b>2c</b>) bearing a 1,4-DAP as orthosteric headgroup.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01857/20170407/images/large/jm-2016-01857v_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01857&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Traditionally, different properties have been attributed to the three individual parts (orthosteric headgroup, linker, and lipophilic appendage) of 1,4-DAPs. While the arylpiperazine including its substituents has been considered responsible for the intrinsic activity of a given ligand, the lipophilic appendage addressing a secondary binding pocket has been thought to promote enhanced affinity with the linker simultaneously controlling subtype-selectivity.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> More recently, a number of compounds with an enlarged 1,4-DAP structure have been described (e.g., compounds <b>2a</b>–<b>c</b>, <a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>) that are able to activate D<sub>2</sub>R in a functionally selective manner.<a onclick="showRef(event, 'ref3 ref10 ref11 ref12 ref13 ref14'); return false;" href="javascript:void(0);" class="ref ref3 ref10 ref11 ref12 ref13 ref14">(3, 10-14)</a> This behavior, also described as ligand bias, is the capacity of a ligand to direct the signaling of a GPCR to a preferential signal transducer while other signaling pathways remain largely unaffected.<a onclick="showRef(event, 'ref15 ref16'); return false;" href="javascript:void(0);" class="ref ref15 ref16">(15, 16)</a> Interestingly, ligands preferably activating G protein-mediated signaling and those preferentially leading to a recruitment of β-arrestins have been found to share high chemical similarity.<a onclick="showRef(event, 'ref10 ref11 ref12 ref13'); return false;" href="javascript:void(0);" class="ref ref10 ref11 ref12 ref13">(10-13)</a> This behavior has been attributed to a complex interplay between the orthosteric aromatic pharmacophores and the lipophilic appendages connected by an appropriate spacer, enabling the ligands to adopt a bitopic orthosteric/allosteric binding mode.<a onclick="showRef(event, 'ref17 ref18 ref19'); return false;" href="javascript:void(0);" class="ref ref17 ref18 ref19">(17-19)</a> In 2014, we presented pyrazolo[1,5-<i>a</i>]pyridine heterocycles as valuable lipophilic moieties providing high D<sub>2</sub>R/D<sub>3</sub>R affinity, when attached to a 2,3-dichlorophenylpiperazine by a butoxy-linker. The ligands including the oxime substituted-pyrazolo[1,5-<i>a</i>]pyridine <b>2a</b> (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>) displayed partial agonist properties for G protein activation, while they were inhibitors for the recruitment of β-arrestin-2 at the D<sub>2</sub>R, thus being high-affinity biased agonists.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> This finding was supported by a very recent report on G protein-biased agonists with a very similar structural architecture replacing the pyrazolo[1,5-<i>a</i>]pyridine moiety by a bioisosteric benzothiazole unit (compound <b>2c</b> and analogs).<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> Extending our previous investigations, we aimed at exploring the different effects of modifications in the linker region as well as variation of the orthosteric recognition element. Thus, we replaced the 2,3-dichlorophenylpiperazine unit by a 2-methoxyphenylpiperazine group. Moreover, an exchange of the oxymethylene part of the linker by an aminocarbonyl group was investigated. To complement the phenylpiperazine-type headgroup by a classical dopamine bioisostere, we planned the incorporation of both enantiomeric forms of 5-hydroxy-<i>N</i>-propyl-2-aminotetraline, a conformationally restricted scaffold known for its agonist properties at D<sub>2</sub>-like receptors.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> On the basis of this comprehensive set of compounds, differential studies of signaling profiles and SAR studies should allow one to identify molecular determinants of functional selectivity. Guided by the hypothesis that in vitro profiles similar to those of the approved drug <b>1a</b> should predict in vivo antipsychotic activity, we performed a proof of concept study in rats. Results indicate the feasibility of pyrazolo[1,5-<i>a</i>]pyridines as useful scaffolds for the development of functionally selective CNS drugs.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Results</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_25836" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_25836" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p"><b>1a</b>, an approved antipsychotic drug, has been previously described as partial D<sub>2</sub>R agonist, preferentially activating G protein-mediated pathways with either little or no efficacy for the recruitment of β-arrestin-2.<a onclick="showRef(event, 'ref10 ref12 ref13 ref21'); return false;" href="javascript:void(0);" class="ref ref10 ref12 ref13 ref21">(10, 12, 13, 21)</a> Employing our recently described affinity-generating pyrazolo[1,5-<i>a</i>]pyridine moieties, we aimed at developing new, biased D<sub>2</sub>R partial agonists with putative antipsychotic activity. The heterocyclic moieties were combined with different orthosteric dopamine surrogates using either butoxy- or butyramido-derived spacers, since ligand bias at D<sub>2</sub>R results from a complex interplay between orthosteric pharmacophores, linker regions, and liphophilic moieties addressing a secondary binding pocket.<a onclick="showRef(event, 'ref3 ref10 ref11 ref12 ref13 ref14 ref19'); return false;" href="javascript:void(0);" class="ref ref3 ref10 ref11 ref12 ref13 ref14 ref19">(3, 10-14, 19)</a></div><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i3" class="anchor-spacer"></div><h3 class="article-section__title" id="_i3"> 5-Butyramido Pyrazolo[1,5-<i>a</i>]pyridines</h3><div class="NLM_p">In a first series of derivatives, the highly flexible butoxy-linker connecting the orthosteric headgroup with the heterocyclic moiety was replaced by an amide moiety, thereby ideally constraining the ligands into a bioactive conformation. The respective 5-butyramido-pyrazolo[1,5-<i>a</i>]pyridines were synthesized by a combination of two independently prepared building blocks (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>). For the synthesis of the orthosteric pharmacophore and linker region, two commercially available phenylpiperazines (2,3-dichloro- and 2-methoxyphenylpiperazine) were subjected to nucleophilic displacement reactions with methyl 4-bromobutyrate, leading to the methyl carboxylates <b>3a</b>,<b><b>b</b></b>. Subsequent ester hydrolysis with sodium hydroxide in methanol/water resulted in formation of the sodium carboxylates <b>4a</b>,<b>b</b>, which were isolated in excellent yield by precipitation.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> Carboxylates <b>4a</b>,<b>b</b> were activated using HATU and coupled to 5-aminopyrazolo[1,5-<i>a</i>]pyridine (<b>5</b>), which was synthesized in analogy to previously described protocols.<a onclick="showRef(event, 'ref23 ref24'); return false;" href="javascript:void(0);" class="ref ref23 ref24">(23, 24)</a> While the resulting amides <b>6a</b>,<b>b</b> represent target compounds on their own, previous studies suggested that the pyrazolo[1,5-<i>a</i>]pyridine scaffold can be further modified in position 3 to enhance affinity for D<sub>2</sub>-like receptors.<a onclick="showRef(event, 'ref10 ref23 ref25'); return false;" href="javascript:void(0);" class="ref ref10 ref23 ref25">(10, 23, 25)</a> Thus, the azaindoles <b>6a</b>,<b>b</b> were reacted under Vilsmeyer conditions to yield the carbaldehydes <b>7a</b>,<b>b</b>. Subsequent conversion into oxime derivatives was realized by refluxing with hydroxylamine hydrochloride in ethanol/water.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> The oximes <b>8a</b>,<b>b</b> were isolated as an inseparable 1:1 mixture of two isomers, which were identified as (<i>E</i>) and s-cis/s-trans isomers by diagnostic NOESY experiments. Finally, the oximes were reacted with acetic acid anhydride under reflux conditions<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> or cyanuric chloride in DMF at room temperature<a onclick="showRef(event, 'ref28 ref29'); return false;" href="javascript:void(0);" class="ref ref28 ref29">(28, 29)</a> to afford the carbonitriles <b>9a</b>,<b>b</b>.</div><figure id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01857/20170407/images/medium/jm-2016-01857v_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01857/20170407/images/large/jm-2016-01857v_0006.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. <sup>a</sup>Synthesis of Pyrazolo[1,5-<i>a</i>]pyridine-Derived Dopaminergics Containing an Amide Linker</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01857/20170407/images/large/jm-2016-01857v_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01857&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) methyl 4-bromobutyrate, TEA, DMF, rt, 24 h (88–98%); (b) 1 M NaOH, MeOH, 65 °C, 6 h (93–94%); (c) 5-aminopyrazolo[1,5-<i>a</i>]pyridine, HATU, DIPEA, DMF/CH<sub>2</sub>Cl<sub>2</sub>, 24h, rt (68–95%); (d) POCl<sub>3</sub>, DMF, 0 °C to rt, 1 h (58–59%); (e) hydroxylamine·HCl, EtOH/H<sub>2</sub>O, reflux, 2 h (77–83%); (f) for <b>9a</b> TCT, DMF, rt, 5 h (75%); and (g) for <b>9b</b> Ac<sub>2</sub>O, reflux, 6 h (12%).</p></p></figure><div class="NLM_p">Prior to functional characterizations, binding affinities of the newly synthesized compounds <b>6a</b>,<b>b</b>–<b>9a</b>,<b>b</b> were determined employing radioligand displacement studies with cell membranes expressing dopamine receptors or related receptors of interest (D<sub>1</sub>R, D<sub>2L</sub>R, D<sub>2S</sub>R, D<sub>3</sub>R, D<sub>4</sub>R, 5-HT<sub>1A</sub>R, 5-HT<sub>2A</sub>R, α<sub>1</sub>R, <a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>). For the entire set of test compounds, competition experiments revealed high binding affinities in the low nanomolar to subnanomolar range for the family of D<sub>2</sub>-like receptors. Among the unmodified pyrazolo[1,5-<i>a</i>]pyridines <b>6a</b>,<b>b</b> and their formyl-substituted congeners <b>7a</b>,<b><b>b</b></b>, affinities were found to depend on the orthosteric phenyliperazine. Test compounds bearing the 2,3-dichlorophenylpiperazine moiety showed 5-fold higher affinity for D<sub>2L</sub>R, D<sub>2S</sub>R, and D<sub>3</sub>R. Introduction of the formyl residue was beneficial for D<sub>2</sub>R affinity, leading to subnanomolar <i>K</i><sub>i</sub> values at D<sub>2L</sub>R and D<sub>2S</sub>R for the carbaldehyde <b>7a</b> (0.30, 0.41, and 1.7 for D<sub>2L</sub>R, D<sub>2S</sub>R, and D<sub>3</sub>R). Further modifications of the substituents only slightly influenced binding affinities for D<sub>2L</sub>R and D<sub>2S</sub>R, preserving the low nanomolar- to subnanomolar binding characteristics (0.50–1.11 nM for <b>8a</b>,<b>b</b> and <b>9a</b>,<b>b</b> at D<sub>2L</sub>R/D<sub>2S</sub>R). Hence, formyl-, oxime-, and cyano-substituted compounds displayed binding affinities for D<sub>2L</sub>R/D<sub>2S</sub>R that are highly similar to those of the antipsychotic drug <b>1a</b> (<i>K</i><sub>i</sub> = 0.54 and 0.45 nM for D<sub>2L</sub>R and D<sub>2S</sub>R, respectively). Independent from the orthosteric phenylpiperazine and the substitution pattern of the pyrazolo[1,5-<i>a</i>]pyridine appendage, target compounds displayed only small differences in their affinity for D<sub>4</sub>R (<i>K</i><sub>i</sub> 8.1–34 nM) and for 5-HT<sub>1A</sub>R (<i>K</i><sub>i</sub> 21–40 nM). At the closely related 5-HT<sub>2A</sub>R subtype the 2,3-dichlorophenylpiperazines <b>6a</b>–<b>9a</b> showed low nanomolar affinity (<i>K</i><sub>i</sub> = 2.6–6.3 nM), whereas affinities of the 2-methoxyphenylpiperazines <b>6b</b>–<b>9b</b> were roughly 50-fold lower (<i>K</i><sub>i</sub> = 120–380 nM). While the compound family displayed week binding affinity (210–2900 nM) and hence selectivity over D<sub>1</sub>R, all 5-butyramidopyrazolo[1,5-<i>a</i>]pyridines also had substantial affinity (1.6–10 nM) for α<sub>1</sub>R.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Binding Affinities and Functional Properties of 5-Butyramidopyrazolo[1,5-<i>a</i>]pyridines <b>6a</b>,<b>b</b>–<b>9a</b>,<b>b<a class="ref internalNav" href="#tbl1-fn1" aria-label="a">a</a></b></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01857/20170407/images/medium/jm-2016-01857v_0008.gif" alt="" id="fx1" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl1-fn1"><div class="footnote" id="tbl1-fn1"><sup>Table a</sup><p class="last">Data represent mean ± SD of two to six independent competition binding experiments, each performed in triplicate. Radioligands:</p></div><div class="footnote" id="t1fn2"><sup>Table b</sup><p class="last">[<sup>3</sup>H]SCH23990,</p></div><div class="footnote" id="t1fn3"><sup>Table c</sup><p class="last">[<sup>3</sup>H]spiperone,</p></div><div class="footnote" id="t1fn4"><sup>Table d</sup><p class="last">[<sup>3</sup>H]WAY100635,</p></div><div class="footnote" id="t1fn5"><sup>Table e</sup><p class="last">[<sup>3</sup>H]ketanserin,</p></div><div class="footnote" id="t1fn6"><sup>Table f</sup><p class="last">[<sup>3</sup>H]prazosin.</p></div><div class="footnote" id="t1fn7"><sup>Table g</sup><p class="last">Data represent mean ± SEM. from the pooled curve of four to seven individual guanine nucleotide binding experiments, each performed in triplicate.</p></div><div class="footnote" id="t1fn8"><sup>Table h</sup><p class="last">Potency given in nM.</p></div><div class="footnote" id="t1fn9"><sup>Table i</sup><p class="last">Efficacy normalized to the reference agonist quinpirole (100%) and buffer (0%).</p></div></div><div></div></div><div class="NLM_p last">To determine functional properties of the test compounds at the Gα<sub>i/o</sub>-coupled D<sub>2S</sub>R and D<sub>3</sub>R, we performed [<sup>35</sup>S]GTPγS incorporation assays with membranes from transiently transfected HEK293T cells. The ability of the ligands to stimulate nucleotide exchange was measured using Gα<sub>oA</sub> as representative G protein subunit, which is known to be activated by both, D<sub>2</sub>R and D<sub>3</sub>R.<a onclick="showRef(event, 'ref30 ref31 ref32 ref33'); return false;" href="javascript:void(0);" class="ref ref30 ref31 ref32 ref33">(30-33)</a> For both subtypes, the antipsychotic drug <b>1a</b> elicited submaximal responses (67% and 52% of the quinpirole effect at D<sub>2S</sub>R and D<sub>3</sub>R, respectively), which is in good agreement with its partial agonist nature (<a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a> and <a class="ref internalNav" href="#notes-1" aria-label="Supplementary Figure 1a">Supplementary Figure 1a</a>). Similar potencies of 39 nM at D<sub>2S</sub>R and 20 nM at D<sub>3</sub>R were observed in the two test systems, indicating little preference for one receptor subtype over the other. In contrast, pyrazolo[1,5-<i>a</i>]pyridines <b>6a</b>,<b>b</b>, <b>7b</b>, <b>8a,b</b>, and <b>9a</b>,<b>b</b> showed a preferential activation of Gα<sub>oA</sub> via D<sub>3</sub>R over D<sub>2S</sub>R (<a class="ref internalNav" href="#notes-1" aria-label="Supplementary Figure 1, panels b, c, and e–i">Supplementary Figure 1, panels b, c, and e–i</a>) with up to 150-fold higher potencies (EC<sub>50</sub> = 3.8–79 nM and 84–870 nM at D<sub>3</sub>R and D<sub>2S</sub>R, respectively) as well as higher efficacies (<i>E</i><sub>max</sub> = 45–83% at D<sub>3</sub>R vs 32–50% at D<sub>2S</sub>R). Only the 2,3-dichlorphenyl-piperazine <b>7a</b> showed a slightly higher potency for the activation of D<sub>2S</sub>R (13 vs 37 nM at D<sub>3</sub>R, <a class="ref internalNav" href="#notes-1" aria-label="Supplementary Figure 1d">Supplementary Figure 1d</a>). The closely related oxime <b>8a</b>, however, was the most potent activator of D<sub>3</sub>R (EC<sub>50</sub> 3.8 nM, <i>E</i><sub>max</sub> 83%, <a class="ref internalNav" href="#notes-1" aria-label="Figure 1f">Figure 1f</a>). Additionally, compounds <b>6a</b>,<b>b</b>–<b>9a</b>,<b>b</b> were examined for their capacity to promote recruitment of β-arrestin-2 to D<sub>2S</sub>R. Similar to the reference antipsychotic <b>1a</b>, none of the pyrazolo[1,5-<i>a</i>]pyridines with amide-substructure induced a significant effect (<a class="ref internalNav" href="#notes-1" aria-label="Supplementary Figure 2a">Supplementary Figure 2a</a>) when they were tested at a concentration of 10 μM in the PathHunter assay. This antagonism stands in contrast to the partial agonist properties observed in the [<sup>35</sup>S]GTPγS binding experiments, identifying 1,4-DAPs with butyramido-spacer and a pyrazolo[1,5-<i>a</i>]pyridine appendage as G protein-biased ligands at D<sub>2</sub>R. Compared to the functional properties of chemical analogs comprising a butoxy-spacer (e.g., the antipsychotic <b>1a</b>), inferior D<sub>2</sub>R partial agonist properties (reduced potencies, efficacies, or both) were observed for <b>6a</b>,<b>b</b>–<b>9a</b>,<b>b</b>. In spite of their subnanomolar binding affinities, reduction of the conformational flexibility by introduction of the amide-spacer did not prove successful in constraining the ligands in a bioactive conformation that fosters receptor activation.</div></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i6" class="anchor-spacer"></div><h3 class="article-section__title" id="_i6"> Modification of the Orthosteric Recognition Element</h3><div class="NLM_p">Complementary to the modifications of the spacer region and the lipophilic appendage, we explored the effects of different aromatic head groups, which serve as primary recognition element for aminergic receptors.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> While previous studies have widely used 2,3-dichlorophenylpiperazines as dopamine surrogate,<a onclick="showRef(event, 'ref10 ref13'); return false;" href="javascript:void(0);" class="ref ref10 ref13">(10, 13)</a> we employed closely related 2-methoxyphenylpiperazines but also more divergent 5-hydroxy-<i>N</i>-propyl-2-aminotetralines, rigidized dopamine scaffolds known for their D<sub>2</sub>R-agonist properties (see <a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>).<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a></div><figure id="sch2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01857/20170407/images/medium/jm-2016-01857v_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01857/20170407/images/large/jm-2016-01857v_0007.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. <sup>a</sup>Synthesis of Prazolo[1,5-<i>a</i>]pyridine-Derived Dopaminergics Containing a Butoxy-Linker</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01857/20170407/images/large/jm-2016-01857v_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01857&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) HBr 48%, reflux, 16 h; (b) KI, DIPEA or TEA, ACN, 85 °C, 6–16 h, (19–89%); (c) LiAlH<sub>4</sub>, Et<sub>2</sub>O, 0 °C to rt, 1 h (74%); (d) MnO<sub>2</sub>, CH<sub>2</sub>Cl<sub>2</sub>, rt, 14 h (97%); (e) hydroxylamine hydrochloride, EtOH/H<sub>2</sub>O, reflux, 2 h (85%); (f) TCT, DMF, rt, 7 h (54%); (g) POCl<sub>3</sub>, DMF, 0 °C to rt, 1 h (79–98%); (h) hydroxylamine·HCl, EtOH/H<sub>2</sub>O, reflux, 2 h (35–89%); and (i) Ac<sub>2</sub>O, reflux, 6 h (79%).</p></p></figure><div class="NLM_p last">Synthesis of target compounds was accomplished starting from either commercially available 2-methoxyphenylpiperazine or (<i>R</i>)/(<i>S</i>)-5-methoxy-<i>N</i>-propyl-2-aminotetraline, which was transformed into the phenol (<i>R</i>)/(<i>S</i>)-<b>11</b> by refluxing in hydrobromic acid. Subsequent coupling to the pyrazolo[1,5-<i>a</i>]pyridine appendage was conducted by nucleophilic displacement reaction with 5- or 6-(4-bromo)butoxypyrazolo[1,5-<i>a</i>]pyridines <b>10a</b> or <b>10b</b>,<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> yielding target compounds <b>12a</b>,<b>b</b> and (<i>R</i>)/(<i>S</i>)-<b>13a</b>,<b>b</b>, respectively. In the same way, 2-substituted pyrazolo[1,5-<i>a</i>]pyridine <b>12c</b> was obtained starting from 2-methoxyphenylpiperazine and the 2-ethoxy-carbonylpyrazolo[1,5-<i>a</i>]pyridine derivative <b>10c</b>.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> The ethyl-carboxylate <b>12c</b> was transformed into the primary alcohol <b>12d</b> using a solution of LiAlH<sub>4</sub> in diethyl ether. Reoxidation with manganese(IV) oxide afforded the aromatic aldehyde <b>12e</b> in excellent yield. The aldehyde could be converted to the aldehydoxime <b>12f</b> by treatment with hydroxylamine hydrochloride in aqueous ethanol. Subsequent reaction with cyanuric chloride in DMF<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> gave the carbonitrile <b>12g</b>. Since addition of polar substituents into position 3 of the pyrazolo[1,5-<i>a</i>]pyridine moiety has previously been shown to have beneficial effects on dopamine D<sub>2</sub>R-like affinity,<a onclick="showRef(event, 'ref10 ref23'); return false;" href="javascript:void(0);" class="ref ref10 ref23">(10, 23)</a> dopaminergics <b>12a</b>,<b>b</b> and (<i>S</i>)-<b>13a</b>,<b>b</b> were further functionalized in analogy to previously described procedures.<a onclick="showRef(event, 'ref10 ref23 ref25'); return false;" href="javascript:void(0);" class="ref ref10 ref23 ref25">(10, 23, 25)</a> Introduction of formyl residues was realized by Vilsymeyer-type formylation affording target compounds <b>14a</b>,<b>b</b> and (<i>S</i>)-<b>15a</b>,<b>b</b> in good yields. The following conversion to the corresponding oximes by refluxing with an aqueous solution of hydroxylamine hydrochloride in ethanol led to a mixture of (<i>E</i>)-<i>s-cis/s-trans</i> configured isomers <b>16a</b>-<b>c</b>, (<i>S</i>)-<b>17a</b>,<b>b</b> which could only be separated in the case of the 5-butoxy-phenylpiperazines <b>16b</b>,<b>c</b>. For the latter, a final conversion into the corresponding 3-cyano-substituted pyrazolo[1,5-<i>a</i>]pyridine <b>18</b> was performed by refluxing in acetic acid anhydride.</div></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i8" class="anchor-spacer"></div><h3 class="article-section__title" id="_i8"> Binding Affinities</h3><div class="NLM_p">Affinities of target compounds <b>12a</b>–<b>g</b> to <b>18</b> for dopamine D<sub>1</sub>R, D<sub>2L</sub>R, D<sub>2S</sub>R, D<sub>3</sub>R, and D<sub>4</sub>R and related 5-HT<sub>1A</sub>R, 5-HT<sub>2A</sub>R, and α<sub>1</sub>R were determined in competition binding experiments (<a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>). Our initial observations were directed toward the identification of the optimal attachment point of the butoxy-linker and the positioning of potential functional groups at the pyrazolo[1,5-<i>a</i>]pyridine appendage. When the two unsubstituted pyrazolo[1,5-<i>a</i>]pyridines <b>12a</b> and <b>12b</b> with the 2-methoxyphenylpiperazine headgroup were compared, the 6-butoxy analog <b>12a</b> showed superior binding properties toward all D<sub>2</sub>-like receptor subtypes (<i>K</i><sub>i</sub> = 0.69–5.0 nM compared to 13–18 nM for <b>12b</b>). Introduction of an ethyl carboxylate-, hydroxymethyl-, or formyl-substituent into position 2 of the 5-butoxypyrazolo[1,5-<i>a</i>]pyridine moiety led to an approximately 2-fold improvement of D<sub>2L</sub>R, D<sub>2S</sub>R, and D<sub>3</sub>R affinities for test compounds <b>12c</b>–<b>e</b> (<i>K</i><sub>i</sub> = 5.1–8.1, 5.5–7.4 nM, and 7.4–15 nM at D<sub>2L</sub>R, D<sub>2S</sub>R, and D<sub>3</sub>R, respectively) compared to the unsubstituted precursor <b>12b</b>. Interestingly, no significant differences in the D<sub>4</sub>R affinity of test compounds <b>12b</b>–<b>e</b> were observed. Conversion into the oxime <b>12f</b> also slightly improved D<sub>2</sub>R, D<sub>3</sub>R, and D<sub>4</sub>R affinity (<i>K</i><sub>i</sub> = 3.3, 1.9, 3.2, and 7.8 nM at D<sub>2L</sub>R, D<sub>2S</sub>R, D<sub>3</sub>R, and D<sub>4</sub>R, respectively), indicating a beneficial effect of position-2 substituents on the D<sub>2</sub>/D<sub>3</sub> receptor affinity. In contrast, introduction of the linear and small cyano-group (<b>12g</b>) did not significantly alter the binding affinity for D<sub>2</sub>R/D<sub>3</sub>R compared to <b>12b</b>. However, none of the position 2 modifications could achieve the subnanomolar D<sub>2</sub>R binding affinity of the unsubstituted 6-butoxypyrazolo[1,5-<i>a</i>]pyridine <b>12a</b>. In comparison to modifications at position 2 of the pyrazolo[1,5-<i>a</i>]pyridine moiety, we investigated the effects of similar substituents in position 3 of the aromatic heterocycle, since this position had previously been identified as a suitable attachment point for different functional groups.<a onclick="showRef(event, 'ref10 ref23'); return false;" href="javascript:void(0);" class="ref ref10 ref23">(10, 23)</a> Interestingly, the introduction of these substituents had opposite effects within the group of 2-methoxyphenylpiperazines. While the introduction of a formyl residue led to an improvement of the D<sub>2</sub>R affinity for the 5-butoxy-derivative <b>14b</b>, D<sub>2</sub>R affinity was reduced for the 6-butoxy analog <b>14a</b> (<i>K</i><sub>i</sub> = 1.8 and 2.3 nM at D<sub>2S</sub>R and D<sub>2L</sub>R for <b>14b</b> vs 7.8 and 7.7 nM for <b>14a</b>). The same trend was also observed for the oxime-substituted analogs <b>16a</b> (6-butoxy, <i>K</i><sub>i</sub> = 4.2 and 1.7 for D<sub>2L</sub>R/D<sub>2S</sub>R) compared to <b>16b</b>/<b>c</b>. Especially, the (<i>E</i>) and <i>s-cis</i> configured isomer <b>16c</b> showed ultrahigh affinity for D<sub>2L</sub>R and D<sub>2S</sub>R (<i>K</i><sub>i</sub> = 0.16 and 0.094 nM, respectively). Subnanomolar binding affinity at D<sub>2L</sub>R/D<sub>2S</sub>R was also observed for the 3-cyano-derivative <b>18</b> (<i>K</i><sub>i</sub> = 0.25 and 0.16 nM). In contrast to the set of 2-methoxyphenylpiperazines, substitution patterns of the pyrazolo[1,5-<i>a</i>]pyridine appendage had only marginal influence on the affinity of compounds within the series of 5-aminotetraline head groups. Compared to the unsubstituted parent compounds (<i>S</i>)-<b>13a</b>/<b>b</b>, introduction of formyl or oxime moieties 3 did not alter D<sub>2</sub>R affinities more than 2-fold. In general, low nanomolar to subnanomolar affinities for D<sub>2</sub>R/D<sub>3</sub>R were observed within the entire compound family. More importantly, the absolute stereochemistry of the 5-hydroxy-<i>N</i>-propyl-2-aminotetraline was found to be responsible for the superaffinity, when the (<i>S</i>)-isomers <b>13a</b>/<b>b</b> were identified as eutomers with a 45- to 190-fold higher D<sub>2</sub>R and 15-fold higher D<sub>3</sub>R affinity compared to the (<i>R</i>)-enantiomers (<i>K</i><sub>i</sub> = 0.63–2.1 nM and 0.71–0.80 nM at D<sub>2</sub>R and D<sub>3</sub>R, respectively, for (<i>S</i>)-<b>13a</b>/<b>b</b> compared to 39–120 nM and 11–13 nM for (<i>R</i>)-<b>13a</b>/<b>b</b>, respectively). All compounds showed weak binding to the D<sub>1</sub>R subtype (<i>K</i><sub>i</sub> = 210–8600 nM). Noteworthy, the α<sub>1</sub> adrenoceptor affinity was found to be strongly correlated to the nature of the orthosteric headgroup. While all target compounds comprising a 2-methoxyphenylpiperazine moiety had binding affinities in the subnanomolar or low nanomolar range (<i>K</i><sub>i</sub> = 0.32–7.2 nM), the α<sub>1</sub>R affinity of ligands with a 5-hydroxy-<i>N</i>-propyl-2-aminotetraline unit was at least 100-fold lower (<i>K</i><sub>i</sub> 77–360 nM). Although not as pronounced, a similar trend was observed at serotonergic 5-HT<sub>2A</sub>R, when aminotetralines displayed 2- to 10-fold lower affinities than 2-methoxyphenylpiperazines (<i>K</i><sub>i</sub> = 880–2300 and 78–1500 nM, respectively). All compounds also displayed high to moderate affinity for 5-HT<sub>1A</sub>R (<i>K</i><sub>i</sub> = 0.087–25 nM).</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Binding Affinities of Pyrazolo[1,5-<i>a</i>]pyridines <b>12a</b>–<b>g</b> to <b>18</b></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01857/20170407/images/medium/jm-2016-01857v_0009.gif" alt="" id="fx2" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="8" align="center" char="±"><i>K</i><sub>i</sub> [nM]<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center">R<sub>1</sub></th><th class="colsep0 rowsep0" align="center">R<sub>2</sub></th><th class="colsep0 rowsep0" align="center" char="±">hD<sub>1</sub><a class="ref internalNav" href="#t2fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center" char="±">hD<sub>2L</sub><a class="ref internalNav" href="#t2fn3" aria-label="c">c</a></th><th class="colsep0 rowsep0" align="center" char="±">hD<sub>2S</sub><a class="ref internalNav" href="#t2fn3" aria-label="c">c</a></th><th class="colsep0 rowsep0" align="center" char="±">hD<sub>3</sub><a class="ref internalNav" href="#t2fn3" aria-label="c">c</a></th><th class="colsep0 rowsep0" align="center" char="±">hD<sub>4</sub><a class="ref internalNav" href="#t2fn3" aria-label="c">c</a></th><th class="colsep0 rowsep0" align="center" char="±">p5-HT<sub>1A</sub><a class="ref internalNav" href="#t2fn4" aria-label="d">d</a></th><th class="colsep0 rowsep0" align="center" char="±">h5-HT<sub>2A</sub><a class="ref internalNav" href="#t2fn5" aria-label="e">e</a></th><th class="colsep0 rowsep0" align="center" char="±">pα<sub>1</sub><a class="ref internalNav" href="#t2fn6" aria-label="f">f</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12a</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">6-A</td><td class="colsep0 rowsep0" align="char" char="±">1100 ± 260</td><td class="colsep0 rowsep0" align="char" char="±">1.8 ± 0.63</td><td class="colsep0 rowsep0" align="char" char="±">0.74 ± 0.16</td><td class="colsep0 rowsep0" align="char" char="±">5.0 ± 2.0</td><td class="colsep0 rowsep0" align="char" char="±">0.69 ± 0.032</td><td class="colsep0 rowsep0" align="char" char="±">3.3 ± 0.6</td><td class="colsep0 rowsep0" align="char" char="±">210 ± 13</td><td class="colsep0 rowsep0" align="char" char="±">1.3 ± 0.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12b</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">5-A</td><td class="colsep0 rowsep0" align="char" char="±">2800 ± 850</td><td class="colsep0 rowsep0" align="char" char="±">18 ± 2.8</td><td class="colsep0 rowsep0" align="char" char="±">14 ± 2.1</td><td class="colsep0 rowsep0" align="char" char="±">20 ± 1.4</td><td class="colsep0 rowsep0" align="char" char="±">13 ± 0.71</td><td class="colsep0 rowsep0" align="char" char="±">3.0 ± 1.4</td><td class="colsep0 rowsep0" align="char" char="±">1100 ± 420</td><td class="colsep0 rowsep0" align="char" char="±">3.4 ± 0.92</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12c</b></td><td class="colsep0 rowsep0" align="left">2-COOEt</td><td class="colsep0 rowsep0" align="left">5-A</td><td class="colsep0 rowsep0" align="char" char="±">410 ± 64</td><td class="colsep0 rowsep0" align="char" char="±">8.1 ± 5.4</td><td class="colsep0 rowsep0" align="char" char="±">7.4 ± 1.8</td><td class="colsep0 rowsep0" align="char" char="±">7.4 ± 2.2</td><td class="colsep0 rowsep0" align="char" char="±">11 ± 2.6</td><td class="colsep0 rowsep0" align="char" char="±">1.8 ± 0.67</td><td class="colsep0 rowsep0" align="char" char="±">78 ± 12</td><td class="colsep0 rowsep0" align="char" char="±">2.2 ± 0.14</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12d</b></td><td class="colsep0 rowsep0" align="left">2-CH<sub>2</sub>OH</td><td class="colsep0 rowsep0" align="left">5-A</td><td class="colsep0 rowsep0" align="char" char="±">920 ± 540</td><td class="colsep0 rowsep0" align="char" char="±">6.0 ± 2.7</td><td class="colsep0 rowsep0" align="char" char="±">5.8 ± 3.7</td><td class="colsep0 rowsep0" align="char" char="±">15 ± 6.7</td><td class="colsep0 rowsep0" align="char" char="±">21 ± 7.0</td><td class="colsep0 rowsep0" align="char" char="±">0.68 ± 0.41</td><td class="colsep0 rowsep0" align="char" char="±">250 ± 28</td><td class="colsep0 rowsep0" align="char" char="±">1.6 ± 0.50</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12e</b></td><td class="colsep0 rowsep0" align="left">2-CHO</td><td class="colsep0 rowsep0" align="left">5-A</td><td class="colsep0 rowsep0" align="char" char="±">470 ± 300</td><td class="colsep0 rowsep0" align="char" char="±">5.1 ± 2.0</td><td class="colsep0 rowsep0" align="char" char="±">5.5 ± 3.0</td><td class="colsep0 rowsep0" align="char" char="±">7.4 ± 1.1</td><td class="colsep0 rowsep0" align="char" char="±">19 ± 3.1</td><td class="colsep0 rowsep0" align="char" char="±">1.0 ± 0.40</td><td class="colsep0 rowsep0" align="char" char="±">180 ± 42</td><td class="colsep0 rowsep0" align="char" char="±">1.8 ± 0.28</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12f</b></td><td class="colsep0 rowsep0" align="left">2-oxime</td><td class="colsep0 rowsep0" align="left">5-A</td><td class="colsep0 rowsep0" align="char" char="±">440 ± 85</td><td class="colsep0 rowsep0" align="char" char="±">3.3 ± 2.5</td><td class="colsep0 rowsep0" align="char" char="±">1.9 ± 1.0</td><td class="colsep0 rowsep0" align="char" char="±">3.2 ± 1.9</td><td class="colsep0 rowsep0" align="char" char="±">7.8 ± 4.5</td><td class="colsep0 rowsep0" align="char" char="±">0.41 ± 0.13</td><td class="colsep0 rowsep0" align="char" char="±">94 ± 29</td><td class="colsep0 rowsep0" align="char" char="±">7.2 ± 7.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12g</b></td><td class="colsep0 rowsep0" align="left">2-CN</td><td class="colsep0 rowsep0" align="left">5-A</td><td class="colsep0 rowsep0" align="char" char="±">280 ± 7.1</td><td class="colsep0 rowsep0" align="char" char="±">12 ± 4.6</td><td class="colsep0 rowsep0" align="char" char="±">12 ± 3.5</td><td class="colsep0 rowsep0" align="char" char="±">12 ± 5.6</td><td class="colsep0 rowsep0" align="char" char="±">5.2 ± 2.5</td><td class="colsep0 rowsep0" align="char" char="±">0.60 ± 0.28</td><td class="colsep0 rowsep0" align="char" char="±">410 ± 210</td><td class="colsep0 rowsep0" align="char" char="±">3.9 ± 1.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">(<i>S</i>)-<b>13a</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">6-B</td><td class="colsep0 rowsep0" align="char" char="±">2100 ± 570</td><td class="colsep0 rowsep0" align="char" char="±">0.63 ± 0.24</td><td class="colsep0 rowsep0" align="char" char="±">0.75 ± 0.12</td><td class="colsep0 rowsep0" align="char" char="±">0.71 ± 0.41</td><td class="colsep0 rowsep0" align="char" char="±">1.5 ± 1.1</td><td class="colsep0 rowsep0" align="char" char="±">5.3 ± 2.5</td><td class="colsep0 rowsep0" align="char" char="±">2000 ± 1000</td><td class="colsep0 rowsep0" align="char" char="±">360 ± 130</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">(<i>R</i>)-<b>13a</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">6-B</td><td class="colsep0 rowsep0" align="char" char="±">8600 ± 4500</td><td class="colsep0 rowsep0" align="char" char="±">120 ± 39</td><td class="colsep0 rowsep0" align="char" char="±">48 ± 23</td><td class="colsep0 rowsep0" align="char" char="±">11 ± 5.7</td><td class="colsep0 rowsep0" align="char" char="±">54 ± 24</td><td class="colsep0 rowsep0" align="char" char="±">25 ± 8.5</td><td class="colsep0 rowsep0" align="char" char="±">1100 ± 320</td><td class="colsep0 rowsep0" align="char" char="±">160 ± 14</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">(<i>S</i>)-<b>13b</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">5-B</td><td class="colsep0 rowsep0" align="char" char="±">800 ± 430</td><td class="colsep0 rowsep0" align="char" char="±">2.1 ± 0.29</td><td class="colsep0 rowsep0" align="char" char="±">0.70 ± 0.28</td><td class="colsep0 rowsep0" align="char" char="±">0.80 ± 0.27</td><td class="colsep0 rowsep0" align="char" char="±">1.2 ± 0.28</td><td class="colsep0 rowsep0" align="char" char="±">7.7 ± 0.78</td><td class="colsep0 rowsep0" align="char" char="±">1200 ± 70</td><td class="colsep0 rowsep0" align="char" char="±">96 ± 5.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">(<i>R</i>)-<b>13b</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">5-B</td><td class="colsep0 rowsep0" align="char" char="±">3700 ± 3500</td><td class="colsep0 rowsep0" align="char" char="±">96 ± 30</td><td class="colsep0 rowsep0" align="char" char="±">39 ± 17</td><td class="colsep0 rowsep0" align="char" char="±">13 ± 1.7</td><td class="colsep0 rowsep0" align="char" char="±">84 ± 39</td><td class="colsep0 rowsep0" align="char" char="±">9.1 ± 1.3</td><td class="colsep0 rowsep0" align="char" char="±">1600 ± 71</td><td class="colsep0 rowsep0" align="char" char="±">310 ± 71</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>14a</b></td><td class="colsep0 rowsep0" align="left">3-CHO</td><td class="colsep0 rowsep0" align="left">6-A</td><td class="colsep0 rowsep0" align="char" char="±">1400 ± 71</td><td class="colsep0 rowsep0" align="char" char="±">7.8 ± 5.1</td><td class="colsep0 rowsep0" align="char" char="±">7.7 ± 2.8</td><td class="colsep0 rowsep0" align="char" char="±">17 ± 14</td><td class="colsep0 rowsep0" align="char" char="±">4.3 ± 0.92</td><td class="colsep0 rowsep0" align="char" char="±">0.59 ± 0.3</td><td class="colsep0 rowsep0" align="char" char="±">1500 ± 160</td><td class="colsep0 rowsep0" align="char" char="±">1.3 ± 0.77</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>14b</b></td><td class="colsep0 rowsep0" align="left">3-CHO</td><td class="colsep0 rowsep0" align="left">5-A</td><td class="colsep0 rowsep0" align="char" char="±">430 ± 240</td><td class="colsep0 rowsep0" align="char" char="±">1.8 ± 0.67</td><td class="colsep0 rowsep0" align="char" char="±">2.3 ± 1.4</td><td class="colsep0 rowsep0" align="char" char="±">12 ± 5.0</td><td class="colsep0 rowsep0" align="char" char="±">7.1 ± 2.5</td><td class="colsep0 rowsep0" align="char" char="±">1.1 ± 0.29</td><td class="colsep0 rowsep0" align="char" char="±">350 ± 85</td><td class="colsep0 rowsep0" align="char" char="±">1.1 ± 0.23</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">(<i>S</i>)-<b>15a</b></td><td class="colsep0 rowsep0" align="left">CHO</td><td class="colsep0 rowsep0" align="left">6-B</td><td class="colsep0 rowsep0" align="char" char="±">1400 ± 350</td><td class="colsep0 rowsep0" align="char" char="±">2.4 ± 0.89</td><td class="colsep0 rowsep0" align="char" char="±">0.94 ± 0.19</td><td class="colsep0 rowsep0" align="char" char="±">1.6 ± 0.87</td><td class="colsep0 rowsep0" align="char" char="±">7.9 ± 4.5</td><td class="colsep0 rowsep0" align="char" char="±">6.6 ± 3.3</td><td class="colsep0 rowsep0" align="char" char="±">2300 ± 280</td><td class="colsep0 rowsep0" align="char" char="±">120 ± 14</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">(<i>S</i>)-<b>15b</b></td><td class="colsep0 rowsep0" align="left">CHO</td><td class="colsep0 rowsep0" align="left">5-B</td><td class="colsep0 rowsep0" align="char" char="±">1300 ± 350</td><td class="colsep0 rowsep0" align="char" char="±">2.3 ± 0.19</td><td class="colsep0 rowsep0" align="char" char="±">0.90 ± 0.21</td><td class="colsep0 rowsep0" align="char" char="±">1.1 ± 0.71</td><td class="colsep0 rowsep0" align="char" char="±">2.2 ± 0.71</td><td class="colsep0 rowsep0" align="char" char="±">1.6 ± 0.71</td><td class="colsep0 rowsep0" align="char" char="±">2200 ± 350</td><td class="colsep0 rowsep0" align="char" char="±">150 ± 42</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>16a</b></td><td class="colsep0 rowsep0" align="left">3-oxime</td><td class="colsep0 rowsep0" align="left">6-A</td><td class="colsep0 rowsep0" align="char" char="±">1000 ± 680</td><td class="colsep0 rowsep0" align="char" char="±">4.2 ± 2.5</td><td class="colsep0 rowsep0" align="char" char="±">1.7 ± 0.34</td><td class="colsep0 rowsep0" align="char" char="±">2.3 ± 0.78</td><td class="colsep0 rowsep0" align="char" char="±">4.7 ± 0.96</td><td class="colsep0 rowsep0" align="char" char="±">0.087 ± 0.054</td><td class="colsep0 rowsep0" align="char" char="±">100 ± 28</td><td class="colsep0 rowsep0" align="char" char="±">1.2 ± 0.40</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>16b</b></td><td class="colsep0 rowsep0" align="left">3-oxime (<i>E</i>)-<i>s-trans</i></td><td class="colsep0 rowsep0" align="left">5-A</td><td class="colsep0 rowsep0" align="char" char="±">710 ± 28</td><td class="colsep0 rowsep0" align="char" char="±">1.2 ± 0.27</td><td class="colsep0 rowsep0" align="char" char="±">0.72 ± 0.32</td><td class="colsep0 rowsep0" align="char" char="±">4.5 ± 2.2</td><td class="colsep0 rowsep0" align="char" char="±">1.5 ± 0.28</td><td class="colsep0 rowsep0" align="char" char="±">6.2 ± 0.21</td><td class="colsep0 rowsep0" align="char" char="±">91 ± 13</td><td class="colsep0 rowsep0" align="char" char="±">0.70 ± 0.01</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>16c</b></td><td class="colsep0 rowsep0" align="left">3-oxime <i>(E)-s-cis</i></td><td class="colsep0 rowsep0" align="left">5-A</td><td class="colsep0 rowsep0" align="char" char="±">860 ± 78</td><td class="colsep0 rowsep0" align="char" char="±">0.16 ± 0.02</td><td class="colsep0 rowsep0" align="char" char="±">0.094 ± 0.027</td><td class="colsep0 rowsep0" align="char" char="±">3.3 ± 1.2</td><td class="colsep0 rowsep0" align="char" char="±">0.73 ± 0.12</td><td class="colsep0 rowsep0" align="char" char="±">6.6 ± 2.1</td><td class="colsep0 rowsep0" align="char" char="±">100 ± 23</td><td class="colsep0 rowsep0" align="char" char="±">0.62 ± 0.18</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">(<i>S</i>)-<b>17a</b></td><td class="colsep0 rowsep0" align="left">3-oxime</td><td class="colsep0 rowsep0" align="left">6-B</td><td class="colsep0 rowsep0" align="char" char="±">600 ± 160</td><td class="colsep0 rowsep0" align="char" char="±">2.5 ± 1.1</td><td class="colsep0 rowsep0" align="char" char="±">0.84 ± 0.28</td><td class="colsep0 rowsep0" align="char" char="±">0.41 ± 0.18</td><td class="colsep0 rowsep0" align="char" char="±">6.5 ± 4.8</td><td class="colsep0 rowsep0" align="char" char="±">5.0 ± 1.9</td><td class="colsep0 rowsep0" align="char" char="±">880 ± 360</td><td class="colsep0 rowsep0" align="char" char="±">77 ± 26</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">(<i>S</i>)-<b>17b</b></td><td class="colsep0 rowsep0" align="left">3-oxime</td><td class="colsep0 rowsep0" align="left">5-B</td><td class="colsep0 rowsep0" align="char" char="±">1800 ± 500</td><td class="colsep0 rowsep0" align="char" char="±">2.2 ± 0.52</td><td class="colsep0 rowsep0" align="char" char="±">0.87 ± 0.20</td><td class="colsep0 rowsep0" align="char" char="±">0.59 ± 0.03</td><td class="colsep0 rowsep0" align="char" char="±">2.0 ± 0.28</td><td class="colsep0 rowsep0" align="char" char="±">3.0 ± 1.5</td><td class="colsep0 rowsep0" align="char" char="±">1600 ± 640</td><td class="colsep0 rowsep0" align="char" char="±">140 ± 7.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>18</b></td><td class="colsep0 rowsep0" align="left">3-CN</td><td class="colsep0 rowsep0" align="left">5-A</td><td class="colsep0 rowsep0" align="char" char="±">210 ± 57</td><td class="colsep0 rowsep0" align="char" char="±">0.25 ± 0.12</td><td class="colsep0 rowsep0" align="char" char="±">0.16 ± 0.02</td><td class="colsep0 rowsep0" align="char" char="±">2.9 ± 2.4</td><td class="colsep0 rowsep0" align="char" char="±">1.3 ± 1.2</td><td class="colsep0 rowsep0" align="char" char="±">1.0 ± 0.0</td><td class="colsep0 rowsep0" align="char" char="±">110 ± 44</td><td class="colsep0 rowsep0" align="char" char="±">0.32 ± 0.04</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup>a</sup><p class="last">Data represent mean ± SD of 2 to 15 independent experiments, each performed in triplicate. Radioligands:</p></div><div class="footnote" id="t2fn2"><sup>b</sup><p class="last">[<sup>3</sup>H]SCH23990,</p></div><div class="footnote" id="t2fn3"><sup>c</sup><p class="last">[<sup>3</sup>H]spiperone,</p></div><div class="footnote" id="t2fn4"><sup>d</sup><p class="last">[<sup>3</sup>H]WAY100635.</p></div><div class="footnote" id="t2fn5"><sup>e</sup><p class="last">[<sup>3</sup>H]ketanserin.</p></div><div class="footnote" id="t2fn6"><sup>f</sup><p class="last">[<sup>3</sup>H]prazosin.</p></div></div></div></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i10" class="anchor-spacer"></div><h3 class="article-section__title" id="_i10"> Activation of G Proteins</h3><div class="NLM_p">The influence of the different attachment points of the 2-methoxyphenylpiperazine via the butoxy-spacer (position 5 or 6 of the heterocycle) and varying polar substituents of the pyrazolo[1,5-<i>a</i>]pyridine moiety on D<sub>2S</sub>R and D<sub>3</sub>R activation was investigated in [<sup>35</sup>S]GTPγS binding experiments (<a class="ref internalNav" href="#tbl3" aria-label="Table 3">Table 3</a>). In addition to studying D<sub>2S</sub>R- and D<sub>3</sub>R-mediated nucleotide exchange with Gα<sub>oA</sub>, we also investigated the D<sub>2S</sub>R promoted activation of the widely expressed Gα<sub>i2</sub> subunit,<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> since D<sub>2</sub>R is known to promiscuously couple to the Gα<sub>i/o</sub> family.<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> In all three test systems, 2-methoxyphenylpiperazines were found to activate the receptors with submaximal efficacy, indicating partial agonists profiles similar to the antipsychotic <b>1a</b>. However, differences in the relative potencies and efficacies were detected in a careful data analysis. Compared to <b>1a</b>, the two unsubstituted pyrazolo[1,5-<i>a</i>]pyridines <b>12a</b> and <b>12b</b> showed lower efficacies for the activation of D<sub>2S</sub>R. Whereas <b>12b</b> displayed potencies similar to <b>1a</b>, <b>12a</b> with the butoxy-spacer in position 6 of the heterocycle was about 10-fold more potent for the activation of D<sub>2S</sub>R. At the D<sub>3</sub>R differences in potencies were less pronounced but <b>1a</b> was less effective than the two target compounds (<a class="ref internalNav" href="#notes-1" aria-label="Supplementary Figures 1a and 3a,b">Supplementary Figures 1a and 3a,b</a>). Introduction of a formyl residue into position 3 of the pyrazolo[1,5-<i>a</i>]pyridine heterocycle preserved the activation properties in the case of the 6-butoxy derivative <b>14a</b> (EC<sub>50</sub> 5.9, 150 nM, and 19 nM, <i>E</i><sub>max</sub> 38%, 25%, and 71% at D<sub>2S</sub>R/Gα<sub>oA</sub>, D<sub>2S</sub>R/Gα<sub>i2</sub>, and D<sub>3</sub>R/Gα<sub>oA</sub>). The same modification led to an increase in potency and intrinsic activity for D<sub>2S</sub>R/Gα<sub>oA</sub> activation for the 5-butoxy analog <b>14b</b> (EC<sub>50</sub> 17 nM, <i>E</i><sub>max</sub> 58%), compared to its precursor <b>12b</b> (<a class="ref internalNav" href="#notes-1" aria-label="Supplementary Figure 3, panels a, b, j, and k">Supplementary Figure 3, panels a, b, j, and k</a>). Interestingly, the efficacy was reduced by a factor of 2 for D<sub>2S</sub>R/Gα<sub>i2</sub>, leading to a substantial preference for Gα<sub>oA</sub> over Gα<sub>i2</sub> activation at D<sub>2S</sub>R for the 3-carbaldehyde <b>14b</b>. In agreement with their high binding affinities, the corresponding oximes <b>16a</b>–<b>c</b> also showed highly potent receptor activation characteristics. Oxime <b>16a</b> with a 6-butoxy spacer showed a relative preference for D<sub>3</sub>R/Gα<sub>oA</sub> activation (<a class="ref internalNav" href="#notes-1" aria-label="Supplementary Figure 3m">Supplementary Figure 3m</a>), while the different stereoisomers with the 5-butoxy-spacer <b>16b</b>,<b>c</b> preferentially activated Gα<sub>oA</sub> proteins via D<sub>2S</sub>R (EC<sub>50</sub> 3.4 and 0.74 nM for D<sub>2S</sub>R/Gα<sub>oA</sub> vs 41 and 18 nM for D<sub>3</sub>R/Gα<sub>oA</sub><a class="ref internalNav" href="#notes-1" aria-label="Supplementary Figure 3, panels n and o">Supplementary Figure 3, panels n and o</a>).</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Functional Properties of Pyrazolo[1,5-<i>a</i>]pyridines <b>12a</b>–<b>g</b> to <b>14a</b>,<b>b</b> and <b>16a</b>–<b>c</b> and <b>18</b> Compared to the Reference <b>1a</b>, Determined by [<sup>35</sup>S]GTPγS Binding</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01857/20170407/images/medium/jm-2016-01857v_0010.gif" alt="" id="fx3" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="char" char="±" /></col><col align="left" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="left" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="left" /></col><col align="char" char="±" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="9" align="center" char="±">[<sup>35</sup>S]GTPγS binding<a class="ref internalNav" href="#t3fn1" aria-label="a">a</a></th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="3" align="center" char="±">D<sub>2S</sub>Gα<sub>oA</sub></th><th class="rowsep1 colsep0" colspan="3" align="center" char="±">D<sub>2S</sub>Gα<sub>i2</sub></th><th class="rowsep1 colsep0" colspan="3" align="center" char="±">D<sub>3</sub>Gα<sub>oA</sub></th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center">R<sub>1</sub></th><th class="colsep0 rowsep0" align="center">R<sub>2</sub></th><th class="colsep0 rowsep0" align="center" char="±">pEC<sub>50</sub></th><th class="colsep0 rowsep0" align="center">EC<sub>50</sub><a class="ref internalNav" href="#t3fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center" char="±"><i>E</i><sub>max</sub><a class="ref internalNav" href="#t3fn3" aria-label="c">c</a></th><th class="colsep0 rowsep0" align="center" char="±">pEC<sub>50</sub></th><th class="colsep0 rowsep0" align="center">EC<sub>50</sub><a class="ref internalNav" href="#t3fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center" char="±"><i>E</i><sub>max</sub><a class="ref internalNav" href="#t3fn3" aria-label="c">c</a></th><th class="colsep0 rowsep0" align="center" char="±">pEC<sub>50</sub></th><th class="colsep0 rowsep0" align="center">EC<sub>50</sub><a class="ref internalNav" href="#t3fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center" char="±"><i>E</i><sub>max</sub><a class="ref internalNav" href="#t3fn3" aria-label="c">c</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1a</b></td><td class="colsep0 rowsep0" align="left">–</td><td class="colsep0 rowsep0" align="left">–</td><td class="colsep0 rowsep0" align="char" char="±">7.41 ± 0.09</td><td class="colsep0 rowsep0" align="left">39</td><td class="colsep0 rowsep0" align="char" char="±">67 ± 2</td><td class="colsep0 rowsep0" align="char" char="±">6.80 ± 0.20</td><td class="colsep0 rowsep0" align="left">160</td><td class="colsep0 rowsep0" align="char" char="±">29 ± 3</td><td class="colsep0 rowsep0" align="char" char="±">7.71 ± 0.17</td><td class="colsep0 rowsep0" align="left">20</td><td class="colsep0 rowsep0" align="char" char="±">52 ± 3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12a</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">6-A</td><td class="colsep0 rowsep0" align="char" char="±">8.39 ± 0.15</td><td class="colsep0 rowsep0" align="left">4.1</td><td class="colsep0 rowsep0" align="char" char="±">30 ± 1</td><td class="colsep0 rowsep0" align="char" char="±">7.64 ± 0.21</td><td class="colsep0 rowsep0" align="left">23</td><td class="colsep0 rowsep0" align="char" char="±">25 ± 2</td><td class="colsep0 rowsep0" align="char" char="±">7.54 ± 0.08</td><td class="colsep0 rowsep0" align="left">29</td><td class="colsep0 rowsep0" align="char" char="±">62 ± 2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12b</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">5-A</td><td class="colsep0 rowsep0" align="char" char="±">7.38 ± 0.05</td><td class="colsep0 rowsep0" align="left">42</td><td class="colsep0 rowsep0" align="char" char="±">48 ± 1</td><td class="colsep0 rowsep0" align="char" char="±">6.73 ± 0.12</td><td class="colsep0 rowsep0" align="left">190</td><td class="colsep0 rowsep0" align="char" char="±">31 ± 2</td><td class="colsep0 rowsep0" align="char" char="±">7.25 ± 0.16</td><td class="colsep0 rowsep0" align="left">56</td><td class="colsep0 rowsep0" align="char" char="±">79 ± 5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12c</b></td><td class="colsep0 rowsep0" align="left">2-COOEt</td><td class="colsep0 rowsep0" align="left">5-A</td><td class="colsep0 rowsep0" align="char" char="±">6.72 ± 0.15</td><td class="colsep0 rowsep0" align="left">190</td><td class="colsep0 rowsep0" align="char" char="±">37 ± 3</td><td class="colsep0 rowsep0" align="char" char="±">6.16 ± 0.15</td><td class="colsep0 rowsep0" align="left">690</td><td class="colsep0 rowsep0" align="char" char="±">28 ± 3</td><td class="colsep0 rowsep0" align="char" char="±">7.30 ± 0.15</td><td class="colsep0 rowsep0" align="left">50</td><td class="colsep0 rowsep0" align="char" char="±">63 ± 3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12d</b></td><td class="colsep0 rowsep0" align="left">2-CH<sub>2</sub>OH</td><td class="colsep0 rowsep0" align="left">5-A</td><td class="colsep0 rowsep0" align="char" char="±">7.14 ± 0.15</td><td class="colsep0 rowsep0" align="left">73</td><td class="colsep0 rowsep0" align="char" char="±">47 ± 3</td><td class="colsep0 rowsep0" align="char" char="±">6.02 ± 0.13</td><td class="colsep0 rowsep0" align="left">960</td><td class="colsep0 rowsep0" align="char" char="±">39 ± 3</td><td class="colsep0 rowsep0" align="char" char="±">7.57 ± 0.19</td><td class="colsep0 rowsep0" align="left">27</td><td class="colsep0 rowsep0" align="char" char="±">65 ± 5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12e</b></td><td class="colsep0 rowsep0" align="left">2-CHO</td><td class="colsep0 rowsep0" align="left">5-A</td><td class="colsep0 rowsep0" align="char" char="±">7.06 ± 0.12</td><td class="colsep0 rowsep0" align="left">88</td><td class="colsep0 rowsep0" align="char" char="±">46 ± 2</td><td class="colsep0 rowsep0" align="char" char="±">5.52 ± 0.19</td><td class="colsep0 rowsep0" align="left">2900</td><td class="colsep0 rowsep0" align="char" char="±">31 ± 6</td><td class="colsep0 rowsep0" align="char" char="±">8.02 ± 0.20</td><td class="colsep0 rowsep0" align="left">9.7</td><td class="colsep0 rowsep0" align="char" char="±">54 ± 4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12f</b></td><td class="colsep0 rowsep0" align="left">2-oxime</td><td class="colsep0 rowsep0" align="left">5-A</td><td class="colsep0 rowsep0" align="char" char="±">6.40 ± 0.12</td><td class="colsep0 rowsep0" align="left">400</td><td class="colsep0 rowsep0" align="char" char="±">35 ± 2</td><td class="colsep0 rowsep0" align="char" char="±">5.97 ± 0.17</td><td class="colsep0 rowsep0" align="left">1100</td><td class="colsep0 rowsep0" align="char" char="±">31 ± 4</td><td class="colsep0 rowsep0" align="char" char="±">7.16 ± 0.17</td><td class="colsep0 rowsep0" align="left">70</td><td class="colsep0 rowsep0" align="char" char="±">52 ± 3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12g</b></td><td class="colsep0 rowsep0" align="left">2-CN</td><td class="colsep0 rowsep0" align="left">5-A</td><td class="colsep0 rowsep0" align="char" char="±">5.85 ± 0.10</td><td class="colsep0 rowsep0" align="left">1400</td><td class="colsep0 rowsep0" align="char" char="±">42 ± 3</td><td class="colsep0 rowsep0" align="char" char="±">6.00 ± 0.21</td><td class="colsep0 rowsep0" align="left">980</td><td class="colsep0 rowsep0" align="char" char="±">29 ± 4</td><td class="colsep0 rowsep0" align="char" char="±">7.51 ± 0.22</td><td class="colsep0 rowsep0" align="left">31</td><td class="colsep0 rowsep0" align="char" char="±">48 ± 4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">(<i>S</i>)-<b>13a</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">6-B</td><td class="colsep0 rowsep0" align="char" char="±">8.69 ± 0.05</td><td class="colsep0 rowsep0" align="left">2.0</td><td class="colsep0 rowsep0" align="char" char="±">95 ± 2</td><td class="colsep0 rowsep0" align="char" char="±">7.59 ± 0.06</td><td class="colsep0 rowsep0" align="left">26</td><td class="colsep0 rowsep0" align="char" char="±">92 ± 2</td><td class="colsep0 rowsep0" align="char" char="±">9.32 ± 0.12</td><td class="colsep0 rowsep0" align="left">0.48</td><td class="colsep0 rowsep0" align="char" char="±">92 ± 4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">(<i>S</i>)-<b>13b</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">5-B</td><td class="colsep0 rowsep0" align="char" char="±">8.31 ± 0.04</td><td class="colsep0 rowsep0" align="left">4.9</td><td class="colsep0 rowsep0" align="char" char="±">102 ± 2</td><td class="colsep0 rowsep0" align="char" char="±">7.26 ± 0.06</td><td class="colsep0 rowsep0" align="left">55</td><td class="colsep0 rowsep0" align="char" char="±">98 ± 2</td><td class="colsep0 rowsep0" align="char" char="±">9.37 ± 0.10</td><td class="colsep0 rowsep0" align="left">0.43</td><td class="colsep0 rowsep0" align="char" char="±">104 ± 3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>14a</b></td><td class="colsep0 rowsep0" align="left">3-CHO</td><td class="colsep0 rowsep0" align="left">6-A</td><td class="colsep0 rowsep0" align="char" char="±">8.23 ± 0.09</td><td class="colsep0 rowsep0" align="left">5.9</td><td class="colsep0 rowsep0" align="char" char="±">38 ± 1</td><td class="colsep0 rowsep0" align="char" char="±">6.81 ± 0.26</td><td class="colsep0 rowsep0" align="left">150</td><td class="colsep0 rowsep0" align="char" char="±">25 ± 3</td><td class="colsep0 rowsep0" align="char" char="±">7.73 ± 0.07</td><td class="colsep0 rowsep0" align="left">19</td><td class="colsep0 rowsep0" align="char" char="±">71 ± 2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>14b</b></td><td class="colsep0 rowsep0" align="left">3-CHO</td><td class="colsep0 rowsep0" align="left">5-A</td><td class="colsep0 rowsep0" align="char" char="±">7.76 ± 0.11</td><td class="colsep0 rowsep0" align="left">17</td><td class="colsep0 rowsep0" align="char" char="±">58 ± 3</td><td class="colsep0 rowsep0" align="char" char="±">7.80 ± 0.34</td><td class="colsep0 rowsep0" align="left">16</td><td class="colsep0 rowsep0" align="char" char="±">17 ± 2</td><td class="colsep0 rowsep0" align="char" char="±">8.11 ± 0.16</td><td class="colsep0 rowsep0" align="left">7.7</td><td class="colsep0 rowsep0" align="char" char="±">54 ± 3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>16a</b></td><td class="colsep0 rowsep0" align="left">3-oxime</td><td class="colsep0 rowsep0" align="left">6-A</td><td class="colsep0 rowsep0" align="char" char="±">8.54 ± 0.06</td><td class="colsep0 rowsep0" align="left">2.9</td><td class="colsep0 rowsep0" align="char" char="±">57 ± 1</td><td class="colsep0 rowsep0" align="char" char="±">9.36 ± 0.46</td><td class="colsep0 rowsep0" align="left">0.44</td><td class="colsep0 rowsep0" align="char" char="±">14 ± 2</td><td class="colsep0 rowsep0" align="char" char="±">9.49 ± 0.09</td><td class="colsep0 rowsep0" align="left">0.32</td><td class="colsep0 rowsep0" align="char" char="±">58 ± 2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>16b</b></td><td class="colsep0 rowsep0" align="left">3-oxime <i>(E)-s-trans</i></td><td class="colsep0 rowsep0" align="left">5-A</td><td class="colsep0 rowsep0" align="char" char="±">8.47 ± 0.09</td><td class="colsep0 rowsep0" align="left">3.4</td><td class="colsep0 rowsep0" align="char" char="±">47 ± 1</td><td class="colsep0 rowsep0" align="char" char="±">6.56 ± 0.17</td><td class="colsep0 rowsep0" align="left">270</td><td class="colsep0 rowsep0" align="char" char="±">25 ± 2</td><td class="colsep0 rowsep0" align="char" char="±">7.39 ± 0.14</td><td class="colsep0 rowsep0" align="left">41</td><td class="colsep0 rowsep0" align="char" char="±">74 ± 4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>16c</b></td><td class="colsep0 rowsep0" align="left">3-oxime <i>(E)-s-cis</i></td><td class="colsep0 rowsep0" align="left">5-A</td><td class="colsep0 rowsep0" align="char" char="±">9.13 ± 0.09</td><td class="colsep0 rowsep0" align="left">0.74</td><td class="colsep0 rowsep0" align="char" char="±">50 ± 1</td><td class="colsep0 rowsep0" align="char" char="±">6.93 ± 0.15</td><td class="colsep0 rowsep0" align="left">120</td><td class="colsep0 rowsep0" align="char" char="±">21 ± 2</td><td class="colsep0 rowsep0" align="char" char="±">7.74 ± 0.10</td><td class="colsep0 rowsep0" align="left">18</td><td class="colsep0 rowsep0" align="char" char="±">76 ± 3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>18</b></td><td class="colsep0 rowsep0" align="left">3-CN</td><td class="colsep0 rowsep0" align="left">5-A</td><td class="colsep0 rowsep0" align="char" char="±">7.89 ± 0.12</td><td class="colsep0 rowsep0" align="left">13</td><td class="colsep0 rowsep0" align="char" char="±">47 ± 2</td><td class="colsep0 rowsep0" align="char" char="±">6.60 ± 0.27</td><td class="colsep0 rowsep0" align="left">250</td><td class="colsep0 rowsep0" align="char" char="±">22 ± 3</td><td class="colsep0 rowsep0" align="char" char="±">7.72 ± 0.19</td><td class="colsep0 rowsep0" align="left">19</td><td class="colsep0 rowsep0" align="char" char="±">75 ± 6</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup>a</sup><p class="last">Data represent mean ± SEM from the pooled curve of four to ten independent experiments, each performed in triplicate.</p></div><div class="footnote" id="t3fn2"><sup>b</sup><p class="last">Potency given in nanomolar.</p></div><div class="footnote" id="t3fn3"><sup>c</sup><p class="last">Efficacy normalized to the reference agonist quinpirole (100%) and buffer (0%).</p></div></div></div><div class="NLM_p last">In contrast to the beneficial effects of substituents in position 3 of the pyrazolo[1,5-<i>a</i>]pyridine heterocyle, the same functional groups did not have a positive impact on D<sub>2</sub>R activation when they were attached to position 2 (<a class="ref internalNav" href="#notes-1" aria-label="Supplementary Figure 3, panels c–g">Supplementary Figure 3, panels c–g</a>). On the contrary, compounds <b>12c</b>–<b>g</b> display lower potencies for promoting nucleotide exchange in membrane preparations from HEK293T cells expressing D<sub>2S</sub>R together with Gα<sub>oA</sub> or Gα<sub>i2</sub> (EC<sub>50</sub> = 73–1400 nM and <i>E</i><sub>max</sub> = 35–47% for Gα<sub>oA</sub>; EC<sub>50</sub> = 690–2900 nM and <i>E</i><sub>max</sub> = 28–39% for Gα<sub>i2</sub>) compared to the unsubstituted congener <b>12b</b> (42 nM, 48% for Gα<sub>oA</sub> and 190 nM, 31% for Gα<sub>i2</sub>). At the same time, introduction of substituents had only a marginal influence on the potency observed for the activation of D<sub>3</sub>R (EC<sub>50</sub> 9.7–70 nM vs 56 nM), while efficacies (<i>E</i><sub>max</sub> = 52–65%) were slightly decreased relative to <b>12b</b> (<i>E</i><sub>max</sub> = 79%). Compared to the partial agonist profiles observed for 2-methoxyphenylpiperazines, two representative pyrazolo[1,5-<i>a</i>]pyridines with an aminotetraline headgroup [(<i>S</i>)-<b>13a</b>,<b>b</b>] displayed full agonist characteristics for the three investigated systems (D<sub>2S</sub>R + Gα<sub>oA</sub>, D<sub>2S</sub>R + Gα<sub>i2</sub>, and D<sub>3</sub>R + Gα<sub>oA</sub>, <a class="ref internalNav" href="#notes-1" aria-label="Supplementary Figure 3, panels h and i">Supplementary Figure 3, panels h and i</a>). Both compounds showed similar low to subnanomolar potencies and the same rank order with the highest potency for the activation of D<sub>3</sub>R/Gα<sub>oA</sub> (EC<sub>50</sub> = 0.48 and 0.43 nM) followed by D<sub>2S</sub>R/Gα<sub>oA</sub> (EC<sub>50</sub> = 2.0 and 4.9 nM) and finally D<sub>2S</sub>R/Gα<sub>i2</sub> (EC<sub>50</sub> = 26 and 55 nM).</div></div><div id="sec2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12"> Further Functional Characterization</h3><div class="NLM_p">Although measurements of nucleotide exchange in the form of [<sup>35</sup>S]GTPγS binding experiments represent a direct method to assess receptor-mediated activation of G proteins without the amplification of second messenger pathways, they also have their limitations.<a onclick="showRef(event, 'ref35 ref36'); return false;" href="javascript:void(0);" class="ref ref35 ref36">(35, 36)</a> For instance, the different Gα isoforms vary in the nucleotide exchange rates, leading to diverse but generally low signal to background ratios, which in turn may require experiments to be carried out under different conditions.<a onclick="showRef(event, 'ref35 ref37'); return false;" href="javascript:void(0);" class="ref ref35 ref37">(35, 37)</a> Very recently, it has been demonstrated that assay kinetics also play an important role when ligand bias or functional selectivity is examined, as it may lead to an observational bias.<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> In order to overcome these issues, we employed recently developed bioluminescence resonance energy transfer (BRET) test system for the activation of G proteins.<a onclick="showRef(event, 'ref39 ref40 ref41 ref42'); return false;" href="javascript:void(0);" class="ref ref39 ref40 ref41 ref42">(39-42)</a> On the basis of resonance energy transfer between <i>Renilla</i> Luciferase (RLucII) tagged-Gα and GFP10-Gγ<sub>2</sub> and hence the separation of Gβγ from Gα subunits, these highly sensitive systems allow a rapid investigation of receptor-mediated G protein activation under highly similar conditions for a broad variety of G proteins and different receptors.<a onclick="showRef(event, 'ref39 ref40 ref41 ref42'); return false;" href="javascript:void(0);" class="ref ref39 ref40 ref41 ref42">(39-42)</a></div><div class="NLM_p">A series of BRET titration experiments was performed to confirm coupling of the different Gα<sub>i/o</sub> biosensors with D<sub>2S</sub>R, D<sub>2L</sub>R, and D<sub>3</sub>R. D<sub>2S</sub>R and D<sub>2L</sub>R gave robust BRET changes upon stimulation with the endogenous agonist dopamine for both G<sub>αi1–3</sub> and Gα<sub>oA/B</sub> (<a class="ref internalNav" href="#notes-1" aria-label="Supplementary Figure 4, panels a–j">Supplementary Figure 4, panels a–j</a>), which coincides with earlier reports on promiscuous coupling of D<sub>2</sub>R to the entire family Gα<sub>i/o</sub> proteins.<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> Robust BRET changes upon dopamine treatment indicated a preferential interaction with Gα<sub>oA/B</sub> for D<sub>3</sub>R,<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> while only small BRET changes were observed with G<sub>αi1–3</sub>, suggesting a minor interaction of D<sub>3</sub>R with these subunits (<a class="ref internalNav" href="#notes-1" aria-label="Supplementary Figure 4, panels k–o">Supplementary Figure 4, panels k–o</a>). From these titrations, optimal transfection conditions were derived for the individual biosensors to obtain dose–response curves for a subset of the newly synthesized ligands and the five Gα<sub>i/o</sub> subunits in coexpression with D<sub>2S</sub>R (<a class="ref internalNav" href="#tbl4" aria-label="Table 4">Table 4</a> and <a class="ref internalNav" href="#notes-1" aria-label="Supplementary Figure 5, panels a–p">Supplementary Figure 5, panels a–p</a>) and D<sub>2L</sub>R and the two Gα<sub>o</sub> isoforms for D<sub>3</sub>R (<a class="ref internalNav" href="#notes-1" aria-label="Supplementary Table 1">Supplementary Table 1</a>). In all investigated systems, the two reference agonists quinpirole and dopamine showed a highly similar behavior (<a class="ref internalNav" href="#notes-1" aria-label="Supplementary Figure 5, panels a and b">Supplementary Figure 5, panels a and b</a>). In general, only small differences were observed among the three Gα<sub>i</sub> or two Gα<sub>o</sub> isoforms, although potencies were found to be slightly better (2–5 fold) for the activation of the Gα<sub>o</sub> proteins. However, dopamine was a little less effective in activating the Gα<sub>o</sub> pathways (<i>E</i><sub>max</sub> 87–92%), which is in good agreement with the results from [<sup>35</sup>S]GTPγS binding experiments. Results obtained with D<sub>2L</sub>R showed no significant differences to those obtained with the short isoform D<sub>2S</sub>R. All compounds sharing an (<i>S</i>)-aminotetraline moiety were found to be highly potent agonists (EC<sub>50</sub> = 0.11–0.96 nM) for the D<sub>2S</sub>R-mediated activation of the different Gα<sub>i/o</sub> isoforms. In agreement with the reduced binding affinities, enantiomers (<i>R</i>)-<b>13a</b>/<b>b</b> were 10- to 20-fold less potent (EC<sub>50</sub> = 1.5–9.8 nM), while retaining full agonist efficacies (<a class="ref internalNav" href="#notes-1" aria-label="Supplementary Figure 5, panels e–h, k, l, o, and p">Supplementary Figure 5, panels e–h, k, l, o, and p</a>). On the contrary, all ligands bearing a 2-methoxyphenylpiperazine pharmacophore shared partial agonist properties for the activation of all Gα<sub>i/o</sub> proteins. Although efficacies were generally found to be higher when compared to the results from [<sup>35</sup>S]GTPγS binding, the preferential activation of Gα<sub>o</sub> over Gα<sub>i</sub> was preserved in the BRET readings. Both, efficacies and potencies were found to be higher for the activation of Gα<sub>oA/B</sub>, (<i>E</i><sub>max</sub> = 77–86% vs 39–62% and EC<sub>50</sub> = 1.5–4.3 nM vs 2.1–13.1 nM for Gα<sub>oA/B</sub> vs Gα<sub>i1–3</sub>), indicating a functionally selective D<sub>2</sub>R activation mode for the investigated 1,4-DAPs. Importantly, when compared to the approved antipsychotic <b>1a</b>, 1,4-DAPs comprising a pyrazolo[1,5-<i>a</i>]pyridine appendage, were found to show similar activation profiles with higher overall potency (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>, panels a–d).</div><figure id="fig3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01857/20170407/images/medium/jm-2016-01857v_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01857/20170407/images/large/jm-2016-01857v_0003.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Functional properties of pyrazolo[1,5-<i>a</i>]pyridines <b>16c</b>, (<i>S</i>)-<b>13b</b>, and (<i>R</i>)-<b>13b</b> in comparison to the full agonist quinpirole and the reference antipsychotic <b>1a</b> at D<sub>2S</sub>R. Activation of Gα<sub>oA</sub> (a and c) and Gα<sub>i2</sub> (b and d) was determined either by (a and b) [<sup>35</sup>S]GTPγS binding or by (c and d) BRET changes occurring upon separation of RLucII-Gα<sub>i/o</sub> from GFP10-Gγ<sub>2</sub>. Ligand-stimulated recruitment of β-arrestin-2 was determined employing (e) the PathHunter assay or (f) an approach based on bystander BRET. Data were normalized relative to the response of quinpirole (100%) and vehicle (0%) and represent mean ± SEM from three to ten independent experiments, each performed at least in duplicate.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01857/20170407/images/large/jm-2016-01857v_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01857&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Functional Properties of Selected Pyrazolo[1,5-<i>a</i>]pyridines Compared to the Reference <b>1a</b>, for the Activation of the Five Different Gα<sub>i/o</sub> Subunits D<sub>2S</sub>R and β-Arrestin Recruitment, Determined by BRET or the PathHunter Assay</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="16" align="center" char="±">D<sub>2S</sub>R activation<a class="ref internalNav" href="#t4fn1" aria-label="a">a</a></th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="14" align="center" char="±">BRET</th><th class="rowsep1 colsep0" colspan="2" align="center">PathHunter</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="2" align="center" char="±">Gα<sub>i1</sub></th><th class="rowsep1 colsep0" colspan="2" align="center" char="±">Gα<sub>i2</sub></th><th class="rowsep1 colsep0" colspan="2" align="center" char="±">Gα<sub>i3</sub></th><th class="rowsep1 colsep0" colspan="2" align="center" char="±">Gα<sub>oA</sub></th><th class="rowsep1 colsep0" colspan="2" align="center" char="±">Gα<sub>oB</sub></th><th class="rowsep1 colsep0" colspan="2" align="center">β-arr1</th><th class="rowsep1 colsep0" colspan="2" align="center">β-arr2</th><th class="rowsep1 colsep0" colspan="2" align="center">β-arr2</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center" char="±">EC<sub>50</sub><a class="ref internalNav" href="#t4fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center" char="±"><i>E</i><sub>max</sub><a class="ref internalNav" href="#t4fn3" aria-label="c">c</a></th><th class="colsep0 rowsep0" align="center" char="±">EC<sub>50</sub><a class="ref internalNav" href="#t4fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center" char="±"><i>E</i><sub>max</sub><a class="ref internalNav" href="#t4fn3" aria-label="c">c</a></th><th class="colsep0 rowsep0" align="center" char="±">EC<sub>50</sub><a class="ref internalNav" href="#t4fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center" char="±"><i>E</i><sub>max</sub><a class="ref internalNav" href="#t4fn3" aria-label="c">c</a></th><th class="colsep0 rowsep0" align="center" char="±">EC<sub>50</sub><a class="ref internalNav" href="#t4fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center" char="±"><i>E</i><sub>max</sub><a class="ref internalNav" href="#t4fn3" aria-label="c">c</a></th><th class="colsep0 rowsep0" align="center" char="±">EC<sub>50</sub><a class="ref internalNav" href="#t4fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center" char="±"><i>E</i><sub>max</sub><a class="ref internalNav" href="#t4fn3" aria-label="c">c</a></th><th class="colsep0 rowsep0" align="center">EC<sub>50</sub><a class="ref internalNav" href="#t4fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center"><i>E</i><sub>max</sub><a class="ref internalNav" href="#t4fn3" aria-label="c">c</a></th><th class="colsep0 rowsep0" align="center">EC<sub>50</sub><a class="ref internalNav" href="#t4fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center"><i>E</i><sub>max</sub><a class="ref internalNav" href="#t4fn3" aria-label="c">c</a></th><th class="colsep0 rowsep0" align="center">EC<sub>50</sub><a class="ref internalNav" href="#t4fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center"><i>E</i><sub>max</sub><a class="ref internalNav" href="#t4fn3" aria-label="c">c</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">quinpirole</td><td class="colsep0 rowsep0" align="char" char="±">3.0 ± 0.5</td><td class="colsep0 rowsep0" align="char" char="±">100 ± 1</td><td class="colsep0 rowsep0" align="char" char="±">5.1 ± 1.3</td><td class="colsep0 rowsep0" align="char" char="±">100 ± 1</td><td class="colsep0 rowsep0" align="char" char="±">5.9 ± 0.7</td><td class="colsep0 rowsep0" align="char" char="±">100 ± 1</td><td class="colsep0 rowsep0" align="char" char="±">1.2 ± 0.10</td><td class="colsep0 rowsep0" align="char" char="±">100 ± 1</td><td class="colsep0 rowsep0" align="char" char="±">1.2 ± 0.1</td><td class="colsep0 rowsep0" align="char" char="±">100 ± 1</td><td class="colsep0 rowsep0" align="left">295 ± 100</td><td class="colsep0 rowsep0" align="left">100 ± 1</td><td class="colsep0 rowsep0" align="left">151 ± 10</td><td class="colsep0 rowsep0" align="left">100 ± 1</td><td class="colsep0 rowsep0" align="left">64 ± 8</td><td class="colsep0 rowsep0" align="left">100 ± 1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">dopamine</td><td class="colsep0 rowsep0" align="char" char="±">2.8 ± 0.6</td><td class="colsep0 rowsep0" align="char" char="±">100 ± 6</td><td class="colsep0 rowsep0" align="char" char="±">3.9 ± 0.6</td><td class="colsep0 rowsep0" align="char" char="±">102 ± 3</td><td class="colsep0 rowsep0" align="char" char="±">4.5 ± 0.2</td><td class="colsep0 rowsep0" align="char" char="±">95 ± 3</td><td class="colsep0 rowsep0" align="char" char="±">0.67 ± 0.17</td><td class="colsep0 rowsep0" align="char" char="±">92 ± 3</td><td class="colsep0 rowsep0" align="char" char="±">0.78 ± 0.15</td><td class="colsep0 rowsep0" align="char" char="±">87 ± 5</td><td class="colsep0 rowsep0" align="left">226 ± 53</td><td class="colsep0 rowsep0" align="left">115 ± 7</td><td class="colsep0 rowsep0" align="left">163 ± 35</td><td class="colsep0 rowsep0" align="left">113 ± 5</td><td class="colsep0 rowsep0" align="left">156 ± 36</td><td class="colsep0 rowsep0" align="left">92 ± 4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1a</b></td><td class="colsep0 rowsep0" align="char" char="±">14.9 ± 7.8</td><td class="colsep0 rowsep0" align="char" char="±">70 ± 2</td><td class="colsep0 rowsep0" align="char" char="±">19.4 ± 9.7</td><td class="colsep0 rowsep0" align="char" char="±">71 ± 2</td><td class="colsep0 rowsep0" align="char" char="±">17.5 ± 7.5</td><td class="colsep0 rowsep0" align="char" char="±">62 ± 1</td><td class="colsep0 rowsep0" align="char" char="±">8.7 ± 4.2</td><td class="colsep0 rowsep0" align="char" char="±">81 ± 6</td><td class="colsep0 rowsep0" align="char" char="±">4.8 ± 1.9</td><td class="colsep0 rowsep0" align="char" char="±">82 ± 5</td><td class="colsep0 rowsep0" align="left">n.d.<a class="ref internalNav" href="#t4fn4" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="left"><15</td><td class="colsep0 rowsep0" align="left">n.d.<a class="ref internalNav" href="#t4fn4" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="left"><10</td><td class="colsep0 rowsep0" align="left">n.d.<a class="ref internalNav" href="#t4fn4" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="left"><10</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12a</b></td><td class="colsep0 rowsep0" align="char" char="±">2.1 ± 0.2</td><td class="colsep0 rowsep0" align="char" char="±">53 ± 5</td><td class="colsep0 rowsep0" align="char" char="±">4.4 ± 0.5</td><td class="colsep0 rowsep0" align="char" char="±">47 ± 6</td><td class="colsep0 rowsep0" align="char" char="±">5.0 ± 0.2</td><td class="colsep0 rowsep0" align="char" char="±">39 ± 5</td><td class="colsep0 rowsep0" align="char" char="±">1.5 ± 0.10</td><td class="colsep0 rowsep0" align="char" char="±">81 ± 2</td><td class="colsep0 rowsep0" align="char" char="±">1.9 ± 0.2</td><td class="colsep0 rowsep0" align="char" char="±">81 ± 3</td><td class="colsep0 rowsep0" align="left">n.d.<a class="ref internalNav" href="#t4fn4" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="left"><10</td><td class="colsep0 rowsep0" align="left">n.d.<a class="ref internalNav" href="#t4fn4" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="left"><10</td><td class="colsep0 rowsep0" align="left">n.d.<a class="ref internalNav" href="#t4fn4" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="left"><10</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">(<i>S</i>)-<b>13a</b></td><td class="colsep0 rowsep0" align="char" char="±">0.30 ± 0.02</td><td class="colsep0 rowsep0" align="char" char="±">95 ± 1</td><td class="colsep0 rowsep0" align="char" char="±">0.61 ± 0.05</td><td class="colsep0 rowsep0" align="char" char="±">102 ± 1</td><td class="colsep0 rowsep0" align="char" char="±">0.81 ± 0.05</td><td class="colsep0 rowsep0" align="char" char="±">102 ± 2</td><td class="colsep0 rowsep0" align="char" char="±">0.13 ± 0.01</td><td class="colsep0 rowsep0" align="char" char="±">98 ± 1</td><td class="colsep0 rowsep0" align="char" char="±">0.11 ± 0.01</td><td class="colsep0 rowsep0" align="char" char="±">99 ± 2</td><td class="colsep0 rowsep0" align="left">13.7 ± 2.8</td><td class="colsep0 rowsep0" align="left">95 ± 2</td><td class="colsep0 rowsep0" align="left">15.9 ± 1.3</td><td class="colsep0 rowsep0" align="left">100 ± 4</td><td class="colsep0 rowsep0" align="left">3.0 ± 0.4</td><td class="colsep0 rowsep0" align="left">93 ± 5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">(<i>R</i>)-<b>13a</b></td><td class="colsep0 rowsep0" align="char" char="±">5.5 ± 0.2</td><td class="colsep0 rowsep0" align="char" char="±">93 ± 1</td><td class="colsep0 rowsep0" align="char" char="±">8.7 ± 0.8</td><td class="colsep0 rowsep0" align="char" char="±">93 ± 2</td><td class="colsep0 rowsep0" align="char" char="±">9.6 ± 0.7</td><td class="colsep0 rowsep0" align="char" char="±">83 ± 2</td><td class="colsep0 rowsep0" align="char" char="±">1.7 ± 0.4</td><td class="colsep0 rowsep0" align="char" char="±">98 ± 3</td><td class="colsep0 rowsep0" align="char" char="±">2.2 ± 0.4</td><td class="colsep0 rowsep0" align="char" char="±">100 ± 2</td><td class="colsep0 rowsep0" align="left">98 ± 40</td><td class="colsep0 rowsep0" align="left">31 ± 4</td><td class="colsep0 rowsep0" align="left">61 ± 20</td><td class="colsep0 rowsep0" align="left">26 ± 1</td><td class="colsep0 rowsep0" align="left">218 ± 33</td><td class="colsep0 rowsep0" align="left">51 ± 3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">(<i>S</i>)-<b>13b</b></td><td class="colsep0 rowsep0" align="char" char="±">0.30 ± 0.01</td><td class="colsep0 rowsep0" align="char" char="±">97 ± 1</td><td class="colsep0 rowsep0" align="char" char="±">0.65 ± 0.03</td><td class="colsep0 rowsep0" align="char" char="±">103 ± 3</td><td class="colsep0 rowsep0" align="char" char="±">0.80 ± 0.18</td><td class="colsep0 rowsep0" align="char" char="±">101 ± 1</td><td class="colsep0 rowsep0" align="char" char="±">0.12 ± 0.01</td><td class="colsep0 rowsep0" align="char" char="±">99 ± 1</td><td class="colsep0 rowsep0" align="char" char="±">0.12 ± 0.01</td><td class="colsep0 rowsep0" align="char" char="±">102 ± 1</td><td class="colsep0 rowsep0" align="left">14.5 ± 3.0</td><td class="colsep0 rowsep0" align="left">100 ± 4</td><td class="colsep0 rowsep0" align="left">10.5 ± 1.0</td><td class="colsep0 rowsep0" align="left">99 ± 5</td><td class="colsep0 rowsep0" align="left">1.3 ± 0.1</td><td class="colsep0 rowsep0" align="left">97 ± 5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">(<i>R</i>)-<b>13b</b></td><td class="colsep0 rowsep0" align="char" char="±">5.2 ± 0.7</td><td class="colsep0 rowsep0" align="char" char="±">101 ± 3</td><td class="colsep0 rowsep0" align="char" char="±">8.4 ± 0.8</td><td class="colsep0 rowsep0" align="char" char="±">96 ± 1</td><td class="colsep0 rowsep0" align="char" char="±">9.8 ± 1.2</td><td class="colsep0 rowsep0" align="char" char="±">88 ± 2</td><td class="colsep0 rowsep0" align="char" char="±">1.5 ± 0.3</td><td class="colsep0 rowsep0" align="char" char="±">95 ± 1</td><td class="colsep0 rowsep0" align="char" char="±">1.7 ± 0.1</td><td class="colsep0 rowsep0" align="char" char="±">100 ± 2</td><td class="colsep0 rowsep0" align="left">48 ± 3.0</td><td class="colsep0 rowsep0" align="left">31 ± 4</td><td class="colsep0 rowsep0" align="left">54 ± 22</td><td class="colsep0 rowsep0" align="left">27 ± 3</td><td class="colsep0 rowsep0" align="left">161 ± 22</td><td class="colsep0 rowsep0" align="left">49 ± 3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>14a</b></td><td class="colsep0 rowsep0" align="char" char="±">4.2 ± 0.2</td><td class="colsep0 rowsep0" align="char" char="±">61 ± 1</td><td class="colsep0 rowsep0" align="char" char="±">7.7 ± 1.2</td><td class="colsep0 rowsep0" align="char" char="±">54 ± 3</td><td class="colsep0 rowsep0" align="char" char="±">10.1 ± 0.78</td><td class="colsep0 rowsep0" align="char" char="±">47 ± 3</td><td class="colsep0 rowsep0" align="char" char="±">2.6 ± 0.6</td><td class="colsep0 rowsep0" align="char" char="±">84 ± 1</td><td class="colsep0 rowsep0" align="char" char="±">2.6 ± 0.2</td><td class="colsep0 rowsep0" align="char" char="±">82 ± 2</td><td class="colsep0 rowsep0" align="left">n.d.<a class="ref internalNav" href="#t4fn4" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="left"><10</td><td class="colsep0 rowsep0" align="left">n.d.<a class="ref internalNav" href="#t4fn4" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="left"><10</td><td class="colsep0 rowsep0" align="left">n.d.<a class="ref internalNav" href="#t4fn4" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="left"><10</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">(<i>S</i>)-<b>15a</b></td><td class="colsep0 rowsep0" align="char" char="±">0.31 ± 0.04</td><td class="colsep0 rowsep0" align="char" char="±">97 ± 1</td><td class="colsep0 rowsep0" align="char" char="±">0.54 ± 0.18</td><td class="colsep0 rowsep0" align="char" char="±">100 ± 1</td><td class="colsep0 rowsep0" align="char" char="±">0.72 ± 0.12</td><td class="colsep0 rowsep0" align="char" char="±">99 ± 1</td><td class="colsep0 rowsep0" align="char" char="±">0.13 ± 0.02</td><td class="colsep0 rowsep0" align="char" char="±">99 ± 1</td><td class="colsep0 rowsep0" align="char" char="±">0.12 ± 0.02</td><td class="colsep0 rowsep0" align="char" char="±">100 ± 1</td><td class="colsep0 rowsep0" align="left">17.7 ± 5.5</td><td class="colsep0 rowsep0" align="left">95 ± 6</td><td class="colsep0 rowsep0" align="left">13.4 ± 1.2</td><td class="colsep0 rowsep0" align="left">96 ± 2</td><td class="colsep0 rowsep0" align="left">3.0 ± 0.9</td><td class="colsep0 rowsep0" align="left">97 ± 4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">(<i>S</i>)-<b>15b</b></td><td class="colsep0 rowsep0" align="char" char="±">0.39 ± 0.05</td><td class="colsep0 rowsep0" align="char" char="±">103 ± 1</td><td class="colsep0 rowsep0" align="char" char="±">0.71 ± 0.12</td><td class="colsep0 rowsep0" align="char" char="±">106 ± 1</td><td class="colsep0 rowsep0" align="char" char="±">0.74 ± 0.02</td><td class="colsep0 rowsep0" align="char" char="±">102 ± 2</td><td class="colsep0 rowsep0" align="char" char="±">0.11 ± 0.01</td><td class="colsep0 rowsep0" align="char" char="±">99 ± 1</td><td class="colsep0 rowsep0" align="char" char="±">0.11 ± 0.01</td><td class="colsep0 rowsep0" align="char" char="±">100 ± 1</td><td class="colsep0 rowsep0" align="left">12.5 ± 1.6</td><td class="colsep0 rowsep0" align="left">99 ± 3</td><td class="colsep0 rowsep0" align="left">12.4 ± 1.5</td><td class="colsep0 rowsep0" align="left">91 ± 6</td><td class="colsep0 rowsep0" align="left">2.9 ± 0.8</td><td class="colsep0 rowsep0" align="left">96 ± 4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>16a</b></td><td class="colsep0 rowsep0" align="char" char="±">6.8 ± 0.7</td><td class="colsep0 rowsep0" align="char" char="±">59 ± 5</td><td class="colsep0 rowsep0" align="char" char="±">10.7 ± 0.3</td><td class="colsep0 rowsep0" align="char" char="±">53 ± 5</td><td class="colsep0 rowsep0" align="char" char="±">13.1 ± 2.8</td><td class="colsep0 rowsep0" align="char" char="±">45 ± 4</td><td class="colsep0 rowsep0" align="char" char="±">2.9 ± 0.8</td><td class="colsep0 rowsep0" align="char" char="±">82 ± 2</td><td class="colsep0 rowsep0" align="char" char="±">4.3 ± 0.4</td><td class="colsep0 rowsep0" align="char" char="±">86 ± 2</td><td class="colsep0 rowsep0" align="left">n.d.<a class="ref internalNav" href="#t4fn4" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="left"><10</td><td class="colsep0 rowsep0" align="left">n.d.<a class="ref internalNav" href="#t4fn4" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="left"><10</td><td class="colsep0 rowsep0" align="left">n.d.<a class="ref internalNav" href="#t4fn4" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="left"><10</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>16b</b></td><td class="colsep0 rowsep0" align="char" char="±">3.7 ± 0.9</td><td class="colsep0 rowsep0" align="char" char="±">59 ± 6</td><td class="colsep0 rowsep0" align="char" char="±">5.7 ± 0.2</td><td class="colsep0 rowsep0" align="char" char="±">56 ± 8</td><td class="colsep0 rowsep0" align="char" char="±">5.7 ± 0.8</td><td class="colsep0 rowsep0" align="char" char="±">43 ± 5</td><td class="colsep0 rowsep0" align="char" char="±">1.8 ± 0.4</td><td class="colsep0 rowsep0" align="char" char="±">86 ± 1</td><td class="colsep0 rowsep0" align="char" char="±">2.1 ± 0.2</td><td class="colsep0 rowsep0" align="char" char="±">84 ± 1</td><td class="colsep0 rowsep0" align="left">n.d.<a class="ref internalNav" href="#t4fn4" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="left"><10</td><td class="colsep0 rowsep0" align="left">n.d.<a class="ref internalNav" href="#t4fn4" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="left"><10</td><td class="colsep0 rowsep0" align="left">n.d.<a class="ref internalNav" href="#t4fn4" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="left"><10</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>16c</b></td><td class="colsep0 rowsep0" align="char" char="±">5.0 ± 2.2</td><td class="colsep0 rowsep0" align="char" char="±">62 ± 3</td><td class="colsep0 rowsep0" align="char" char="±">5.8 ± 2.2</td><td class="colsep0 rowsep0" align="char" char="±">59 ± 2</td><td class="colsep0 rowsep0" align="char" char="±">6.2 ± 2.4</td><td class="colsep0 rowsep0" align="char" char="±">50 ± 2</td><td class="colsep0 rowsep0" align="char" char="±">2.5 ± 0.7</td><td class="colsep0 rowsep0" align="char" char="±">77 ± 5</td><td class="colsep0 rowsep0" align="char" char="±">2.0 ± 0.7</td><td class="colsep0 rowsep0" align="char" char="±">82 ± 4</td><td class="colsep0 rowsep0" align="left">n.d.<a class="ref internalNav" href="#t4fn4" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="left"><15</td><td class="colsep0 rowsep0" align="left">n.d.<a class="ref internalNav" href="#t4fn4" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="left"><10</td><td class="colsep0 rowsep0" align="left">n.d.<a class="ref internalNav" href="#t4fn4" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="left"><10</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">(<i>S</i>)-<b>17a</b></td><td class="colsep0 rowsep0" align="char" char="±">0.39 ± 0.09</td><td class="colsep0 rowsep0" align="char" char="±">99 ± 4</td><td class="colsep0 rowsep0" align="char" char="±">0.60 ± 0.02</td><td class="colsep0 rowsep0" align="char" char="±">103 ± 3</td><td class="colsep0 rowsep0" align="char" char="±">0.94 ± 0.12</td><td class="colsep0 rowsep0" align="char" char="±">99 ± 2</td><td class="colsep0 rowsep0" align="char" char="±">0.19 ± 0.02</td><td class="colsep0 rowsep0" align="char" char="±">99 ± 1</td><td class="colsep0 rowsep0" align="char" char="±">0.16 ± 0.01</td><td class="colsep0 rowsep0" align="char" char="±">103 ± 1</td><td class="colsep0 rowsep0" align="left">13.1 ± 1.3</td><td class="colsep0 rowsep0" align="left">92 ± 6</td><td class="colsep0 rowsep0" align="left">12.1 ± 1.3</td><td class="colsep0 rowsep0" align="left">96 ± 5</td><td class="colsep0 rowsep0" align="left">1.5 ± 0.2</td><td class="colsep0 rowsep0" align="left">99 ± 4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">(<i>S</i>)-<b>17b</b></td><td class="colsep0 rowsep0" align="char" char="±">0.49 ± 0.08</td><td class="colsep0 rowsep0" align="char" char="±">99 ± 1</td><td class="colsep0 rowsep0" align="char" char="±">0.67 ± 0.08</td><td class="colsep0 rowsep0" align="char" char="±">101 ± 1</td><td class="colsep0 rowsep0" align="char" char="±">0.96 ± 0.14</td><td class="colsep0 rowsep0" align="char" char="±">98 ± 1</td><td class="colsep0 rowsep0" align="char" char="±">0.21 ± 0.04</td><td class="colsep0 rowsep0" align="char" char="±">101 ± 2</td><td class="colsep0 rowsep0" align="char" char="±">0.17 ± 0.03</td><td class="colsep0 rowsep0" align="char" char="±">101 ± 1</td><td class="colsep0 rowsep0" align="left">11.9 ± 1.6</td><td class="colsep0 rowsep0" align="left">83 ± 2</td><td class="colsep0 rowsep0" align="left">13.2 ± 2.2</td><td class="colsep0 rowsep0" align="left">92 ± 2</td><td class="colsep0 rowsep0" align="left">1.7 ± 0.4</td><td class="colsep0 rowsep0" align="left">105 ± 6</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup>a</sup><p class="last">Data represent mean ± SEM from three to six independent experiments, each performed in duplicates.</p></div><div class="footnote" id="t4fn2"><sup>b</sup><p class="last">EC<sub>50</sub> given in nanomolar.</p></div><div class="footnote" id="t4fn3"><sup>c</sup><p class="last"><i>E</i><sub>max</sub> relative to the effect of vehicle (0%) and the saturating effect of quinpirole (100%).</p></div><div class="footnote" id="t4fn4"><sup>d</sup><p class="last">Not determined.</p></div></div></div></div><div id="sec2_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> Recruitment of β-Arrestins</h3><div class="NLM_p">In addition to the investigations of canonical G protein signaling, we determined the ligands’ ability to induce β-arrestin-2 recruitment upon binding to D<sub>2S</sub>R, employing the PathHunter assay, as previously described.<a onclick="showRef(event, 'ref10 ref23'); return false;" href="javascript:void(0);" class="ref ref10 ref23">(10, 23)</a> Experiments unambiguously showed the impact of the orthosteric headgroup on the intrinsic activity (<a class="ref internalNav" href="#tbl4" aria-label="Table 4">Table 4</a> and <a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>, panels e and f). Similar to the reference antipsychotic <b>1a</b>, the investigated 2-methoxyphenylpiperazines displayed antagonist, or at most weak partial agonist properties with a maximum effect less than 10% of the reference agonist quinpirole at D<sub>2S</sub>R (<a class="ref internalNav" href="#tbl4" aria-label="Table 4">Table 4</a> and <a class="ref internalNav" href="#notes-1" aria-label="Supplementary Figure 2b">Supplementary Figure 2b</a>). In contrast, all compounds sharing a (<i>S</i>)-5-hydroxy-2-aminotetraline headgroup were found to be potent agonists. Observed maximum effects (<i>E</i><sub>max</sub> = 93–105%) were comparable to the reference agonist quinpirole or dopamine, and in agreement with their superior binding affinities and potencies to activate G proteins, ligands (<i>S</i>)-<b>13a</b>,<b>b</b>, (<i>S</i>)-<b>15a</b>,<b>b</b>, and (<i>S</i>)-<b>17a</b>,<b>b</b> were found to be up to 120-fold more potent (EC<sub>50</sub> 1.3–3.0 nM) than the endogenous agonist. Similar to the above-described results, addition of functional groups to the pyrazolo[1,5-<i>a</i>]pyridine appendage did not significantly influence β-arrestin-2 recruitment for ligands with an 5-hydroxy-2-aminotetraline headgroup. Importantly, inversion of the stereogenic center into its (<i>R</i>)-configuration converted the potent agonists into partial agonists with only moderate potencies (<i>E</i><sub>max</sub> = 49–51%, EC<sub>50</sub> = 161–218 nM). Since the same compounds were found to fully activate the panel of Gα<sub>i/o</sub> proteins, the inversion of the stereogenic center converted the two balanced agonists (<i>S</i>)-<b>13a</b>,<b>b</b> into G-protein-biased ligands ((<i>R</i>)-<b>13a</b>,<b>b</b>). The apparent preference for G protein mediated-signaling of (<i>R</i>)-<b>13a,b</b> was further confirmed by a quantitative analysis of ligand bias using the operational model of agonism.<a onclick="showRef(event, 'ref43 ref44 ref45'); return false;" href="javascript:void(0);" class="ref ref43 ref44 ref45">(43-45)</a> As representative pathways, we selected the activation of Gα<sub>oA</sub> as G protein readout and compared it to the recruitment of β-arrestin-2 determined in the PathHunter assay. While (<i>S</i>)-<b>13a/b</b> showed only small differences from the reference ligand quinpirole with a slight preference for the arrestin signaling (ΔΔlog(τ/<i>K</i><sub>A</sub>) = −0.25 and −0.46, <a class="ref internalNav" href="#notes-1" aria-label="Supplementary Table 2">Supplementary Table 2</a>), the respective (<i>R</i>)-enantiomers displayed an almost 10-fold preference for the canonical signaling pathway (ΔΔlog(τ/<i>K</i><sub>A</sub>) = 0.96 and 0.88, bias factors 9.09 and 7.65 for (<i>R</i>)-<b>13a</b> and (<i>R</i>)-<b>13b</b>, respectively). Interestingly, the quantification also revealed a preferential activation of β-arrestin-2, signaling the oxime-substituted analogs (<i>S</i>)-<b>17a,b</b> (ΔΔlog(τ/<i>K</i><sub>A</sub>) = −0.65 and −0.58), which was statistically significant but not obvious from the visual analysis. Since the operational model is not feasible for the analysis of very weak partial agonists or antagonists,<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a> ligand bias between Gα<sub>oA</sub> activation and β-arrestin-2 recruitment could not be quantified for the family of 1,4-DAPs.</div><div class="NLM_p last">Considering the importance of cell background, kinetics, and experimental conditions in the context of putative ligand bias,<a onclick="showRef(event, 'ref38 ref47'); return false;" href="javascript:void(0);" class="ref ref38 ref47">(38, 47)</a> we intended to complement our β-arrestin recruitment studies by an orthogonal BRET assay. Thus, we employed a recently described approach, which is based on enhanced bystander BRET between RLucII-β-arrestin-1 or β-arrestin-2 and the CAAX-motif of KRas C-terminally fused to <i>Renilla reniformis</i> green fluorescent protein (rGFP).<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a> This system allowed one to asses G protein activation and β-arrestin recruitment on the same time scale (within minutes) and in the same cell background (HEK293). We also coexpressed G protein-coupled receptor kinase 2 (GRK2), as it has been shown to enhance ligand-induced β-arrestin recruitment, especially for D<sub>2</sub>R partial agonists.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> Using this setup, highly similar results were obtained for pyrazolo[1,5-<i>a</i>]pyridine-derived test compounds. Indeed, the propensity to induce β-arrestin recruitment at D<sub>2S</sub>R (<a class="ref internalNav" href="#tbl4" aria-label="Table 4">Table 4</a>) or D<sub>2L</sub>R (<a class="ref internalNav" href="#notes-1" aria-label="Supplementary Table 1">Supplementary Table 1</a>) was confirmed to depend on the orthosteric headgroup. While (<i>S</i>)-aminotetralines acted as full agonists (<i>E</i><sub>max</sub> = 83–100%, EC<sub>50</sub> = 10.5–17.7 nM), their (<i>R</i>)-enantiomers showed moderate partial agonist characteristics (<i>E</i><sub>max</sub> = 26–31% and EC<sub>50</sub> = 48–98 nM) for the two β-arrestin isoforms. Again no significant β-arrestin recruitment was observed for ligands containing a 2-methoxyphenylpiperazine pharmacophore. These antagonist properties were further confirmed by inhibition experiments with both, the PathHunter and BRET-based assays, when the ligands were able to inhibit the effect of 0.1 or 1 μM quinpirole, respectively (<a class="ref internalNav" href="#notes-1" aria-label="Supplementary Figure 6, panels a–d">Supplementary Figure 6, panels a–d</a>).</div></div><div id="sec2_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> Activation of Inwardly Rectifying Potassium Channels</h3><div class="NLM_p">In addition to the measurements of nucleotide exchange or resonance energy transfer at the G protein level, we examined the intrinsic activity of representative partial agonists further downstream at the level of G protein-coupled, inwardly rectifying potassium (GIRK) channels. GIRK-mediated signaling is involved in a number of important physiological processes, including nociception, reward-related behavior, cognition, mood, and the regulation of the heart rate.<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a> GIRK activation increases outward K<sup>+</sup>-currents, leads to cellular hyperpolarization,<a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a> and is therefore known as key inhibitory mediator for the control of electrical excitability.<a onclick="showRef(event, 'ref51'); return false;" href="javascript:void(0);" class="ref ref51">(51)</a> Recently, a genome-wide association study revealed a link between the <i>KCNJ3</i>, the gene encoding GIRK1, and the susceptibility for schizophrenia and bipolar disorders in Asian populations.<a onclick="showRef(event, 'ref52 ref53'); return false;" href="javascript:void(0);" class="ref ref52 ref53">(52, 53)</a> Furthermore, it has been demonstrated that lithium exerts its efficacy in bipolar disorders by a dual regulation of GIRKs.<a onclick="showRef(event, 'ref54'); return false;" href="javascript:void(0);" class="ref ref54">(54)</a> Both, D<sub>2</sub>R and D<sub>3</sub>R have been shown to couple to GIRK channels in vitro.<a onclick="showRef(event, 'ref55 ref56'); return false;" href="javascript:void(0);" class="ref ref55 ref56">(55, 56)</a> Interestingly, typical antipsychotics including haloperidol act as antagonists or even inverse agonists for D<sub>2</sub>R mediated GIRK activation, while newer generation antipsychotics including <b>1a</b> have been described as antagonists or partial agonists.<a onclick="showRef(event, 'ref57 ref58'); return false;" href="javascript:void(0);" class="ref ref57 ref58">(57, 58)</a> To compare the properties of the high affinity, high potency pyrazolo[1,5-<i>a</i>]pyridine <b>16c</b> with the marketed drug <b>1a</b> and the endogenous agonist dopamine, we performed voltage clamp experiments in analogy to a previously described procedure.<a onclick="showRef(event, 'ref59'); return false;" href="javascript:void(0);" class="ref ref59">(59)</a> When HEK293T cells expressing either D<sub>2L</sub>R or D<sub>3</sub>R together with GIRK1/2, the predominant GIRK heteromer in the CNS,<a onclick="showRef(event, 'ref60'); return false;" href="javascript:void(0);" class="ref ref60">(60)</a> were stimulated with the endogenous agonist dopamine, robust K<sup>+</sup>-currents were observed (<a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>a). Current–voltage diagrams revealed typical inwardly rectifying profiles (<a class="ref internalNav" href="#notes-1" aria-label="Supplementary Figure 7, panels a and b">Supplementary Figure 7, panels a and b</a>) and currents were efficiently blocked by application of Ba<sup>2+</sup> or the D<sub>2</sub>R/D<sub>3</sub>R-antagonist haloperidol (<a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>a, <a class="ref internalNav" href="#notes-1" aria-label="Supplementary Figure 7, panels c and d">Supplementary Figure 7, panels c and d</a>). Currents were evoked in a Gα<sub>i/o</sub>-specific manner, as overnight incubation with pertussis toxin completely abolished the dopamine-mediated effects (<a class="ref internalNav" href="#notes-1" aria-label="Supplementary Figure 7, panels e and f">Supplementary Figure 7, panels e and f</a>). Although not to the same extent as dopamine, phenylpiperazines <b>1a</b> and <b>16c</b> stimulated GIRK1/2 activation when they were applied at a concentration of 1 μM to cells expressing D<sub>2L</sub>R and GIRK1/2. Again, the effect was inhibited by application of the pore blocker Ba<sup>2+</sup>. At lower concentration (0.1 μM) only <b>16c</b> but not <b>1a</b> induced a significant effect (<a class="ref internalNav" href="#notes-1" aria-label="Supplementary Figure 7g">Supplementary Figure 7g</a>) pointing toward a higher potency of the pyrazolo[1,5-<i>a</i>]pyridine.</div><figure id="fig4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01857/20170407/images/medium/jm-2016-01857v_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01857/20170407/images/large/jm-2016-01857v_0004.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Ligand-induced activation of GIRK1/2 channels. When HEK293T cells expressing D<sub>2L</sub>R and GIRK1/2 cells were stimulated with (a) 10 μM dopamine, (b) 1 μM <b>1a</b>, or (c) 1 μM <b>16c</b>, a robust K<sup>+</sup> current is induced at the holding potential of −70 mV in high K<sup>+</sup> external solution. Currents are completely inhibited by subsequent addition of a 2 mM BaCl<sub>2</sub> into the bath solution. (d) Quantification of D<sub>2L</sub>R activation from ramp currents shows a partial response is elicited by <b>1a</b> and <b>16c</b> compared to the endogenous agonist dopamine. (e) In HEK293T cells expressing D<sub>3</sub>R and GIRK1/2, only dopamine, but not 1 μM solutions of <b>1a</b> or <b>16c</b>, evoke a significant K<sup>+</sup> current. Data represent mean ± SEM from 9 to 30 individual cells, VEH = vehicle, **<i>p</i> < 0.01, ***<i>p</i> < 0.001, one-way ANOVA.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01857/20170407/images/large/jm-2016-01857v_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01857&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">In the absence of receptors, neither dopamine nor <b>1a</b> or <b>16c</b> elicited an increase in K<sup>+</sup>-currents (<a class="ref internalNav" href="#notes-1" aria-label="Supplementary Figure 7h">Supplementary Figure 7h</a>). In cells expressing the D<sub>3</sub>R, no effect was observed for the partial agonists (<a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>e), indicating a different capacity of the ligands to stimulate GIRK1/2 by means of D<sub>2L</sub>R or D<sub>3</sub>R. Moreover, differences in GIRK1/2 activation may reflect the distinctions observed in signaling signatures for D<sub>2L</sub>R and D<sub>3</sub>R observed by BRET. While D<sub>2L</sub>R is capable of equally engaging Gα<sub>i</sub> and Gα<sub>o</sub>, D<sub>3</sub>R shows a strong preference for the Gα<sub>o</sub> subtypes and only minor coupling to Gα<sub>i1–3</sub> (<a class="ref internalNav" href="#notes-1" aria-label="Supplementary Figure 4">Supplementary Figure 4</a>).</div></div><div id="sec2_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> In Vivo Antipsychotic Activity</h3><div class="NLM_p">In order to examine if G protein-biased D<sub>2</sub>R/D<sub>3</sub>R partial agonists comprising a pyrazolo[1,5-<i>a</i>]pyridine appendage possess antipsychotic activity in vivo, we investigated the representative test compound <b>16c</b> in comparison to <b>1a</b>, regarding their effects on schizophrenia-related behaviors in rats. As readouts, we examined locomotion and anxiety, which have been used extensively in animal models of schizophrenia.<a onclick="showRef(event, 'ref61 ref62 ref63'); return false;" href="javascript:void(0);" class="ref ref61 ref62 ref63">(61-63)</a> Additionally, we investigated light-induced activity (LIA), a nonaversively motivated sensorimotor processing measure,<a onclick="showRef(event, 'ref64 ref65'); return false;" href="javascript:void(0);" class="ref ref64 ref65">(64, 65)</a> to assess the intactness of the sensorimotor gating system.<a onclick="showRef(event, 'ref64 ref66'); return false;" href="javascript:void(0);" class="ref ref64 ref66">(64, 66)</a> In order to induce schizophrenia-like alterations in animals, we used an amphetamine (AMPH)-sensitization regimen that has been developed by Peleg-Raibstein et al. and shown to effectively induce these disruptions.<a onclick="showRef(event, 'ref62'); return false;" href="javascript:void(0);" class="ref ref62">(62)</a> Thus, after a six-day sensitization with escalating doses of AMPH, antipsychotic <b>1a,</b> test compound <b>16c</b> (both at a dose of 1.5 mg/kg/day), or vehicle were continuously administered via an osmotic Alzet mini pump over the course of 7 days. LIA was measured on day five after mini pump implantation, and behavioral testing in the open field (OF) environment was performed on treatment day seven before (baseline) and after an acute AMPH (1.5 mg/kg) challenge. Preplanned comparisons revealed a decrement in the baseline locomotor activity in all treatment groups relative to the SAL/VEH control group (<a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a>, panels a and b and <a class="ref internalNav" href="#notes-1" aria-label="Supplementary Results">Supplementary Results</a>). Compared to this baseline activity, we found increased horizontal and vertical (rearing) locomotor responses to the low dose amphetamine-challenge in AMPH-sensitized animals, which has been frequently reported (for a review, see ref <a onclick="showRef(event, 'ref67'); return false;" href="javascript:void(0);" class="ref ref67">67</a>). These elevations were reversed by continuous treatment with both <b>1a</b> and <b>16c</b>. <b>16c</b> treatment was arguably more effective than <b>1a</b> treatment in inhibiting AMPH-induced hyper-locomotor activity (<a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a>, panels d, g, e, and h). However, baseline activity was influenced by the treatments. Indeed, <b>16c</b> treatment inhibited the baseline locomotor activity as opposed to no alterations observed with <b>1a</b> (<a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a>, panels a and b). Central activity in the OF test is a useful parameter to estimate the anxiety level of animals,<a onclick="showRef(event, 'ref68'); return false;" href="javascript:void(0);" class="ref ref68">(68)</a> and several comorbid anxiety disorders have been associated with AMPH abusers<a onclick="showRef(event, 'ref69'); return false;" href="javascript:void(0);" class="ref ref69">(69)</a> and schizophrenia patients.<a onclick="showRef(event, 'ref70 ref71'); return false;" href="javascript:void(0);" class="ref ref70 ref71">(70, 71)</a> AMPH-pretreated animals showed elevated anxiety, as indicated by a decreased time spent in the center of the OF (<a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a>c). Treatment with <b>1a</b> or <b>16c</b> did not alter baseline anxiety levels. However, <b>16c</b> but not <b>1a</b>, at least partially reversed the effects of an acute amphetamine challenge (Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>, panels f and i). Finally, AMPH-sensitization caused disruptions in sensorimotor gating, which was measured by a light-induced activity test. These disruptions were partially improved by both <b>1a</b> and <b>16c</b> treatments (<a class="ref internalNav" href="#notes-1" aria-label="Supplementary Figure 8, panels a and b">Supplementary Figure 8, panels a and b</a>). The results show that <b>16c</b> treatment effectively reverses amphetamine-induced hyper-locomotor activity in rats, but unlike <b>1a</b>, <b>16c</b> treatment exacerbates the baseline locomotion-related attenuations induced by AMPH-pretreatment. Extrapyramidal deficits are common side effects of many antipsychotic drugs, including both typical and atypical ones.<a onclick="showRef(event, 'ref72 ref73'); return false;" href="javascript:void(0);" class="ref ref72 ref73">(72, 73)</a> Altogether, these results indicate that <b>16c</b> treatment can effectively improve schizophrenia-like disruptions in vivo but, as a side effect, may reduce general locomotor activity.</div><figure id="fig5" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01857/20170407/images/medium/jm-2016-01857v_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01857/20170407/images/large/jm-2016-01857v_0005.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Effects of <b>16c</b> compared to <b>1a</b> on schizophrenia-like behavior in rats. Animals received i.p. injections of amphetamine (AMPH) with a sensitization regimen or saline (SAL). Subsequently, the animals were continuously treated with <b>1a</b> (1.5 mg/kg/day), <b>16c</b> (1.5 mg/kg/day), or vehicle (VEH) for 7 days. Baseline activity: (a) baseline horizontal locomotion, (b) rearing, and (c) center duration in the open field on treatment day 7 are shown for SAL/VEH (<i>n</i> = 11), AMPH/VEH (<i>n</i> = 12), AMPH/<b>1a</b> (<i>n</i> = 12), and AMPH/<b>16c</b> (<i>n</i> = 9) groups as a 20 min total activity. AMPH-induced activity: the effects of a challenge AMPH injection (1.5 mg/kg) on (d) horizontal locomotion, (e) rearing, and (f) center duration are shown in 5 min intervals and as the area under the curve (AUC) total activity (g, h, i, respectively). AMPH-induced behaviors are calculated as Δ baseline (vs last 5 min of baseline). Values are shown as mean ± SEM, *<i>p</i> < 0.05, **<i>p</i> < 0.01, and ***<i>p</i> < 0.001 compared to SAL/VEH. #<i>p</i> < 0.05, ##<i>p</i> < 0.01, and ###<i>p</i> < 0.001 compared to AMPH/VEH.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01857/20170407/images/large/jm-2016-01857v_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01857&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i17">Discussion and Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_31163" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_31163" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The combination of 1,4-disubstituted phenylpiperazines with pyrazolo[1,5-<i>a</i>]pyridine heterocyles by an appropriate linker led to a series of ligands with subnanomolar affinity for the dopamine D<sub>2</sub>R. Intensive pharmacological investigations employing classical [<sup>35</sup>S]GTPγS binding experiments but also highly sensitive BRET biosensors revealed partial agonist properties for the activation of Gα<sub>i/o</sub> proteins at D<sub>2L</sub>R, D<sub>2S</sub>R, and D<sub>3</sub>R. Receptor subtype-selectivity as well as potencies and efficacies could be modulated by the substitution pattern and the attachment of the linker subunit to the pyrazolo[1,5-<i>a</i>]pyridine appendage. While substituents in position 2 of the heterocycle or attachment of the linker via an aminocarbonyl moiety led to relatively weak efficacies and/or potencies, oxymethylene spacers and the addition of polar functional groups to position 3 of the heterocycle were highly beneficial for the intrinsic activity of 1,4-DAP-based dopaminergics. Interestingly, the family of phenylpiperazines preferentially activated the Gα<sub>o</sub> subtypes, with both, higher efficacies and potencies when compared to Gα<sub>i</sub> activation. At the same time, the compounds bearing either a 2,3-dichloro- or 2-methoxyphenylpiperazine moiety were inhibitors of β-arrestin recruitment at D<sub>2L</sub>R and D<sub>2S</sub>R, indicating substantial G protein bias.</div><div class="NLM_p">When the substituted phenylpiperazine unit was replaced by a 5-hydroxy-<i>N</i>-propyl-2-aminotetraline group, superaffinity dopamine receptor agonists were discovered. Here, receptor affinities and potencies were only slightly influenced by substitutions at the pyrazolo[1,5-<i>a</i>]pyridine appendage but strongly dependent on the absolute configuration of the stereogenic center. Compounds in the (<i>S</i>)-configuration were found to be full agonists for the activation of all signaling pathways at D<sub>2S</sub>R, D<sub>2L</sub>R, and D<sub>3</sub>R. In contrast, (<i>R</i>)-<b>13a</b>,<b>b</b> activated G proteins to the full extent but were only partial agonists for the recruitment of β-arrestins at D<sub>2S</sub>R and D<sub>2L</sub>R. Although these ligands might not serve as antipsychotics due to their high efficacy for G protein-mediated signaling, they present an interesting starting point for further SAR for understanding the molecular determinants of functional selectivity at the D<sub>2</sub>R, since the same headgroup in combination with a different lipophilic appendage has previously been reported to disfavor G protein-mediated signaling.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a></div><div class="NLM_p">Besides the investigation of receptor activation at the level of G proteins, we examined the effects of <b>16c</b>, a representative 2-methoxyphenylpiperazine with high D<sub>2</sub>R-affinity, in comparison to the antipsychotic <b>1a</b> further downstream at the level of the GIRK channels. These K<sup>+</sup>-channels have been shown to be highly associated with D<sub>2</sub>R<a onclick="showRef(event, 'ref56'); return false;" href="javascript:void(0);" class="ref ref56">(56)</a> and are key inhibitory mediators for the control of electrical excitability.<a onclick="showRef(event, 'ref51'); return false;" href="javascript:void(0);" class="ref ref51">(51)</a> In good agreement with their partial agonist nature observed in biochemical and cell-based assays, <b>1a</b> and <b>16c</b> were able to mediate submaximal GIRK activation via D<sub>2</sub>R stimulation in electrophysiological recordings. Compared to the antipsychotic <b>1a</b>, currents elicited by <b>16c</b> were stronger and, in good agreement with the higher potencies observed in [<sup>35</sup>S]GTPγS binding and BRET assays for <b>16c</b>, occurred at lower concentrations. However, both phenylpiperazines did not lead to significant activation of GIRK by stimulation of the closely related D<sub>3</sub>R subtype. The different behavior in GIRK1/2 activation may reflect the distinct coupling properties of D<sub>2</sub>R and D<sub>3</sub>R toward the Gα<sub>i</sub> and Gα<sub>o</sub> subtypes and, hence, lead to a lower degree of overall activation of the G proteins by the partial agonists in D<sub>3</sub>R expressing cells.</div><div class="NLM_p">Motivated by the highly similar in vitro profiles of <b>1a</b> and <b>16c</b>, we investigated whether G protein-biased D<sub>2</sub>R partial agonists with pyrazolo[1,5-<i>a</i>]pyridine substructure possess antipsychotic activity in vivo and could therefore serve as potential novel therapeutics. Thus, we investigated continuously administered <b>16c</b> in comparison to <b>1a</b> for their influence on schizophrenia-like alterations in rats. Both compounds were able to reverse amphetamine-induced hyper-locomotion, which models the psychotic symptoms of the disease.<a onclick="showRef(event, 'ref74'); return false;" href="javascript:void(0);" class="ref ref74">(74)</a> Furthermore, amphetamine-pretreated animals showed elevated anxiety, which was partially reversed by <b>16c</b> but not <b>1a</b>. However, unlike <b>1a</b>, <b>16c</b> treatment exacerbates the baseline locomotion-related attenuations induced by amphetamine pretreatment. These results indicate that <b>16c</b> treatment can effectively improve schizophrenia-like disruptions in vivo but, as a side effect, may reduce general locomotor activity. Nevertheless, given the additional anxiolytic effects, in a personalized medicine approach <b>16c</b> may be a specific treatment option for schizophrenia patients with a comorbid anxiety disorder.<a onclick="showRef(event, 'ref70 ref71'); return false;" href="javascript:void(0);" class="ref ref70 ref71">(70, 71)</a> However, in our in vitro studies, <b>16c</b> and <b>1a</b> were highly similar, although <b>16c</b> displayed a higher preference for Gα<sub>o</sub> over Gα<sub>i</sub> activation at D<sub>2</sub>R. It will therefore be interesting to further investigate the signaling profiles of <b>16c</b> and <b>1a</b> in vitro and relate them to the differences in the functional responses observed in vivo.</div><div class="NLM_p last">Altogether, our study revealed 1,4-DAPs with a pyrazolo[1,5-<i>a</i>]pyridine appendage as highly potent G protein-biased partial agonists devoid of β-arrestin recruitment at D<sub>2</sub>R. Compounds with this kind of activity profile represent potential novel antipsychotics as we could demonstrate in vivo antipsychotic activity for the representative oxime <b>16c</b>. Indeed, antagonism of β-arrestin recruitment at D<sub>2</sub>R has been identified as common mechanism of clinically effective antipsychotics.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> Moreover, the pyrazolo[1,5-<i>a</i>]pyridine appendage represents a valuable tool for the fine-tuning of agonistic and functionally selective properties in conjunction with different orthosteric head groups as illustrated by the different enantiomers of the 5-hydroxy-<i>N</i>-propyl-2-aminotetralines.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i18">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_14320" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_14320" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> Chemistry</h3><div class="NLM_p">Reagents and dry solvents were of commercial grade and used as purchased. Reactions requiring anhydrous conditions were carried out under nitrogen atmosphere. MS was run on a Bruker Esquire 2000 by APC or ES ionisatzion. HR-EIMS was run on a JEOL JMS-GC mate II with a solid inlet and EI (70 eV) using Peak-Matching (M/ΔM > 5000) or at the Chair of Organic Chemistry, Friedrich Alexander University Erlangen-Nuremberg on a micrOTOF, source type ESI. NMR spectra were obtained on a Bruker Avance 360 or 600 spectrometer at ambient temperature. <sup>1</sup>H and <sup>13</sup>C chemical shifts are reported in ppm (δ) relative to TMS in the solvents indicated. Melting points were determined with a MEL-TEMP II apparatus (Laboratory Devices, U.S.) in open capillaries. IR spectra were obtained on a Jasco FT/IR 410 or 4100 spectrometer. Purification by column chromatography was performed using silica gel 60. TLC analyses were performed on Merck 60 F254 aluminum sheets and analyzed by UV light (254 nm) or KMnO<sub>4</sub> staining. Analytical HPLC was performed on Agilent 1100 or 1200 HPLC systems employing a VWL or DAD detector with a Zorbax eclipse XDB-C8 (4.6 × 150 mm, 5 μm) column. HPLC purity was measured using the following binary solvent system (system 1): eluent CH<sub>3</sub>OH in 0.1% aqueous formic acid, 10% for 3 min, 10–100% CH<sub>3</sub>OH in 15 min, 100% for 6 min, flow rate 0.5 mL/min, and λ = 254 nm. The purity of all test compounds and key intermediates was determined to be >95%. Preparative RP-HPLC was performed using an Agilent 1100 preparative series instrument with detection wavelengths set to 220 and 254 nm and a Nucleodur C18 HTec column (32 × 250 mm, 5 μm). Compounds were eluted using the following binary solvent system (method A) at a flow rate of 32 mL/min: acetonitrile (ACN), water 0.1% TFA, gradient: 5–50% ACN in 0–20 min, 50–95% ACN in 20–22 min, 95% ACN in 22–25 min, and 95–5% ACN in 25–30 min. CHN elementary analyses were performed at the Chair of Organic Chemistry, Friedrich Alexander University Erlangen-Nuremberg.</div><div id="sec4_1_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i20" class="anchor-spacer"></div><h4 class="article-section__title" id="_i20"> 5-{4-[4-(2,3-Dichlorophenyl)piperazin-1-yl]butyramido}pyrazolo[1,5-<i>a</i>]pyridine (<b>6a</b>)</h4><div class="NLM_p last">A solution of <b>4a</b> (252 mg, 0.745 mmol) and HATU (283 mg, 0.745 mmol) in dry DMF (13 mL) was stirred at room temperature for 15 min before DIPEA (0.16 mL, 0.994 mmol) was added. After an additional 15 min of stirring, a solution of 5-aminopyrazolo-[1,5-<i>a</i>]pyridine (<b>5</b>) (66.2 mg, 0.497 mmol) in dry dichloromethane (6.0 mL) was added. After 24 h of stirring at room temperature, the mixture was diluted with water (100 mL), adjusted to pH 10 with DIPEA, and extracted with dichloromethane. The combined organic layers were dried over MgSO<sub>4</sub> and evaporated. The crude product was purified by column chromatography (dichloromethane/methanol 99:1 to 95:5) to yield <b>6a</b> as a gray solid (146 mg, 68%). Mp: 117 °C. IR (NaCl): 3389, 2954, 2826, 1646, 1577, 1508, 1447, 1342, 1240, 1190, 1127, 846 cm<sup>–1</sup>. <sup>1</sup>H NMR (CDCl<sub>3</sub>/CD<sub>3</sub>OD, 600 MHz, δ): 2.03 (quin. <i>J</i> = 7.3 Hz, 2 H), 2.53 (t, <i>J</i> = 7.1 Hz, 2 H), 2.78 (t, <i>J</i> = 7.6 Hz, 2 H), 2.95 (m, 4 H), 3.16 (m, 4 H), 6.45 (dd, <i>J</i> = 2.3 Hz, 0.8 Hz, 1 H), 6.92 (dd, <i>J</i> = 7.6 Hz, 2.5 Hz, 1 H), 7.00 (dd, <i>J</i> = 7.4 Hz, 2.1 Hz, 1 H), 7.19 (m, 2 H), 7.87 (d, <i>J</i> = 2.5 Hz, 1 H), 8.11 (d, <i>J</i> = 1.9 Hz, 1 H), 8.36 (dd, <i>J</i> = 7.6 Hz, 0.8 Hz, 1 H), NH n.d. <sup>13</sup>C NMR (CDCl<sub>3</sub>/CD<sub>3</sub>OD, 90 MHz, δ): 22.1, 35.1, 50.9, 53.6, 58.2, 97.4, 106.0, 108.0, 119.5, 125.8, 128.1, 128.4, 128.9, 134.7, 135.6, 141.4, 142.9, 151.2, 173.5. HPLC (system 1): <i>t</i><sub>R</sub> = 16.3 min, purity 95%. HR-EIMS: [M<sup>+</sup>] calcd for C<sub>21</sub>H<sub>23</sub>N<sub>5</sub>OCl<sub>2</sub>, 431.1280; found, 431.1280.</div></div><div id="sec4_1_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i21" class="anchor-spacer"></div><h4 class="article-section__title" id="_i21"> 5-{4-[4-(2-Methoxyphenyl)piperazin-1-yl]butyramido}pyrazolo[1,5-<i>a</i>]pyridine (<b>6b</b>)</h4><div class="NLM_p last">Compound <b>6b</b> was prepared according to the protocol of <b>6a</b> using a solution of <b>4b</b> (286 mg, 0.952 mmol) and HATU (362 mg, 0.952 mmol) in dry DMF (15 mL) as well as DIPEA (0.20 mL, 1.27 mmol) and 5-aminopyrazolo[1,5-<i>a</i>]pyridine (<b>5</b>) (84.5 mg, 0.634 mmol) in dichloromethane (6.0 mL). Purification by column chromatography (dichloromethane/methanol 99:1 to 95:5) yielded <b>6b</b> as off-white solid (239 mg, 95%). Mp: 95 °C. IR (NaCl): 3773, 3401, 2944, 2833, 1647, 1573, 1526, 1502, 1439, 1343, 1304, 1241, 1118, 1024, 915, 843 cm<sup>–1</sup>. <sup>1</sup>H NMR (CDCl<sub>3</sub>, 600 MHz, δ): 1.97–2.07 (m, 2 H), 2.65 (t, <i>J</i> = 6.3 Hz, 2 H), 2.91 (t, <i>J</i> = 5.9 Hz, 2 H), 3.04–3.13 (m, 4 H), 3.21–3.30 (m, 4 H), 3.84 (s, 3 H), 6.37 (dd, <i>J</i> = 2.2 Hz, 0.7 Hz, 1 H), 6.78 (dd, <i>J</i> = 7.5 Hz, 2.3 Hz, 1 H), 6.85 (dd, <i>J</i> = 7.9 Hz, 1.3 Hz, 1 H), 6.88–6.90 (m, 1 H), 6.91 (dd, <i>J</i> = 7.8 Hz, 1.3 Hz, 1 H), 7.00–7.05 (m, 1 H), 7.84 (d, <i>J</i> = 2.3 Hz, 1 H), 7.90 (d, <i>J</i> = 1.9 Hz, 1 H), 8.29 (dt, <i>J</i> = 7.4 Hz, 0.7 Hz, 1 H), 8.75 (s, 1 H). <sup>13</sup>C NMR (CDCl<sub>3</sub>, 90 MHz, δ): 20.4, 35.3, 50.8, 53.3, 55.5, 57.7, 96.9, 106.3, 107.0, 111.5, 118.6, 121.2, 124.1, 128.8, 133.4, 139.5, 140.2, 142.7, 152.3, 172.9. HPLC (system 1): <i>t</i><sub>R</sub> = 14.7 min, purity 97%. HR-EIMS: [M<sup>+</sup>] calcd for C<sub>22</sub>H<sub>27</sub>N<sub>5</sub>O<sub>2</sub>, 393.2165; found, 393.2164.</div></div><div id="sec4_1_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i22" class="anchor-spacer"></div><h4 class="article-section__title" id="_i22"> 5-{4-[4-(2,3-Dichlorophenyl)piperazin-1-yl]butyramido}pyrazolo[1,5-<i>a</i>]pyridine-3-carbaldehyde (<b>7a</b>)</h4><div class="NLM_p last">A solution of <b>6a</b> (183 mg, 0.423 mmol) in dry DMF (2.0 mL) was cooled to 0 °C, before 0.61 mL (1.31 mmol) of a preformed Vilsmeyer reagent (0.4 mL POCl<sub>3</sub> in 1.6 mL dry DMF) was added dropwise. After stirring at room temperature for 1 h, distilled water was added and the mixture was alkalized by addition of 5 M NaOH. The mixture was extracted with chloroform, the combined organic layers were dried over MgSO<sub>4</sub> and evaporated. Purification by column chromatography (dichloromethane/methanol 97:3) yielded <b>7a</b> as a white solid (114 mg, 59%). Mp: 189 °C. IR (NaCl): 3300, 3248, 3138, 3042, 2936, 2817, 2251, 1695, 1654, 1628, 1527, 1450, 1400, 1195, 959, 879 cm<sup>–1</sup>. <sup>1</sup>H NMR (CDCl<sub>3</sub>, 600 MHz, δ): 1.97–2.04 (m, 2 H), 2.57 (t, <i>J</i> = 6.8 Hz, 2 H), 2.59 (t, <i>J</i> = 6.5 Hz, 2 H), 2.68–2.76 (m, 4 H), 3.10–3.20 (m, 4 H), 7.01 (dd, <i>J</i> = 7.6 Hz, 1.8 Hz, 1 H), 7.13 (t, <i>J</i> = 7.8 Hz, 1 H), 7.16 (dd, <i>J</i> = 8.0 Hz, 1.8 Hz, 1 H) 8.05 (dd, <i>J</i> = 7.5 Hz, 1.3 Hz, 1 H), 8.16 (d, <i>J</i> = 1.9 Hz, 1 H), 8.32 (s, 1 H), 8.49 (d, <i>J</i> = 7.5 Hz, 1 H), 9.93 (br s, 1 H), 9.96 (s, 1 H). <sup>13</sup>C NMR (CDCl<sub>3</sub>, 90 MHz, δ): 21.9, 36.1, 51.3, 53.2, 57.2, 105.6, 109.4, 113.2, 118.8, 124.8, 127.5, 127.5, 129.8, 134.0, 140.4, 141.0, 147.5, 150.9, 172.2, 183.0. HPLC (system 1): <i>t</i><sub>R</sub> = 16.1 min, purity 96%. HR-EIMS: [M<sup>+</sup>] calcd for C<sub>22</sub>H<sub>23</sub>N<sub>5</sub>O<sub>2</sub>Cl<sub>2</sub>, 459.1229; found, 459.1228.</div></div><div id="sec4_1_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i23" class="anchor-spacer"></div><h4 class="article-section__title" id="_i23"> 5-{4-[4-(2-Methoxyphenyl)piperazin-1-yl]butyramido}pyrazolo[1,5-<i>a</i>]pyridine-3-carbaldehyde (<b>7b</b>)</h4><div class="NLM_p last">Compound <b>7b</b> was prepared according to the protocol of compound <b>7a</b> using a solution of <b>6b</b> (192 mg, 0.488 mmol) in DMF (3.0 mL) and 0.70 mL of the preformed Vilsmeyer reagent (1.51 mmol). Purification by column chromatography (dichloromethane/methanol 97:3) yielded <b>7b</b> as light yellow solid (118 mg, 58%). Mp: 108 °C. IR (NaCl): 3403, 2021, 2950, 2820, 1660, 1635, 1579, 1529, 1500, 1482, 1460, 1403, 1368, 1300, 1240, 1196, 1022, 916, 847 cm<sup>–1</sup>. <sup>1</sup>H NMR (CDCl<sub>3</sub>, 600 MHz, δ): 1.98–2.04 (m, 2 H), 2.60 (t, <i>J</i> = 6.9 Hz, 2 H), 2.64 (t, <i>J</i> = 7.1 Hz, 2 H), 2.72–2.80 (m, 4 H), 3.14–3.20 (m, 4 H), 3.86 (s, 3 H), 6.86 (dd, <i>J</i> = 8.1 Hz, 1.4 Hz, 1 H), 6.91 (ddd, <i>J</i> = 7.6 Hz, 7.6 Hz, 1.4 Hz, 1 H), 6.96 (dd, <i>J</i> = 7.9 Hz, 1.7 Hz, 1 H), 7.00 (ddd, <i>J</i> = 7.8 Hz, 7.5 Hz, 1.6 Hz, 1 H), 7.94 (dd, <i>J =</i> 7.6 Hz, 1.9 Hz, 1 H), 8.29 (s, 1 H), 8.34 (d, <i>J</i> = 2.1 Hz, 1 H), 8.45 (d, <i>J</i> = 7.6 Hz, 1 H), 9.93 (s, 1 H), 10.48 (br s, 1 H). <sup>13</sup>C NMR (CDCl<sub>3</sub>, 90 MHz, δ): 21.9, 25.6, 50.4, 53.3, 55.4, 57.2, 105.4, 109.6, 111.3, 113.2, 118.3, 121.0, 123.1, 129.6, 140.5, 141.0, 141.2, 147.3, 152.2, 172.7, 182.8. HPLC (system 1): <i>t</i><sub>R</sub> = 14.5 min, purity 97%. HR-EIMS: [M<sup>+</sup>] calcd for C<sub>23</sub>H<sub>27</sub>N<sub>5</sub>O<sub>3</sub>, 421.2114; found, 421.2117.</div></div><div id="sec4_1_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i24" class="anchor-spacer"></div><h4 class="article-section__title" id="_i24"> 5-{4-[4-(2,3-Dichlorophenyl)piperazin-1-yl]butyramido}pyrazolo[1,5-<i>a</i>]pyridine-3-carbaldehydoxime (<b>8a</b>)</h4><div class="NLM_p last">A solution of hydroxylamine hydrochloride (34.6 mg, 0.498 mmol) in distilled water (1.4 mL) and 2 M NaOH (0.25 mL, 0.50 mmol) was cooled to 0 °C and adjusted to pH 5.0 by addition of 2 M HCl, before a solution of <b>7a</b> (115 mg, 0.249 mmol) in ethanol (12.4 mL) was added and the mixture was heated to reflux for 2 h. After cooling, saturated NaHCO<sub>3</sub> solution was added and the mixture was extracted with CH<sub>2</sub>Cl<sub>2</sub>. The combined organic layers were dried (MgSO<sub>4</sub>) and concentrated in vacuo. Purification by column chromatography (dichloromethane/methanol 97:3 to 95:5) yielded <b>8a</b> as a white solid (91.7 mg, 77% as mixture of two isomers in a 50% to 50% ratio). Mp: 146 °C. IR (NaCl) 3214, 2823, 2359, 1646, 1576, 1506, 1449, 1353, 1241, 1211, 1130, 961 cm<sup>–1</sup>. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 600 MHz, δ): (Isomer 1, 50%) 1.76–1.85 (m, 2 H), 2.37–2.46 (m, 4 H), 2.51–2.56 (m, 4 H), 2.91–2.97 (m, 4 H), 7.02 (dd, <i>J =</i> 7.9 Hz, 2.1 Hz, 1 H), 7.08 (dd, <i>J =</i> 7.4 Hz, 2.3 Hz, 1 H), 7.21–7.28 (m, 2 H), 7.54 (s, 1 H), 8.36 (d, <i>J =</i> 2.5 Hz, 1 H), 8.58 (d, <i>J</i> = 2.5 Hz, 1 H), 8.64 (d, <i>J</i> = 7.6 Hz, 1 H), 10.35 (s, 1 H), 11.21 (s, 1 H); (Isomer 2 50%) 1.76–1.85 (m, 2 H), 2.37–2.46 (m, 4 H), 2.51–2.56 (m, 4 H), 2.91–2.97 (m, 4 H), 7.02 (dd, <i>J</i> = 7.9 Hz, 2.1 Hz, 1 H), 7.03 (dd, <i>J</i> = 7.5 Hz, 2.4 Hz, 1 H), 7.21–7.28 (m, 2 H), 8.08 (s, 1 H), 8.22 (s, 1 H), 8.55 (d, <i>J</i> = 2.5 Hz, 1 H), 8.65 (d, <i>J</i> = 7.6 Hz, 1 H), 10.32 (s, 1 H), 10.71 (s, 1 H). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>, 90 MHz, δ): (Isomer 1, 50%) 22.0, 34.5, 50.9, 52.7, 57.1, 101.9, 102.7, 107.8, 119.4, 124.3, 126.0, 128.3, 129.5, 132.5, 136.0, 137.1, 138.7, 145.0, 151.2, 172.1; (Isomer 2 50%) 22.0, 34.5, 50.9, 52.7, 57.1, 104.2, 104.5, 107.7, 119.4, 124.3, 126.0, 128.3, 129.5, 132.5, 136.9, 137.1, 142.1, 143.1, 151.2, 171.9. HPLC (system 1): <i>t</i><sub>R</sub> = 15.8 min, purity 96%. HR-EIMS: [M<sup>+</sup>] calcd for C<sub>22</sub>H<sub>24</sub>N<sub>6</sub>O<sub>2</sub>Cl<sub>2</sub>, 474.1338; found, 474.1338.</div></div><div id="sec4_1_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i25" class="anchor-spacer"></div><h4 class="article-section__title" id="_i25"> 5-{4-[4-(2-Methoxyphenyl)piperazin-1-yl]butyramido}pyrazolo[1,5-<i>a</i>]pyridine-3-carbaldehydoxime (<b>8b</b>)</h4><div class="NLM_p last">Compound <b>8b</b> was prepared according to the protocol of <b>8a</b> using a solution of hydroxylamine hydrochloride (36.9 mg, 0.53 mmol) in distilled water (1.5 mL) and 2 M NaOH (0.27 mL, 0.53 mmol) as well as a solution of <b>7b</b> (112 mg, 0.265 mmol) in ethanol (13.1 mL). Purification by column chromatography (dichloromethane/methanol 98:2 to 95:5) yielded <b>8b</b> as light yellow solid (108 mg, 83% mixture of two isomers in a 50% to 50% ratio). Mp: 118 °C. IR (NaCl): 3398, 3021, 1646, 1581, 1502, 1463, 1355, 1243, 1180, 1117, 1021, 915, 866 cm<sup>–1</sup>. <sup>1</sup>H NMR (CDCl<sub>3</sub>, 600 MHz, δ): (Isomer 1, 50%) 1.99–2.09 (m, 2 H), 2.54–2.63 (m, 4 H), 2.73–2.81 (m, 4 H), 3.15–3.25 (m, 4 H), 3.87 (s, 3 H), 6.88 (dd, <i>J</i> = 7.9 Hz, 1.2 Hz, 1 H), 6.88–6.96 (m, 2 H), 6.97–7.02 (m, 1 H), 7.22 (dd, <i>J</i> = 7.6 Hz, 2.4 Hz, 1 H), 7.57 (s, 1 H), 8.11 (dd, <i>J</i> = 2.4 Hz, 0.7 Hz, 1 H), 8.30 (dd, <i>J</i> = 7.5 Hz, 0.7 Hz, 1 H), 8.73 (s, 1 H), 9.51 (br s, 1 H), free OH n. d.; (Isomer 2, 50%) 1.99–2.09 (m, 2 H), 2.54–2.63 (m, 4 H), 2.73–2.81 (m, 4 H), 3.15–3.25 (m, 4 H), 3.87 (s, 3 H), 6.86 (dd, <i>J</i> = 7.9 Hz, 1.2 Hz, 1 H), 6.88–6.96 (m, 2 H), 6.97–7.02 (m, 1 H), 7.03 (dd, <i>J</i> = 7.6 Hz, 2.3 Hz, 1 H), 7.95 (s, 1 H), 8.13 (dd, <i>J</i> = 2.4 Hz, 0.7 Hz, 1 H), 8.26 (s, 1 H), 8.35 (dd, <i>J</i> = 7.5 Hz, 0.7 Hz, 1 H), 9.38 (b s, 1 H), free OH n. d. <sup>13</sup>C NMR (CDCl<sub>3</sub>, 90 MHz, δ): (Isomer 1, 50%) 22.0, 35.9, 50.1, 53.4, 55.4, 57.5, 104.3, 104.5, 107.9, 111.3, 118.2, 121.0, 123.1, 129.0, 137.5, 137.9, 141.0, 143.4, 143.4, 152.2, 172.5; (Isomer 2, 50%) 22.0, 35.6, 49.9, 53.3, 55.4, 57.5, 103.0, 103.4, 108.3, 111.3, 118.2, 121.0, 123.1, 129.1, 137.6, 139.7, 141.0, 146.1, 136.9, 152.2, 172.7. HPLC (system 1): <i>t</i><sub>R</sub> = 12.5 min, purity 100%. HR-EIMS: [M<sup>+</sup>] calcd for C<sub>23</sub>H<sub>28</sub>N<sub>6</sub>O<sub>3</sub>, 436.2223; found, 436.2222.</div></div><div id="sec4_1_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i26" class="anchor-spacer"></div><h4 class="article-section__title" id="_i26"> 5-{4-[4-(2,3-Dichlorophenyl)piperazin-1-yl]butyramido}pyrazolo[1,5-<i>a</i>]pyridine-3-carbonitrile (<b>9a</b>)</h4><div class="NLM_p last">A solution of TCT (46.4 mg, 0.25 mmol) in DMF (1.0 mL) was stirred at room temperature for 1 h. Subsequently, 0.54 mL of the preformed TCT/DMF complex were added to a solution of <b>8a</b> (60.1 mg, 127 μmol) in DMF (1.6 mL). After stirring at room temperature for 5 h, the mixture was diluted with saturated sodium bicarbonate solution and extracted with CHCl<sub>3</sub>. The combined organic layers were dried (MgSO<sub>4</sub>) and evaporated. The residue was purified by chromatography (dichloromethane/methanol 98:2 to 95:5) to yield <b>9a</b> as light yellow solid (43.6 mg, 75%). Mp: 180 °C. IR (NaCl): 3305, 3069, 2942, 2819, 2218, 1697, 1650, 1577, 1532, 1510, 1450, 1421, 1240, 1045, 960 cm<sup>–1</sup>. <sup>1</sup>H NMR (CDCl<sub>3</sub>, 600 MHz, δ): 2.03–2.09 (m, 2 H), 2.59 (t, <i>J</i> = 6.8 Hz, 2 H), 2.69 (t, <i>J</i> = 6.4 Hz, 2 H), 2.80–2.90 (m, 4 H), 3.13–3.23 (m, 4 H), 6.98 (dd, <i>J</i> = 7.7 Hz, 1.8 Hz, 1 H), 7.17 (t, <i>J</i> = 7.8 Hz, 1 H), 7.20 (dd, <i>J</i> = 8.0 Hz, 1.8 Hz, 1 H), 7.35 (dd, <i>J</i> = 7.5 Hz, 2.2 Hz, 1 H), 8.04 (d, <i>J</i> = 2.1 Hz, 1 H), 8.16 (s, 1 H), 8.44 (d, <i>J</i> = 7.6 Hz, 1 H), 9.40 (s, 1 H). <sup>13</sup>C NMR (CDCl<sub>3</sub>, 90 MHz, δ): 21.6, 35.7, 50.6, 53.0, 57.0, 81.5, 103.4, 108.9, 114.1, 118.7, 125.2, 127.6, 127.6, 130.0, 134.2, 138.7, 143.3, 145.9, 150.5, 171.8. HPLC (system 1): <i>t</i><sub>R</sub> = 16.8 min, purity 97%. HR-EIMS: [M<sup>+</sup>] calcd for C<sub>22</sub>H<sub>22</sub>N<sub>6</sub>OCl<sub>2</sub>, 456.1232; found, 456.1232.</div></div><div id="sec4_1_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i27" class="anchor-spacer"></div><h4 class="article-section__title" id="_i27"> 5-{4-[4-(2-Methoxyphenyl)piperazin-1-yl]butyramido}pyrazolo[1,5-<i>a</i>]pyridine-3-carbonitrile (<b>9b</b>)</h4><div class="NLM_p last">A solution of <b>8b</b> (22.0 mg, 50 μmol) in acetic acid anhydride (2.0 mL) was heated to reflux for 6 h. After cooling, the mixture was diluted with ice water and extracted with CHCl<sub>3</sub>. The combined organic layers were dried (MgSO<sub>4</sub>) and evaporated under vacuo. Purification by column chromatography (dichloromethane/methanol 98:2 to 95:5) yielded <b>9b</b> as colorless oil (2.5 mg, 12%). IR (NaCl): 2960, 2819, 2218, 1698, 1649, 1582, 1534, 1501, 1454, 1241, 1025 cm<sup>–1</sup>. <sup>1</sup>H NMR (CDCl<sub>3</sub>, 600 MHz, δ): 2.03–2.09 (m, 2 H), 2.62 (t, <i>J</i> = 6.8 Hz, 2 H), 2.74 (t, <i>J</i> = 6.4 Hz, 2 H), 2.87–2.92 (m, 4 H), 3.18–3.29 (m, 4 H), 3.87 (s, 3 H), 6.88 (dd, <i>J</i> = 8.2 Hz, 1.2 Hz, 1 H), 6.93–6.96 (m, 2 H), 7.02–7.06 (m, 1 H), 7.26 (dd, <i>J</i> = 7.6 Hz, 2.3 Hz, 1 H), 8.15 (s, 1 H), 8.17 (dd, <i>J</i> = 2.3 Hz, 0.8 Hz, 1 H), 8.41 (dd, <i>J</i> = 7.6 Hz, 0.8 Hz, 1 H), 9.71 (bs, 1 H). <sup>13</sup>C NMR (CDCl<sub>3</sub>, 90 MHz, δ): 21.4, 35.5, 49.5, 53.0, 55.4, 56.7, 81.6, 103.6, 108.9, 111.4, 114.1, 118.4, 121.2, 123.7, 129.9, 138.6, 140.2, 143.3, 145.9, 152.2, 171.8. HPLC (system 1): <i>t</i><sub>R</sub> = 15.0 min, purity 99%. HR-EIMS: [M<sup>+</sup>] calcd for C<sub>23</sub>H<sub>26</sub>N<sub>6</sub>O<sub>2</sub>, 418.2117; found, 418.2116.</div></div><div id="sec4_1_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i28" class="anchor-spacer"></div><h4 class="article-section__title" id="_i28"> 6-{4-[4-(2-Methoxyphenyl)piperazin-1-yl]butoxy}lpyrazolo[1,5-<i>a</i>]pyridine (<b>12a</b>)</h4><div class="NLM_p last">A solution of <b>10a</b> (40 mg, 0.149 mmol) and NaI (33.5 mg, 0.223 mmol) in acetonitrile (0.9 mL) was heated to 85 °C for 30 min, before 1-(2-methoxyphenyl)piperazine (31.4 mg, 0.164 mmol) and triethylamine (0.05 mL, 0.316 mmol) were added and the mixture was stirred at 85 °C for another 5 h. After cooling, saturated NaHCO<sub>3</sub> solution was added and the mixture was extracted with CH<sub>2</sub>Cl<sub>2</sub>. The combined organic layers were dried (Na<sub>2</sub>SO<sub>4</sub>) and evaporated in vacuo. Purification of the residue by column chromatography (dichloromethane/methanol 98:2 to 95:5) yielded <b>12a</b> as an off-white oil (50.0 mg, 89%). IR (NaCl): 3108, 2942, 2817, 1643, 1499, 1292, 1240, 1199, 748 cm<sup>–1</sup>. <sup>1</sup>H NMR (CDCl<sub>3</sub>, 600 MHz, δ): 1.80–1.85 (m, 2 H), 1.87–1.91 (m, 2 H), 2.59 (t, <i>J</i> = 7.6 Hz, 2 H), 2.77–2.82 (m, 4 H), 3.17–3.22 (m, 4 H), 3.86 (s, 3 H), 3.99 (t, <i>J</i> = 6.3 Hz, 2 H), 6.45 (d, <i>J</i> = 2.1 Hz, 1 H), 6.87 (dd, <i>J</i> = 7.9 Hz, 1.0 Hz, 1 H), 6.91–6.93 (m, 2 H), 6.95 (dd, <i>J</i> = 7.5 Hz, 2.0 Hz, 1 H), 7.01 (ddd, <i>J</i> = 7.9 Hz, 7.0 Hz, 2.0 Hz, 1 H), 7.41 (d, <i>J</i> = 9.6 Hz, 1 H), 7.84 (d, <i>J</i> = 2.2 Hz, 1 H), 8.06–8.07 (m, 1 H). <sup>13</sup>C NMR (CDCl<sub>3</sub>, 90 MHz, δ): 23.1, 27.1, 50.2, 53.4, 55.4, 58.1, 68.7, 96.7, 111.2, 111.8, 117.9, 118.4, 119.1, 121.1, 123.2, 136.5, 140.8, 141.0, 148.3, 152.3. HPLC (system 1): <i>t</i><sub>R</sub> = 17.5 min, purity 100%. HR-EIMS: [M<sup>+</sup>] calcd for C<sub>22</sub>H<sub>28</sub>N<sub>4</sub>O<sub>2</sub>, 380.2212; found, 380.2214.</div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i29" class="anchor-spacer"></div><h4 class="article-section__title" id="_i29"> 5-{4-[4-(2-Methoxyphenyl)piperazin-1-yl]butoxy}lpyrazolo[1,5-<i>a</i>]pyridine (<b>12b</b>)</h4><div class="NLM_p last">Compound <b>12b</b> was synthesized according to the protocol of <b>12a</b> employing a solution of <b>10b</b> 200 mg, 0.74 mmol) and sodium iodide (167 mg, 1.1 mmol) in acetonitrile (3.3 mL) as well as 1-(2-methoxyphenyl)piperazine (157 mg, 0.818 mmol) and triethylamine (0.11 mL, 0.818 mmol). Purification by column chromatography (hexanes/ethyl acetate 1:9) afforded <b>12b</b> as off-white solid (252 mg, 89%). Mp: 121 °C, IR (NaCl) 3098, 2942, 2815, 16448, 1500, 1291, 1241, 1228, 1190, 748 cm<sup>–1</sup>. <sup>1</sup>H NMR (CDCl<sub>3</sub>, 600 MHz, δ): 1.71–1.76 (m, 2 H), 1.85–1.90 (m, 2 H), 2.49 (t, <i>J</i> = 7.6 Hz, 2 H), 2.66–2.70 (m, 4 H), 3.08–3.14 (m, 4 H), 3.86 (s, 3 H), 4.02 (t, <i>J</i> = 6.3 Hz, 2 H), 6.29–6.30 (m, 1 H), 6.44 (dd, <i>J</i> = 7.6 Hz, 2.6 Hz, 1 H), 6.73 (d, <i>J</i> = 2.6 Hz, 1 H), 6.86 (dd, <i>J</i> = 7.8 Hz, 0.9 Hz, 1 H), 6.92 (ddd, <i>J</i> = 7.5 Hz, 7.0 Hz, 0.9 Hz, 1 H), 6.95 (dd, <i>J</i> = 7.5 Hz, 1.7 Hz, 1 H) 7.00 (ddd <i>J</i> = 7.8 Hz, 7.0 Hz, 1.7 Hz, 1 H), 7.84 (d, <i>J</i> = 2.1 Hz, 1 H), 8.28 (d, <i>J</i> = 7.6 Hz, 1 H). <sup>13</sup>C NMR (CDCl<sub>3</sub>, 90 MHz, δ): 23.5, 27.0, 50.7, 53.5, 55.4, 58.2, 68.0, 95.3, 95.4, 106.7, 111.2, 118.2, 121.0, 122.9, 129.3, 141.1, 141.3, 142.7, 152.3, 155.7. ESI-MS: <i>m</i>/<i>z</i> 380.0 [M<sup>+</sup>]. Anal. Calcd (%) for C<sub>22</sub>H<sub>28</sub>N<sub>4</sub>O<sub>2</sub> × 0.3 H<sub>2</sub>O: C, 68.48; H, 7.47; N, 14.52; found: C, 68.51; H, 7.71; N, 14.38.</div></div><div id="sec4_2_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i30" class="anchor-spacer"></div><h4 class="article-section__title" id="_i30"> Ethyl 5-{4-[4-(2-methoxyphenyl)piperazin-1-yl]butoxy}lpyrazolo[1,5-<i>a</i>]pyridine-2-carboxylate (<b>12c</b>)</h4><div class="NLM_p last">Compound <b>12c</b> was synthesized according to the protocol of <b>12a</b> using a solution of <b>10c</b> (302 mg, 0.885 mmol) and sodium iodide (199 mg, 1.33 mmol) in acetonitrile (5.0 mL) as well as a solution of 1-(2-methoxyphenyl)piperazine (187 mg, 0.973 mmol) and triethylamine (0.14 mL, 1.01 mmol) in acetonitrile (2.0 mL) and allowing a reaction time of 8 h. Purification by column chromatography (dichloromethane/methanol 98:2) yielded <b>12c</b> as light yellow solid (350 mg, 87%). Mp: 105 °C. IR (NaCl): 2941, 2813, 1720, 1649, 1593, 1539, 1499, 1448, 1406, 1302, 1240, 1147, 1099, 1026, 981, 925, 819 cm<sup>–1</sup>. <sup>1</sup>H NMR (CDCl<sub>3</sub>, 600 MHz, δ): 1.44 (t, <i>J</i> = 7.1 Hz, 3 H), 1.68–1.79 (m, 2 H), 1.83–1.94 (m, 2 H), 2.50 (t, <i>J</i> = 7.4 Hz, 2 H), 2.63–2.73 (m, 4 H), 3.06–3.18 (m, 4 H), 3.87 (s, 3 H), 4.03 (6, <i>J</i> = 6.3 Hz, 2 H), 4.46 (q, <i>J</i> = 7.1 Hz, 2 H), 6.58 (dd, <i>J</i> = 7.7 Hz, 2.7 Hz, 1 H), 6.76 (d, <i>J</i> = 2.5 Hz, 1 H), 6.86 (d, <i>J</i> = 0.8 Hz, 1 H), 6.86 (dd, <i>J</i> = 7.8 Hz, 1.3 Hz, 1 H), 6.91 (ddd, <i>J</i> = 7.9 Hz, 6.6 Hz, 1.3 Hz, 1 H), 6.95 (dd, <i>J</i> = 7.9 Hz, 2.7 Hz, 1 H), 7.00 (ddd, <i>J</i> = 7.8 Hz, 6.5 Hz, 2.6 Hz, 1 H), 8.34 (dt, <i>J</i> = 7.7 Hz, 0.7 Hz, 1 H). <sup>13</sup>C NMR (CDCl<sub>3</sub>, 150 MHz, δ): 14.4, 23.4, 26.9, 50.7, 53.5, 55.3, 58.2, 61.3, 68.3, 95.9, 98.6, 109.5, 111.2, 118.2, 121.0, 122.9, 129.6, 141.3, 141.9, 145.8, 152.3, 156.0, 162.9. HPLC (system 1): <i>t</i><sub>R</sub> = 15.7 min, purity 99%. HR-EIMS: [M<sup>+</sup>] calcd for C<sub>25</sub>H<sub>32</sub>N<sub>4</sub>O<sub>4</sub>, 452.2424; found, 452.2423.</div></div><div id="sec4_2_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i31" class="anchor-spacer"></div><h4 class="article-section__title" id="_i31"> 5-{4-[4-(2-Methoxyphenyl)piperazin-1-yl]butoxy}-2-hydroxymethylpyrazolo[1,5-<i>a</i>]pyridine (<b>12d</b>)</h4><div class="NLM_p last">To a solution of <b>12c</b> (230 mg, 0.508 mmol) in diethyl ether (25 mL) was added a solution of LiAlH<sub>4</sub> in diethyl ether (4 M, 130 μL, 0.508 mmol). After stirring at 0 °C for 1 h and at room temperature for 2 h, the reaction was quenched by addition of saturated NaHCO<sub>3</sub> solution. After extraction with CH<sub>2</sub>Cl<sub>2</sub>, the combined organic layers were dried (MgSO<sub>4</sub>) and evaporated. Purification by column chromatography (dichloromethane/methanol 95:5) yielded <b>12d</b> as light yellow solid (155 mg, 74%). Mp: 48 °C. IR (NaCl): 3328, 2937, 2818, 1648, 1593, 1541, 1500, 1445, 1300, 1240, 1202, 1116, 1028, 817 cm<sup>–1</sup>. <sup>1</sup>H NMR (CDCl<sub>3</sub>, 600 MHz, δ): 1.71–1.77 (m, 2 H), 1.84–1.90 (m, 2 H), 2.51 (t, <i>J</i> = 7.6 Hz, 2 H), 2.65–2.73 (m, 4 H), 3.07–3.17 (m, 4 H), 3.86 (s, 3 H), 4.01 (t, <i>J</i> = 6.3 Hz, 2 H), 4.84 (s, 2 H), 6.28 (s, 1 H), 6.42 (dd, <i>J</i> = 7.6 Hz, 2.6 Hz, 1 H), 6.68 (d, <i>J</i> = 2.6 Hz, 1 H), 6.86 (dd, <i>J</i> = 8.1 Hz, 1.3 Hz, 1 H), 6.92 (ddd, <i>J</i> = 7.8 Hz, 6.9 Hz, 1.3 Hz, 1 H), 6.95 (dd, <i>J</i> = 7.9 Hz, 2.1 Hz, 1 H), 7.00 (ddd, <i>J</i> = 8.0 Hz, 7.1 Hz, 2.0 Hz, 1 H), 8.20 (d, <i>J</i> = 7.6 Hz, 1 H), free OH n. d. <sup>13</sup>C NMR (CDCl<sub>3</sub>, 90 MHz, δ): 23.3, 27.0, 50.6, 53.5, 55.4, 58.2, 59.5, 68.0, 93.5, 95.3, 106.7, 111.2, 118.2, 121.0, 123.0, 129.2, 141.3, 142.2, 152.3, 155.7, 155.9. HPLC (system 1): <i>t</i><sub>R</sub> = 13.9 min, purity 96%. HR-EIMS: [M<sup>+</sup>] calcd for C<sub>23</sub>H<sub>30</sub>N<sub>4</sub>O<sub>3</sub>, 410.2318; found, 410.2318.</div></div><div id="sec4_2_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i32" class="anchor-spacer"></div><h4 class="article-section__title" id="_i32"> 5-{4-[4-(2-Methoxyphenyl)piperazin-1-yl]butoxy}pyrazolo[1,5-<i>a</i>]pyridine-2-carbaldehyde (<b>12e</b>)</h4><div class="NLM_p last">A suspension of <b>12d</b> (125 mg, 0.305 mmol) and MnO<sub>2</sub> (266 mg, 3.05 mmol) in dichloromethane (12 mL) was stirred at room temperature for 14 h. After filtration, the filtrate was evaporated and the residue was purified by column chromatography (dichloromethane/methanol/dimethyl ethylamine 99:0.5:0.5) to give <b>12e</b> as a yellow solid (121 mg, 97%). Mp: 98 °C. IR (NaCl): 2940, 2874, 2812, 1699, 1648, 1593, 1540, 1499, 1446, 1240, 1207, 1147, 1026 cm<sup>–1</sup>. <sup>1</sup>H NMR (CDCl<sub>3</sub>, 600 MHz, δ): 1.70–1.80 (m, 2 H), 1.85–1.95 (m, 2 H), 2.50 (t, <i>J</i> = 7.5 Hz, 2 H), 2.63–2.73 (m, 4 H), 3.06–3.17 (m, 4 H), 3.86 (s, 3 H), 4.04 (t, <i>J</i> = 6.4 Hz, 2 H), 6.42 (dd, <i>J</i> = 7.6 Hz, 2.6 Hz, 1 H), 6.79 (d, <i>J</i> = 2.4 Hz, 1 H), 6.81 (d, <i>J</i> = 0.8 Hz, 1 H), 6.86 (dd, <i>J</i> = 7.8 Hz, 1.2 Hz, 1 H), 6.92 (ddd, <i>J</i> = 7.8 Hz, 6.5 Hz, 1.3 Hz, 1 H), 6.95 (dd, <i>J</i> = 7.9 Hz, 2.5 Hz, 1 H), 7.00 (ddd, <i>J</i> = 7.9 Hz, 6.5 Hz, 2.5 Hz, 1 H), 8.30 (dt, <i>J</i> = 7.6 Hz, 0.8 Hz, 1 H), 10.13 (s, 1 H). <sup>13</sup>C NMR (CDCl<sub>3</sub>, 90 MHz, δ): 23.4, 26.9, 50.6, 53.5, 55.4, 58.2, 68.3, 95.5, 96.3, 110.3, 111.2, 118.2, 121.0, 122.9, 129.6, 141.3, 142.3, 152.3, 152.4, 156.2, 187.8. HPLC (system 1): <i>t</i><sub>R</sub> = 14.5 min, purity 95%. HR-EIMS: [M<sup>+</sup>] calcd for C<sub>23</sub>H<sub>28</sub>N<sub>4</sub>O<sub>3</sub>, 408.2161; found, 408.2162.</div></div><div id="sec4_2_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i33" class="anchor-spacer"></div><h4 class="article-section__title" id="_i33"> 5-{4-[4-(2-Methoxyphenyl)piperazin-1-yl]butoxy}pyrazolo[1,5-<i>a</i>]pyridine-2-aldehydoxime (<b>12f</b>)</h4><div class="NLM_p last">A solution of hydroxylamine hydrochloride (53.3 mg, 0.752 mmol) in distilled water (2.1 mL) and 2 M NaOH (0.38 mL, 0.76 mmol) was cooled to 0 °C and adjusted to pH 5.0 by addition of 2 M HCl. Subsequently, a solution of <b>12e</b> (154 mg, 0.376 mmol) in ethanol (16.5 mL) was added, and the mixture was heated to reflux for 2 h. After cooling and addition of saturated NaHCO<sub>3</sub> solution, the mixture was extracted with CH<sub>2</sub>Cl<sub>2</sub>. The combined organic layers were dried (MgSO<sub>4</sub>) and evaporated. Purification by column chromatography (dichloromethane/methanol 98:2 to 95:5) yielded <b>12f</b> as a white solid (136 mg, 85% mixture of two isomers in an 80% to 20% ratio). Mp: 138 °C. IR (NaCl): 3189, 2941, 2874, 2828, 1647, 1593, 1540, 1499, 1450, 1388, 1241, 1207, 1117, 1025, 974, 911, 811 cm<sup>–1</sup>. <sup>1</sup>H NMR (CDCl<sub>3</sub>, 600 MHz, δ): (major isomer) 1.76–1.83 (m, 2 H), 1.85–1.92 (m, 2 H), 2.54 (t, <i>J</i> = 7.5 Hz, 2 H), 2.71–2.80 (m, 4 H), 3.09–.20 (m, 4 H), 3.87 (s, 3 H), 4.00 (t, <i>J</i> = 6.2 Hz, 2 H), 6.44 (dd, <i>J</i> = 7.6 Hz, 2.6 Hz, 1 H), 6.50 (s, 1 H), 6.63 (d, <i>J</i> = 2.3 Hz, 1 H), 6.86 (dd, <i>J</i> = 8.0 Hz, 1.2 Hz, 1 H), 6.92 (ddd, <i>J</i> = 7.7 Hz, 7.3 Hz, 1.4 Hz, 1 H), 6.96 (dd, <i>J</i> = 7.9 Hz, 1.9 Hz, 1 H), 7.00 (ddd, <i>J</i> = 7.9 Hz, 7.3 Hz, 1.7 Hz, 1 H), 8.19 (d, <i>J</i> = 7.6 Hz, 1 H), 8.25 (s, 1 H), free OH n. d.; (minor isomer) 1.76–1.83 (m, 2 H), 1.85–1.92 (m, 2 H), 2.54 (t, <i>J</i> = 7.5 Hz, 2 H), 2.71–2.80 (m, 4 H), 3.09–3.20 (m, 4 H), 3.87 (s, 3 H), 4.00 (t, <i>J</i> = 6.2 Hz, 2 H), 6.55 (dd, <i>J</i> = 7.6 Hz, 2.6 Hz, 1 H), 6.74 (d, <i>J</i> = 2.5 Hz, 1 H), 6.82 (s, 1 H), 6.86 (dd, <i>J</i> = 8.0 Hz, 1.2 Hz, 1 H), 6.92 (ddd, <i>J</i> = 7.7 Hz, 7.3 Hz, 1.4 Hz, 1 H), 6.96 (dd, <i>J</i> = 7.9 Hz, 1.9 Hz, 1 H), 7.00 (ddd, <i>J</i> = 7.9 Hz, 7.3 Hz, 1.7 Hz, 1 H), 7.70 (s, 1 H), 8.23 (d, <i>J</i> = 7.6 Hz, 1 H), free OH n. d. <sup>13</sup>C NMR (CDCl<sub>3</sub>, 90 MHz, δ): (major isomer) 23.2, 26.9, 50.4, 53.5, 55.4, 58.1, 68.0, 93.2, 95.2, 107.6, 111.2, 118.3, 121.0, 123.0, 129.0, 141.2, 141.3, 142.0, 146.4, 152.3, 156.1; (minor isomer) 23.2, 26.9, 50.5, 53.5, 55.4, 58.1, 68.2, 95.6, 98.6, 108.9, 111.2, 118.3, 121.0, 123.0, 129.2, 141.2, 141.3, 142.0, 148.5, 152.3, 156.1. HPLC (system 1): <i>t</i><sub>R</sub> = 14.8 min, purity 95%. HR-EIMS: [M<sup>+</sup>] calcd for C<sub>23</sub>H<sub>29</sub>N<sub>5</sub>O<sub>3</sub>, 423.2270; found, 423.2271.</div></div><div id="sec4_2_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i34" class="anchor-spacer"></div><h4 class="article-section__title" id="_i34"> 5-{4-[4-(2-Methoxyphenyl)piperazin-1-yl]butoxy}pyrazolo[1,5-<i>a</i>]pyridin-2-carbonitrile (<b>12g</b>)</h4><div class="NLM_p last">A solution of TCT (46.4 mg, 0.25 mmol) in DMF (1.0 mL) was stirred at room temperature. Subsequently, 0.27 mL of this preformed complex were added to a solution of <b>12f</b> (29.1 mg, 69 μmol) in DMF (0.8 mL). After stirring at room temperature for 7 h, the reaction was quenched by addition of saturated NaHCO<sub>3</sub> solution and extracted with CHCl3. The combined organic layers were dried (MgSO<sub>4</sub>) and evaporated. Purification by column chromatography (dichloromethane/methanol 99:1) yielded <b>12g</b> as white solid (15.1 mg, 54%). IR (NaCl): 2922, 2855, 2806, 2359, 1648, 1593, 1499, 1428, 1379, 1240, 1208, 1115 cm-1. <sup>1</sup>H NMR (CD<sub>3</sub>OD, 600 MHz, δ): 1.82–1.89 (m, 2 H), 1.89–1.94 (m, 2 H), 2.80 (t, <i>J</i> = 7.6 Hz, 2 H), 2.93–3.02 (m, 4 H), 3.11–3.20 (m, 4H), 3.85 (s, 3H), 4.13 (t, <i>J</i> = 6.0 Hz, 2 H), 6.80 (dd, <i>J</i> = 7.6 Hz, 2.7 Hz, 1 H), 6.88 (d, <i>J</i> = 0.8 Hz, 1 H), 6.91 (ddd, <i>J</i> = 7.8 Hz, 7.4 Hz, 1.9 Hz, 1 H), 6.96 (dd, <i>J</i> = 8.2 Hz, 1.4 Hz, 1 H), 6.97 (dd, <i>J</i> = 7.8 Hz, 1.6 Hz, 1 H), 7.03 (ddd, <i>J</i> = 8.1 Hz, 7.4 Hz, 1.7 Hz, 1 H), 8.45 (dt, <i>J</i> = 7.6 Hz, 0.8 Hz, 1 H). <sup>13</sup>C NMR (CD<sub>3</sub>OD, 150 MHz, δ): 23.3, 27.6, 50.6, 54.0, 56.0, 58.7, 69.4, 97.2, 102.5, 111.7, 112.9, 115.2, 119.6, 122.2, 125.1, 128.0, 130.7, 141.6, 143.4, 154.0, 158.3. HPLC (system 1): <i>t</i><sub>R</sub> = 15.1 min, purity 100%. HR-EIMS: [M<sup>+</sup>] calcd for C<sub>23</sub>H<sub>27</sub>N<sub>5</sub>O<sub>2</sub>, 405.2165; found, 405.2165.</div></div><div id="sec4_2_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i35" class="anchor-spacer"></div><h4 class="article-section__title" id="_i35"> (<i>S</i>)-6-{Propyl[4-(pyrazolo[1,5-<i>a</i>]pyridin-6-yloxy)butyl]amino}-5,6,7,8-tetrahydro naphthalen-1-ol (<i>(S)-</i><b>13a</b>)</h4><div class="NLM_p last">Compound <b>11a</b> (9.2 mg, 0.034 mmol) was dissolved in 3 mL acetonitrile and KI (8.5 mg, 0.051 mmol) was added, and the mixture was refluxed for 30 min. Then DIPEA (8.4 μL, 0.051 mmol) and a solution of (<i>S</i>)<i>-</i><b>10b</b> (9.0 mg, 0.044 mmol) in 1 mL acetonitrile were added, and the reaction mixture was heated at 85 °C for 16 h. The reaction was quenched with water and extracted three times with ethyl acetate. The organic layer was dried over anhydrous Na<sub>2</sub>SO<sub>4</sub> and evaporated in vacuo. Preparative HPLC purification employing method A (<i>t</i><sub>R</sub> = 19.5 min), yielded 8 mg (60%) of (<i>S</i>)-<b>13a</b> as colorless oil. <sup>1</sup>H NMR (600 MHz, CD<sub>3</sub>OD, δ): 1.06 (t, <i>J</i> = 7.3 Hz, 3 H), 1.77–1.87 (m, 2 H), 1.91–2.05 (m, 6 H), 2.35 (bs, 1 H), 2.63–2.69 (m, 2 H), 3.07–3.22 (m, 4 H), 3.41–3.48 (m, 1 H), 3.73–3.77 (m, 1 H), 4.14 (bs, 2 H), 6.61–6.64 (m, 2 H), 6.95–6.98 (m, 2 H), 7.04 (d, <i>J</i> = 9.4 Hz, 1 H), 7.79 (s, 1 H), 8.17 (s, 1 H), 8.43 (s, 1 H). <sup>13</sup>C NMR (90 MHz, CD<sub>3</sub>OD, δ): 11.3, 19.9, 23.2, 23.7, 25.0, 27.3, 30.9, 52.0, 54.1, 61.9, 69.2, 112.7, 113.6, 119.7, 120.4, 121.2, 123.1, 128.1, 134.7, 147.6, 149.9, 156.2, 159.7. HPLC (system 1): <i>t</i><sub>R</sub> = 17.8 min, purity 99%. [α]<sub>589</sub> = −36.0° (21 °C, c 0.5, MeOH). HRMS-ESI: [M+H<sup>+</sup>] calcd for C<sub>24</sub>H<sub>32</sub>N<sub>3</sub>O<sub>2</sub>, 394.2489; found, 394.2488. (<i>R</i>)-<b>13a</b> (8 mg, 19%, [α]<sub>589</sub> = +34.1° (21 °C, c 0.16, MeOH) was prepared from (<i>R</i>)-<b>10b</b> (17.2 mg, 0.08 mmol) as described above for (<i>S</i>)-<b>13a</b>.</div></div><div id="sec4_2_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i36" class="anchor-spacer"></div><h4 class="article-section__title" id="_i36"> (<i>S</i>)-6-{Propyl[4-(pyrazolo[1,5-<i>a</i>]pyridin-5-yloxy)butyl]amino}-5,6,7,8-tetrahydro naphthalen-1-ol ((<i>S</i>)-<b>13b</b>)</h4><div class="NLM_p last">Compound <b>11b</b> (48 mg, 0.18 mmol) was dissolved in 5 mL acetonitrile, and KI (44.4 mg, 0.27 mmol) was added. The mixture was refluxed for 30 min. Then DIPEA (32 μL, 0.19 mmol) and a solution of (<i>S</i>)-<b>10b</b> (54.9 mg, 0.27 mmol) in 1 mL acetonitrile were added, and the reaction mixture was heated at 85 °C for 16 h. The reaction was quenched with water and extracted three times with ethyl acetate. The organic layer was dried over anhydrous Na<sub>2</sub>SO<sub>4</sub> and evaporated in vacuo. Column chromatographic purification using ethyl acetate and 0.1% ammonia yielded (<i>S</i>)-<b>13b</b> as a colorless oil (16 mg, 23%). <sup>1</sup>H NMR (600 MHz, CD<sub>3</sub>OD, δ): 0.92 (t, <i>J</i> = 7.2 Hz, 3 H), 1.50–1.60 (m, 3 H), 1.67–1.72 (m, 2 H), 1.83–1.88 (m, 2 H), 2.07–2.12 (m, 1 H), 2.47–2.52 (m, 1 H), 2.55–2.57 (m, 2 H), 2.66–2.69 (m, 2 H), 2.71–2.75 (m, 1 H), 2.81–2.85 (m, 1 H), 2.92–2.99 (m, 2 H), 4.06 (t, <i>J</i> = 6.2 Hz, 2 H), 6.37 (dd, <i>J</i> = 0.8, 2.3 Hz, 1 H), 6.53–6.55 (m, 3 H), 6.88 (t, <i>J</i> = 7.7 Hz, 1 H), 6.94 (d, <i>J</i> = 2.5 Hz, 1 H), 7.82 (d, <i>J</i> = 2.3 Hz, 1 H), 8.3 (d, <i>J</i> = 7.7 Hz, 1 H). <sup>13</sup>C NMR (150 MHz, CD<sub>3</sub>OD, δ): 12.3, 22.5, 24.8, 25.8, 26.7, 28.0, 33.1, 51.3, 53.7, 58.2, 69.4, 96.7, 108.5, 112.7, 121.6, 124.3, 127.2, 129.9, 138.6, 142.9, 143.3, 155.9, 157.5. HPLC (system 1) <i>t</i><sub>R</sub> = 14.7 min, purity 96%. [α]<sub>589</sub> = −36.0° (26 °C, c 0.64, MeOH). ESI-MS: <i>m</i>/<i>z</i> 394.8 [M + H<sup>+</sup>]. HRMS-ESI: [M + H<sup>+</sup>] calcd for C<sub>24</sub>H<sub>32</sub>N<sub>3</sub>O<sub>2</sub>, 394.2489; found, 394.2488. (<i>R</i>)-<b>13b</b> (8 mg, 19%, [α]<sub>589</sub> = +26.5° (20 °C, c 0.67, MeOH) was prepared from (<i>R</i>)-<b>10b</b> (22.9 mg, 0.11 mmol) as described above for (<i>S</i>)-<b>13b</b>.</div></div><div id="sec4_2_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i37" class="anchor-spacer"></div><h4 class="article-section__title" id="_i37"> 6-{4-[4-(2-Methoxyphenyl)piperazin-1-yl]butoxy}pyrazolo[1,5-<i>a</i>]pyridine-3-carbaldehyde (<b>14a</b>)</h4><div class="NLM_p last">To a solution of <b>12a</b> (54.4 mg, 0.143 mmol) in dry DMF (0.46 mL) was added POCl3 (40 μL, 0.443 mmol). After stirring at room temperature for 1 h, the reaction was quenched by addition of ice cold water and alkalized by addition of 5 M NaOH. The mixture was extracted twice with CHCl<sub>3</sub>, and the combined organic layers were dried (Na<sub>2</sub>SO<sub>4</sub>). After evaporation, the crude product was purified by column chromatography (dichloromethane/methanol 98:2 to 95:5) to afford <b>14a</b> as an orange solid (46.3 mg, 79%). Mp: 87 °C. IR (NaCl): 3099, 2943, 2816, 1663, 1519, 1278, 1241, 1185, 748 cm<sup>–1</sup>. <sup>1</sup>H NMR (CDCl<sub>3</sub>, 600 MHz, δ): 1.71–1.79 (m, 2 H), 1.87–1.95 (m, 2 H), 2.50 (t, <i>J</i> = 7.6 Hz, 2 H), 2.66–2.70 (m, 4 H), 3.09–3.14 (m, 4 H), 3.86 (s, 3 H), 4.05 (t, <i>J</i> = 6.4 Hz, 2 H), 6.86 (dd, <i>J</i> = 8.0 Hz, 1.3 Hz, 1 H), 6.89–6.96 (m, 2 H), 7.00 (ddd, <i>J</i> = 8.0 Hz, 6.6 Hz, 2.5 Hz, 1 H), 7.30 (dd, <i>J</i> = 9.7 Hz, 2.2 Hz, 1 H), 8.15–8.18 (m, 2 H), 8.28 (s, 1 H), 9.98 (s, 1 H). <sup>13</sup>C NMR (CDCl<sub>3</sub>, 90 MHz, δ): 23.3, 27.1, 50.7, 53.5, 55.4, 58.2, 69.1, 111.3, 112.7, 113.8, 118.2, 119.0, 121.0, 122.9, 123.7, 135.5, 141.4, 146.2, 150.6, 152.3, 183.1. ESI-MS: <i>m</i>/<i>z</i> 409 [M + H<sup>+</sup>]. Anal. Calcd (%) for C<sub>23</sub>H<sub>28</sub>N<sub>4</sub>O<sub>3</sub> × 0.3 H<sub>2</sub>O: C, 66.74; H, 6.97; N, 13.54; found: C, 66.39; H, 6.76; N, 13.89.</div></div><div id="sec4_2_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i38" class="anchor-spacer"></div><h4 class="article-section__title" id="_i38"> 5-{4-[4-(2-Methoxyphenyl)piperazin-1-yl]butoxy}pyrazolo[1,5-<i>a</i>]pyridine-3-carbaldehyde (<b>14b</b>)</h4><div class="NLM_p last">Compound <b>14b</b> was prepared according to the protocol of <b>14a</b> employing a solution of <b>12b</b> (800 mg, 2.11 mmol) in dry DMF (6.74 mL) and POCl<sub>3</sub> (0.61 mL). Purification by column chromatography (dichloromethane/methanol 98:2 to 95:5) afforded <b>14b</b> as an off-white solid (840 mg, 98%) Mp: 90 °C. IR (NaCl): 2941, 2816, 1663, 1527, 1275, 1241, 1194, 772 cm<sup>–1</sup>. <sup>1</sup>H NMR (CDCl<sub>3</sub>, 600 MHz, δ): 1.72–1.77 (m, 2 H), 1.89–1.93 (m, 2 H), 2.50 (t, <i>J</i> = 7.6 Hz, 2 H), 2.67–2.70 (m, 4 H), 3.09–3.13 (m, 4 H), 3.86 (s, 3 H), 4.15 (t, <i>J</i> = 6.3 Hz, 2 H), 6.71 (dd, <i>J</i> = 7.6 Hz, 2.6 Hz, 1 H), 6.86 (dd, <i>J</i> = 7.9 Hz, 1.0 Hz, 1 H), 6.92 (ddd, <i>J</i> = 7.5 Hz, 7.0 Hz, 1.0 Hz, 1 H), 6.95 (dd, <i>J</i> = 7.5 Hz, 1.7 Hz, 1 H), 6.99 (ddd, <i>J</i> = 7.9 Hz, 7.0 Hz, 1.7 Hz, 1 H), 7.57 (d, <i>J</i> = 2.6 Hz, 1 H), 8.26 (s, 1 H), 8.37 (d, <i>J</i> = 7.6 Hz, 1 H), 9.94 (s, 1 H). <sup>13</sup>C NMR (CDCl<sub>3</sub>, 90 MHz, δ): 23.4, 26.9, 50.7, 53.5, 55.4, 58.2, 69.0, 97.8, 109.6, 111.3, 113.3, 118.3, 121.1, 123.0, 130.1, 141.4, 141.6, 147.5, 152.3, 160.7, 183.1. HR-EIMS: [M<sup>+</sup>] calcd for C<sub>23</sub>H<sub>28</sub>N<sub>4</sub>O<sub>3</sub>, 408.2161; found, 408.2164. Anal. Calcd (%) for C<sub>23</sub>H<sub>28</sub>N<sub>4</sub>O<sub>3</sub> × 0.3 H<sub>2</sub>O: C, 66.74; H, 6.97; N, 13.54; found: C, 66.62; H, 6.79; N, 13.52.</div></div><div id="sec4_2_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i39" class="anchor-spacer"></div><h4 class="article-section__title" id="_i39"> (<i>S</i>)-6-{4-[(5-Hydroxy-1,2,3,4-tetrahydronaphthalen-2-yl) (propyl)amino]butoxy} pyrazolo[1,5-<i>a</i>]pyridine-3-carbaldehyde ((<i>S</i>)-<b>15a</b>)</h4><div class="NLM_p last">Compound (<i>S</i>)-<b>13a</b> (40 mg, 0.10 mmol) was dissolved in 2 mL dry DMF before POCl<sub>3</sub> (28 μL, 0.30 mmol) was added, and the reaction mixture was stirred for 1 h at room temperature. Then the reaction mixture was cooled down to 0 °C and quenched with water, alkylized with 5 M NaOH solution, and extracted three times with dichloromethane. The organic layer was dried over anhydrous Na<sub>2</sub>SO<sub>4</sub> and evaporated in vacuo. Column chromatographic purification using ethyl acetate and methanol (8:2) yielded 35 mg (82%) of (<i>S</i>)-<b>15a</b> as colorless oil. <sup>1</sup>H NMR (600 MHz, CD<sub>3</sub>OD, δ): 0.93 (t, <i>J</i> = 7.4 Hz, 3 H), 1.51–1.62 (m, 3 H), 1.70–1.75 (m, 2 H), 1.86–1.90 (m, 2 H), 2.09–2.12 (m, 1 H), 2.47–2.52 (m, 1 H), 2.59–2.62 (m, 2 H), 2.71–2.77 (m, 3 H), 2.82–2.86 (m, 1 H), 2.94–3.00 (m, 2 H), 4.08–4.12 (m, 2 H), 6.53 (d, <i>J</i> = 7.5 Hz, 2 H), 6.87 (t, <i>J</i> = 7.4 Hz, 1 H), 7.42 (dd, <i>J</i> = 2.2, 9.5 Hz, 1 H), 8.11 (d, <i>J</i> = 9.3 Hz, 1 H), 8.40 (d, <i>J</i> = 2.2 Hz, 1 H), 8.41 (s, 1 H), 9.89 (s, 1 H). <sup>13</sup>C NMR (150 MHz, CD<sub>3</sub>OD, δ): 12.2, 22.4, 24.7, 25.6, 26.6, 28.1, 32.9, 51.3, 58.4, 61.7, 70.4, 112.7, 114.4, 114.9, 119.6, 121.5, 124.3, 125.4, 127.3, 136.7, 138.4, 147.7, 152.3, 155.9, 185.2. HPLC (system 1): <i>t</i><sub>R</sub> = 14.0 min, purity 95%. [α]<sub>589</sub> = −26.7° (28.4 °C, c 0.51, MeOH). ESI-MS: <i>m</i>/<i>z</i> 422.9 [M + H<sup>+</sup>]. HRMS-ESI: [M + H<sup>+</sup>] calcd for C<sub>25</sub>H<sub>32</sub>N<sub>3</sub>O<sub>3</sub>, 422.2438; found, 422.2433.</div></div><div id="sec4_2_11" class="NLM_sec NLM_sec_level_3"><div id="ac_i40" class="anchor-spacer"></div><h4 class="article-section__title" id="_i40"> (<i>S</i>)-5-{4-[(5-Hydroxy-1,2,3,4-tetrahydronaphthalen-2-yl) (propyl)amino]butoxy} pyrazolo[1,5-<i>a</i>]pyridine-3-carbaldehyde ((<i>S</i>)-<b>15b</b>)</h4><div class="NLM_p last">Compound (<i>S</i>)-<b>13b</b> (46 mg, 0.12 mmol) was dissolved in 2 mL dry DMF, before POCl<sub>3</sub> (32 μL, 0.35 mmol) was added, and the reaction mixture was stirred for 1 h at room temperature. Then the reaction mixture was cooled down to 0 °C and quenched with water and alkylated with 5 M NaOH solution and extracted three times with dichloromethane. The organic layer was dried over anhydrous Na<sub>2</sub>SO<sub>4</sub> and evaporated in vacuo. Column chromatographic purification using ethyl acetate and methanol (8:2) yielded 41 mg (83%) of (<i>S</i>)-<b>15b</b> as colorless oil. <sup>1</sup>H NMR (CD<sub>3</sub>OD, 600 MHz, δ): 1.00 (t, <i>J</i> = 7.2 Hz, 3 H), 1.69 (sextet, <i>J</i> = 7.5 Hz, 2 H), 1.73–1.79 (m, 1 H), 1.85–1.90 (m, 2 H), 1.94–1.98 (m, 2 H), 2.21–2.24 (m, 1 H), 2.55–2.61 (m, 1 H), 2.89–2.94 (m, 3 H), 2.97–3.06 (m, 4 H), 3.34–3.38 (m, 1 H), 4.24 (t, <i>J</i> = 6.2 Hz, 2 H), 6.58 (bd, <i>J</i> = 8.2 Hz, 2 H), 6.86 (dd, <i>J</i> = 2.9, 7.4 Hz, 1 H), 6.93 (t, <i>J</i> = 7.7 Hz, 1 H), 7.62 (d, <i>J</i> = 2.8 Hz, 1 H), 8.41 (s, 1 H), 8.56 (d, <i>J</i> = 7.6 Hz, 1 H), 9.87 (s, 1 H). <sup>13</sup>C NMR (CD<sub>3</sub>OD, 150 MHz, δ): 11.8, 21.2, 24.3, 24.4, 25.8, 27.5, 31.4, 51.6, 53.8, 60.0, 69.7, 98.6, 110.7, 113.1, 114.3, 121.4, 123.7, 127.7, 131.9, 142.9, 148.9, 156.1, 162.5, 185.3. HPLC (system 1): <i>t</i><sub>R</sub> = 14.0 min, purity 99%. [α]<sub>589</sub> = −22.5° (28 °C, c 0.48, MeOH) ESI-MS: <i>m</i>/<i>z</i> 422.9 [M + H<sup>+</sup>]. HRMS-ESI: [M + H<sup>+</sup>] calcd for C<sub>25</sub>H<sub>32</sub>N<sub>3</sub>O<sub>3</sub>, 422.2438; found, 422.2428.</div></div><div id="sec4_2_12" class="NLM_sec NLM_sec_level_3"><div id="ac_i41" class="anchor-spacer"></div><h4 class="article-section__title" id="_i41"> 6-{4-[4-(2-Methoxyphenyl)piperazin-1-yl]butoxy}lpyrazolo[1,5-<i>a</i>]pyridine-3-carbaldehydoxime (<b>16a</b>)</h4><div class="NLM_p last">Title compound <b>16a</b> was prepared according to the protocol of <b>12f</b>, employing a solution of <b>14a</b> (35 mg, 0.08 mmol) and hydroxylamine hydrochloride (12 mg, 0.16 mmol). Preparative HPLC purification of the crude product under conditions of method A (<i>t</i><sub>R</sub> = 15.9 min) yielded <b>16a</b> as a white solid (30 mg, 70%). <sup>1</sup>H NMR (600 MHz, CD<sub>3</sub>OD, δ): 1.95–1.99 (m, 2 H), 2.01–2.06 (m, 2 H), 3.05 (t, <i>J</i> = 12.3 Hz, 2 H), 3.29–3.35 (m, 4 H), 3.61 (d, <i>J</i> = 13.2 Hz, 2 H), 3.68 (d, <i>J</i> = 12.3 Hz, 2 H), 3.87 (s, 3 H), 4.14 (t, <i>J</i> = 5.9 Hz, 2 H), 6.93 (dt, <i>J</i> = 6.9, 1.3 Hz, 1 H), 7.00 (dd, <i>J</i> = 7.8, 1.3 Hz, 2 H), 7.07–7.09 (m, 1 H), 7.23 (d, J = 9.4 Hz, 1 H), 7.72 (bs, 1 H), 7.91 (d, J = 9.4 Hz, 1 H), 9.38 (s, 1 H), 8.67 (s, 1 H). <sup>13</sup>C NMR (CDCl<sub>3</sub>, 150 MHz, δ): 20.8, 26.2, 26.3, 47.7, 52.2, 55.4, 56.7, 56.8, 67.8, 68.0, 111.3, 112.7, 118.9, 120.5, 120.7, 121.2, 123.4, 124.6, 138.8, 148.9, 150.1, 152.08. HPLC (system 1): <i>t</i><sub>R</sub> = 12.1 min, purity 95%. ESI-MS: <i>m</i>/<i>z</i> 424.7 [M + H<sup>+</sup>]. HRMS-ESI: [M + H<sup>+</sup>] calcd for C<sub>23</sub>H<sub>30</sub>N<sub>5</sub>O<sub>3</sub>, 424.2343; found, 424.2341.</div></div><div id="sec4_2_13" class="NLM_sec NLM_sec_level_3"><div id="ac_i42" class="anchor-spacer"></div><h4 class="article-section__title" id="_i42"> 5-{4-[4-(2-Methoxyphenyl)piperazin-1-yl]butoxy}lpyrazolo[1,5-<i>a</i>]pyridine-3-carbaldehydoxime (<b>16b</b>, <b>16c</b>)</h4><div class="NLM_p last">Compounds <b>16b</b> and <b>16c</b> were prepared according to the protocol of <b>12f</b>, employing a solution of hydroxylamine hydrochloride (30.1 mg, 0.433 mmol) in distilled water (1.2 mL) and 2 M NaOH (0.11 mL, 0.22 mmol), as well as a solution of <b>14b</b> (88.4 mg, 0.217 mmol) in ethanol (10.9 mL). Purification of the crude product by column chromatography (dichloromethane/methanol 98:2 to 95:5) separately afforded the <i>s-trans</i> isomer <b>16b</b> (42 mg, 46%) and the <i>s-cis</i> isomer <b>16c</b> (39 mg, 43%) in a 1:1 ratio. Analytical data for <b>16b</b>: Mp: 77 °C. IR (NaCl): 3257, 3064, 2945, 2823, 1647, 1541, 1269, 1242, 1026, 750 cm<sup>–1</sup>. <sup>1</sup>H NMR (CDCl<sub>3</sub>, 360 MHz, δ): 1.78–1.83 (m, 2 H), 1.86–1.90 (m, 2 H), 2.55 (t, <i>J</i> = 7.6 Hz, 2 H), 2.71–2.77 (m, 4 H), 3.14–3.20 (m, 4 H), 3.87 (s, 3 H), 4.05 (t, <i>J</i> = 6.3 Hz, 2 H), 6.45 (dd, <i>J</i> = 7.6 Hz, 2.6 Hz, 1 H), 6.86 (dd, <i>J</i> = 7.9 Hz, 1.0 Hz, 1 H), 6.91 (ddd, <i>J</i> = 7.5 Hz, 7.0 Hz, 1.0 Hz, 1 H), 6.96 (dd, <i>J</i> = 7.5 Hz, 2.0 Hz, 1 H), 7.00 (ddd, <i>J</i> = 7.9 Hz, 7.0 Hz, 2.0 Hz, 1 H), 7.20 (d, <i>J</i> = 2.6 Hz, 1 H). 7.93 (s, 1 H), 8.22 (d, <i>J</i> = 7.6 Hz, 1 H), 8.27 (s, 1 H), free OH n. d. <sup>13</sup>C NMR (CDCl<sub>3</sub>, 90 MHz, δ): 23.3, 27.0, 50.4, 53.4, 55.4, 58.3, 68.3, 97.2, 103.7, 107.9, 111.2, 118. 4, 121.1, 123.1, 129.5, 138.6, 141.1, 143.3, 143.6, 152.3, 157.6. ESI-MS: 423 [M<sup>+</sup>]. Anal. Calcd (%) for C<sub>23</sub>H<sub>29</sub>N<sub>5</sub>O<sub>3</sub> × 0.5 H<sub>2</sub>O: C, 63.87; H, 6.99; N, 16.19; found: C, 63.88; H, 6.88; N, 16.02. Analytical data for <b>16c</b>: Mp: 138 °C. IR (NaCl): 3324, 2945, 2821, 1647, 1541, 1238, 1026, 750 cm<sup>–1</sup>. <sup>1</sup>H NMR (CDCl<sub>3</sub>, 600 MHz, δ): 1.74–1.82 (m, 2 H), 1.87–1.94 (m, 2 H), 2.54 (t, <i>J</i> = 7.6 Hz, 2 H), 2.70–2.75 (m, 4 H), 3.12–3.18 (m, 4 H), 3.87 (s, 3 H), 4.08 (t, <i>J</i> = 6.3 Hz, 2 H), 6.54 (dd, <i>J</i> = 7.6 Hz, 2.6 Hz, 1 H), 6.86 (dd, <i>J</i> = 7.9 Hz, 1.0 Hz, 1 H), 6.88–7.02 (m, 4 H), 7.50 (s, 1 H), 8.30 (d, <i>J</i> = 7.6 Hz, 1 H), 8.67 (s, 1 H), free OH n. d. <sup>13</sup>C NMR (CDCl<sub>3</sub>, 90 MHz, δ): 23.3, 26.9, 50.5, 53.5, 55.4, 58.1, 68.4, 94.4, 102.4, 107.7, 111.3, 118.3, 121.1, 123.0, 129.9, 137.9, 140.5, 141.3, 146.2, 152.3, 157.6. ESI-MS: 423 [M<sup>+</sup>]. Anal. Calcd (%) for C<sub>23</sub>H<sub>29</sub>N<sub>5</sub>O<sub>3</sub> × 0.7 H<sub>2</sub>O: C, 63.34; H, 7.03; N, 16.06; found: C, 63.21; H, 6.77; N, 15.90.</div></div><div id="sec4_2_14" class="NLM_sec NLM_sec_level_3"><div id="ac_i43" class="anchor-spacer"></div><h4 class="article-section__title" id="_i43"> (<i>S</i>)-6-{4-[(5-Hydroxy-1,2,3,4-tetrahydronaphthalen-2-yl) (propyl)amino]butoxy} pyrazolo[1,5-<i>a</i>]pyridine-3-carbaldehyde oxime (<i>(S)-</i><b>17a</b>)</h4><div class="NLM_p last">Title compound (<i>S</i>)-<b>17a</b> was prepared according to the synthesis of <b>12f</b>, employing (<i>S</i>)-<b>15a</b> (19 mg, 0.04 mmol) and hydroxylamine hydrochloride (6 mg, 0.10 mmol). Column chromatographic purification (ethyl acetate/methanol 95:5) yielded (<i>S</i>)-<b>17a</b> as a colorless oil (15 mg, 76%). <sup>1</sup>H NMR (CDCl<sub>3</sub>, 600 MHz, δ): 0.95 (t, <i>J</i> = 7.3 Hz, 3 H), 1.57–1.68 (m, 3 H), 1.74–1.80 (m, 2 H), 1.86–1.91 (m, 2 H), 2.14–2.17 (m, 1 H), 2.50–2.56 (m, 1 H), 2.71–2.74 (m, 2 H), 2.79–2.85 (m, 3 H), 2.88–2.92 (m, 1 H), 2.97–3.01 (m, 1 H), 3.11–3.15 (m, 1 H), 4.07 (q, <i>J</i> = 6.0 Hz, 2 H), 6.53 (dd, <i>J</i> = 3.0, 7.6 Hz, 0.15 H), 6.56 (d, <i>J</i> = 7.7 Hz, 2 H), 6.89 (t, <i>J</i> = 7.7 Hz, 1 H), 6.94 (d, <i>J</i> = 2.7 Hz, 0.15 H), 7.13 (dd, <i>J</i> = 2.2, 9.6 Hz, 0.4 H), 7.17 (dd, <i>J</i> = 2.2, 9.6 Hz, 0.4 H), 7.60 (s, 0.4 H), 7.82 (d, <i>J</i> = 2.7 Hz, 0.15 H), 7.83 (d, <i>J</i> = 9.8 Hz, 0.4 H), 7.92 (d, <i>J</i> = 9.8 Hz, 0.4 H), 7.98 (s, 0.4 H), 8.19 (d, <i>J</i> = 2.0 Hz, 0.4 H), 8.21 (d, <i>J</i> = 2.0 Hz, 0.4 H), 8.24 (s, 0.4 H), 8.30 (d, <i>J</i> = 8.0 Hz, 0.15 H), 8.63 (s, 0.4 H). <sup>13</sup>C NMR (CD<sub>3</sub>OD, 150 MHz, δ): 12.1, 14.5, 20.9, 21.9, 24.6, 25.2, 26.3, 27.9, 28.0, 32.6, 51.5, 53.8, 59.1, 61.6, 69.9, 70.0, 96.8, 106.9, 108.5, 112.9, 113.0, 113.1, 117.9, 120.2, 121.5, 124.1, 127.5, 134.9, 136.7, 137.7, 142.0, 143.5, 145.2, 151.1, 156.0. HPLC (system 1): <i>t</i><sub>R</sub> = 14.1 min, purity 96%. ESI-MS: <i>m</i>/<i>z</i> 437.9 [M + H<sup>+</sup>]. HRMS-ESI: [M + H<sup>+</sup>] calcd for C<sub>25</sub>H<sub>33</sub>N<sub>4</sub>O<sub>3</sub>, 437.2547; found, 437.2546.</div></div><div id="sec4_2_15" class="NLM_sec NLM_sec_level_3"><div id="ac_i44" class="anchor-spacer"></div><h4 class="article-section__title" id="_i44"> (<i>S</i>)-5-{4-[(5-Hydroxy-1,2,3,4-tetrahydronaphthalen-2-yl) (propyl)amino]butoxy} pyrazolo[1,5-<i>a</i>]pyridine-3-carbaldehyde oxime ((<i>S</i>)-<b>17b</b>)</h4><div class="NLM_p last">Title compound (<i>S</i>)-<b>17b</b> was prepared according to the protocol of <b>12f</b>, employing (<i>S</i>)-<b>15b</b> (41 mg, 0.10 mmol) and hydroxylamine hydrochloride (13 mg, 0.20 mmol). Column chromatographic purification (ethyl acetate) yielded (<i>S</i>)-<b>17b</b> as a colorless oil (15 mg, 35%). <sup>1</sup>H NMR (CDCl<sub>3</sub>, 600 MHz, δ): 0.93 (t, <i>J</i> = 7.4 Hz, 3 H), 1.55–1.59 (m, 2 H), 1.63–1.75 (m, 3 H), 1.81–1.88 (m, 2 H), 2.14–2.18 (m 1 H), 2.55–2.61 (m, 3 H), 2.69–2.71 (m, 2 H), 2.79–2.84 (m, 1 H), 2.90–2.92 (m, 1 H), 2.95–3.00 (m, 1 H), 3.06–3.10 (m, 1 H), 3.99–4.03 (m, 2 H), 6.51 (dd, <i>J</i> = 2.7, 7.4 Hz, 1 H), 6.63 (d, <i>J</i> = 7.4 Hz, 1 H), 6.67 (d, <i>J</i> = 7.4 Hz, 1 H), 6.98 (t, <i>J</i> = 7.4 Hz, 1 H), 7.22 (d, <i>J</i> = 2.8 Hz, 1 H), 7.94 (s, 1 H), 8.27 (d, <i>J</i> = 7.7 Hz, 1 H), 8.29 (s, 1 H). <sup>13</sup>C NMR (CDCl<sub>3</sub>), 90 MHz, δ): 11.9, 14.2, 21.0, 23.6, 25.3, 26.8, 31.4, 50.1, 52.4, 60.4, 68.4, 97.3, 103.5, 108.0, 112.1, 121.7, 122.9, 126.5, 129.6, 137.9, 138.7, 143.4, 144.0, 153.6, 157.4. HPLC (system 1): <i>t</i><sub>R</sub> = 13.7 min, purity 98%. ESI-MS: <i>m</i>/<i>z</i> 437.9 [M + H<sup>+</sup>]. HRMS-ESI: [M + H<sup>+</sup>] calcd for C<sub>25</sub>H<sub>33</sub>N<sub>4</sub>O<sub>3</sub>, 437.2547; found, 437.2549.</div></div><div id="sec4_2_16" class="NLM_sec NLM_sec_level_3"><div id="ac_i45" class="anchor-spacer"></div><h4 class="article-section__title" id="_i45"> 5-{4-[4-(2-Methoxyphenyl)piperazin-1-yl]butoxy}lpyrazolo[1,5-<i>a</i>]pyridine-3-carbonitrile (<b>18</b>)</h4><div class="NLM_p last">A solution of <b>16b</b>/<b>c</b> (40.1 mg, 0.095 mmol) in acetic acid anhydride (0.47 mL) was refluxed for 7 h. After cooling, the reaction mixture was diluted with ice cold water and extracted with CH<sub>2</sub>Cl<sub>2</sub>. The combined organic layers were dried (Na<sub>2</sub>SO<sub>4</sub>) and evaporated in vacuo. Purification by column chromatography (dichloromethane/methanol 98:2 to 95:5) afforded <b>18</b> as white solid (31 mg, 79%) Mp: 92 °C. IR (NaCl): 3070, 2937, 2816, 2219, 1648, 1542, 1240, 1028, 749 cm<sup>–1</sup>. <sup>1</sup>H NMR (CDCl<sub>3</sub>, 360 MHz, δ): 1.71–1.80 (m, 2 H), 1.88–1.96 (m, 2 H), 2.52 (t, <i>J</i> = 8.0 Hz, 2 H), 2.68–2.72 (m, 4 H), 3.10–3.14 (m, 4 H), 3.86 (s, 3 H), 4.11 (t, <i>J</i> = 6.1 Hz, 2 H), 6.66 (dd, <i>J</i> = 7.6 Hz, 2.6 Hz, 1 H), 6.86 (dd, <i>J</i> = 7.8 Hz, 1.4 Hz, 1 H), 6.91–6.96 (m, 3 H), 7.02 (ddd, <i>J</i> = 7.8 Hz, 6.8 Hz, 2.5 Hz, 1 H), 8.10 (s, 1 H), 8.34 (d, <i>J</i> = 7.6 Hz, 1 H). <sup>13</sup>C NMR (CDCl<sub>3</sub>, 90 MHz, δ): 23.3, 26.9, 50.6, 53.5, 55.4, 58.1, 69.0, 80.9, 95.0, 109.3, 111.3, 114.5, 118.3, 121.1, 123.0, 130.5, 141.4, 144.4, 145.6, 152.4, 159.3. HPLC (system 1): <i>t</i><sub>R</sub> = 14.9 min, purity >99%. HR-EIMS: [M<sup>+</sup>] calcd for C<sub>23</sub>H<sub>27</sub>N<sub>5</sub>O<sub>2</sub>, 405.2165; found, 405.2168.</div></div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i46" class="anchor-spacer"></div><h3 class="article-section__title" id="_i46"> Membrane Preparations</h3><div class="NLM_p last">Membranes were obtained using a previously described protocol.<a onclick="showRef(event, 'ref75'); return false;" href="javascript:void(0);" class="ref ref75">(75)</a> Briefly, HEK293T cells were grown to a confluence of 70% and transiently transfected with the receptor of interest with or without cotransfection of a PTX insensitive Gα subunit using the Mirus TransIT-293 transfection reagent (MoBiTec, Goettingen, Germany) or CaHPO<sub>4</sub> precipitation. Forty-eight hours after transfection, cells were washed with ice cold phosphate-buffered saline (PBS, pH 7.4) and detached with harvest buffer (10 mM Tris-HCl, 0.5 mM EDTA, 5.4 mM KCl, 140 mM NaCl, pH 7.4). After centrifugation (8 min, 220<i>g</i>) the pellet was resuspended in 10 mL ice cold homogenate buffer (50 mM Tris-HCl, 5 mM EDTA, 1.5 mM CaCl<sub>2</sub> 5 mM MgCl<sub>2</sub>, 5 mM KCl, 120 mM NaCl, pH 7.4), and cells were lysed with an ultraturrax. After ultracentrifugation (30 min, 50000<i>g</i>), membranes were resuspended in binding buffer (50 mM Tris-HCl, 1 mM EDTA, 5 mM MgCl<sub>2</sub>, 100 μg/mL bacitracin, 5 μg/mL soybean trypsin inhibitor, pH 7.4) and homogenized with a glass-Teflon homogenizer at 4 °C. Membrane preparations were shock-frozen in liquid nitrogen and stored at −80 °C. The protein concentration was determined with the method of Lowry,<a onclick="showRef(event, 'ref76'); return false;" href="javascript:void(0);" class="ref ref76">(76)</a> applying bovine serum albumin as a standard. Membranes from stably transfected CHO cells were obtained in an analogous manner.</div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i47" class="anchor-spacer"></div><h3 class="article-section__title" id="_i47"> Competition Binding Experiments</h3><div class="NLM_p last">Receptor binding studies were carried out as described previously.<a onclick="showRef(event, 'ref77'); return false;" href="javascript:void(0);" class="ref ref77">(77)</a> Briefly, for competition binding experiments with the human D<sub>2L</sub>,R, D<sub>2S</sub>R, D<sub>3</sub>R, and D<sub>4</sub>R, preparations of membranes from CHO cells stably expressing the corresponding receptors were used together with [<sup>3</sup>H]spiperone (specific activity of 81 Ci/mmol, PerkinElmer, Rodgau, Germany) at a final concentration of 0.10–0.30 nM (<i>K</i><sub>D</sub> = 0.03–0.085, 0.085–0.18, 0.03–0.095, and 0.13–0.29 nM, respectively). Competition binding experiments with the human D<sub>1</sub>R and 5-HT<sub>2A</sub>R were performed in an analogous manner with membranes from transiently transfected HEK293T cells together with [<sup>3</sup>H]SCH23990 (60 Ci/mmol, Biotrend, Cologne, Germany, final concentration 0.40–0.50 nM, <i>K</i><sub>D</sub> = 0.32–0.48 nM) or [<sup>3</sup>H]ketanserin (53 Ci/mmol, PerkinElmer, final concentration = 0.20–0.50 nM, <i>K</i><sub>D</sub> = 0.19–0.40 nM), respectively. Binding studies with porcine α<sub>1</sub>R or 5-HT<sub>1A</sub>R were carried out as described previously with homogenates from porcine cerebral cortex,<a onclick="showRef(event, 'ref77'); return false;" href="javascript:void(0);" class="ref ref77">(77)</a> in the presence of the radioligands [<sup>3</sup>H]prazosin (83 Ci/mmol, PerkinElmer, 0.10–0.20 nM final concentration, <i>K</i><sub>D</sub> = 0.040–0.087 nM) or [<sup>3</sup>H]WAY100635 (80 Ci/mmol, Biotrend, 0.30 nM final concentration, <i>K</i><sub>D</sub> = 0.030–0.060 nM). Resulting competition curves were analyzed by nonlinear regression using the algorithms in PRISM 6.0 (GraphPad software, San Diego, CA). The data were fit using a sigmoid model to provide an IC<sub>50</sub> value which was transformed into a <i>K</i><sub>i</sub> value employing the equation of Cheng and Prusoff.<a onclick="showRef(event, 'ref78'); return false;" href="javascript:void(0);" class="ref ref78">(78)</a></div></div><div id="sec4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i48" class="anchor-spacer"></div><h3 class="article-section__title" id="_i48"> [<sup>35</sup>S]GTPγS Binding Experiments</h3><div class="NLM_p last">[<sup>35</sup>S]GTPγS incorporation assays were performed as described previously.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> Membranes from HEK293T cells transiently transfected with D<sub>2S</sub>R or D<sub>3</sub>R and G protein subunits Gα<sub>oA</sub> or Gα<sub>i2</sub> (protein concentration 30 μg/mL) were incubated with 10 μM GDP and the test compounds in incubation buffer (20 mM HEPES, 10 mM MgCl<sub>2</sub>·6H<sub>2</sub>O, 100 mM NMDG, and 70 mg/L saponin) for 30 min at 37 °C in a final volume of 200 μL. After the addition of 0.1 nM [<sup>35</sup>S]GTPγS (1250 Ci/mmol, PerkinElmer), incubation was continued for another 75 min at 37 °C (30 min for D<sub>2S</sub> + Gα<sub>oA</sub>). The reaction was terminated by filtration through Whatman GF/B filters soaked with ice cold PBS. Bound radioactivity was measured as described previously.<a onclick="showRef(event, 'ref75'); return false;" href="javascript:void(0);" class="ref ref75">(75)</a> Four to six experiments per compound were performed with each concentration (0.1 pM to 10 μM) in triplicate. Dose response curves were analyzed using the algorithms for nonlinear regression in Prism 6.0. All responses were normalized to the reference agonist quinpirole (100%) and buffer conditions (0%).</div></div><div id="sec4_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i49" class="anchor-spacer"></div><h3 class="article-section__title" id="_i49"> PathHunter Assay</h3><div class="NLM_p last">D<sub>2S</sub>R-mediated β-arrestin-2 recruitment was determined using the PathHunter assay (DiscoveRx, Birmingham, U.K.) as described previously.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> In brief, HEK293 cells stably expressing the enzyme acceptor (EA) tagged β-arrestin-2 fusion protein were transiently transfected with the ProLink tagged D<sub>2S</sub>R-ARMS2-PK2 construct employing Mirus TransIT-293. Twenty-four hours after transfection, cells were detached from the culture dish with Versene (Life Technologies, Darmstadt, Germany), seeded into 384-well plates (5000 cells/well), and maintained for 24 h at 37 °C, 5% CO<sub>2</sub>. After incubation with the test compounds dissolved in PBS for 5 h at 37 °C, the detection mix was added and incubation was continued for a further 60 min at room temperature. Chemiluminescence was determined using the Victor<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a>-V plate reader (PerkinElmer, Rodgau, Germany). Three to eight experiments per compound were performed, with each concentration in duplicate. All responses were normalized to the effect of 10 μM quinpirole (100%) and buffer conditions (0%).</div></div><div id="sec4_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i50" class="anchor-spacer"></div><h3 class="article-section__title" id="_i50"> Bioluminescence Resonance Energy Transfer</h3><div class="NLM_p last">D<sub>2S</sub>, D<sub>2L</sub>, and D<sub>3</sub> receptor-mediated activation of Gα<sub>i/o</sub> proteins was determined employing BRET<sup>2</sup>-biosensors based on the separation of RLucII-Gα and Gβγ-GFP10 as previously described.<a onclick="showRef(event, 'ref39 ref40 ref41 ref42'); return false;" href="javascript:void(0);" class="ref ref39 ref40 ref41 ref42">(39-42)</a> Recruitment of RLucII-β-arrestin-1 and RLucII-β-arrestin-2 was determined employing a recently described protocol based on bystander BRET with CAAX-rGFP.<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a> Briefly, HEK293 cells were seeded into 12-well plates (1.2 mL/2.4 × 10<sup>5</sup> cells/mL) in DMEM supplemented with 10% FBS, 100 μg/mL penicillin, and 100 μg/mL streptomycin and transfected using a solution of polyethylenimine in PBS (PEI, linear 25 kDa, Polysciences, 1 mg/mL) as a transfection reagent at a 3:1 PEI to cDNA ratio. Cells were simultaneously transfected with N-terminal FLAG-tagged D<sub>2L</sub>R, D<sub>2S</sub>R, or D<sub>3</sub>R, RLucII-Gα<sub>i1–3</sub> or RLucII-Gα<sub>oA/B</sub>, Gβ<sub>1</sub> and Gγ<sub>2</sub>-GFP10, or FLAG-tagged D<sub>2L</sub>R, D<sub>2S</sub>R, RLucII-β-arrestin-1 or RLucII-β-arrestin--2 and CAAX-rGFP, respectively. The total amount of cDNA was kept at 1 μg cDNA/well by addition of single-stranded salmon sperm DNA (Sigma-Aldrich). Transfected cells were transferred to white 96-well plates (100 μL/well, Greiner, Frickenhausen, Germany) pretreated with poly-<span class="smallcaps smallerCapital">d</span>-lysine (0.1 mg/mL, MP-Biomedicals, Illkirch, France) and incubated at 37 °C, 5% CO<sub>2</sub>. Forty-eight hours after transfection, cells were rinsed with PBS twice and incubated with 90 μL tyrode’s buffer (137 mM NaCl, 0.9 mM KCl, 1 mM MgCl<sub>2</sub>·6H<sub>2</sub>O, 1 mM CaCl<sub>2</sub>, 11.9 mM NaH<sub>2</sub>PO<sub>4</sub>, 5.5 mM <span class="smallcaps smallerCapital">d</span>-glucose, 3.6 mM NaHCO<sub>3</sub>, 25 mM HEPES, pH 7.4) at 37 °C for 1–2 h. For each combination of biosensors, BRET titration experiments were performed to determine optimal donor/acceptor cDNA ratios.<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> A constant amount of RlucII-tagged donor cDNA was coexpressed with increasing amounts of GFP10- or rGFP-tagged acceptor cDNA, respectively. GFP-fluorescence was determined on a FLEX-stationII (PerkinElmer) with an excitation wavelength of 400 nm and emission wavelength at 515 nm for GFP10 or 480 and 538 nm for rGFP. For G protein activation, cells were incubated with 10 μM dopamine or vehicle for 10 min at 37 °C. For β-arrestin recruitment, incubation time was increased to 15 min. Coelenterazine 400a (DBC, 2.5 μM final concentration) was added 5 min before the BRET measurement. BRET readings were obtained on a NeoSynergy (Biotek Instruments, Bad Friedrichshall, Germany) with the respective filter set (donor 410 ± 80 nm and acceptor 515 ± 30 nm) as the ratio of the light emitted by the acceptor (GFP10 or rGFP) divided by signal from the light emitted by the donor (RLucII). Specific BRET (netBRET) was determined as the difference of the observed absolute BRET and the BRET occurring in the absence of any fluorescent acceptor protein. Saturation curves were obtained in the absence and presence of 10 μM dopamine by plotting the specific BRET over the ratio of fluorescence (determined on FLEX-stationII) over luminescence determined at 410 nm. Data was analyzed using the algorithms for specific one-site binding in PRISM 6.0. Three independent experiments were performed, with each donor/acceptor ratio in quadruplicates. For dose–response curves, optimal transfection conditions were derived from the titration experiments. Ligand-induced changes in the BRET signal (ΔBRET) were calculated as the difference between the BRET ratio obtained under vehicle conditions and the BRET ratio obtained with addition of ligands. Dose–response curves were fitted using the algorithms for three parameter nonlinear regression in PRISM 6.0. Responses were normalized to the effect of 10 μM quinpirole (100%) and vehicle (0%). Three to eight experiments per compound were performed, with each concentration in duplicate.</div></div><div id="sec4_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i51" class="anchor-spacer"></div><h3 class="article-section__title" id="_i51"> Bias Quantification</h3><div class="NLM_p last">The operational model of agonism<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> was used to quantify ligand bias following recently published protocols.<a onclick="showRef(event, 'ref45 ref79'); return false;" href="javascript:void(0);" class="ref ref45 ref79">(45, 79)</a> In brief, transduction ratios (τ/K<sub>A</sub>) were obtained in their logarithmic form from data analysis with the algorithms implemented in PRISM6.0. Thus, normalized data for the activation of Gα<sub>oA</sub> (recorded by BRET) and the recruitment of β-arrestin-2 (determined in the PathHunter assay) were analyzed using the following equation:<span class="NLM_disp-formula" id="ueq1"><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01857/20170407/images/jm-2016-01857v_m001.gif" alt="" /></img></span>with basal being the response of a the system in the absence of an agonist, <i>E</i><sub>m</sub> the maximal response, [<i>X</i>] the concentration of the agonist, and <i>n</i> the transducer slope. Parameters <i>E</i><sub>m</sub> and <i>n</i> were globally shared during the analysis, while basal was constrained to zero. Transduction coefficients (τ/<i>K</i><sub>A</sub>) were then normalized to the response of the reference agonist quinpirole to account for cell-system-dependent factors between different assay systems using<span class="NLM_disp-formula" id="ueq2"><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01857/20170407/images/jm-2016-01857v_m002.gif" alt="" /></img></span>separately for each ligand and investigated signaling pathway. Determination of bias was performed by calculation of the difference for two investigated pathways for the same ligand:<span class="NLM_disp-formula" id="ueq3"><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01857/20170407/images/jm-2016-01857v_m003.gif" alt="" /></img></span><span class="NLM_disp-formula" id="ueq4"><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01857/20170407/images/jm-2016-01857v_m004.gif" alt="" /></img></span>Standard errors were estimated as described previously<a onclick="showRef(event, 'ref79'); return false;" href="javascript:void(0);" class="ref ref79">(79)</a> using the following equation:<span class="NLM_disp-formula" id="ueq5"><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01857/20170407/images/jm-2016-01857v_m005.gif" alt="" /></img></span>Statistical significance was calculated using one-way ANOVA followed by Dunnett’s posthoc test at the level of ΔΔlog(τ/<i>K</i><sub>A</sub>) and accepting <i>p</i> < 0.05 as the level of significance.</div></div><div id="sec4_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i52" class="anchor-spacer"></div><h3 class="article-section__title" id="_i52"> Electrophysiological Recordings</h3><div class="NLM_p last">Activation of GIRK1/2 (Kir3.1/3.2) channels by D<sub>2L</sub>R or D<sub>3</sub>R was assessed in the analogy to a previously described protocol involving GIRK1/2 and Gα<sub>i/o</sub>-coupled 5-HT<sub>1A</sub>R.<a onclick="showRef(event, 'ref59'); return false;" href="javascript:void(0);" class="ref ref59">(59)</a> Forty-eight hours before the experiment, HEK293T were transfected with the receptor of interest, a plasmid encoding GIRK1/2 and GFP employing Mirus TransIT-293. A total amount of 900 ng cDNA was used per culture dish (⌀ 6 cm). On the day of the experiment, cells were detached using Versene and distributed into 35 mm dishes (BD Falcon) containing fresh medium (DMEM/F-12, 10% FBS, 100 μg/mL penicillin, 100 μg/mL streptomycin, and 0.5 mg/mL <span class="smallcaps smallerCapital">l</span>-glutamine, Gibco, Life Technologies). Cells were allowed to attach for at least 30 min. Cells were washed twice with high K<sup>+</sup> bath solution (120 mM KCl, 5 mM NaCl, 2 mM CaCl<sub>2</sub>, 2 mM MgCl<sub>2</sub>, 5 mM HEPES, 10 mM glucose, 50 mM mannitol, pH 7.4, 315–330 mosmol/L) and covered with 2 mL of the bath solution for the recordings. All recordings were performed at room temperature (20–22 °C) in one-pipet whole-cell configuration and in the voltage clamp mode. Transfected cells were identified by detection of the eGFP fluorescence under an inverted microscope. Recordings were sampled at 20 kHz and filtered at 5 kHz employing a Multiclamp 700B Amplifier and an Axon Digidata 1332A interface (Axon instruments, Molecular Devices, Biberach, Germany) with pClamp 10.3 or 10.4 software. Borosilicate capillaries were pulled to patch pipettes with a resistance of 2.5–3.5 MΩ when filled with internal solution (135 mM potassium gluconate, 2 mM NaCl, 3 mM MgCl<sub>2</sub>, 5 mM HEPES, 5 mM EGTA, 0.3 mM Na GTP, 2 mM Na<sub>2</sub>ATP, pH 7.2, 315–330 mosmol/L) employing a DMZ-Universal puller (Zeitz-Instruments, Martinsried, Germany). After obtaining the whole-cell configuration, access resistance was typically in the range of 2.5–5 MΩ before series resistance compensation (75%). Cells showed a typical capacitance of 10–20 pF. Recordings were started no earlier than 3 min after obtaining whole-cell access. Drugs were applied with a puff-pipet with a pressure of 1 bar. Puff-pipettes for the delivery of drugs were pulled under the same conditions used for the patch pipettes and were made from borosilicate capillaries with an internal filament. Antagonist solutions or the channel blocker Ba<sup>2+</sup> (2 mM) were manually added to the bath solution. Recordings were either performed at a constant holding potential of −70 mV or with a voltage ramp from −120 mV to +60 mV executed within 1.1 s. Data analysis was performed using pClamp10.3 and PRISM 6.0. For the quantification of absolute currents, results from the voltage ramp protocols at the time point corresponding to −80 mV were used. Statistical analysis was performed with PRISM 6.0 applying one-way analysis of variance (one-way ANOVA) followed by a post hoc Tukey’s test for multiple comparisons. Data are expressed as mean ± SEM, and <i>p</i> < 0.05 was accepted as the level of significance.</div></div><div id="sec4_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i53" class="anchor-spacer"></div><h3 class="article-section__title" id="_i53"> Animal Studies</h3><div class="NLM_p last">All experiments were carried out with the agreement of Animal Protection Law of the Federal Republic of Germany and the European Communities Council Directive of 24 November 1986 (86/609/EEC). Male Sprague–Dawley rats (Charles River, Germany) weighing 300–350 g at the beginning of the experiment were housed four animals per cage with food and water ad libitum. The housing room was maintained at 22 ± 2 °C and a relative humidity of 55 ± 10%, under a 12 h/12 h light-dark cycle (lights on from 7am to 7 pm). Experiments were carried out in the lights on phase only. After handling and habituating the animals to the testing equipment, 44 animals were randomly divided into four groups, with three groups receiving intra peritoneal (i.p.) injections of escalating doses of <span class="smallcaps smallerCapital">d</span>-amphetamine sulfate in 0.9% saline (AMPH; 1 mL/kg; Fagron, <i>n</i> = 33) and the other group receiving i.p. injections of 0.9% saline (SAL; 1 mL/kg, <i>n</i> = 11) three times per day (9am; 1 pm and 5 pm) for 6 days. The concentration of AMPH was increased from 1 to 8 mg/kg during the first eight injections and sustained at 8 mg/kg for the following ten injections.<a onclick="showRef(event, 'ref62'); return false;" href="javascript:void(0);" class="ref ref62">(62)</a><b>1a</b> (Sigma-Aldrich, Germany, 1.5 mg/kg/day) and <b>16c</b> (1.5 mg/kg/day) were dissolved in a 2% glacial acetic acid/H<sub>2</sub>O with 25% DMSO. Drugs or vehicle (VEH, glacial acetic acid/H<sub>2</sub>O, 25% DMSO) were administered via an Alzet osmotic mini pump (model 2ML1; 7 day delivery; DURECT Corporation). Alzet pumps were implanted 1 day after the last AMPH or SAL injection under isoflurane (Baxter Germany GMBH; 5% induction, 2% maintenance) anesthesia mixed with oxygen, which was administered by a nose cone. A small skin incision was made on the lower back of each animal, and a small pocket was formed by loosening the subcutaneous connective tissues with a hemostat. The pump was inserted with the flow moderator pointing away from the incision. The incision was closed using surgical staples and disinfected with aluminum spray.<a onclick="showRef(event, 'ref80'); return false;" href="javascript:void(0);" class="ref ref80">(80)</a> SAL-injected animals received VEH treatment, and the AMPH-injected animals received VEH, <b>1a</b> (1.5 mg/kg/day) or <b>16c</b> (1.5 mg/kg/day) treatment, which resulted in four treatment groups: SAL/VEH (<i>n</i> = 11), AMPH/VEH (<i>n</i> = 12), AMPH/<b>1a</b> (<i>n</i> = 12), and AMPH/<b>16c</b> (<i>n</i> = 9).</div></div><div id="sec4_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i54" class="anchor-spacer"></div><h3 class="article-section__title" id="_i54"> Amphetamine-Induced Hyperactivity</h3><div class="NLM_p last">AMPH-induced hyperlocomotion was tested in an open field (OF). Animals were allowed to freely explore a cubic gray acrylic arena with the dimensions of 50 × 50 × 50 cm with evenly distributed 25 lx white light. The central zone was defined as a square that resided in the center of the box with the dimensions of 25 × 25 cm. The activities of the animals were recorded by video and analyzed using Biobserve Viewer III (Biobserve GMBH, Germany). The horizontal locomotion and central zone duration were measured using Biobserve Viewer III software, whereas the vertical activity was determined manually. When an animal raised both of its front legs, this activity was considered as a vertical activity. Each parameter was measured in blocks of 5 min. Animals were allowed to habituate twice to an OF apparatus in 20 min sessions before the AMPH-sensitization procedure. Seven days after the mini pump implantation, animals were tested in the OF. First, the baseline activity of the animals was assessed for 20 min. After this period, each animal was i.p. injected with 1.5 mg/kg AMPH, and their locomotor activities and anxiety-related behaviors were measured for 20 min. AMPH-induced effects were normalized to the activity during the last 5 min of the baseline period. The AMPH-induced activity was calculated as delta (Δ) from this baseline interval.</div></div><div id="sec4_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i55" class="anchor-spacer"></div><h3 class="article-section__title" id="_i55"> Light-Induced Activity (LIA)</h3><div class="NLM_p last">Five days after the mini pump implantation, the light-induced activity test was conducted to determine horizontal and vertical activities of animals induced by a white light stimulus. Therefore, a commercialized TruScan system arena (Coulbourn Instruments, Allentown, PA) was used to measure the behavioral activity by a light beam system within a 40 × 40 × 39 cm open field box, which was situated in a sound- and light-isolated room. The horizontal activity was measured by the number of interruptions of the two-dimensional (X and Y) beams (located 3 cm above the floor of the box) detected automatically by a computer. The vertical activity was measured by the disruptions of the light beams located 12 cm above the floor of the test box. The test boxes were illuminated by 2.6 lx red light throughout the experimental session. A fluorescent lamp (16W, 82 lx), which was mounted on the top of the test box, was used for white light stimulation.<a onclick="showRef(event, 'ref64 ref66'); return false;" href="javascript:void(0);" class="ref ref64 ref66">(64, 66)</a> For the first 20 min, animals were habituated to the test box in the absence of light induction. This baseline period was followed by a 20 min test session, in which 10 randomly distributed light stimuli (82 lx) with 30 s duration were presented according to the protocol used in previous studies.<a onclick="showRef(event, 'ref64'); return false;" href="javascript:void(0);" class="ref ref64">(64)</a> Horizontal and vertical activities were automatically measured by the TruScan system. Light-induced effects were normalized to the activity in the last 5 min of the habituation period. The subsequent light-induced activity was calculated as Δ from this baseline interval.</div></div><div id="sec4_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i56" class="anchor-spacer"></div><h3 class="article-section__title" id="_i56"> Statistical Analysis</h3><div class="NLM_p last">Data from behavioral experiments was analyzed as mean ± SEM. All the experiments were analyzed by a two-way ANOVA with the factors treatment and time. Preplanned analyses were calculated to compare group differences using Bonferroni-corrected LSD tests. Differences were calculated as both overall activity and activity at single time points. For LIA analyses, two-tailed <i>t</i> tests were conducted. Statistical significance was set <i>p</i> < 0.05 for all tests. All statistical analyses were carried out with IBM SPSS 21 software (SPSS Inc., Chicago, IL).</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i57"><a href="/doi/suppl/10.1021/acs.jmedchem.6b01857">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_38824" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_38824" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.6b01857" class="ext-link">10.1021/acs.jmedchem.6b01857</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Supplementary figures, supplementary results of functional assays and in vivo characterization, and <sup>1</sup>H and <sup>13</sup>C NMR spectra (<a href="/doi/suppl/10.1021/acs.jmedchem.6b01857/suppl_file/jm6b01857_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">Molecular formula strings (<a href="/doi/suppl/10.1021/acs.jmedchem.6b01857/suppl_file/jm6b01857_si_002.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.6b01857/suppl_file/jm6b01857_si_001.pdf">jm6b01857_si_001.pdf (2.46 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.6b01857/suppl_file/jm6b01857_si_002.csv">jm6b01857_si_002.csv (3.09 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.6b01857" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_27712" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_27712" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Peter Gmeiner</span> - <span class="hlFld-Affiliation affiliation">Department
of Chemistry and Pharmacy, Medicinal Chemistry, Friedrich-Alexander University Erlangen-Nürnberg, Schuhstraße 19, 91052 Erlangen, Germany</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-4127-197X" title="Orcid link">http://orcid.org/0000-0002-4127-197X</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#83f3e6f7e6f1ade4eee6eaede6f1c3e5e2f6ade7e6"><span class="__cf_email__" data-cfemail="8dfde8f9e8ffa3eae0e8e4e3e8ffcdebecf8a3e9e8">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Dorothee Möller</span> - <span class="hlFld-Affiliation affiliation">Department
of Chemistry and Pharmacy, Medicinal Chemistry, Friedrich-Alexander University Erlangen-Nürnberg, Schuhstraße 19, 91052 Erlangen, Germany</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ashutosh Banerjee</span> - <span class="hlFld-Affiliation affiliation">Department
of Chemistry and Pharmacy, Medicinal Chemistry, Friedrich-Alexander University Erlangen-Nürnberg, Schuhstraße 19, 91052 Erlangen, Germany</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Taygun C. Uzuneser</span> - <span class="hlFld-Affiliation affiliation">Department
of Psychiatry and Psychotherapy, Friedrich-Alexander
University Erlangen-Nürnberg, Schwabachanlage 6, 91054 Erlangen, Germany</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Marika Skultety</span> - <span class="hlFld-Affiliation affiliation">Department
of Chemistry and Pharmacy, Medicinal Chemistry, Friedrich-Alexander University Erlangen-Nürnberg, Schuhstraße 19, 91052 Erlangen, Germany</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Tobias Huth</span> - <span class="hlFld-Affiliation affiliation">Institute
of Physiology and Pathophysiology, Friedrich-Alexander
University Erlangen-Nürnberg, Universitätsstraße 17, 91054 Erlangen, Germany</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Bianca Plouffe</span> - <span class="hlFld-Affiliation affiliation">Institute
for Research in Immunology and Cancer (IRIC), Department of Biochemistry
and Molecular Medicine, University of Montreal, Québec, Canada H3C 1J4</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Harald Hübner</span> - <span class="hlFld-Affiliation affiliation">Department
of Chemistry and Pharmacy, Medicinal Chemistry, Friedrich-Alexander University Erlangen-Nürnberg, Schuhstraße 19, 91052 Erlangen, Germany</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Christian Alzheimer</span> - <span class="hlFld-Affiliation affiliation">Institute
of Physiology and Pathophysiology, Friedrich-Alexander
University Erlangen-Nürnberg, Universitätsstraße 17, 91054 Erlangen, Germany</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kristina Friedland</span> - <span class="hlFld-Affiliation affiliation">Department
of Chemistry and Pharmacy, Molecular and Clinical Pharmacy, Friedrich-Alexander University Erlangen-Nürnberg, Cauerstraße 4, 91058 Erlangen, Germany</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Christian P. Müller</span> - <span class="hlFld-Affiliation affiliation">Department
of Psychiatry and Psychotherapy, Friedrich-Alexander
University Erlangen-Nürnberg, Schwabachanlage 6, 91054 Erlangen, Germany</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Michel Bouvier</span> - <span class="hlFld-Affiliation affiliation">Institute
for Research in Immunology and Cancer (IRIC), Department of Biochemistry
and Molecular Medicine, University of Montreal, Québec, Canada H3C 1J4</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d207e9571-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i58">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_75604" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_75604" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">This work was supported by the Deutsche Forschungsgemeinschaft (DFG) grants GRK1910 to P.G. and MU2789/7-1 to C.P.M. and by a grant from the Canadian Institute for Health Research (CIHR) no. 11215 to M.B. M.B. holds a Canada Research Chair in Signal Transduction and Molecular Pharmacology. We thank Dr. Monique Lagacé (IRIC, University of Montreal, Canada) for help with the BRET experiments and helpful discussions. We thank Prof. Graeme Milligan (University of Glasgow, U.K.) for providing us with the cDNA for Gα<sub>oA</sub> and Gα<sub>i2</sub> proteins.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i59" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i59"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i60" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i60"> Abbreviations Used</h2><tr><td class="NLM_term">AMPH</td><td class="NLM_def"><p class="first last">amphetamine</p></td></tr><tr><td class="NLM_term">APCI</td><td class="NLM_def"><p class="first last">atmospheric pressure chemical ionization</p></td></tr><tr><td class="NLM_term">BRET</td><td class="NLM_def"><p class="first last">bioluminescence resonance energy transfer</p></td></tr><tr><td class="NLM_term">CHO</td><td class="NLM_def"><p class="first last">chinese hamster ovary</p></td></tr><tr><td class="NLM_term">1,4-DAP</td><td class="NLM_def"><p class="first last">1,4-disubstituted-aromatic piperazine</p></td></tr><tr><td class="NLM_term">D<sub><i>x</i></sub>R</td><td class="NLM_def"><p class="first last">dopamine D<sub><i>x</i></sub> receptor</p></td></tr><tr><td class="NLM_term">Gα<sub><i>x</i></sub></td><td class="NLM_def"><p class="first last">G protein subunit Gα<sub><i>x</i></sub></p></td></tr><tr><td class="NLM_term">GFP10</td><td class="NLM_def"><p class="first last">green fluorescent protein variant</p></td></tr><tr><td class="NLM_term">rGFP</td><td class="NLM_def"><p class="first last"><i>Renilla reniformis</i> green fluorescent protein</p></td></tr><tr><td class="NLM_term">GIRK</td><td class="NLM_def"><p class="first last">G protein-coupled inward rectifying potassium channel</p></td></tr><tr><td class="NLM_term">GTPγS</td><td class="NLM_def"><p class="first last">guanosine 5′-<i>O</i>-(thiotriphosphate)</p></td></tr><tr><td class="NLM_term">HATU</td><td class="NLM_def"><p class="first last">(1-[Bis(dimethylamino)methylene]-1<i>H</i>-1,2,3-triazolo[4,5-<i>b</i>]pyridinium 3-oxid hexafluorophosphate)</p></td></tr><tr><td class="NLM_term">hD<sub><i>x</i></sub>R</td><td class="NLM_def"><p class="first last">human dopamine D<sub><i>x</i></sub> receptor</p></td></tr><tr><td class="NLM_term">h5-HT<sub><i>x</i></sub>R</td><td class="NLM_def"><p class="first last">human serotonin 5-HT<sub><i>x</i></sub> receptor</p></td></tr><tr><td class="NLM_term">LIA</td><td class="NLM_def"><p class="first last">light-induced activity</p></td></tr><tr><td class="NLM_term">pα<sub><i>x</i></sub>R</td><td class="NLM_def"><p class="first last">porcine adrenergic α<sub><i>x</i></sub> receptor</p></td></tr><tr><td class="NLM_term">p5-HT<sub><i>x</i></sub>R</td><td class="NLM_def"><p class="first last">porcine serotonin 5-HT<sub><i>x</i></sub> receptor</p></td></tr><tr><td class="NLM_term">PPI</td><td class="NLM_def"><p class="first last">prepulse inhibition</p></td></tr><tr><td class="NLM_term">PTX</td><td class="NLM_def"><p class="first last">pertussis toxin</p></td></tr><tr><td class="NLM_term">RLucII</td><td class="NLM_def"><p class="first last">Renilla luciferase</p></td></tr><tr><td class="NLM_term">SAL</td><td class="NLM_def"><p class="first last">saline</p></td></tr><tr><td class="NLM_term">SD</td><td class="NLM_def"><p class="first last">standard deviation</p></td></tr><tr><td class="NLM_term">SEM</td><td class="NLM_def"><p class="first last">standard error of mean</p></td></tr><tr><td class="NLM_term">TM</td><td class="NLM_def"><p class="first last">transmembrane helix</p></td></tr><tr><td class="NLM_term">VEH</td><td class="NLM_def"><p class="first last">vehicle</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i61">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_56202" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_56202" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 80 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Welsch, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Snyder, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stockwell, B. R.</span><span> </span><span class="NLM_article-title">Privileged Scaffolds for Library Design and Drug Discovery</span> <span class="citation_source-journal">Curr. Opin. Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">347</span><span class="NLM_x">–</span> <span class="NLM_lpage">361</span><span class="refDoi"> DOI: 10.1016/j.cbpa.2010.02.018</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01857&amp;key=10.1016%2Fj.cbpa.2010.02.018" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01857&amp;key=20303320" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01857&amp;key=1%3ACAS%3A528%3ADC%252BC3cXmvVWqsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2010&pages=347-361&author=M.+E.+Welschauthor=S.+A.+Snyderauthor=B.+R.+Stockwell&title=Privileged+Scaffolds+for+Library+Design+and+Drug+Discovery&doi=10.1016%2Fj.cbpa.2010.02.018"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Privileged scaffolds for library design and drug discovery</span></div><div class="casAuthors">Welsch, Matthew E.; Snyder, Scott A.; Stockwell, Brent R.</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Chemical Biology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">347-361</span>CODEN:
                <span class="NLM_cas:coden">COCBF4</span>;
        ISSN:<span class="NLM_cas:issn">1367-5931</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">This review explores the concept of using privileged scaffolds to identify biol. active compds. through building chem. libraries.  We hope to accomplish three main objectives: to provide one of the most comprehensive listings of privileged scaffolds; to reveal through four selected examples the present state of the art in privileged scaffold library synthesis (in hopes of inspiring new and even more creative approaches); and also to offer some thoughts on how new privileged scaffolds might be identified and exploited.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqWQPxdsWawiLVg90H21EOLACvtfcHk0lg-9gmMSHxvuQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXmvVWqsLs%253D&md5=fd0c2a642f063fd6f42f2c34fd186f8a</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1016%2Fj.cbpa.2010.02.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cbpa.2010.02.018%26sid%3Dliteratum%253Aachs%26aulast%3DWelsch%26aufirst%3DM.%2BE.%26aulast%3DSnyder%26aufirst%3DS.%2BA.%26aulast%3DStockwell%26aufirst%3DB.%2BR.%26atitle%3DPrivileged%2520Scaffolds%2520for%2520Library%2520Design%2520and%2520Drug%2520Discovery%26jtitle%3DCurr.%2520Opin.%2520Chem.%2520Biol.%26date%3D2010%26volume%3D14%26spage%3D347%26epage%3D361%26doi%3D10.1016%2Fj.cbpa.2010.02.018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Löber, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hübner, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tschammer, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gmeiner, P.</span><span> </span><span class="NLM_article-title">Recent Advances in the Search for D3- and D4-Selective Drugs: Probes, Models and Candidates</span> <span class="citation_source-journal">Trends Pharmacol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">148</span><span class="NLM_x">–</span> <span class="NLM_lpage">157</span><span class="refDoi"> DOI: 10.1016/j.tips.2010.12.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01857&amp;key=10.1016%2Fj.tips.2010.12.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01857&amp;key=21232805" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01857&amp;key=1%3ACAS%3A280%3ADC%252BC3M3ktVWnsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2011&pages=148-157&author=S.+L%C3%B6berauthor=H.+H%C3%BCbnerauthor=N.+Tschammerauthor=P.+Gmeiner&title=Recent+Advances+in+the+Search+for+D3-+and+D4-Selective+Drugs%3A+Probes%2C+Models+and+Candidates&doi=10.1016%2Fj.tips.2010.12.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Recent advances in the search for D3- and D4-selective drugs: probes, models and candidates</span></div><div class="casAuthors">Lober Stefan; Hubner Harald; Tschammer Nuska; Gmeiner Peter</div><div class="citationInfo"><span class="NLM_cas:title">Trends in pharmacological sciences</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">148-57</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Dopamine D(2)-like receptors (including D(2), D(3) and D(4)) belong to the 'rhodopsin-like' family of G protein-coupled receptors (GPCRs), which represent the largest group of targets for bioactive molecules.  Due to their high sequence similarity, the design of subtype-selective ligands requires rational and effective strategies.  The general formula of 1,4-disubstituted aromatic piperidines and piperazines (1,4-DAPs) was extracted from classical dopaminergic drugs.  The biological properties of this compound family are encoded by an aromatic head group that controls intrinsic activity, an amine moiety and a lipophilic appendage.  D(3)- and D(4)-selective molecular probes and drug candidates were generated from the general formula of 1,4-DAP.  Formal structural rearrangement led to investigational drugs beyond the 1,4-DAP structure.  The very recent publication of the X-ray crystal structure of D(3) should facilitate efficient discovery of unprecedented chemotypes.  However, the development of D(3)-selective agonists, functionally selective ligands and the exploitation of homo- and heteromers remain challenging.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSJYDidIFGFwMjl5L8hwNX0fW6udTcc2eaaG_0IKTq0iLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3M3ktVWnsg%253D%253D&md5=9b688525eaa75c6d965b634617c16d70</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1016%2Fj.tips.2010.12.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tips.2010.12.003%26sid%3Dliteratum%253Aachs%26aulast%3DL%25C3%25B6ber%26aufirst%3DS.%26aulast%3DH%25C3%25BCbner%26aufirst%3DH.%26aulast%3DTschammer%26aufirst%3DN.%26aulast%3DGmeiner%26aufirst%3DP.%26atitle%3DRecent%2520Advances%2520in%2520the%2520Search%2520for%2520D3-%2520and%2520D4-Selective%2520Drugs%253A%2520Probes%252C%2520Models%2520and%2520Candidates%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D2011%26volume%3D32%26spage%3D148%26epage%3D157%26doi%3D10.1016%2Fj.tips.2010.12.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Szabo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klein Herenbrink, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christopoulos, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lane, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Capuano, B.</span><span> </span><span class="NLM_article-title">Structure–Activity Relationships of Privileged Structures Lead to the Discovery of Novel Biased Ligands at the Dopamine D2 Receptor</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">4924</span><span class="NLM_x">–</span> <span class="NLM_lpage">4939</span><span class="refDoi"> DOI: 10.1021/jm500457x</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm500457x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=4924-4939&author=M.+Szaboauthor=C.+Klein+Herenbrinkauthor=A.+Christopoulosauthor=J.+R.+Laneauthor=B.+Capuano&title=Structure%E2%80%93Activity+Relationships+of+Privileged+Structures+Lead+to+the+Discovery+of+Novel+Biased+Ligands+at+the+Dopamine+D2+Receptor&doi=10.1021%2Fjm500457x"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1021%2Fjm500457x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm500457x%26sid%3Dliteratum%253Aachs%26aulast%3DSzabo%26aufirst%3DM.%26aulast%3DKlein%2BHerenbrink%26aufirst%3DC.%26aulast%3DChristopoulos%26aufirst%3DA.%26aulast%3DLane%26aufirst%3DJ.%2BR.%26aulast%3DCapuano%26aufirst%3DB.%26atitle%3DStructure%25E2%2580%2593Activity%2520Relationships%2520of%2520Privileged%2520Structures%2520Lead%2520to%2520the%2520Discovery%2520of%2520Novel%2520Biased%2520Ligands%2520at%2520the%2520Dopamine%2520D2%2520Receptor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D4924%26epage%3D4939%26doi%3D10.1021%2Fjm500457x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Newman, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beuming, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Banala, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Donthamsetti, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pongetti, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LaBounty, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levy, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cao, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Michino, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luedtke, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Javitch, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, L.</span><span> </span><span class="NLM_article-title">Molecular Determinants of Selectivity and Efficacy at the Dopamine D3 Receptor</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">6689</span><span class="NLM_x">–</span> <span class="NLM_lpage">6699</span><span class="refDoi"> DOI: 10.1021/jm300482h</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm300482h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01857&amp;key=1%3ACAS%3A528%3ADC%252BC38XnsFCkt7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=6689-6699&author=A.+H.+Newmanauthor=T.+Beumingauthor=A.+K.+Banalaauthor=P.+Donthamsettiauthor=K.+Pongettiauthor=A.+LaBountyauthor=B.+Levyauthor=J.+Caoauthor=M.+Michinoauthor=R.+R.+Luedtkeauthor=J.+A.+Javitchauthor=L.+Shi&title=Molecular+Determinants+of+Selectivity+and+Efficacy+at+the+Dopamine+D3+Receptor&doi=10.1021%2Fjm300482h"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular Determinants of Selectivity and Efficacy at the Dopamine D3 Receptor</span></div><div class="casAuthors">Newman, Amy Hauck; Beuming, Thijs; Banala, Ashwini K.; Donthamsetti, Prashant; Pongetti, Katherine; LaBounty, Alex; Levy, Benjamin; Cao, Jianjing; Michino, Mayako; Luedtke, Robert R.; Javitch, Jonathan A.; Shi, Lei</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">6689-6699</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The dopamine D3 receptor (D3R) has been implicated in substance abuse and other neuropsychiatric disorders.  The high sequence homol. between the D3R and D2R, esp. within the orthosteric binding site (OBS) that binds dopamine, has made the development of D3R-selective compds. challenging.  Here, we deconstruct into pharmacophoric elements a series of D3R-selective substituted-4-phenylpiperazine compds. and use computational simulations and binding and activation studies to dissect the structural bases for D3R selectivity and efficacy.  We find that selectivity arises from divergent interactions within a second binding pocket (SBP) sep. from the OBS, whereas efficacy depends on the binding mode in the OBS.  Our findings reveal structural features of the receptor that are crit. to selectivity and efficacy that can be used to design highly D3R-selective ligands with targeted efficacies.  These findings are generalizable to other GPCRs in which the SBP can be targeted by bitopic or allosteric ligands.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqmBJU7uyvVg7Vg90H21EOLACvtfcHk0lg3xGfiHpLOZg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XnsFCkt7c%253D&md5=033dd49282723650828a3ec0a31211e5</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1021%2Fjm300482h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300482h%26sid%3Dliteratum%253Aachs%26aulast%3DNewman%26aufirst%3DA.%2BH.%26aulast%3DBeuming%26aufirst%3DT.%26aulast%3DBanala%26aufirst%3DA.%2BK.%26aulast%3DDonthamsetti%26aufirst%3DP.%26aulast%3DPongetti%26aufirst%3DK.%26aulast%3DLaBounty%26aufirst%3DA.%26aulast%3DLevy%26aufirst%3DB.%26aulast%3DCao%26aufirst%3DJ.%26aulast%3DMichino%26aufirst%3DM.%26aulast%3DLuedtke%26aufirst%3DR.%2BR.%26aulast%3DJavitch%26aufirst%3DJ.%2BA.%26aulast%3DShi%26aufirst%3DL.%26atitle%3DMolecular%2520Determinants%2520of%2520Selectivity%2520and%2520Efficacy%2520at%2520the%2520Dopamine%2520D3%2520Receptor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D6689%26epage%3D6699%26doi%3D10.1021%2Fjm300482h" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Ehrlich, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Götz, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bollinger, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tschammer, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bettinetti, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Härterich, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hübner, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lanig, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gmeiner, P.</span><span> </span><span class="NLM_article-title">Dopamine D2, D3, and D4 Selective Phenylpiperazines as Molecular Probes to Explore the Origins of Subtype Specific Receptor Binding</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">4923</span><span class="NLM_x">–</span> <span class="NLM_lpage">4935</span><span class="refDoi"> DOI: 10.1021/jm900690y</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm900690y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01857&amp;key=1%3ACAS%3A528%3ADC%252BD1MXos1ehtLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=4923-4935&author=K.+Ehrlichauthor=A.+G%C3%B6tzauthor=S.+Bollingerauthor=N.+Tschammerauthor=L.+Bettinettiauthor=S.+H%C3%A4rterichauthor=H.+H%C3%BCbnerauthor=H.+Lanigauthor=P.+Gmeiner&title=Dopamine+D2%2C+D3%2C+and+D4+Selective+Phenylpiperazines+as+Molecular+Probes+to+Explore+the+Origins+of+Subtype+Specific+Receptor+Binding&doi=10.1021%2Fjm900690y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Dopamine D2, D3, and D4 Selective Phenylpiperazines as Molecular Probes To Explore the Origins of Subtype Specific Receptor Binding</span></div><div class="casAuthors">Ehrlich, Katharina; Gotz, Angela; Bollinger, Stefan; Tschammer, Nuska; Bettinetti, Laura; Harterich, Steffen; Hubner, Harald; Lanig, Harald; Gmeiner, Peter</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">4923-4935</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Assembling phenylpiperazines with 7a-azaindole via different spacer elements, we developed subtype selective dopamine receptor ligands, e.g. I, preferentially interacting with D4, D2, and D3, resp.  To complete this set, the methylthio analogs exceeding the affinity of methoxy derivs. by one order of magnitude and a structural intermediate II were synthesized.  These chem. similar but biol. divergent target compds. served as mol. probes for radioligand displacement expts., mutagenesis, and docking studies on homol. models based on the recent crystal structure of the β2-adrenergic receptor.  Specific interactions with the highly conserved amino acids Asp3.32 and His6.55 and less conserved residues at positions 2.61, 2.64, 3.28, and 3.29 were identified.  Inclusion of a carefully modeled extracellular loop 2 displayed two nonconserved residues in EL2 that differently contribute to ligand binding.  Obviously, subtype selectivity is caused by nonconserved but frequently mediated by conserved amino acids.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpX2fsUqpFTIbVg90H21EOLACvtfcHk0lg3xGfiHpLOZg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXos1ehtLk%253D&md5=99880da2621063e269f8b7f765e09d55</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1021%2Fjm900690y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm900690y%26sid%3Dliteratum%253Aachs%26aulast%3DEhrlich%26aufirst%3DK.%26aulast%3DG%25C3%25B6tz%26aufirst%3DA.%26aulast%3DBollinger%26aufirst%3DS.%26aulast%3DTschammer%26aufirst%3DN.%26aulast%3DBettinetti%26aufirst%3DL.%26aulast%3DH%25C3%25A4rterich%26aufirst%3DS.%26aulast%3DH%25C3%25BCbner%26aufirst%3DH.%26aulast%3DLanig%26aufirst%3DH.%26aulast%3DGmeiner%26aufirst%3DP.%26atitle%3DDopamine%2520D2%252C%2520D3%252C%2520and%2520D4%2520Selective%2520Phenylpiperazines%2520as%2520Molecular%2520Probes%2520to%2520Explore%2520the%2520Origins%2520of%2520Subtype%2520Specific%2520Receptor%2520Binding%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D4923%26epage%3D4935%26doi%3D10.1021%2Fjm900690y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Burris, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Molski, T. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ryan, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tottori, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kikuchi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yocca, F. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Molinoff, P. B.</span><span> </span><span class="NLM_article-title">Aripiprazole, a Novel Antipsychotic, Is a High-Affinity Partial Agonist at Human Dopamine D2 Receptors</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">302</span><span class="NLM_x">, </span> <span class="NLM_fpage">381</span><span class="NLM_x">–</span> <span class="NLM_lpage">389</span><span class="refDoi"> DOI: 10.1124/jpet.102.033175</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01857&amp;key=10.1124%2Fjpet.102.033175" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01857&amp;key=12065741" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01857&amp;key=1%3ACAS%3A528%3ADC%252BD38Xlt1SnsLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=302&publication_year=2002&pages=381-389&author=K.+D.+Burrisauthor=T.+F.+Molskiauthor=C.+Xuauthor=E.+Ryanauthor=K.+Tottoriauthor=T.+Kikuchiauthor=F.+D.+Yoccaauthor=P.+B.+Molinoff&title=Aripiprazole%2C+a+Novel+Antipsychotic%2C+Is+a+High-Affinity+Partial+Agonist+at+Human+Dopamine+D2+Receptors&doi=10.1124%2Fjpet.102.033175"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Aripiprazole, a novel antipsychotic, is a high-affinity partial agonist at human dopamine D2 receptors</span></div><div class="casAuthors">Burris, Kevin D.; Molski, Thaddeus F.; Xu, Cen; Ryan, Elaine; Tottori, Katsura; Kikuchi, Tetsuro; Yocca, Frank D.; Molinoff, Perry B.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">302</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">381-389</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Aripiprazole is the first next-generation atypical antipsychotic with a mechanism of action that differs from currently marketed typical and atypical antipsychotics.  Aripiprazole displays properties of an agonist and antagonist in animal models of dopaminergic hypoactivity and hyperactivity, resp.  This study examd. the interactions of aripiprazole with a single population of human D2 receptors to clarify further its pharmacol. properties.  In membranes prepd. from Chinese hamster ovary cells that express recombinant D2L receptors, aripiprazole bound with high affinity to both the G protein-coupled and uncoupled states of receptors.  Aripiprazole potently activated D2 receptor-mediated inhibition of cAMP accumulation.  Partial receptor inactivation using the alkylating agent N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ) significantly reduced the max. effect of aripiprazole on inhibition of cAMP accumulation.  This effect was seen with concns. of EEDQ that did not alter the maximal inhibitory effect of dopamine.  Consistent with the expected effects of a partial agonist, increasing concns. of aripiprazole blocked the action of dopamine with maximal blockade equal to the agonist effect of aripiprazole alone.  The efficacy of aripiprazole relative to that of dopamine varied from 25% in cells that lacked spare receptors for dopamine to 90% in cells with receptor reserve.  These results, together with previous studies demonstrating partial agonist activity at serotonin 5-hydroxytryptamine (5-HT)1A receptors and antagonist activity at 5-HT2A receptors, support the identification of aripiprazole as a dopamine-serotonin system stabilizer.  The receptor activity profile may underlie the unique activity of aripiprazole in animals and its antipsychotic activity in humans.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqu--oNCiWjJ7Vg90H21EOLACvtfcHk0ljPqwFy1afjTQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xlt1SnsLY%253D&md5=907bbba92bdfb6c4d2ee703f289c32f6</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1124%2Fjpet.102.033175&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.102.033175%26sid%3Dliteratum%253Aachs%26aulast%3DBurris%26aufirst%3DK.%2BD.%26aulast%3DMolski%26aufirst%3DT.%2BF.%26aulast%3DXu%26aufirst%3DC.%26aulast%3DRyan%26aufirst%3DE.%26aulast%3DTottori%26aufirst%3DK.%26aulast%3DKikuchi%26aufirst%3DT.%26aulast%3DYocca%26aufirst%3DF.%2BD.%26aulast%3DMolinoff%26aufirst%3DP.%2BB.%26atitle%3DAripiprazole%252C%2520a%2520Novel%2520Antipsychotic%252C%2520Is%2520a%2520High-Affinity%2520Partial%2520Agonist%2520at%2520Human%2520Dopamine%2520D2%2520Receptors%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2002%26volume%3D302%26spage%3D381%26epage%3D389%26doi%3D10.1124%2Fjpet.102.033175" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Kiss, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Horvath, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nemethy, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laszlovszky, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bugovics, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fazekas, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hornok, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orosz, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gyertyan, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Agai-Csongor, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Domany, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tihanyi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adham, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Szombathelyi, Z.</span><span> </span><span class="NLM_article-title">Cariprazine (RGH-188), a Dopamine D3 Receptor-Preferring, D3/D2 Dopamine Receptor Antagonist-Partial Agonist Antipsychotic Candidate: In Vitro and Neurochemical Profile</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">333</span><span class="NLM_x">, </span> <span class="NLM_fpage">328</span><span class="NLM_x">–</span> <span class="NLM_lpage">340</span><span class="refDoi"> DOI: 10.1124/jpet.109.160432</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01857&amp;key=10.1124%2Fjpet.109.160432" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01857&amp;key=20093397" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01857&amp;key=1%3ACAS%3A528%3ADC%252BC3cXkvFGktLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=333&publication_year=2010&pages=328-340&author=B.+Kissauthor=A.+Horvathauthor=Z.+Nemethyauthor=E.+Schmidtauthor=I.+Laszlovszkyauthor=G.+Bugovicsauthor=K.+Fazekasauthor=K.+Hornokauthor=S.+Oroszauthor=I.+Gyertyanauthor=E.+Agai-Csongorauthor=G.+Domanyauthor=K.+Tihanyiauthor=N.+Adhamauthor=Z.+Szombathelyi&title=Cariprazine+%28RGH-188%29%2C+a+Dopamine+D3+Receptor-Preferring%2C+D3%2FD2+Dopamine+Receptor+Antagonist-Partial+Agonist+Antipsychotic+Candidate%3A+In+Vitro+and+Neurochemical+Profile&doi=10.1124%2Fjpet.109.160432"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Cariprazine (RGH-188), a dopamine D3 receptor-preferring, D3/D2 dopamine receptor antagonist-partial agonist antipsychotic candidate: in vitro and neurochemical profile</span></div><div class="casAuthors">Kiss, Bela; Horvath, Attila; Nemethy, Zsolt; Schmidt, Eva; Laszlovszky, Istvan; Bugovics, Gyula; Fazekas, Karoly; Hornok, Katalin; Orosz, Szabolcs; Gyertyan, Istvan; Agai-Csongor, Eva; Domany, Gyorgy; Tihanyi, Karoly; Adham, Nika; Szombathelyi, Zsolt</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">333</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">328-340</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Cariprazine {RGH-188; trans-N-[4-[2-[4-(2,3-dichlorophenyl)piperazin-1-yl]ethyl]cyclohexyl]-N',N'-dimethylurea hydrochloride}, a novel candidate antipsychotic, demonstrated approx. 10-fold higher affinity for human D3 vs. human D2L and human D2S receptors (pKi 10.07, 9.16, and 9.31, resp.).  It displayed high affinity at human serotonin (5-HT) type 2B receptors (pKi 9.24) with pure antagonism.  Cariprazine had lower affinity at human and rat hippocampal 5-HT1A receptors (pKi 8.59 and 8.34, resp.) and demonstrated low intrinsic efficacy.  Cariprazine displayed low affinity at human 5-HT2A receptors (pKi 7.73).  Moderate or low affinity for histamine H1 and 5-HT2C receptors (pKi 7.63 and 6.87, resp.) suggest cariprazine's reduced propensity for adverse events related to these receptors.  Cariprazine demonstrated different functional profiles at dopamine receptors depending on the assay system.  It displayed D2 and D3 antagonism in [35S]GTPγS binding assays, but stimulated inositol phosphate (IP) prodn. (pEC50 8.50, Emax 30%) and antagonized (±)-quinpirole-induced IP accumulation (pKb 9.22) in murine cells expressing human D2L receptors.  It had partial agonist activity (pEC50 8.58, Emax 71%) by inhibiting cAMP accumulation in Chinese hamster ovary cells expressing human D3 receptors and potently antagonized R(+)-2-dipropylamino-7-hydroxy-1,2,3,4-tetrahydronaphthalene HBr (7-OH-DPAT)-induced suppression of cAMP formation (pKb 9.57).  In these functional assays, cariprazine showed similar (D2) or higher (D3) antagonist-partial agonist affinity and greater (3- to 10-fold) D3 vs. D2 selectivity compared with aripiprazole.  In in vivo turnover and biosynthesis expts., cariprazine demonstrated D2-related partial agonist and antagonist properties, depending on actual dopaminergic tone.  The antagonist-partial agonist properties of cariprazine at D3 and D2 receptors, with very high and preferential affinity to D3 receptors, make it a candidate antipsychotic with a unique pharmacol. profile among known antipsychotics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrk5eSWEiD1ibVg90H21EOLACvtfcHk0ljPqwFy1afjTQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXkvFGktLs%253D&md5=3a949dfc5f907c0a72f24b61af2a944e</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1124%2Fjpet.109.160432&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.109.160432%26sid%3Dliteratum%253Aachs%26aulast%3DKiss%26aufirst%3DB.%26aulast%3DHorvath%26aufirst%3DA.%26aulast%3DNemethy%26aufirst%3DZ.%26aulast%3DSchmidt%26aufirst%3DE.%26aulast%3DLaszlovszky%26aufirst%3DI.%26aulast%3DBugovics%26aufirst%3DG.%26aulast%3DFazekas%26aufirst%3DK.%26aulast%3DHornok%26aufirst%3DK.%26aulast%3DOrosz%26aufirst%3DS.%26aulast%3DGyertyan%26aufirst%3DI.%26aulast%3DAgai-Csongor%26aufirst%3DE.%26aulast%3DDomany%26aufirst%3DG.%26aulast%3DTihanyi%26aufirst%3DK.%26aulast%3DAdham%26aufirst%3DN.%26aulast%3DSzombathelyi%26aufirst%3DZ.%26atitle%3DCariprazine%2520%2528RGH-188%2529%252C%2520a%2520Dopamine%2520D3%2520Receptor-Preferring%252C%2520D3%252FD2%2520Dopamine%2520Receptor%2520Antagonist-Partial%2520Agonist%2520Antipsychotic%2520Candidate%253A%2520In%2520Vitro%2520and%2520Neurochemical%2520Profile%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2010%26volume%3D333%26spage%3D328%26epage%3D340%26doi%3D10.1124%2Fjpet.109.160432" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Maeda, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sugino, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akazawa, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amada, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shimada, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Futamura, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamashita, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ito, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McQuade, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mørk, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pehrson, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hentzer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nielsen, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bundgaard, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arnt, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stensbøl, T. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kikuchi, T.</span><span> </span><span class="NLM_article-title">Brexpiprazole I: In Vitro and in Vivo Characterization of a Novel Serotonin-Dopamine Activity Modulator</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">350</span><span class="NLM_x">, </span> <span class="NLM_fpage">589</span><span class="refDoi"> DOI: 10.1124/jpet.114.213793</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01857&amp;key=10.1124%2Fjpet.114.213793" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01857&amp;key=24947465" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01857&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhs1artLrI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=350&publication_year=2014&pages=589&author=K.+Maedaauthor=H.+Suginoauthor=H.+Akazawaauthor=N.+Amadaauthor=J.+Shimadaauthor=T.+Futamuraauthor=H.+Yamashitaauthor=N.+Itoauthor=R.+D.+McQuadeauthor=A.+M%C3%B8rkauthor=A.+L.+Pehrsonauthor=M.+Hentzerauthor=V.+Nielsenauthor=C.+Bundgaardauthor=J.+Arntauthor=T.+B.+Stensb%C3%B8lauthor=T.+Kikuchi&title=Brexpiprazole+I%3A+In+Vitro+and+in+Vivo+Characterization+of+a+Novel+Serotonin-Dopamine+Activity+Modulator&doi=10.1124%2Fjpet.114.213793"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Brexpiprazole I: in vitro and in vivo characterization of a novel serotonin-dopamine activity modulator</span></div><div class="casAuthors">Maeda, Kenji; Sugino, Haruhiko; Akazawa, Hitomi; Amada, Naoki; Shimada, Jun; Futamura, Takashi; Yamashita, Hiroshi; Ito, Nobuaki; McQuade, Robert D.; Moerk, Arne; Pehrson, Alan L.; Hentzer, Morten; Nielsen, Vibeke; Bundgaard, Christoffer; Arnt, Joern; Stensboel, Tine Bryan; Kikuchi, Tetsuro</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">350</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">589-604, 16 pp.</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">1521-0103</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Brexpiprazole (OPC-34712, 7-{4-[4-(1-benzothiophen-4-yl) piperazin-1-yl]butoxy}quinolin-2(1H)-one) is a novel drug candidate in clin. development for psychiatric disorders with high affinity for serotonin, dopamine, and noradrenaline receptors.  In particular, it bound with high affinity (Ki < 1 nM) to human serotonin 1A (h5-HT1A)-, h5-HT2A-, long form of human D2(hD2L)-, hα1B-, and hα2C-adrenergic receptors.  It displayed partial agonism at h5-HT1A and hD2 receptors in cloned receptor systems and potent antagonism of h5-HT2A receptors and hα1B/2C-adrenoceptors.  Brexpiprazole also had affinity (Ki < 5 nM) for hD3-, h5-HT2B-, h5-HT7-, hα1A-, and hα1D-adrenergic receptors, moderate affinity for hH1 (Ki = 19 nM), and low affinity for hM1 receptors (K1 > 1000 nM).  Brexpiprazole potently bound to rat 5-HT2A and D2 receptors in vivo, and ex vivo binding studies further confirmed high 5-HT1A receptor binding potency.  Brexpiprazole inhibited DOI (2,5-dimethoxy-4-iodoamphetamine)-induced head twitches in rats, suggestive of 5-HT2A antagonism.  Furthermore, in vivo D2 partial agonist activity of brexpiprazole was confirmed by its inhibitory effect on reserpine-induced DOPA accumulation in rats.  In rat microdialysis studies, brexpiprazole slightly reduced extracellular dopamine in nucleus accumbens but not in prefrontal cortex, whereas moderate increases of the dopamine metabolites, homovanillic acid and DOPAC (3,4-dihydroxy-phenyl-acetic acid), in these areas also suggested in vivo D2 partial agonist activity.  In particular, based on a lower intrinsic activity at D2 receptors and higher binding affinities for 5-HT1A/2A receptors than aripiprazole, brexpiprazole would have a favorable antipsychotic potential without D2 receptor agonist- and antagonist-related adverse effects.  In conclusion, brexpiprazole is a serotonin-dopamine activity modulator with a unique pharmacol., which may offer novel treatment options across a broad spectrum of central nervous system disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqOd8uBhM0Ua7Vg90H21EOLACvtfcHk0ljPqwFy1afjTQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhs1artLrI&md5=9e0436e35bbb10762bc42b3552a33341</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1124%2Fjpet.114.213793&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.114.213793%26sid%3Dliteratum%253Aachs%26aulast%3DMaeda%26aufirst%3DK.%26aulast%3DSugino%26aufirst%3DH.%26aulast%3DAkazawa%26aufirst%3DH.%26aulast%3DAmada%26aufirst%3DN.%26aulast%3DShimada%26aufirst%3DJ.%26aulast%3DFutamura%26aufirst%3DT.%26aulast%3DYamashita%26aufirst%3DH.%26aulast%3DIto%26aufirst%3DN.%26aulast%3DMcQuade%26aufirst%3DR.%2BD.%26aulast%3DM%25C3%25B8rk%26aufirst%3DA.%26aulast%3DPehrson%26aufirst%3DA.%2BL.%26aulast%3DHentzer%26aufirst%3DM.%26aulast%3DNielsen%26aufirst%3DV.%26aulast%3DBundgaard%26aufirst%3DC.%26aulast%3DArnt%26aufirst%3DJ.%26aulast%3DStensb%25C3%25B8l%26aufirst%3DT.%2BB.%26aulast%3DKikuchi%26aufirst%3DT.%26atitle%3DBrexpiprazole%2520I%253A%2520In%2520Vitro%2520and%2520in%2520Vivo%2520Characterization%2520of%2520a%2520Novel%2520Serotonin-Dopamine%2520Activity%2520Modulator%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2014%26volume%3D350%26spage%3D589%26doi%3D10.1124%2Fjpet.114.213793" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Citrome, L.</span><span> </span><span class="NLM_article-title">The ABC’s of Dopamine Receptor Partial Agonists – Aripiprazole, Brexpiprazole and Cariprazine: The 15-min Challenge to Sort These Agents Out</span> <span class="citation_source-journal">Int. J. Clin. Pract.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">69</span><span class="NLM_x">, </span> <span class="NLM_fpage">1211</span><span class="NLM_x">–</span> <span class="NLM_lpage">1220</span><span class="refDoi"> DOI: 10.1111/ijcp.12752</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01857&amp;key=10.1111%2Fijcp.12752" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01857&amp;key=26477545" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01857&amp;key=1%3ACAS%3A280%3ADC%252BC28zivVOruw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2015&pages=1211-1220&author=L.+Citrome&title=The+ABC%E2%80%99s+of+Dopamine+Receptor+Partial+Agonists+%E2%80%93+Aripiprazole%2C+Brexpiprazole+and+Cariprazine%3A+The+15-min+Challenge+to+Sort+These+Agents+Out&doi=10.1111%2Fijcp.12752"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">The ABC's of dopamine receptor partial agonists - aripiprazole, brexpiprazole and cariprazine: the 15-min challenge to sort these agents out</span></div><div class="casAuthors">Citrome L</div><div class="citationInfo"><span class="NLM_cas:title">International journal of clinical practice</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">69</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1211-20</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcR5dufhzNPDzckU0YCbOU3EfW6udTcc2ebhMGwIYCdElbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC28zivVOruw%253D%253D&md5=ed3806f83eb24513241153fcb0bc65e0</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1111%2Fijcp.12752&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fijcp.12752%26sid%3Dliteratum%253Aachs%26aulast%3DCitrome%26aufirst%3DL.%26atitle%3DThe%2520ABC%25E2%2580%2599s%2520of%2520Dopamine%2520Receptor%2520Partial%2520Agonists%2520%25E2%2580%2593%2520Aripiprazole%252C%2520Brexpiprazole%2520and%2520Cariprazine%253A%2520The%252015-min%2520Challenge%2520to%2520Sort%2520These%2520Agents%2520Out%26jtitle%3DInt.%2520J.%2520Clin.%2520Pract.%26date%3D2015%26volume%3D69%26spage%3D1211%26epage%3D1220%26doi%3D10.1111%2Fijcp.12752" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Möller, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kling, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skultety, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leuner, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hübner, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gmeiner, P.</span><span> </span><span class="NLM_article-title">Functionally Selective Dopamine D2, D3 Receptor Partial Agonists</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">4861</span><span class="NLM_x">–</span> <span class="NLM_lpage">4875</span><span class="refDoi"> DOI: 10.1021/jm5004039</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm5004039" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=4861-4875&author=D.+M%C3%B6llerauthor=R.+C.+Klingauthor=M.+Skultetyauthor=K.+Leunerauthor=H.+H%C3%BCbnerauthor=P.+Gmeiner&title=Functionally+Selective+Dopamine+D2%2C+D3+Receptor+Partial+Agonists&doi=10.1021%2Fjm5004039"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1021%2Fjm5004039&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm5004039%26sid%3Dliteratum%253Aachs%26aulast%3DM%25C3%25B6ller%26aufirst%3DD.%26aulast%3DKling%26aufirst%3DR.%2BC.%26aulast%3DSkultety%26aufirst%3DM.%26aulast%3DLeuner%26aufirst%3DK.%26aulast%3DH%25C3%25BCbner%26aufirst%3DH.%26aulast%3DGmeiner%26aufirst%3DP.%26atitle%3DFunctionally%2520Selective%2520Dopamine%2520D2%252C%2520D3%2520Receptor%2520Partial%2520Agonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D4861%26epage%3D4875%26doi%3D10.1021%2Fjm5004039" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Allen, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yost, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Setola, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sassano, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peterson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yadav, P. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, X. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feng, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jensen, N. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Che, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bai, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frye, S. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wetsel, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caron, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Javitch, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roth, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jin, J.</span><span> </span><span class="NLM_article-title">Discovery of Beta-Arrestin-Biased Dopamine D2 Ligands for Probing Signal Transduction Pathways Essential for Antipsychotic Efficacy</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">108</span><span class="NLM_x">, </span> <span class="NLM_fpage">18488</span><span class="NLM_x">–</span> <span class="NLM_lpage">18493</span><span class="refDoi"> DOI: 10.1073/pnas.1104807108</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01857&amp;key=10.1073%2Fpnas.1104807108" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01857&amp;key=22025698" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01857&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsFymtLzK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=108&publication_year=2011&pages=18488-18493&author=J.+A.+Allenauthor=J.+M.+Yostauthor=V.+Setolaauthor=X.+Chenauthor=M.+F.+Sassanoauthor=M.+Chenauthor=S.+Petersonauthor=P.+N.+Yadavauthor=X.+P.+Huangauthor=B.+Fengauthor=N.+H.+Jensenauthor=X.+Cheauthor=X.+Baiauthor=S.+V.+Fryeauthor=W.+C.+Wetselauthor=M.+G.+Caronauthor=J.+A.+Javitchauthor=B.+L.+Rothauthor=J.+Jin&title=Discovery+of+Beta-Arrestin-Biased+Dopamine+D2+Ligands+for+Probing+Signal+Transduction+Pathways+Essential+for+Antipsychotic+Efficacy&doi=10.1073%2Fpnas.1104807108"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of β-arrestin-biased dopamine D2 ligands for probing signal transduction pathways essential for antipsychotic efficacy</span></div><div class="casAuthors">Allen, John A.; Yost, Julianne M.; Setola, Vincent; Chen, Xin; Sassano, Maria F.; Chen, Meng; Peterson, Sean; Yadav, Prem N.; Huang, Xi-Ping; Feng, Bo; Jensen, Niels H.; Che, Xin; Bai, Xu; Frye, Stephen V.; Wetsel, William C.; Caron, Marc G.; Javitch, Jonathan A.; Roth, Bryan L.; Jin, Jian</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">108</span>
        (<span class="NLM_cas:issue">45</span>),
    <span class="NLM_cas:pages">18488-18493, S18488/1-S18488/15</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Elucidating the key signal transduction pathways essential for both antipsychotic efficacy and side-effect profiles is essential for developing safer and more effective therapies.  Recent work has highlighted noncanonical modes of dopamine D2 receptor (D2R) signaling via β-arrestins as being important for the therapeutic actions of both antipsychotic and antimanic agents.  We thus sought to create unique D2R agonists that display signaling bias via β-arrestinergic signaling.  Through a robust diversity-oriented modification of the scaffold represented by aripiprazole (1), we discovered UNC9975 (2), UNC0006 (3); and UNC9994 (4) as unprecedented β-arrestin-biased D2R ligands.  These compds. also represent unprecedented β-arrestin-biased ligands for a Gi-coupled G protein-coupled receptor (GPCR).  Significantly, UNC9975, UNC0006, and UNC9994 are simultaneously antagonists of Gi-regulated cAMP prodn. and partial agonists for D2R/β-arrestin-2 interactions.  Importantly, VNC9975 displayed potent antipsychotic-like activity without inducing motoric side effects in inbred C57BL/6 mice in vivo.  Genetic deletion of β-arrestin-2 simultaneously attenuated the antipsychotic actions of UNC9975 and transformed it into a typical antipsychotic .drug with a high propensity to induce catalepsy.  Similarly, the antipsychotic-like activity displayed by UNC9994, an extremely β-arrestin-biased D2R agonist, in wild-type mice was completely abolished in β-arrestin-2 knockout mice.  Taken together, our results suggest that β-arrestin signaling and recruitment can be simultaneously a significant contributor to antipsychotic efficacy and protective against motoric side effects.  These functionally selective, β-arrestin-biased D2R ligands represent valuable chem. probes for further investigations of D2R signaling in health and disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr87mjP6jm447Vg90H21EOLACvtfcHk0lhPtAgd1UjKMg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsFymtLzK&md5=d5b06e4ac4d2cc4cd04fd1de760ec628</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1104807108&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1104807108%26sid%3Dliteratum%253Aachs%26aulast%3DAllen%26aufirst%3DJ.%2BA.%26aulast%3DYost%26aufirst%3DJ.%2BM.%26aulast%3DSetola%26aufirst%3DV.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DSassano%26aufirst%3DM.%2BF.%26aulast%3DChen%26aufirst%3DM.%26aulast%3DPeterson%26aufirst%3DS.%26aulast%3DYadav%26aufirst%3DP.%2BN.%26aulast%3DHuang%26aufirst%3DX.%2BP.%26aulast%3DFeng%26aufirst%3DB.%26aulast%3DJensen%26aufirst%3DN.%2BH.%26aulast%3DChe%26aufirst%3DX.%26aulast%3DBai%26aufirst%3DX.%26aulast%3DFrye%26aufirst%3DS.%2BV.%26aulast%3DWetsel%26aufirst%3DW.%2BC.%26aulast%3DCaron%26aufirst%3DM.%2BG.%26aulast%3DJavitch%26aufirst%3DJ.%2BA.%26aulast%3DRoth%26aufirst%3DB.%2BL.%26aulast%3DJin%26aufirst%3DJ.%26atitle%3DDiscovery%2520of%2520Beta-Arrestin-Biased%2520Dopamine%2520D2%2520Ligands%2520for%2520Probing%2520Signal%2520Transduction%2520Pathways%2520Essential%2520for%2520Antipsychotic%2520Efficacy%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2011%26volume%3D108%26spage%3D18488%26epage%3D18493%26doi%3D10.1073%2Fpnas.1104807108" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Chen, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCorvy, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fischer, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Butler, K. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roth, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jin, J.</span><span> </span><span class="NLM_article-title">Discovery of G Protein-Biased D2 Dopamine Receptor Partial Agonists</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">10601</span><span class="NLM_x">–</span> <span class="NLM_lpage">10618</span><span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b01208</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b01208" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01857&amp;key=1%3ACAS%3A528%3ADC%252BC28XhslOqs7vK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=10601-10618&author=X.+Chenauthor=J.+D.+McCorvyauthor=M.+G.+Fischerauthor=K.+V.+Butlerauthor=Y.+Shenauthor=B.+L.+Rothauthor=J.+Jin&title=Discovery+of+G+Protein-Biased+D2+Dopamine+Receptor+Partial+Agonists&doi=10.1021%2Facs.jmedchem.6b01208"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of G Protein-Biased D2 Dopamine Receptor Partial Agonists</span></div><div class="casAuthors">Chen, Xin; McCorvy, John D.; Fischer, Matthew G.; Butler, Kyle V.; Shen, Yudao; Roth, Bryan L.; Jin, Jian</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">10601-10618</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Biased ligands (also known as functionally selective ligands) of G protein-coupled receptors are valuable tools for dissecting the roles of G protein-dependent and independent signaling pathways in health and disease.  Biased ligands have also been increasingly pursued by the biomedical community as promising therapeutics with improved efficacy and reduced side effects compared with unbiased ligands.  The authors previously discovered first-in-class β-arrestin-biased agonists of dopamine D2 receptor (D2R) by extensively exploring multiple regions of aripiprazole, a balanced D2R agonist.  In the authors' continuing efforts to identify biased agonists of D2R, the authors unexpectedly discovered a G protein-biased agonist of D2R, compd. 1 (5-(4-(4-(2,3-dichlorophenyl)piperazin-1-yl)butoxy)-2-methylbenzo[d]thiazole), which is the first G protein-biased D2R agonist from the aripiprazole scaffold.  The authors designed and synthesized novel analogs to explore two regions of 1 and conducted structure-functional selectivity relationship (SFSR) studies.  Here the authors report the discovery of 1, findings from the authors' SFSR studies, and characterization of novel G protein-biased D2R agonists.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoeKlhGCqSPxLVg90H21EOLACvtfcHk0liQmq97I60nzg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhslOqs7vK&md5=81b1435b1ae82438aa3f270f7ee4f853</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b01208&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b01208%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DX.%26aulast%3DMcCorvy%26aufirst%3DJ.%2BD.%26aulast%3DFischer%26aufirst%3DM.%2BG.%26aulast%3DButler%26aufirst%3DK.%2BV.%26aulast%3DShen%26aufirst%3DY.%26aulast%3DRoth%26aufirst%3DB.%2BL.%26aulast%3DJin%26aufirst%3DJ.%26atitle%3DDiscovery%2520of%2520G%2520Protein-Biased%2520D2%2520Dopamine%2520Receptor%2520Partial%2520Agonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D10601%26epage%3D10618%26doi%3D10.1021%2Facs.jmedchem.6b01208" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Chen, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sassano, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zheng, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Setola, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bai, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frye, S. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wetsel, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roth, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jin, J.</span><span> </span><span class="NLM_article-title">Structure-Functional Selectivity Relationship Studies of Beta-Arrestin-Biased Dopamine D2 Receptor Agonists</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">7141</span><span class="NLM_x">–</span> <span class="NLM_lpage">7153</span><span class="refDoi"> DOI: 10.1021/jm300603y</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm300603y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=7141-7153&author=X.+Chenauthor=M.+F.+Sassanoauthor=L.+Zhengauthor=V.+Setolaauthor=M.+Chenauthor=X.+Baiauthor=S.+V.+Fryeauthor=W.+C.+Wetselauthor=B.+L.+Rothauthor=J.+Jin&title=Structure-Functional+Selectivity+Relationship+Studies+of+Beta-Arrestin-Biased+Dopamine+D2+Receptor+Agonists&doi=10.1021%2Fjm300603y"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1021%2Fjm300603y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300603y%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DX.%26aulast%3DSassano%26aufirst%3DM.%2BF.%26aulast%3DZheng%26aufirst%3DL.%26aulast%3DSetola%26aufirst%3DV.%26aulast%3DChen%26aufirst%3DM.%26aulast%3DBai%26aufirst%3DX.%26aulast%3DFrye%26aufirst%3DS.%2BV.%26aulast%3DWetsel%26aufirst%3DW.%2BC.%26aulast%3DRoth%26aufirst%3DB.%2BL.%26aulast%3DJin%26aufirst%3DJ.%26atitle%3DStructure-Functional%2520Selectivity%2520Relationship%2520Studies%2520of%2520Beta-Arrestin-Biased%2520Dopamine%2520D2%2520Receptor%2520Agonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D7141%26epage%3D7153%26doi%3D10.1021%2Fjm300603y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Shonberg, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herenbrink, C. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lopez, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christopoulos, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scammells, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Capuano, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lane, J. R.</span><span> </span><span class="NLM_article-title">A Structure-Activity Analysis of Biased Agonism at the Dopamine D2 Receptor</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">9199</span><span class="NLM_x">–</span> <span class="NLM_lpage">9221</span><span class="refDoi"> DOI: 10.1021/jm401318w</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm401318w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01857&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhs1CktrbJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=9199-9221&author=J.+Shonbergauthor=C.+K.+Herenbrinkauthor=L.+Lopezauthor=A.+Christopoulosauthor=P.+J.+Scammellsauthor=B.+Capuanoauthor=J.+R.+Lane&title=A+Structure-Activity+Analysis+of+Biased+Agonism+at+the+Dopamine+D2+Receptor&doi=10.1021%2Fjm401318w"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">A Structure-Activity Analysis of Biased Agonism at the Dopamine D2 Receptor</span></div><div class="casAuthors">Shonberg, Jeremy; Herenbrink, Carmen Klein; Lopez, Laura; Christopoulos, Arthur; Scammells, Peter J.; Capuano, Ben; Lane, J. Robert</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">9199-9221</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Biased agonism offers an opportunity for the medicinal chemist to discover pathway-selective ligands for GPCRs.  A no. of studies have suggested that biased agonism at the dopamine D2 receptor (D2R) may be advantageous for the treatment of neuropsychiatric disorders, including schizophrenia.  As such, it is of great importance to gain insight into the SAR of biased agonism at this receptor.  The authors have generated SAR based on a novel D2R partial agonist, tert-Bu (trans-4-(2-(3,4-dihydroisoquinolin-2-(1H)-yl)-ethyl)-cyclohexyl)-carbamate.  This ligand shares structural similarity to cariprazine, a drug awaiting FDA approval for the treatment of schizophrenia, yet displays a distinct bias toward two different signaling end points.  The authors synthesized a no. of derivs. of tert-Bu (trans-4-(2-(3,4-dihydroisoquinolin-2-(1H)-yl)-ethyl)-cyclohexyl)-carbamate with subtle structural modifications, including incorporation of cariprazine fragments.  By combining pharmacol. profiling with anal. methodol. to identify and to quantify bias, the authors have demonstrated that efficacy and biased agonism can be finely tuned by minor structural modifications to the head group contg. the tertiary amine, a tail group that extends away from this moiety, and the orientation and length of a spacer region between these two moieties.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGocktbsOBHWB7Vg90H21EOLACvtfcHk0liQmq97I60nzg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhs1CktrbJ&md5=124b940132336819740ec30d2962a3a3</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1021%2Fjm401318w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm401318w%26sid%3Dliteratum%253Aachs%26aulast%3DShonberg%26aufirst%3DJ.%26aulast%3DHerenbrink%26aufirst%3DC.%2BK.%26aulast%3DLopez%26aufirst%3DL.%26aulast%3DChristopoulos%26aufirst%3DA.%26aulast%3DScammells%26aufirst%3DP.%2BJ.%26aulast%3DCapuano%26aufirst%3DB.%26aulast%3DLane%26aufirst%3DJ.%2BR.%26atitle%3DA%2520Structure-Activity%2520Analysis%2520of%2520Biased%2520Agonism%2520at%2520the%2520Dopamine%2520D2%2520Receptor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D9199%26epage%3D9221%26doi%3D10.1021%2Fjm401318w" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Costa-Neto, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parreiras-e-Silva, L. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bouvier, M.</span><span> </span><span class="NLM_article-title">A Pluridimensional View of Biased Agonism</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">90</span><span class="NLM_x">, </span> <span class="NLM_fpage">587</span><span class="NLM_x">–</span> <span class="NLM_lpage">595</span><span class="refDoi"> DOI: 10.1124/mol.116.105940</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01857&amp;key=10.1124%2Fmol.116.105940" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01857&amp;key=27638872" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01857&amp;key=1%3ACAS%3A528%3ADC%252BC2sXitVaktbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=90&publication_year=2016&pages=587-595&author=C.+M.+Costa-Netoauthor=L.+T.+Parreiras-e-Silvaauthor=M.+Bouvier&title=A+Pluridimensional+View+of+Biased+Agonism&doi=10.1124%2Fmol.116.105940"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">A pluridimensional view of biased agonism</span></div><div class="casAuthors">Costa-Neto, Claudio M.; Parreiras-e-Silva, Lucas T.; Bouvier, Michel</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmacology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">90</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">587-595</span>CODEN:
                <span class="NLM_cas:coden">MOPMA3</span>;
        ISSN:<span class="NLM_cas:issn">1521-0111</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">A review.  When studying G protein-coupled receptor (GPCR) signaling and ligand-biased agonism, at least three dimensional spaces must be considered, as follows: (1) the distinct conformations that can be stabilized by different ligands promoting the engagement of different signaling effectors and accessory regulators; (2) the distinct subcellular trafficking that can be conferred by different ligands, which results in spatially distinct signals; and (3) the differential binding kinetics that maintain the receptor in specific conformation and/or subcellular localization for different periods of time, allowing for the engagement of distinct signaling effector subsets.  These three pluridimensional aspects of signaling contribute to different faces of functional selectivity and provide a complex, interconnected way to define the signaling profile of each individual ligand acting at GPCRs.  In this review, we discuss how each of these aspects may contribute to the diversity of signaling, but also how they shed light on the complexity of data analyses and interpretation.  The impact of phenotype variability as a source of signaling diversity, and the influence of novel and more sensitive assays in the detection and anal. of signaling pluridimensionality, is also discussed.  Finally, we discuss perspectives for the use of the concept of pluridimensional signaling in drug discovery, in which we highlight future predictive tools that may facilitate the identification of compds. with optimal therapeutic and safety properties based on the signaling signatures of drug candidates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo1fNh8j-db6LVg90H21EOLACvtfcHk0liQmq97I60nzg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXitVaktbc%253D&md5=959701333007f859e11126cc6629336e</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1124%2Fmol.116.105940&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.116.105940%26sid%3Dliteratum%253Aachs%26aulast%3DCosta-Neto%26aufirst%3DC.%2BM.%26aulast%3DParreiras-e-Silva%26aufirst%3DL.%2BT.%26aulast%3DBouvier%26aufirst%3DM.%26atitle%3DA%2520Pluridimensional%2520View%2520of%2520Biased%2520Agonism%26jtitle%3DMol.%2520Pharmacol.%26date%3D2016%26volume%3D90%26spage%3D587%26epage%3D595%26doi%3D10.1124%2Fmol.116.105940" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Galandrin, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oligny-Longpré, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bouvier, M.</span><span> </span><span class="NLM_article-title">The Evasive Nature of Drug Efficacy: Implications for Drug Discovery</span> <span class="citation_source-journal">Trends Pharmacol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">423</span><span class="NLM_x">–</span> <span class="NLM_lpage">430</span><span class="refDoi"> DOI: 10.1016/j.tips.2007.06.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01857&amp;key=10.1016%2Fj.tips.2007.06.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01857&amp;key=17659355" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01857&amp;key=1%3ACAS%3A528%3ADC%252BD2sXotlWltb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2007&pages=423-430&author=S.+Galandrinauthor=G.+Oligny-Longpr%C3%A9author=M.+Bouvier&title=The+Evasive+Nature+of+Drug+Efficacy%3A+Implications+for+Drug+Discovery&doi=10.1016%2Fj.tips.2007.06.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">The evasive nature of drug efficacy: implications for drug discovery</span></div><div class="casAuthors">Galandrin, Segolene; Oligny-Longpre, Genevieve; Bouvier, Michel</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Pharmacological Sciences</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">423-430</span>CODEN:
                <span class="NLM_cas:coden">TPHSDY</span>;
        ISSN:<span class="NLM_cas:issn">0165-6147</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  The efficacy of a drug is generally detd. by the drug's ability to promote a quantifiable biol. response.  In the context of the classical receptor-occupancy theory, the efficacy is considered an intrinsic property of the ligand/receptor pair, and it is often assumed to be the same for all the responses evoked by this pair.  The recognition that a single receptor can engage different signaling pathways and that various drugs binding to this receptor might differentially influence each of these pathways led to the reassessment of the efficacy concept.  Of particular notice is the fact that ligands that behave as agonists toward a given signaling pathway can act, through the same receptor, as antagonists or even inverse agonists on a different pathway in the same cell.  These observations, variously referred to as 'ligand-directed trafficking of receptor signaling' (LDTRS), functional selectivity', 'biased agonism', 'ligand-biased efficacy', 'collateral efficacy' or 'pluridimensional efficacy', have important implications for the mol. definition of efficacy and the process of drug discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrY1ZaH2DyMSrVg90H21EOLACvtfcHk0ljlyQXUo-bd_w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXotlWltb4%253D&md5=d0db88b9a041d115cd9f739854a5d480</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1016%2Fj.tips.2007.06.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tips.2007.06.005%26sid%3Dliteratum%253Aachs%26aulast%3DGalandrin%26aufirst%3DS.%26aulast%3DOligny-Longpr%25C3%25A9%26aufirst%3DG.%26aulast%3DBouvier%26aufirst%3DM.%26atitle%3DThe%2520Evasive%2520Nature%2520of%2520Drug%2520Efficacy%253A%2520Implications%2520for%2520Drug%2520Discovery%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D2007%26volume%3D28%26spage%3D423%26epage%3D430%26doi%3D10.1016%2Fj.tips.2007.06.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Bock, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kostenis, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tränkle, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lohse, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mohr, K.</span><span> </span><span class="NLM_article-title">Pilot the Pulse: Controlling the Multiplicity of Receptor Dynamics</span> <span class="citation_source-journal">Trends Pharmacol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">35</span><span class="NLM_x">, </span> <span class="NLM_fpage">630</span><span class="NLM_x">–</span> <span class="NLM_lpage">638</span><span class="refDoi"> DOI: 10.1016/j.tips.2014.10.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01857&amp;key=10.1016%2Fj.tips.2014.10.002" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2014&pages=630-638&author=A.+Bockauthor=E.+Kostenisauthor=C.+Tr%C3%A4nkleauthor=M.+J.+Lohseauthor=K.+Mohr&title=Pilot+the+Pulse%3A+Controlling+the+Multiplicity+of+Receptor+Dynamics&doi=10.1016%2Fj.tips.2014.10.002"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1016%2Fj.tips.2014.10.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tips.2014.10.002%26sid%3Dliteratum%253Aachs%26aulast%3DBock%26aufirst%3DA.%26aulast%3DKostenis%26aufirst%3DE.%26aulast%3DTr%25C3%25A4nkle%26aufirst%3DC.%26aulast%3DLohse%26aufirst%3DM.%2BJ.%26aulast%3DMohr%26aufirst%3DK.%26atitle%3DPilot%2520the%2520Pulse%253A%2520Controlling%2520the%2520Multiplicity%2520of%2520Receptor%2520Dynamics%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D2014%26volume%3D35%26spage%3D630%26epage%3D638%26doi%3D10.1016%2Fj.tips.2014.10.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Lane, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Donthamsetti, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shonberg, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Draper-Joyce, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dentry, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Michino, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">López, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scammells, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Capuano, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sexton, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Javitch, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christopoulos, A.</span><span> </span><span class="NLM_article-title">A New Mechanism of Allostery in a G Protein–Coupled Receptor Dimer</span> <span class="citation_source-journal">Nat. Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">745</span><span class="NLM_x">–</span> <span class="NLM_lpage">752</span><span class="refDoi"> DOI: 10.1038/nchembio.1593</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01857&amp;key=10.1038%2Fnchembio.1593" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01857&amp;key=25108820" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01857&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtlahurrL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2014&pages=745-752&author=J.+R.+Laneauthor=P.+Donthamsettiauthor=J.+Shonbergauthor=C.+J.+Draper-Joyceauthor=S.+Dentryauthor=M.+Michinoauthor=L.+Shiauthor=L.+L%C3%B3pezauthor=P.+J.+Scammellsauthor=B.+Capuanoauthor=P.+M.+Sextonauthor=J.+A.+Javitchauthor=A.+Christopoulos&title=A+New+Mechanism+of+Allostery+in+a+G+Protein%E2%80%93Coupled+Receptor+Dimer&doi=10.1038%2Fnchembio.1593"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">A new mechanism of allostery in a G protein-coupled receptor dimer</span></div><div class="casAuthors">Lane, J. Robert; Donthamsetti, Prashant; Shonberg, Jeremy; Draper-Joyce, Christopher J.; Dentry, Samuel; Michino, Mayako; Shi, Lei; Lopez, Laura; Scammells, Peter J.; Capuano, Ben; Sexton, Patrick M.; Javitch, Jonathan A.; Christopoulos, Arthur</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">745-752</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">SB269652 is to our knowledge the first drug-like allosteric modulator of the dopamine D2 receptor (D2R), but it contains structural features assocd. with orthosteric D2R antagonists.  Using a functional complementation system to control the identity of individual protomers within a dimeric D2R complex, we converted the pharmacol. of the interaction between SB269652 and dopamine from allosteric to competitive by impairing ligand binding to one of the protomers, indicating that the allostery requires D2R dimers.  Addnl. expts. identified a 'bitopic' pose for SB269652 extending from the orthosteric site into a secondary pocket at the extracellular end of the transmembrane (TM) domain, involving TM2 and TM7.  Engagement of this secondary pocket was a requirement for the allosteric pharmacol. of SB269652.  This suggests a new mechanism whereby a bitopic ligand binds in an extended pose on one G protein-coupled receptor protomer to allosterically modulate the binding of a ligand to the orthosteric site of a second protomer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpBF9SXb0jATLVg90H21EOLACvtfcHk0ljlyQXUo-bd_w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtlahurrL&md5=ececb5fc0e3e9b803807f700dc2c2cad</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.1593&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.1593%26sid%3Dliteratum%253Aachs%26aulast%3DLane%26aufirst%3DJ.%2BR.%26aulast%3DDonthamsetti%26aufirst%3DP.%26aulast%3DShonberg%26aufirst%3DJ.%26aulast%3DDraper-Joyce%26aufirst%3DC.%2BJ.%26aulast%3DDentry%26aufirst%3DS.%26aulast%3DMichino%26aufirst%3DM.%26aulast%3DShi%26aufirst%3DL.%26aulast%3DL%25C3%25B3pez%26aufirst%3DL.%26aulast%3DScammells%26aufirst%3DP.%2BJ.%26aulast%3DCapuano%26aufirst%3DB.%26aulast%3DSexton%26aufirst%3DP.%2BM.%26aulast%3DJavitch%26aufirst%3DJ.%2BA.%26aulast%3DChristopoulos%26aufirst%3DA.%26atitle%3DA%2520New%2520Mechanism%2520of%2520Allostery%2520in%2520a%2520G%2520Protein%25E2%2580%2593Coupled%2520Receptor%2520Dimer%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2014%26volume%3D10%26spage%3D745%26epage%3D752%26doi%3D10.1038%2Fnchembio.1593" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Weichert, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Banerjee, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hiller, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kling, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hübner, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gmeiner, P.</span><span> </span><span class="NLM_article-title">Molecular Determinants of Biased Agonism at the Dopamine D2 Receptor</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">2703</span><span class="NLM_x">–</span> <span class="NLM_lpage">2717</span><span class="refDoi"> DOI: 10.1021/jm501889t</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm501889t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01857&amp;key=1%3ACAS%3A528%3ADC%252BC2MXjslelsrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=2703-2717&author=D.+Weichertauthor=A.+Banerjeeauthor=C.+Hillerauthor=R.+C.+Klingauthor=H.+H%C3%BCbnerauthor=P.+Gmeiner&title=Molecular+Determinants+of+Biased+Agonism+at+the+Dopamine+D2+Receptor&doi=10.1021%2Fjm501889t"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular Determinants of Biased Agonism at the Dopamine D2 Receptor</span></div><div class="casAuthors">Weichert, Dietmar; Banerjee, Ashutosh; Hiller, Christine; Kling, Ralf C.; Huebner, Harald; Gmeiner, Peter</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2703-2717</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The development of biased (functionally selective) ligands provides a formidable challenge in medicinal chem.  In an effort to learn to design functionally selective mol. tools for the highly therapeutically relevant dopamine D2 receptor, we synthesized a collection of agonists based on structurally distinct head groups derived from canonical or atypical dopaminergic pharmacophores.  The test compds. feature a long lipophilic appendage that was shown to mediate biased signaling.  By employing functional assays and mol. dynamics simulations, we could show that atypical dopamine surrogates of type 1 and 2 promote biased signaling, while ligands built from classical dopaminergic head groups (type 3 and 4) typically elicit more balanced signaling profiles.  Besides this, we found a strong influence of the stereochem. of type 4 aminotetraline-derived agonists on functional selectivity at D2 receptors.  Whereas the (S)-enantiomer behaved as a full agonist, the biased ligand (R)-4 induced poor G protein coupling but substantial β-arrestin recruitment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqLUr0k5gvdy7Vg90H21EOLACvtfcHk0ljlyQXUo-bd_w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXjslelsrc%253D&md5=cdf8f3ed9dff5f14ae06dbbc227fb14a</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Fjm501889t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm501889t%26sid%3Dliteratum%253Aachs%26aulast%3DWeichert%26aufirst%3DD.%26aulast%3DBanerjee%26aufirst%3DA.%26aulast%3DHiller%26aufirst%3DC.%26aulast%3DKling%26aufirst%3DR.%2BC.%26aulast%3DH%25C3%25BCbner%26aufirst%3DH.%26aulast%3DGmeiner%26aufirst%3DP.%26atitle%3DMolecular%2520Determinants%2520of%2520Biased%2520Agonism%2520at%2520the%2520Dopamine%2520D2%2520Receptor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D2703%26epage%3D2717%26doi%3D10.1021%2Fjm501889t" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Cannon, J. G.</span><span> </span><span class="NLM_article-title">Structure-Activity Relationships of Dopamine Agonists</span> <span class="citation_source-journal">Annu. Rev. Pharmacol. Toxicol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1983</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">103</span><span class="NLM_x">–</span> <span class="NLM_lpage">129</span><span class="refDoi"> DOI: 10.1146/annurev.pa.23.040183.000535</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01857&amp;key=10.1146%2Fannurev.pa.23.040183.000535" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=1983&pages=103-129&author=J.+G.+Cannon&title=Structure-Activity+Relationships+of+Dopamine+Agonists&doi=10.1146%2Fannurev.pa.23.040183.000535"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1146%2Fannurev.pa.23.040183.000535&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev.pa.23.040183.000535%26sid%3Dliteratum%253Aachs%26aulast%3DCannon%26aufirst%3DJ.%2BG.%26atitle%3DStructure-Activity%2520Relationships%2520of%2520Dopamine%2520Agonists%26jtitle%3DAnnu.%2520Rev.%2520Pharmacol.%2520Toxicol.%26date%3D1983%26volume%3D23%26spage%3D103%26epage%3D129%26doi%3D10.1146%2Fannurev.pa.23.040183.000535" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Masri, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salahpour, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Didriksen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghisi, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beaulieu, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gainetdinov, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caron, M. G.</span><span> </span><span class="NLM_article-title">Antagonism of Dopamine D2 Receptor/Beta-Arrestin 2 Interaction Is a Common Property of Clinically Effective Antipsychotics</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">105</span><span class="NLM_x">, </span> <span class="NLM_fpage">13656</span><span class="NLM_x">–</span> <span class="NLM_lpage">13661</span><span class="refDoi"> DOI: 10.1073/pnas.0803522105</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01857&amp;key=10.1073%2Fpnas.0803522105" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=105&publication_year=2008&pages=13656-13661&author=B.+Masriauthor=A.+Salahpourauthor=M.+Didriksenauthor=V.+Ghisiauthor=J.+M.+Beaulieuauthor=R.+R.+Gainetdinovauthor=M.+G.+Caron&title=Antagonism+of+Dopamine+D2+Receptor%2FBeta-Arrestin+2+Interaction+Is+a+Common+Property+of+Clinically+Effective+Antipsychotics&doi=10.1073%2Fpnas.0803522105"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0803522105&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0803522105%26sid%3Dliteratum%253Aachs%26aulast%3DMasri%26aufirst%3DB.%26aulast%3DSalahpour%26aufirst%3DA.%26aulast%3DDidriksen%26aufirst%3DM.%26aulast%3DGhisi%26aufirst%3DV.%26aulast%3DBeaulieu%26aufirst%3DJ.%2BM.%26aulast%3DGainetdinov%26aufirst%3DR.%2BR.%26aulast%3DCaron%26aufirst%3DM.%2BG.%26atitle%3DAntagonism%2520of%2520Dopamine%2520D2%2520Receptor%252FBeta-Arrestin%25202%2520Interaction%2520Is%2520a%2520Common%2520Property%2520of%2520Clinically%2520Effective%2520Antipsychotics%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2008%26volume%3D105%26spage%3D13656%26epage%3D13661%26doi%3D10.1073%2Fpnas.0803522105" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Sandanayaka, V.; Singh, J.; Zhou, L.-M.; Gurney, M. E.</span><span> </span><span class="NLM_article-title">Biaryl Nitrogen-Heterocycle Inhibitors of LTA4H for Treating Inflammation</span>. U.S. Patent 2007/0149544A1,<span class="NLM_x"> </span><span class="NLM_year">2007</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2007&author=V.+Sandanayaka&author=J.+Singh&author=L.-M.+Zhou&author=M.+E.+Gurney&title=Biaryl+Nitrogen-Heterocycle+Inhibitors+of+LTA4H+for+Treating+Inflammation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DSandanayaka%26aufirst%3DV.%26atitle%3DBiaryl%2520Nitrogen-Heterocycle%2520Inhibitors%2520of%2520LTA4H%2520for%2520Treating%2520Inflammation%26date%3D2007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Möller, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salama, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kling, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hübner, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gmeiner, P.</span><span> </span><span class="NLM_article-title">1,4-Disubstituted Aromatic Piperazines with High 5-HT2a/D2 Selectivity: Quantitative Structure-Selectivity Investigations, Docking, Synthesis and Biological Evaluation</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">6195</span><span class="NLM_x">–</span> <span class="NLM_lpage">6209</span><span class="refDoi"> DOI: 10.1016/j.bmc.2015.07.050</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01857&amp;key=10.1016%2Fj.bmc.2015.07.050" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2015&pages=6195-6209&author=D.+M%C3%B6llerauthor=I.+Salamaauthor=R.+C.+Klingauthor=H.+H%C3%BCbnerauthor=P.+Gmeiner&title=1%2C4-Disubstituted+Aromatic+Piperazines+with+High+5-HT2a%2FD2+Selectivity%3A+Quantitative+Structure-Selectivity+Investigations%2C+Docking%2C+Synthesis+and+Biological+Evaluation&doi=10.1016%2Fj.bmc.2015.07.050"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2015.07.050&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2015.07.050%26sid%3Dliteratum%253Aachs%26aulast%3DM%25C3%25B6ller%26aufirst%3DD.%26aulast%3DSalama%26aufirst%3DI.%26aulast%3DKling%26aufirst%3DR.%2BC.%26aulast%3DH%25C3%25BCbner%26aufirst%3DH.%26aulast%3DGmeiner%26aufirst%3DP.%26atitle%3D1%252C4-Disubstituted%2520Aromatic%2520Piperazines%2520with%2520High%25205-HT2a%252FD2%2520Selectivity%253A%2520Quantitative%2520Structure-Selectivity%2520Investigations%252C%2520Docking%252C%2520Synthesis%2520and%2520Biological%2520Evaluation%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2015%26volume%3D23%26spage%3D6195%26epage%3D6209%26doi%3D10.1016%2Fj.bmc.2015.07.050" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Kendall, J. D.; Marshall, A. J.</span><span> </span><span class="NLM_article-title">Pyrazolo[1,5-<i>a</i>]Pyridine Derivatives as PI3 Kinase Inhibitors and Their Preparation, Pharmaceutical Compositions and Use in the Treatment of Cancers</span>. Patent WO2009008748A1,<span class="NLM_x"> </span><span class="NLM_year">2009</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&author=J.+D.+Kendall&author=A.+J.+Marshall&title=Pyrazolo%5B1%2C5-a%5DPyridine+Derivatives+as+PI3+Kinase+Inhibitors+and+Their+Preparation%2C+Pharmaceutical+Compositions+and+Use+in+the+Treatment+of+Cancers"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DKendall%26aufirst%3DJ.%2BD.%26atitle%3DPyrazolo%255B1%252C5-a%255DPyridine%2520Derivatives%2520as%2520PI3%2520Kinase%2520Inhibitors%2520and%2520Their%2520Preparation%252C%2520Pharmaceutical%2520Compositions%2520and%2520Use%2520in%2520the%2520Treatment%2520of%2520Cancers%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Gmeiner, P.; Huebner, H.; Skultety, M.</span><span> </span><span class="NLM_article-title">Preparation of Indolizines and Aza-Analog Derivatives Thereof as CNS Active Compounds</span>. Patent WO2008113559A2,<span class="NLM_x"> </span><span class="NLM_year">2008</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&author=P.+Gmeiner&author=H.+Huebner&author=M.+Skultety&title=Preparation+of+Indolizines+and+Aza-Analog+Derivatives+Thereof+as+CNS+Active+Compounds"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DGmeiner%26aufirst%3DP.%26atitle%3DPreparation%2520of%2520Indolizines%2520and%2520Aza-Analog%2520Derivatives%2520Thereof%2520as%2520CNS%2520Active%2520Compounds%26date%3D2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Boeckler, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohnmacht, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lehmann, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Utz, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hübner, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gmeiner, P.</span><span> </span><span class="NLM_article-title">COMFA and COMSIA Investigations Revealing Novel Insights into the Binding Modes of Dopamine D3 Receptor Agonists</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">2493</span><span class="NLM_x">–</span> <span class="NLM_lpage">2508</span><span class="refDoi"> DOI: 10.1021/jm049269+</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm049269%2B" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=2493-2508&author=F.+Boecklerauthor=U.+Ohnmachtauthor=T.+Lehmannauthor=W.+Utzauthor=H.+H%C3%BCbnerauthor=P.+Gmeiner&title=COMFA+and+COMSIA+Investigations+Revealing+Novel+Insights+into+the+Binding+Modes+of+Dopamine+D3+Receptor+Agonists&doi=10.1021%2Fjm049269%2B"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1021%2Fjm049269%2B&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm049269%252B%26sid%3Dliteratum%253Aachs%26aulast%3DBoeckler%26aufirst%3DF.%26aulast%3DOhnmacht%26aufirst%3DU.%26aulast%3DLehmann%26aufirst%3DT.%26aulast%3DUtz%26aufirst%3DW.%26aulast%3DH%25C3%25BCbner%26aufirst%3DH.%26aulast%3DGmeiner%26aufirst%3DP.%26atitle%3DCOMFA%2520and%2520COMSIA%2520Investigations%2520Revealing%2520Novel%2520Insights%2520into%2520the%2520Binding%2520Modes%2520of%2520Dopamine%2520D3%2520Receptor%2520Agonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D2493%26epage%3D2508%26doi%3D10.1021%2Fjm049269%2B" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Moffett, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hanze, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seay, P. H.</span><span> </span><span class="NLM_article-title">Central Nervous System Depressants. V. Polyhydroxy and Methoxyphenyl Ketones, Carbinols, and Derivatives</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1964</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">178</span><span class="NLM_x">–</span> <span class="NLM_lpage">186</span><span class="refDoi"> DOI: 10.1021/jm00332a013</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm00332a013" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=1964&pages=178-186&author=R.+B.+Moffettauthor=A.+R.+Hanzeauthor=P.+H.+Seay&title=Central+Nervous+System+Depressants.+V.+Polyhydroxy+and+Methoxyphenyl+Ketones%2C+Carbinols%2C+and+Derivatives&doi=10.1021%2Fjm00332a013"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1021%2Fjm00332a013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00332a013%26sid%3Dliteratum%253Aachs%26aulast%3DMoffett%26aufirst%3DR.%2BB.%26aulast%3DHanze%26aufirst%3DA.%2BR.%26aulast%3DSeay%26aufirst%3DP.%2BH.%26atitle%3DCentral%2520Nervous%2520System%2520Depressants.%2520V.%2520Polyhydroxy%2520and%2520Methoxyphenyl%2520Ketones%252C%2520Carbinols%252C%2520and%2520Derivatives%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1964%26volume%3D7%26spage%3D178%26epage%3D186%26doi%3D10.1021%2Fjm00332a013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">De Luca, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giacomelli, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Porcheddu, A.</span><span> </span><span class="NLM_article-title">Beckmann Rearrangement of Oximes under Very Mild Conditions</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">67</span><span class="NLM_x">, </span> <span class="NLM_fpage">6272</span><span class="NLM_x">–</span> <span class="NLM_lpage">6274</span><span class="refDoi"> DOI: 10.1021/jo025960d</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo025960d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01857&amp;key=1%3ACAS%3A528%3ADC%252BD38XlsFals78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2002&pages=6272-6274&author=L.+De+Lucaauthor=G.+Giacomelliauthor=A.+Porcheddu&title=Beckmann+Rearrangement+of+Oximes+under+Very+Mild+Conditions&doi=10.1021%2Fjo025960d"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Beckmann Rearrangement of Oximes under Very Mild Conditions</span></div><div class="casAuthors">De Luca, Lidia; Giacomelli, Giampaolo; Porcheddu, Andrea</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">6272-6274</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A variety of ketoximes, easily prepd. from the corresponding ketones, undergo the Beckmann rearrangement upon treatment with 2,4,6-trichloro[1,3,5]triazine in DMF at room temp. in excellent yields.  This procedure can be applied to aldoximes for obtaining the corresponding nitriles.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqHuyV4LhDjT7Vg90H21EOLACvtfcHk0ljdzNMitLuqzQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XlsFals78%253D&md5=ca020b2ef4bd9a3880baed63e669e442</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1021%2Fjo025960d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo025960d%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BLuca%26aufirst%3DL.%26aulast%3DGiacomelli%26aufirst%3DG.%26aulast%3DPorcheddu%26aufirst%3DA.%26atitle%3DBeckmann%2520Rearrangement%2520of%2520Oximes%2520under%2520Very%2520Mild%2520Conditions%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2002%26volume%3D67%26spage%3D6272%26epage%3D6274%26doi%3D10.1021%2Fjo025960d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Dulcere, J. P.</span><span> </span><span class="NLM_article-title">Vilsmeier Reagent for a High-Yield Conversion of Aldoximes to Nitriles</span> <span class="citation_source-journal">Tetrahedron Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1981</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">1599</span><span class="NLM_x">–</span> <span class="NLM_lpage">1600</span><span class="refDoi"> DOI: 10.1016/S0040-4039(01)90387-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01857&amp;key=10.1016%2FS0040-4039%2801%2990387-9" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=1981&pages=1599-1600&author=J.+P.+Dulcere&title=Vilsmeier+Reagent+for+a+High-Yield+Conversion+of+Aldoximes+to+Nitriles&doi=10.1016%2FS0040-4039%2801%2990387-9"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1016%2FS0040-4039%2801%2990387-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0040-4039%252801%252990387-9%26sid%3Dliteratum%253Aachs%26aulast%3DDulcere%26aufirst%3DJ.%2BP.%26atitle%3DVilsmeier%2520Reagent%2520for%2520a%2520High-Yield%2520Conversion%2520of%2520Aldoximes%2520to%2520Nitriles%26jtitle%3DTetrahedron%2520Lett.%26date%3D1981%26volume%3D22%26spage%3D1599%26epage%3D1600%26doi%3D10.1016%2FS0040-4039%2801%2990387-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Lane, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Powney, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wise, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rees, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milligan, G. G.</span><span> </span><span class="NLM_article-title">Protein Coupling and Ligand Selectivity of the D2L and D3 Dopamine Receptors</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">325</span><span class="NLM_x">, </span> <span class="NLM_fpage">319</span><span class="NLM_x">–</span> <span class="NLM_lpage">330</span><span class="refDoi"> DOI: 10.1124/jpet.107.134296</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01857&amp;key=10.1124%2Fjpet.107.134296" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01857&amp;key=18218829" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01857&amp;key=1%3ACAS%3A528%3ADC%252BD1cXktFGjur0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=325&publication_year=2008&pages=319-330&author=J.+R.+Laneauthor=B.+Powneyauthor=A.+Wiseauthor=S.+Reesauthor=G.+G.+Milligan&title=Protein+Coupling+and+Ligand+Selectivity+of+the+D2L+and+D3+Dopamine+Receptors&doi=10.1124%2Fjpet.107.134296"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">G protein coupling and ligand selectivity of the D2L and D3 dopamine receptors</span></div><div class="casAuthors">Lane, J. Robert; Powney, Ben; Wise, Alan; Rees, Stephen; Milligan, Graeme</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">325</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">319-330</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The human dopamine D2L receptor couples promiscuously to multiple members of the Gαi/o subfamily.  Despite the high homol. of the D2L and D3 receptors, the G protein coupling specificity of the human D3 receptor is less clearly characterized.  The primary aim of this study, then, was the parallel characterization of the G protein coupling specificity of the D2L and D3 receptors.  By using both receptor-G protein fusion proteins and stable cell lines in which pertussis toxin-resistant mutants of individual Gαi-family G proteins were expressed in an inducible fashion, we demonstrated highly selective coupling of the D3 receptor to Gαo1.  Furthermore, by using the fusion proteins to ensure identical stoichiometry of receptor to G protein for each pairing, a range of ligands displayed higher potency and, for partial agonists, higher efficacy at the D3 receptor when coupled to Gαo1 compared with the D2L receptor.  The second aim of this study was to investigate the mol. basis of the above differential G protein coupling specificity.  The importance of a 12-amino acid sequence from the C-terminal end of the third intracellular loop of the D2L receptor in providing promiscuity in G protein coupling was demonstrated using a chimeric D3/D2 receptor in which the equiv. region of the D3 receptor was exchanged for this sequence.  This chimera displayed D3-like affinity for [3H]spiperone and potency for agonists but gained D2-like ability to couple to each of Gαi1-3 as well as Gαo1.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqxa1ewwkwA2bVg90H21EOLACvtfcHk0lhJKPXu5mBPzQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXktFGjur0%253D&md5=dd55e53f17554e5fdf1740b788b9028c</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1124%2Fjpet.107.134296&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.107.134296%26sid%3Dliteratum%253Aachs%26aulast%3DLane%26aufirst%3DJ.%2BR.%26aulast%3DPowney%26aufirst%3DB.%26aulast%3DWise%26aufirst%3DA.%26aulast%3DRees%26aufirst%3DS.%26aulast%3DMilligan%26aufirst%3DG.%2BG.%26atitle%3DProtein%2520Coupling%2520and%2520Ligand%2520Selectivity%2520of%2520the%2520D2L%2520and%2520D3%2520Dopamine%2520Receptors%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2008%26volume%3D325%26spage%3D319%26epage%3D330%26doi%3D10.1124%2Fjpet.107.134296" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Gazi, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strange, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nickolls, S. A.</span><span> </span><span class="NLM_article-title">Functional Coupling of the Human Dopamine D2 Receptor with Galphai1, Galphai2, Galphai3, and Galphao G Proteins: Evidence for Agonist Regulation of G Protein Selectivity</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">138</span><span class="NLM_x">, </span> <span class="NLM_fpage">775</span><span class="NLM_x">–</span> <span class="NLM_lpage">786</span><span class="refDoi"> DOI: 10.1038/sj.bjp.0705116</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01857&amp;key=10.1038%2Fsj.bjp.0705116" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01857&amp;key=12642378" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01857&amp;key=1%3ACAS%3A528%3ADC%252BD3sXisFegs7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=138&publication_year=2003&pages=775-786&author=L.+Gaziauthor=P.+G.+Strangeauthor=S.+A.+Nickolls&title=Functional+Coupling+of+the+Human+Dopamine+D2+Receptor+with+Galphai1%2C+Galphai2%2C+Galphai3%2C+and+Galphao+G+Proteins%3A+Evidence+for+Agonist+Regulation+of+G+Protein+Selectivity&doi=10.1038%2Fsj.bjp.0705116"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Functional coupling of the human dopamine D2 receptor with Gαi1, Gαi2, Gαi3 and Gαo G proteins: Evidence for agonist regulation of G protein selectivity</span></div><div class="casAuthors">Gazi, Lucien; Nickolls, Sarah A.; Strange, Philip G.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">138</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">775-786</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The human dopamine D2long (D2L) receptor was expressed with four different G proteins in Sf9 cells using the baculovirus expression system.  When co-expressed with Gi/Go G proteins (Gi1α, Gi2α, Gi3α, or Goα, plus Gβ1 and Gγ2), the receptor displayed a high-affinity binding site for the agonists (dopamine and NPA), which was sensitive to GTP (100 μM), demonstrating interaction between the receptor and the different G proteins.  The receptor to G protein ratio (R:G ratio) was evaluated using [3H]-spiperone satn. binding (R) and [35S]-GTPγS satn. binding (G).  R:G ratios of 1:12, 1:3, 1:14 and 1:5 were found for Gi1, Gi2, Gi3, and Go prepns., resp.  However, when R:G ratios of 1:2 and 1:12 were compared for Gi2 and Go, no difference was found for the stimulation of [35S]-GTPγS binding.  Several agonists were tested for their ability to stimulate [35S]-GTPγS binding to membranes co-expressing the receptor and various G proteins.  All the compds. tested showed agonist activity in prepns. expressing Gi3 and Go.  However, for Gi2 and Gi1 prepns., compds. such as S-(-)-3-PPP and p-tyramine were unable to stimulate [35S]-GTPγS binding.  Most of the compds. showed higher relative efficacies (compared to dopamine) and higher potencies in the prepn. expressing Go.  Comparison of the effects of different agonists in the different prepns. showed that each agonist differentially activates the four G proteins.  We conclude that the degree of selectivity of G protein activation by the D2L receptor can depend on the conformation of the receptor stabilized by an agonist.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpSCewgdeU6SbVg90H21EOLACvtfcHk0lhJKPXu5mBPzQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXisFegs7s%253D&md5=f0417b2243b11377ab4df51a98aebaff</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjp.0705116&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjp.0705116%26sid%3Dliteratum%253Aachs%26aulast%3DGazi%26aufirst%3DL.%26aulast%3DStrange%26aufirst%3DP.%2BG.%26aulast%3DNickolls%26aufirst%3DS.%2BA.%26atitle%3DFunctional%2520Coupling%2520of%2520the%2520Human%2520Dopamine%2520D2%2520Receptor%2520with%2520Galphai1%252C%2520Galphai2%252C%2520Galphai3%252C%2520and%2520Galphao%2520G%2520Proteins%253A%2520Evidence%2520for%2520Agonist%2520Regulation%2520of%2520G%2520Protein%2520Selectivity%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2003%26volume%3D138%26spage%3D775%26epage%3D786%26doi%3D10.1038%2Fsj.bjp.0705116" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Ahlgren-Beckendorf, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levant, B.</span><span> </span><span class="NLM_article-title">Signaling Mechanisms of the D3 Dopamine Receptor</span> <span class="citation_source-journal">J. Recept. Signal Transduction Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">117</span><span class="NLM_x">–</span> <span class="NLM_lpage">130</span><span class="refDoi"> DOI: 10.1081/RRS-200029953</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01857&amp;key=10.1081%2FRRS-200029953" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01857&amp;key=15521358" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01857&amp;key=1%3ACAS%3A528%3ADC%252BD2cXnvVKhs7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2004&pages=117-130&author=J.+A.+Ahlgren-Beckendorfauthor=B.+Levant&title=Signaling+Mechanisms+of+the+D3+Dopamine+Receptor&doi=10.1081%2FRRS-200029953"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Signaling Mechanisms of the D3 Dopamine Receptor</span></div><div class="casAuthors">Ahlgren-Beckendorf, Joy A.; Levant, Beth</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Receptors and Signal Transduction</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">117-130</span>CODEN:
                <span class="NLM_cas:coden">JRSTCT</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    
            (<span class="NLM_cas:orgname">Marcel Dekker, Inc.</span>)
        </div><div class="casAbstract">A review.  A substantial body of evidence shows the capacity of the dopamine D3 receptor to couple functionally to G proteins when expressed in an appropriate milieu in heterologous expression systems.  In these systems, activation of D3 receptors inhibits adenylate cyclase, modulates ion flow through potassium and calcium channels, and activates kinases, most notably mitogen-activated protein kinase.  Coupling to Gi/Go is implicated in many of these effects, but other G proteins may contribute.  Studies with chimeric receptors implicate the 3rd intracellular loop in the mediation of agonist-induced signal transduction.  Finally, D3-preferring drugs modulate expression of c-fos in neuronal cultures and brain.  Signaling mechanisms of the D3 receptor in brain, however, remain to be definitively detd.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpOl-65wNzGh7Vg90H21EOLACvtfcHk0lhJKPXu5mBPzQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXnvVKhs7w%253D&md5=30ff8f18d95ab96ae90c078458ff4dc6</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1081%2FRRS-200029953&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1081%252FRRS-200029953%26sid%3Dliteratum%253Aachs%26aulast%3DAhlgren-Beckendorf%26aufirst%3DJ.%2BA.%26aulast%3DLevant%26aufirst%3DB.%26atitle%3DSignaling%2520Mechanisms%2520of%2520the%2520D3%2520Dopamine%2520Receptor%26jtitle%3DJ.%2520Recept.%2520Signal%2520Transduction%2520Res.%26date%3D2004%26volume%3D24%26spage%3D117%26epage%3D130%26doi%3D10.1081%2FRRS-200029953" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Jiang, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spicher, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boulay, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Birnbaumer, L.</span><span> </span><span class="NLM_article-title">Most Central Nervous System D2 Dopamine Receptors Are Coupled to Their Effectors by Go</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">98</span><span class="NLM_x">, </span> <span class="NLM_fpage">3577</span><span class="NLM_x">–</span> <span class="NLM_lpage">3582</span><span class="refDoi"> DOI: 10.1073/pnas.051632598</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01857&amp;key=10.1073%2Fpnas.051632598" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=98&publication_year=2001&pages=3577-3582&author=M.+Jiangauthor=K.+Spicherauthor=G.+Boulayauthor=Y.+Wangauthor=L.+Birnbaumer&title=Most+Central+Nervous+System+D2+Dopamine+Receptors+Are+Coupled+to+Their+Effectors+by+Go&doi=10.1073%2Fpnas.051632598"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1073%2Fpnas.051632598&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.051632598%26sid%3Dliteratum%253Aachs%26aulast%3DJiang%26aufirst%3DM.%26aulast%3DSpicher%26aufirst%3DK.%26aulast%3DBoulay%26aufirst%3DG.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DBirnbaumer%26aufirst%3DL.%26atitle%3DMost%2520Central%2520Nervous%2520System%2520D2%2520Dopamine%2520Receptors%2520Are%2520Coupled%2520to%2520Their%2520Effectors%2520by%2520Go%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2001%26volume%3D98%26spage%3D3577%26epage%3D3582%26doi%3D10.1073%2Fpnas.051632598" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Asano, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morishita, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Semba, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Itoh, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaziro, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kato, K.</span><span> </span><span class="NLM_article-title">Identification of Lung Major Gtp-Binding Protein as Gi2 and Its Distribution in Various Rat-Tissues Determined by Immunoassay</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1989</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">4749</span><span class="NLM_x">–</span> <span class="NLM_lpage">4754</span><span class="refDoi"> DOI: 10.1021/bi00437a035</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi00437a035" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=1989&pages=4749-4754&author=T.+Asanoauthor=R.+Morishitaauthor=R.+Sembaauthor=H.+Itohauthor=Y.+Kaziroauthor=K.+Kato&title=Identification+of+Lung+Major+Gtp-Binding+Protein+as+Gi2+and+Its+Distribution+in+Various+Rat-Tissues+Determined+by+Immunoassay&doi=10.1021%2Fbi00437a035"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1021%2Fbi00437a035&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi00437a035%26sid%3Dliteratum%253Aachs%26aulast%3DAsano%26aufirst%3DT.%26aulast%3DMorishita%26aufirst%3DR.%26aulast%3DSemba%26aufirst%3DR.%26aulast%3DItoh%26aufirst%3DH.%26aulast%3DKaziro%26aufirst%3DY.%26aulast%3DKato%26aufirst%3DK.%26atitle%3DIdentification%2520of%2520Lung%2520Major%2520Gtp-Binding%2520Protein%2520as%2520Gi2%2520and%2520Its%2520Distribution%2520in%2520Various%2520Rat-Tissues%2520Determined%2520by%2520Immunoassay%26jtitle%3DBiochemistry%26date%3D1989%26volume%3D28%26spage%3D4749%26epage%3D4754%26doi%3D10.1021%2Fbi00437a035" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group">Strange, P. G.</span><span> </span><span class="NLM_article-title">Use of the Gtpgammas Binding Assay for Analysis of Ligand Potency and Efficacy at G Protein-Coupled Receptors</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">161</span><span class="NLM_x">, </span> <span class="NLM_fpage">1238</span><span class="NLM_x">–</span> <span class="NLM_lpage">1249</span><span class="refDoi"> DOI: 10.1111/j.1476-5381.2010.00963.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01857&amp;key=10.1111%2Fj.1476-5381.2010.00963.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01857&amp;key=20662841" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01857&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsFWhsr3K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=161&publication_year=2010&pages=1238-1249&author=P.+G.+Strange&title=Use+of+the+Gtpgammas+Binding+Assay+for+Analysis+of+Ligand+Potency+and+Efficacy+at+G+Protein-Coupled+Receptors&doi=10.1111%2Fj.1476-5381.2010.00963.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Use of the GTPγS ([35S]GTPγS and Eu-GTPγS) binding assay for analysis of ligand potency and efficacy at G protein-coupled receptors</span></div><div class="casAuthors">Strange, Philip G.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">161</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1238-1249</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">1476-5381</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  In this review I consider assays for G protein-coupled receptor (GPCR) activity based on the binding of labeled analogs of GTPγS ([35S]GTPγS or Eu-GTPγS) to G proteins in tissues (GTPγS binding assays).  Such assays provide convenient measures of GPCR activity close to the receptor in the signaling cascade.  In order to set up a GTPγS binding assay, the requirements of the assay must be considered.  These are tissue source, GTPγS analog, G protein, GDP, Mg2+/Na+ ions, saponin, incubation time.  The assay, once optimized, can be used to generate concn./response curves for GPCRs signaling via Gi/o proteins (or to other G proteins with a modified assay) and actions of agonists, inverse agonists and antagonists may, in principle, be assessed.  For agonists and inverse agonists, data for the maximal agonist effect, the concn. of ligand giving a half-maximal response and the Hill coeff. may be derived.  For antagonists, data for the equil. dissocn. const. can be obtained.  The mechanistic basis of the assay is considered.  Although the assay can be used to profile ligands, under the conditions it is used, it may not be measuring the same event that dets. GPCR action in cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGonpFh81URvabVg90H21EOLACvtfcHk0liOwZfAdMNKMw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsFWhsr3K&md5=8fa11a4e869eec381bae3880f4051dc2</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1111%2Fj.1476-5381.2010.00963.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1476-5381.2010.00963.x%26sid%3Dliteratum%253Aachs%26aulast%3DStrange%26aufirst%3DP.%2BG.%26atitle%3DUse%2520of%2520the%2520Gtpgammas%2520Binding%2520Assay%2520for%2520Analysis%2520of%2520Ligand%2520Potency%2520and%2520Efficacy%2520at%2520G%2520Protein-Coupled%2520Receptors%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2010%26volume%3D161%26spage%3D1238%26epage%3D1249%26doi%3D10.1111%2Fj.1476-5381.2010.00963.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group">Harrison, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Traynor, J. R.</span><span> </span><span class="NLM_article-title">The [35s]Gtpγs Binding Assay: Approaches and Applications in Pharmacology</span> <span class="citation_source-journal">Life Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">74</span><span class="NLM_x">, </span> <span class="NLM_fpage">489</span><span class="NLM_x">–</span> <span class="NLM_lpage">508</span><span class="refDoi"> DOI: 10.1016/j.lfs.2003.07.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01857&amp;key=10.1016%2Fj.lfs.2003.07.005" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=74&publication_year=2003&pages=489-508&author=C.+Harrisonauthor=J.+R.+Traynor&title=The+%5B35s%5DGtp%CE%B3s+Binding+Assay%3A+Approaches+and+Applications+in+Pharmacology&doi=10.1016%2Fj.lfs.2003.07.005"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1016%2Fj.lfs.2003.07.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.lfs.2003.07.005%26sid%3Dliteratum%253Aachs%26aulast%3DHarrison%26aufirst%3DC.%26aulast%3DTraynor%26aufirst%3DJ.%2BR.%26atitle%3DThe%2520%255B35s%255DGtp%25CE%25B3s%2520Binding%2520Assay%253A%2520Approaches%2520and%2520Applications%2520in%2520Pharmacology%26jtitle%3DLife%2520Sci.%26date%3D2003%26volume%3D74%26spage%3D489%26epage%3D508%26doi%3D10.1016%2Fj.lfs.2003.07.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span>In  <span class="citation_source-book">Assay Guidance Manual</span>; <span class="NLM_contrib-group">Sittampalam, G. S.; Coussens, N. P.; Nelson, H.; Arkin, M.; Auld, D.; Austin, C.; Bejcek, B.; Glicksman, M.; Inglese, J.; Iversen, P. W.; Li, Z.; McGee, J.; McManus, O.; Minor, L.; Napper, A.; Peltier, J. M.; Riss, T.; Trask, O. J.,  Jr.; Weidner, J.</span>, Eds.; <span class="NLM_publisher-name">Eli Lilly & Company and the National Center for Advancing Translational Sciences</span>: <span class="NLM_publisher-loc">Bethesda, MD</span>,<span class="NLM_x"> </span><span class="NLM_year">2004</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2004&author=G.+S.+Sittampalam&author=N.+P.+Coussens&author=H.+Nelson&author=M.+Arkin&author=D.+Auld&author=C.+Austin&author=B.+Bejcek&author=M.+Glicksman&author=J.+Inglese&author=P.+W.+Iversen&author=Z.+Li&author=J.+McGee&author=O.+McManus&author=L.+Minor&author=A.+Napper&author=J.+M.+Peltier&author=T.+Riss&author=O.+J.+Trask&author=J.+Weidner&title=Assay+Guidance+Manual"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26btitle%3DAssay%2520Guidance%2520Manual%26aulast%3DSittampalam%26aufirst%3DG.%2BS.%26pub%3DEli%2520Lilly%2520%2526%2520Company%2520and%2520the%2520National%2520Center%2520for%2520Advancing%2520Translational%2520Sciences%26date%3D2004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group">Klein Herenbrink, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sykes, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Donthamsetti, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Canals, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coudrat, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shonberg, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scammells, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Capuano, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sexton, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Charlton, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Javitch, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christopoulos, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lane, J. R.</span><span> </span><span class="NLM_article-title">The Role of Kinetic Context in Apparent Biased Agonism at GPCRs</span> <span class="citation_source-journal">Nat. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">10842</span><span class="refDoi"> DOI: 10.1038/ncomms10842</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01857&amp;key=10.1038%2Fncomms10842" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01857&amp;key=26905976" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01857&amp;key=1%3ACAS%3A528%3ADC%252BC28Xjt1emtbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=10842&author=C.+Klein+Herenbrinkauthor=D.+A.+Sykesauthor=P.+Donthamsettiauthor=M.+Canalsauthor=T.+Coudratauthor=J.+Shonbergauthor=P.+J.+Scammellsauthor=B.+Capuanoauthor=P.+M.+Sextonauthor=S.+J.+Charltonauthor=J.+A.+Javitchauthor=A.+Christopoulosauthor=J.+R.+Lane&title=The+Role+of+Kinetic+Context+in+Apparent+Biased+Agonism+at+GPCRs&doi=10.1038%2Fncomms10842"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">The role of kinetic context in apparent biased agonism at GPCRs</span></div><div class="casAuthors">Klein Herenbrink, Carmen; Sykes, David A.; Donthamsetti, Prashant; Canals, Meritxell; Coudrat, Thomas; Shonberg, Jeremy; Scammells, Peter J.; Capuano, Ben; Sexton, Patrick M.; Charlton, Steven J.; Javitch, Jonathan A.; Christopoulos, Arthur; Lane, J. Robert</div><div class="citationInfo"><span class="NLM_cas:title">Nature Communications</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">10842</span>CODEN:
                <span class="NLM_cas:coden">NCAOBW</span>;
        ISSN:<span class="NLM_cas:issn">2041-1723</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Biased agonism describes the ability of ligands to stabilize different conformations of a GPCR linked to distinct functional outcomes and offers the prospect of designing pathway-specific drugs that avoid on-target side effects.  This mechanism is usually inferred from pharmacol. data with the assumption that the confounding influences of observational (i.e., assay dependent) and system (i.e., cell background dependent) bias are excluded by exptl. design and anal.  Here we reveal that 'kinetic context', as detd. by ligand-binding kinetics and the temporal pattern of receptor-signalling processes, can have a profound influence on the apparent bias of a series of agonists for the dopamine D2 receptor and can even lead to reversals in the direction of bias.  We propose that kinetic context must be acknowledged in the design and interpretation of studies of biased agonism.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoboe6-_23rF7Vg90H21EOLACvtfcHk0liOwZfAdMNKMw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xjt1emtbk%253D&md5=3afdebd5ad1c8a8b1db93478e9b2c7d4</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1038%2Fncomms10842&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncomms10842%26sid%3Dliteratum%253Aachs%26aulast%3DKlein%2BHerenbrink%26aufirst%3DC.%26aulast%3DSykes%26aufirst%3DD.%2BA.%26aulast%3DDonthamsetti%26aufirst%3DP.%26aulast%3DCanals%26aufirst%3DM.%26aulast%3DCoudrat%26aufirst%3DT.%26aulast%3DShonberg%26aufirst%3DJ.%26aulast%3DScammells%26aufirst%3DP.%2BJ.%26aulast%3DCapuano%26aufirst%3DB.%26aulast%3DSexton%26aufirst%3DP.%2BM.%26aulast%3DCharlton%26aufirst%3DS.%2BJ.%26aulast%3DJavitch%26aufirst%3DJ.%2BA.%26aulast%3DChristopoulos%26aufirst%3DA.%26aulast%3DLane%26aufirst%3DJ.%2BR.%26atitle%3DThe%2520Role%2520of%2520Kinetic%2520Context%2520in%2520Apparent%2520Biased%2520Agonism%2520at%2520GPCRs%26jtitle%3DNat.%2520Commun.%26date%3D2016%26volume%3D7%26spage%3D10842%26doi%3D10.1038%2Fncomms10842" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group">Gales, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rebois, R. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hogue, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trieu, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Breit, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hebert, T. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bouvier, M.</span><span> </span><span class="NLM_article-title">Real-Time Monitoring of Receptor and G-Protein Interactions in Living Cells</span> <span class="citation_source-journal">Nat. Methods</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">177</span><span class="NLM_x">–</span> <span class="NLM_lpage">184</span><span class="refDoi"> DOI: 10.1038/nmeth743</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01857&amp;key=10.1038%2Fnmeth743" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01857&amp;key=15782186" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01857&amp;key=1%3ACAS%3A528%3ADC%252BD2MXisVGisrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2005&pages=177-184&author=C.+Galesauthor=R.+V.+Reboisauthor=M.+Hogueauthor=P.+Trieuauthor=A.+Breitauthor=T.+E.+Hebertauthor=M.+Bouvier&title=Real-Time+Monitoring+of+Receptor+and+G-Protein+Interactions+in+Living+Cells&doi=10.1038%2Fnmeth743"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Real-time monitoring of receptor and G-protein interactions in living cells</span></div><div class="casAuthors">Gales, Celine; Rebois, R. Victor; Hogue, Mireille; Trieu, Phan; Breit, Andreas; Hebert, Terence E.; Bouvier, Michel</div><div class="citationInfo"><span class="NLM_cas:title">Nature Methods</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">177-184</span>CODEN:
                <span class="NLM_cas:coden">NMAEA3</span>;
        ISSN:<span class="NLM_cas:issn">1548-7091</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">G protein-coupled receptors (GPCRs) represent the largest family of proteins involved in signal transduction.  Here we present a bioLuminescence resonance energy transfer (BRET) assay that directly monitors in real time the early interactions between human GPCRs and their cognate G-protein subunits in living human cells.  In addn. to detecting basal precoupling of the receptors to Gα-, Gβ- and Gγ-subunits, BRET measured very rapid ligand-induced increases in the interaction between receptor and Gαβγ-complexes (t1/2 ∼ 300 ms) followed by a slower (several minutes) decrease, reflecting receptor desensitization.  The agonist-promoted increase in GPCR-Gβγ interaction was highly dependent on the identity of the Gα-subunit present in the complex.  Therefore, this G protein- activity biosensor provides a novel tool to directly probe the dynamics and selectivity of receptor-mediated, G-protein activation-deactivation cycles that could be advantageously used to identify ligands for orphan GPCRs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpz1sC3NFz4krVg90H21EOLACvtfcHk0liudA_3DSpWOA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXisVGisrk%253D&md5=257987f332dee95f8df83bd0343190f5</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1038%2Fnmeth743&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnmeth743%26sid%3Dliteratum%253Aachs%26aulast%3DGales%26aufirst%3DC.%26aulast%3DRebois%26aufirst%3DR.%2BV.%26aulast%3DHogue%26aufirst%3DM.%26aulast%3DTrieu%26aufirst%3DP.%26aulast%3DBreit%26aufirst%3DA.%26aulast%3DHebert%26aufirst%3DT.%2BE.%26aulast%3DBouvier%26aufirst%3DM.%26atitle%3DReal-Time%2520Monitoring%2520of%2520Receptor%2520and%2520G-Protein%2520Interactions%2520in%2520Living%2520Cells%26jtitle%3DNat.%2520Methods%26date%3D2005%26volume%3D2%26spage%3D177%26epage%3D184%26doi%3D10.1038%2Fnmeth743" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group">Richard-Lalonde, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nagi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Audet, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sleno, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amraei, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hogue, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balboni, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schiller, P. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bouvier, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hébert, T. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pineyro, G.</span><span> </span><span class="NLM_article-title">Conformational Dynamics of Kir3.1/Kir3.2 Channel Activation Via δ-Opioid Receptors</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">83</span><span class="NLM_x">, </span> <span class="NLM_fpage">416</span><span class="NLM_x">–</span> <span class="NLM_lpage">428</span><span class="refDoi"> DOI: 10.1124/mol.112.081950</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01857&amp;key=10.1124%2Fmol.112.081950" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=83&publication_year=2013&pages=416-428&author=M.+Richard-Lalondeauthor=K.+Nagiauthor=N.+Audetauthor=R.+Slenoauthor=M.+Amraeiauthor=M.+Hogueauthor=G.+Balboniauthor=P.+W.+Schillerauthor=M.+Bouvierauthor=T.+E.+H%C3%A9bertauthor=G.+Pineyro&title=Conformational+Dynamics+of+Kir3.1%2FKir3.2+Channel+Activation+Via+%CE%B4-Opioid+Receptors&doi=10.1124%2Fmol.112.081950"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1124%2Fmol.112.081950&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.112.081950%26sid%3Dliteratum%253Aachs%26aulast%3DRichard-Lalonde%26aufirst%3DM.%26aulast%3DNagi%26aufirst%3DK.%26aulast%3DAudet%26aufirst%3DN.%26aulast%3DSleno%26aufirst%3DR.%26aulast%3DAmraei%26aufirst%3DM.%26aulast%3DHogue%26aufirst%3DM.%26aulast%3DBalboni%26aufirst%3DG.%26aulast%3DSchiller%26aufirst%3DP.%2BW.%26aulast%3DBouvier%26aufirst%3DM.%26aulast%3DH%25C3%25A9bert%26aufirst%3DT.%2BE.%26aulast%3DPineyro%26aufirst%3DG.%26atitle%3DConformational%2520Dynamics%2520of%2520Kir3.1%252FKir3.2%2520Channel%2520Activation%2520Via%2520%25CE%25B4-Opioid%2520Receptors%26jtitle%3DMol.%2520Pharmacol.%26date%3D2013%26volume%3D83%26spage%3D416%26epage%3D428%26doi%3D10.1124%2Fmol.112.081950" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group">Quoyer, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janz, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ren, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Armando, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lukashova, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benovic, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carlson, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hunt, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bouvier, M.</span><span> </span><span class="NLM_article-title">Pepducin Targeting the C-X-C Chemokine Receptor Type 4 Acts as a Biased Agonist Favoring Activation of the Inhibitory G Protein</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">110</span><span class="NLM_x">, </span> <span class="NLM_fpage">E5088</span><span class="NLM_x">–</span> <span class="NLM_lpage">E5097</span><span class="refDoi"> DOI: 10.1073/pnas.1312515110</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01857&amp;key=10.1073%2Fpnas.1312515110" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01857&amp;key=24309376" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01857&amp;key=1%3ACAS%3A528%3ADC%252BC2cXns1SjtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=110&publication_year=2013&pages=E5088-E5097&author=J.+Quoyerauthor=J.+M.+Janzauthor=J.+Luoauthor=Y.+Renauthor=S.+Armandoauthor=V.+Lukashovaauthor=J.+L.+Benovicauthor=K.+E.+Carlsonauthor=S.+W.+Huntauthor=M.+Bouvier&title=Pepducin+Targeting+the+C-X-C+Chemokine+Receptor+Type+4+Acts+as+a+Biased+Agonist+Favoring+Activation+of+the+Inhibitory+G+Protein&doi=10.1073%2Fpnas.1312515110"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Pepducin targeting the C-X-C chemokine receptor type 4 acts as a biased agonist favoring activation of the inhibitory G protein</span></div><div class="casAuthors">Quoyer, Julie; Janz, Jay M.; Luo, Jiansong; Ren, Yong; Armando, Sylvain; Lukashova, Viktoria; Benovic, Jeffrey L.; Carlson, Kenneth E.; Hunt, Stephen W., III; Bouvier, Michel</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">110</span>
        (<span class="NLM_cas:issue">52</span>),
    <span class="NLM_cas:pages">E5088-E5097,SE5088/1-SE5088/6</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Short lipidated peptide sequences derived from various intracellular loop regions of G protein-coupled receptors (GPCRs) are named pepducins and act as allosteric modulators of a no. of GPCRs.  Recently, a pepducin selectively targeting the C-X-C chemokine receptor type 4 (CXCR4) was found to be an allosteric agonist, active in both cell-based assays and in vivo.  However, the precise mechanism of action of this class of ligands remains poorly understood.  In particular, given the diversity of signaling effectors that can be engaged by a given receptor, it is not clear whether pepducins can show biased signaling leading to functional selectivity.  To explore the ligand-biased potential of pepducins, the authors assessed the effect of the CXCR4 selective pepducin, ATI-2341, on the ability of the receptor to engage the inhibitory G proteins (Gi1, Gi2 and Gi3), G13, and β-arrestins.  Using bioluminescence resonance energy transfer-based biosensors, the authors found that, in contrast to the natural CXCR4 ligand, stromal cell-derived factor-1α, which promotes the engagement of the three Gi subtypes, G13 and the two β-arrestins, ATI-2341 leads to the engagement of the Gi subtypes but not G13 or the β-arrestins.  Calcn. of the transduction ratio for each pathway revealed a strong neg. bias of ATI-2341 toward G13 and β-arrestins, revealing functional selectivity for the Gi pathways.  The neg. bias toward β-arrestins results from the reduced ability of the pepducin to promote GPCR kinase-mediated phosphorylation of the receptor.  In addn. to revealing ligand-biased signaling of pepducins, these findings shed some light on the mechanism of action of a unique class of allosteric regulators.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoBOvGh6qLDbLVg90H21EOLACvtfcHk0liudA_3DSpWOA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXns1SjtQ%253D%253D&md5=748ab512167787aa3fe31642f7c244b1</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1312515110&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1312515110%26sid%3Dliteratum%253Aachs%26aulast%3DQuoyer%26aufirst%3DJ.%26aulast%3DJanz%26aufirst%3DJ.%2BM.%26aulast%3DLuo%26aufirst%3DJ.%26aulast%3DRen%26aufirst%3DY.%26aulast%3DArmando%26aufirst%3DS.%26aulast%3DLukashova%26aufirst%3DV.%26aulast%3DBenovic%26aufirst%3DJ.%2BL.%26aulast%3DCarlson%26aufirst%3DK.%2BE.%26aulast%3DHunt%26aufirst%3DS.%2BW.%26aulast%3DBouvier%26aufirst%3DM.%26atitle%3DPepducin%2520Targeting%2520the%2520C-X-C%2520Chemokine%2520Receptor%2520Type%25204%2520Acts%2520as%2520a%2520Biased%2520Agonist%2520Favoring%2520Activation%2520of%2520the%2520Inhibitory%2520G%2520Protein%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2013%26volume%3D110%26spage%3DE5088%26epage%3DE5097%26doi%3D10.1073%2Fpnas.1312515110" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group">Gales, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Durm, J. J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schaak, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pontier, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Percherancier, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Audet, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paris, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bouvier, M.</span><span> </span><span class="NLM_article-title">Probing the Activation-Promoted Structural Rearrangements in Preassembled Receptor-G Protein Complexes</span> <span class="citation_source-journal">Nat. Struct. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">778</span><span class="NLM_x">–</span> <span class="NLM_lpage">786</span><span class="refDoi"> DOI: 10.1038/nsmb1134</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01857&amp;key=10.1038%2Fnsmb1134" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01857&amp;key=16906158" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01857&amp;key=1%3ACAS%3A528%3ADC%252BD28XptFWitbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2006&pages=778-786&author=C.+Galesauthor=J.+J.+J.+Van+Durmauthor=S.+Schaakauthor=S.+Pontierauthor=Y.+Percherancierauthor=M.+Audetauthor=H.+Parisauthor=M.+Bouvier&title=Probing+the+Activation-Promoted+Structural+Rearrangements+in+Preassembled+Receptor-G+Protein+Complexes&doi=10.1038%2Fnsmb1134"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Probing the activation-promoted structural rearrangements in preassembled receptor-G protein complexes</span></div><div class="casAuthors">Gales, Celine; Van Durm, Joost J. J.; Schaak, Stephane; Pontier, Stephanie; Percherancier, Yann; Audet, Martin; Paris, Herve; Bouvier, Michel</div><div class="citationInfo"><span class="NLM_cas:title">Nature Structural & Molecular Biology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">778-786</span>CODEN:
                <span class="NLM_cas:coden">NSMBCU</span>;
        ISSN:<span class="NLM_cas:issn">1545-9993</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Activation of heterotrimeric G proteins by their cognate seven transmembrane domain receptors is believed to involve conformational changes propagated from the receptor to the G proteins.  However, the nature of these changes remains unknown.  We monitored the conformational rearrangements at the interfaces between receptors and G proteins and between G protein subunits by measuring bioluminescence resonance energy transfer (BRET) between probes inserted at multiple sites in receptor-G protein complexes.  Using the data obtained for the α2AAR-Gαi1β1γ2 complex and the available crystal structures of Gαi1β1γ2, we propose a model wherein agonist binding induces conformational reorganization of a preexisting receptor-G protein complex, leading the Gα-Gβγ interface to open but not dissoc.  This conformational change may represent the movement required to allow nucleotide exit from the Gα subunit, thus reflecting the initial activation event.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGocRdOHDSfyEbVg90H21EOLACvtfcHk0lgBjZJNJKzGmA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XptFWitbg%253D&md5=a060403bc8d77ebf07dd76cd1d0c87fc</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1038%2Fnsmb1134&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnsmb1134%26sid%3Dliteratum%253Aachs%26aulast%3DGales%26aufirst%3DC.%26aulast%3DVan%2BDurm%26aufirst%3DJ.%2BJ.%2BJ.%26aulast%3DSchaak%26aufirst%3DS.%26aulast%3DPontier%26aufirst%3DS.%26aulast%3DPercherancier%26aufirst%3DY.%26aulast%3DAudet%26aufirst%3DM.%26aulast%3DParis%26aufirst%3DH.%26aulast%3DBouvier%26aufirst%3DM.%26atitle%3DProbing%2520the%2520Activation-Promoted%2520Structural%2520Rearrangements%2520in%2520Preassembled%2520Receptor-G%2520Protein%2520Complexes%26jtitle%3DNat.%2520Struct.%2520Mol.%2520Biol.%26date%3D2006%26volume%3D13%26spage%3D778%26epage%3D786%26doi%3D10.1038%2Fnsmb1134" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group">Black, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leff, P.</span><span> </span><span class="NLM_article-title">Operational Models of Pharmacological Agonism</span> <span class="citation_source-journal">Proc. R. Soc. London, Ser. B</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1983</span><span class="NLM_x">, </span> <span class="NLM_volume">220</span><span class="NLM_x">, </span> <span class="NLM_fpage">141</span><span class="NLM_x">–</span> <span class="NLM_lpage">162</span><span class="refDoi"> DOI: 10.1098/rspb.1983.0093</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01857&amp;key=10.1098%2Frspb.1983.0093" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01857&amp;key=6141562" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01857&amp;key=1%3ACAS%3A528%3ADyaL2cXmtFaqtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=220&publication_year=1983&pages=141-162&author=J.+W.+Blackauthor=P.+Leff&title=Operational+Models+of+Pharmacological+Agonism&doi=10.1098%2Frspb.1983.0093"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Operational models of pharmacological agonism</span></div><div class="casAuthors">Black, J. W.; Leff, P.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the Royal Society of London, Series B:  Biological Sciences</span>
        (<span class="NLM_cas:date">1983</span>),
    <span class="NLM_cas:volume">220</span>
        (<span class="NLM_cas:issue">1219</span>),
    <span class="NLM_cas:pages">141-62</span>CODEN:
                <span class="NLM_cas:coden">PRLBA4</span>;
        ISSN:<span class="NLM_cas:issn">0080-4649</span>.
    </div><div class="casAbstract">A general, operational model is presented which explicitly describes pharmacol. agonism in terms of 3 parameters: an agonist-receptor dissocn. const., the total receptor concn. [Ro], and a parameter (KE) which defines the transduction of the agonist-receptor complex into pharmacol. effect.  The ratio RO/KE, the transducer ratio (τ), is a logical definition for the efficacy of an agonist in a system.  The model provides a chem. definition of intrinsic efficacy, making this parameter exptl. accessible in principle.  Alternate models are compared and contrasted with regard to their practical and conceptual utilities in exptl. pharmacol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGonpXVldFQ_nbVg90H21EOLACvtfcHk0lgBjZJNJKzGmA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2cXmtFaqtA%253D%253D&md5=a0421df9c56495d48d076010acf44b65</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1098%2Frspb.1983.0093&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1098%252Frspb.1983.0093%26sid%3Dliteratum%253Aachs%26aulast%3DBlack%26aufirst%3DJ.%2BW.%26aulast%3DLeff%26aufirst%3DP.%26atitle%3DOperational%2520Models%2520of%2520Pharmacological%2520Agonism%26jtitle%3DProc.%2520R.%2520Soc.%2520London%252C%2520Ser.%2520B%26date%3D1983%26volume%3D220%26spage%3D141%26epage%3D162%26doi%3D10.1098%2Frspb.1983.0093" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group">Kenakin, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watson, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muniz-Medina, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christopoulos, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Novick, S.</span><span> </span><span class="NLM_article-title">A Simple Method for Quantifying Functional Selectivity and Agonist Bias</span> <span class="citation_source-journal">ACS Chem. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">193</span><span class="NLM_x">–</span> <span class="NLM_lpage">203</span><span class="refDoi"> DOI: 10.1021/cn200111m</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cn200111m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01857&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhs1ChtLvN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2012&pages=193-203&author=T.+Kenakinauthor=C.+Watsonauthor=V.+Muniz-Medinaauthor=A.+Christopoulosauthor=S.+Novick&title=A+Simple+Method+for+Quantifying+Functional+Selectivity+and+Agonist+Bias&doi=10.1021%2Fcn200111m"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">A Simple Method for Quantifying Functional Selectivity and Agonist Bias</span></div><div class="casAuthors">Kenakin, Terry; Watson, Christian; Muniz-Medina, Vanessa; Christopoulos, Arthur; Novick, Steven</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">193-203</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Activation of seven-transmembrane (7TM) receptors by agonists does not always lead to uniform activation of all signaling pathways mediated by a given receptor.  Relative to other ligands, many agonists are "biased" toward producing subsets of receptor behaviors.  A hallmark of such "functional selectivity" is cell type dependence; this poses a particular problem for the profiling of agonists in whole cell test systems removed from the therapeutic one(s).  Such response-specific cell-based variability makes it difficult to guide medicinal chem. efforts aimed at identifying and optimizing therapeutically meaningful agonist bias.  For this reason, we present a scale, based on the Black and Leff operational model, that contains the key elements required to describe 7TM agonism, namely, affinity (KA-1) for the receptor and efficacy (τ) in activating a particular signaling pathway.  Utilizing a "transduction coeff." term, log(τ/KA), this scale can statistically evaluate selective agonist effects in a manner that can theor. inform structure-activity studies and/or drug candidate selection matrixes.  The bias of four chemokines for CCR5-mediated inositol phosphate prodn. vs. internalization is quantified to illustrate the practical application of this method.  The independence of this method with respect to receptor d. and the calcn. of statistical ests. of confidence of differences are specifically discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoxSkELs1bHQLVg90H21EOLACvtfcHk0lgBjZJNJKzGmA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhs1ChtLvN&md5=270841d11f9720caaf3e59a6fe0aee74</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1021%2Fcn200111m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcn200111m%26sid%3Dliteratum%253Aachs%26aulast%3DKenakin%26aufirst%3DT.%26aulast%3DWatson%26aufirst%3DC.%26aulast%3DMuniz-Medina%26aufirst%3DV.%26aulast%3DChristopoulos%26aufirst%3DA.%26aulast%3DNovick%26aufirst%3DS.%26atitle%3DA%2520Simple%2520Method%2520for%2520Quantifying%2520Functional%2520Selectivity%2520and%2520Agonist%2520Bias%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2012%26volume%3D3%26spage%3D193%26epage%3D203%26doi%3D10.1021%2Fcn200111m" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group">van der Westhuizen, E. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Breton, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christopoulos, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bouvier, M.</span><span> </span><span class="NLM_article-title">Quantification of Ligand Bias for Clinically Relevant B2-Adrenergic Receptor Ligands: Implications for Drug Taxonomy</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">85</span><span class="NLM_x">, </span> <span class="NLM_fpage">492</span><span class="NLM_x">–</span> <span class="NLM_lpage">509</span><span class="refDoi"> DOI: 10.1124/mol.113.088880</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01857&amp;key=10.1124%2Fmol.113.088880" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=85&publication_year=2014&pages=492-509&author=E.+T.+van+der+Westhuizenauthor=B.+Bretonauthor=A.+Christopoulosauthor=M.+Bouvier&title=Quantification+of+Ligand+Bias+for+Clinically+Relevant+B2-Adrenergic+Receptor+Ligands%3A+Implications+for+Drug+Taxonomy&doi=10.1124%2Fmol.113.088880"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1124%2Fmol.113.088880&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.113.088880%26sid%3Dliteratum%253Aachs%26aulast%3Dvan%2Bder%2BWesthuizen%26aufirst%3DE.%2BT.%26aulast%3DBreton%26aufirst%3DB.%26aulast%3DChristopoulos%26aufirst%3DA.%26aulast%3DBouvier%26aufirst%3DM.%26atitle%3DQuantification%2520of%2520Ligand%2520Bias%2520for%2520Clinically%2520Relevant%2520B2-Adrenergic%2520Receptor%2520Ligands%253A%2520Implications%2520for%2520Drug%2520Taxonomy%26jtitle%3DMol.%2520Pharmacol.%26date%3D2014%26volume%3D85%26spage%3D492%26epage%3D509%26doi%3D10.1124%2Fmol.113.088880" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group">Shonberg, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lopez, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scammells, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christopoulos, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Capuano, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lane, J. R.</span><span> </span><span class="NLM_article-title">Biased Agonism at G Protein-Coupled Receptors: The Promise and the Challenges - a Medicinal Chemistry Perspective</span> <span class="citation_source-journal">Med. Res. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">1286</span><span class="NLM_x">–</span> <span class="NLM_lpage">330</span><span class="refDoi"> DOI: 10.1002/med.21318</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01857&amp;key=10.1002%2Fmed.21318" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01857&amp;key=24796277" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01857&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhslalu7rJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2014&pages=1286-330&author=J.+Shonbergauthor=L.+Lopezauthor=P.+J.+Scammellsauthor=A.+Christopoulosauthor=B.+Capuanoauthor=J.+R.+Lane&title=Biased+Agonism+at+G+Protein-Coupled+Receptors%3A+The+Promise+and+the+Challenges+-+a+Medicinal+Chemistry+Perspective&doi=10.1002%2Fmed.21318"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Biased Agonism at G Protein-Coupled Receptors: The Promise and the Challenges-A Medicinal Chemistry Perspective</span></div><div class="casAuthors">Shonberg, Jeremy; Lopez, Laura; Scammells, Peter J.; Christopoulos, Arthur; Capuano, Ben; Lane, J. Robert</div><div class="citationInfo"><span class="NLM_cas:title">Medicinal Research Reviews</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1286-1330</span>CODEN:
                <span class="NLM_cas:coden">MRREDD</span>;
        ISSN:<span class="NLM_cas:issn">0198-6325</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">Historically, detn. of G protein-coupled receptor (GPCR) ligand efficacy has often been restricted to identifying the ligand as an agonist or antagonist at a given signaling pathway.  This classification was deemed sufficient to predict compd. efficacy at all signaling endpoints, including the therapeutically relevant one(s).  However, it is now apparent that ligands acting at the same GPCR can stabilize multiple, distinct, receptor conformations linked to different functional outcomes.  This phenomenon, known as biased agonism, stimulus bias, or functional selectivity offers the opportunity to sep. on-target therapeutic effects from side effects through the design of drugs that show pathway selectivity.  However, the medicinal chemist faces numerous challenges to develop biased ligands, including the detection and quantification of biased agonism.  This review summarizes the current state of the field of research into biased agonism at GPCRs, with a particular focus on efforts to relate biased agonism to ligand structure.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpg-egFZpSKvbVg90H21EOLACvtfcHk0lgAA-aFGPxvlA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhslalu7rJ&md5=85a5b385750d21856ae044391c46ee75</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1002%2Fmed.21318&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fmed.21318%26sid%3Dliteratum%253Aachs%26aulast%3DShonberg%26aufirst%3DJ.%26aulast%3DLopez%26aufirst%3DL.%26aulast%3DScammells%26aufirst%3DP.%2BJ.%26aulast%3DChristopoulos%26aufirst%3DA.%26aulast%3DCapuano%26aufirst%3DB.%26aulast%3DLane%26aufirst%3DJ.%2BR.%26atitle%3DBiased%2520Agonism%2520at%2520G%2520Protein-Coupled%2520Receptors%253A%2520The%2520Promise%2520and%2520the%2520Challenges%2520-%2520a%2520Medicinal%2520Chemistry%2520Perspective%26jtitle%3DMed.%2520Res.%2520Rev.%26date%3D2014%26volume%3D34%26spage%3D1286%26epage%3D330%26doi%3D10.1002%2Fmed.21318" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group">Kenakin, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christopoulos, A.</span><span> </span><span class="NLM_article-title">Signalling Bias in New Drug Discovery: Detection, Quantification and Therapeutic Impact</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">205</span><span class="NLM_x">–</span> <span class="NLM_lpage">216</span><span class="refDoi"> DOI: 10.1038/nrd3954</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01857&amp;key=10.1038%2Fnrd3954" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01857&amp;key=23411724" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2012&pages=205-216&author=T.+Kenakinauthor=A.+Christopoulos&title=Signalling+Bias+in+New+Drug+Discovery%3A+Detection%2C+Quantification+and+Therapeutic+Impact&doi=10.1038%2Fnrd3954"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1038%2Fnrd3954&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd3954%26sid%3Dliteratum%253Aachs%26aulast%3DKenakin%26aufirst%3DT.%26aulast%3DChristopoulos%26aufirst%3DA.%26atitle%3DSignalling%2520Bias%2520in%2520New%2520Drug%2520Discovery%253A%2520Detection%252C%2520Quantification%2520and%2520Therapeutic%2520Impact%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2012%26volume%3D12%26spage%3D205%26epage%3D216%26doi%3D10.1038%2Fnrd3954" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group">Namkung, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le Gouill, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lukashova, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kobayashi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hogue, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khoury, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Song, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bouvier, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laporte, S. A.</span><span> </span><span class="NLM_article-title">Monitoring G Protein-Coupled Receptor and Beta-Arrestin Trafficking in Live Cells Using Enhanced Bystander Bret</span> <span class="citation_source-journal">Nat. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">12178</span><span class="refDoi"> DOI: 10.1038/ncomms12178</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01857&amp;key=10.1038%2Fncomms12178" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01857&amp;key=27397672" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01857&amp;key=1%3ACAS%3A280%3ADC%252BC2s7psVKjtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=12178&author=Y.+Namkungauthor=C.+Le+Gouillauthor=V.+Lukashovaauthor=H.+Kobayashiauthor=M.+Hogueauthor=E.+Khouryauthor=M.+Songauthor=M.+Bouvierauthor=S.+A.+Laporte&title=Monitoring+G+Protein-Coupled+Receptor+and+Beta-Arrestin+Trafficking+in+Live+Cells+Using+Enhanced+Bystander+Bret&doi=10.1038%2Fncomms12178"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Monitoring G protein-coupled receptor and β-arrestin trafficking in live cells using enhanced bystander BRET</span></div><div class="casAuthors">Namkung Yoon; Khoury Etienne; Song Mideum; Laporte Stephane A; Le Gouill Christian; Lukashova Viktoria; Kobayashi Hiroyuki; Hogue Mireille; Bouvier Michel; Laporte Stephane A; Laporte Stephane A</div><div class="citationInfo"><span class="NLM_cas:title">Nature communications</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">12178</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Endocytosis and intracellular trafficking of receptors are pivotal to maintain physiological functions and drug action; however, robust quantitative approaches are lacking to study such processes in live cells.  Here we present new bioluminescence resonance energy transfer (BRET) sensors to quantitatively monitor G protein-coupled receptors (GPCRs) and β-arrestin trafficking.  These sensors are based on bystander BRET and use the naturally interacting chromophores luciferase (RLuc) and green fluorescent protein (rGFP) from Renilla.  The versatility and robustness of this approach are exemplified by anchoring rGFP at the plasma membrane or in endosomes to generate high dynamic spectrometric BRET signals on ligand-promoted recruitment or sequestration of RLuc-tagged proteins to, or from, specific cell compartments, as well as sensitive subcellular BRET imaging for protein translocation visualization.  These sensors are scalable to high-throughput formats and allow quantitative pharmacological studies of GPCR trafficking in real time, in live cells, revealing ligand-dependent biased trafficking of receptor/β-arrestin complexes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRxqtzvqqnir4qdXsLcGTEUfW6udTcc2ebfuMkP7djub7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2s7psVKjtA%253D%253D&md5=db78058cbea3a04028c8b15f93810a17</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1038%2Fncomms12178&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncomms12178%26sid%3Dliteratum%253Aachs%26aulast%3DNamkung%26aufirst%3DY.%26aulast%3DLe%2BGouill%26aufirst%3DC.%26aulast%3DLukashova%26aufirst%3DV.%26aulast%3DKobayashi%26aufirst%3DH.%26aulast%3DHogue%26aufirst%3DM.%26aulast%3DKhoury%26aufirst%3DE.%26aulast%3DSong%26aufirst%3DM.%26aulast%3DBouvier%26aufirst%3DM.%26aulast%3DLaporte%26aufirst%3DS.%2BA.%26atitle%3DMonitoring%2520G%2520Protein-Coupled%2520Receptor%2520and%2520Beta-Arrestin%2520Trafficking%2520in%2520Live%2520Cells%2520Using%2520Enhanced%2520Bystander%2520Bret%26jtitle%3DNat.%2520Commun.%26date%3D2016%26volume%3D7%26spage%3D12178%26doi%3D10.1038%2Fncomms12178" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group">Luján, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marron Fernandez de Velasco, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aguado, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wickman, K.</span><span> </span><span class="NLM_article-title">New Insights into the Therapeutic Potential of Girk Channels</span> <span class="citation_source-journal">Trends Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x">, </span> <span class="NLM_fpage">20</span><span class="NLM_x">–</span> <span class="NLM_lpage">29</span><span class="refDoi"> DOI: 10.1016/j.tins.2013.10.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01857&amp;key=10.1016%2Fj.tins.2013.10.006" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2014&pages=20-29&author=R.+Luj%C3%A1nauthor=E.+Marron+Fernandez+de+Velascoauthor=C.+Aguadoauthor=K.+Wickman&title=New+Insights+into+the+Therapeutic+Potential+of+Girk+Channels&doi=10.1016%2Fj.tins.2013.10.006"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1016%2Fj.tins.2013.10.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tins.2013.10.006%26sid%3Dliteratum%253Aachs%26aulast%3DLuj%25C3%25A1n%26aufirst%3DR.%26aulast%3DMarron%2BFernandez%2Bde%2BVelasco%26aufirst%3DE.%26aulast%3DAguado%26aufirst%3DC.%26aulast%3DWickman%26aufirst%3DK.%26atitle%3DNew%2520Insights%2520into%2520the%2520Therapeutic%2520Potential%2520of%2520Girk%2520Channels%26jtitle%3DTrends%2520Neurosci.%26date%3D2014%26volume%3D37%26spage%3D20%26epage%3D29%26doi%3D10.1016%2Fj.tins.2013.10.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group">Lüscher, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Slesinger, P. A.</span><span> </span><span class="NLM_article-title">Emerging Concepts for G Protein-Gated Inwardly Rectifying Potassium (GIRK) Channels in Health and Disease</span> <span class="citation_source-journal">Nat. Rev. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">301</span><span class="NLM_x">–</span> <span class="NLM_lpage">315</span><span class="refDoi"> DOI: 10.1038/nrn2834</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01857&amp;key=10.1038%2Fnrn2834" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01857&amp;key=20389305" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01857&amp;key=1%3ACAS%3A280%3ADC%252BC3c3ntlWlug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2010&pages=301-315&author=C.+L%C3%BCscherauthor=P.+A.+Slesinger&title=Emerging+Concepts+for+G+Protein-Gated+Inwardly+Rectifying+Potassium+%28GIRK%29+Channels+in+Health+and+Disease&doi=10.1038%2Fnrn2834"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Emerging roles for G protein-gated inwardly rectifying potassium (GIRK) channels in health and disease</span></div><div class="casAuthors">Luscher Christian; Slesinger Paul A</div><div class="citationInfo"><span class="NLM_cas:title">Nature reviews. Neuroscience</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">301-15</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">G protein-gated inwardly rectifying potassium (GIRK) channels hyperpolarize neurons in response to activation of many different G protein-coupled receptors and thus control the excitability of neurons through GIRK-mediated self-inhibition, slow synaptic potentials and volume transmission.  GIRK channel function and trafficking are highly dependent on the channel subunit composition.  Pharmacological investigations of GIRK channels and studies in animal models suggest that GIRK activity has an important role in physiological responses, including pain perception and memory modulation.  Moreover, abnormal GIRK function has been implicated in altering neuronal excitability and cell death, which may be important in the pathophysiology of diseases such as epilepsy, Down's syndrome, Parkinson's disease and drug addiction.  GIRK channels may therefore prove to be a valuable new therapeutic target.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRaDoT2N_WTNS6Ufuk_1xoTfW6udTcc2ebfuMkP7djub7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3c3ntlWlug%253D%253D&md5=087130f9aa185e685d39911042294672</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1038%2Fnrn2834&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrn2834%26sid%3Dliteratum%253Aachs%26aulast%3DL%25C3%25BCscher%26aufirst%3DC.%26aulast%3DSlesinger%26aufirst%3DP.%2BA.%26atitle%3DEmerging%2520Concepts%2520for%2520G%2520Protein-Gated%2520Inwardly%2520Rectifying%2520Potassium%2520%2528GIRK%2529%2520Channels%2520in%2520Health%2520and%2520Disease%26jtitle%3DNat.%2520Rev.%2520Neurosci.%26date%3D2010%26volume%3D11%26spage%3D301%26epage%3D315%26doi%3D10.1038%2Fnrn2834" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group">Whorton, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MacKinnon, R.</span><span> </span><span class="NLM_article-title">X-Ray Structure of the Mammalian GIRK2-Beta Gamma G-Protein Complex</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">498</span><span class="NLM_x">, </span> <span class="NLM_fpage">190</span><span class="NLM_x">–</span> <span class="NLM_lpage">197</span><span class="refDoi"> DOI: 10.1038/nature12241</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01857&amp;key=10.1038%2Fnature12241" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=498&publication_year=2013&pages=190-197&author=M.+R.+Whortonauthor=R.+MacKinnon&title=X-Ray+Structure+of+the+Mammalian+GIRK2-Beta+Gamma+G-Protein+Complex&doi=10.1038%2Fnature12241"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1038%2Fnature12241&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature12241%26sid%3Dliteratum%253Aachs%26aulast%3DWhorton%26aufirst%3DM.%2BR.%26aulast%3DMacKinnon%26aufirst%3DR.%26atitle%3DX-Ray%2520Structure%2520of%2520the%2520Mammalian%2520GIRK2-Beta%2520Gamma%2520G-Protein%2520Complex%26jtitle%3DNature%26date%3D2013%26volume%3D498%26spage%3D190%26epage%3D197%26doi%3D10.1038%2Fnature12241" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group">Yamada, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iwayama, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toyota, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohnishi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohba, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maekawa, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshikawa, T.</span><span> </span><span class="NLM_article-title">Association Study of the Kcnj3 Gene as a Susceptibility Candidate for Schizophrenia in the Chinese Population</span> <span class="citation_source-journal">Hum. Genet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">131</span><span class="NLM_x">, </span> <span class="NLM_fpage">443</span><span class="NLM_x">–</span> <span class="NLM_lpage">451</span><span class="refDoi"> DOI: 10.1007/s00439-011-1089-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01857&amp;key=10.1007%2Fs00439-011-1089-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01857&amp;key=21927946" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01857&amp;key=1%3ACAS%3A528%3ADC%252BC38XitlGisr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=131&publication_year=2012&pages=443-451&author=K.+Yamadaauthor=Y.+Iwayamaauthor=T.+Toyotaauthor=T.+Ohnishiauthor=H.+Ohbaauthor=M.+Maekawaauthor=T.+Yoshikawa&title=Association+Study+of+the+Kcnj3+Gene+as+a+Susceptibility+Candidate+for+Schizophrenia+in+the+Chinese+Population&doi=10.1007%2Fs00439-011-1089-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Association study of the KCNJ3 gene as a susceptibility candidate for schizophrenia in the Chinese population</span></div><div class="casAuthors">Yamada, Kazuo; Iwayama, Yoshimi; Toyota, Tomoko; Ohnishi, Tetsuo; Ohba, Hisako; Maekawa, Motoko; Yoshikawa, Takeo</div><div class="citationInfo"><span class="NLM_cas:title">Human Genetics</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">131</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">443-451</span>CODEN:
                <span class="NLM_cas:coden">HUGEDQ</span>;
        ISSN:<span class="NLM_cas:issn">0340-6717</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">We recently reported the results of a genome-wide assocn. study (GWAS) of schizophrenia in the Japanese population.  In that study, a single nucleotide polymorphism (SNP) (rs3106653) in the KCNJ3 (potassium inwardly rectifying channel, subfamily J, member 3) gene located at 2q24.1 showed assocn. with schizophrenia in two independent sample sets.  KCNJ3, also termed GIRK1 or Kir3.1, is a member of the G protein-activated inwardly rectifying K+ channel (GIRK) group.  GIRKs are widely distributed in the brain and play an important role in regulating neural excitability through the activation of various G protein-coupled receptors.  In this study, we set out to examine this assocn. using a different population.  We first performed a gene-centric assocn. study of the KCNJ3 gene, by genotyping 38 tagSNPs in the Chinese population.  We detected nine SNPs that displayed significant assocn. with schizophrenia (lowest P = 0.0016 for rs3106658, Global significance = 0.036).  The initial marker SNP (rs3106653) examd. in our prior GWAS in the Japanese population also showed nominally significant assocn. in the Chinese population (P = 0.028).  Next, we analyzed transcript levels in the dorsolateral prefrontal cortex of postmortem brains from patients with schizophrenia and bipolar disorder and from healthy controls, using real-time quant. RT-PCR.  We found significantly lower KCNJ3 expression in postmortem brains from schizophrenic and bipolar patients compared with controls.  These data suggest that the KCNJ3 gene is genetically assocd. with schizophrenia in Asian populations and add further evidence to the "channelopathy theory of psychiatric illnesses".</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGofPx0Jz3BOkbVg90H21EOLACvtfcHk0lg_yo4IhpjmSg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XitlGisr4%253D&md5=dc03299798c57ac86f3801941dbf6ce9</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1007%2Fs00439-011-1089-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00439-011-1089-3%26sid%3Dliteratum%253Aachs%26aulast%3DYamada%26aufirst%3DK.%26aulast%3DIwayama%26aufirst%3DY.%26aulast%3DToyota%26aufirst%3DT.%26aulast%3DOhnishi%26aufirst%3DT.%26aulast%3DOhba%26aufirst%3DH.%26aulast%3DMaekawa%26aufirst%3DM.%26aulast%3DYoshikawa%26aufirst%3DT.%26atitle%3DAssociation%2520Study%2520of%2520the%2520Kcnj3%2520Gene%2520as%2520a%2520Susceptibility%2520Candidate%2520for%2520Schizophrenia%2520in%2520the%2520Chinese%2520Population%26jtitle%3DHum.%2520Genet.%26date%3D2012%26volume%3D131%26spage%3D443%26epage%3D451%26doi%3D10.1007%2Fs00439-011-1089-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group">Yamada, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iwayama, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hattori, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iwamoto, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toyota, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohnishi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohba, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maekawa, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kato, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshikawa, T.</span><span> </span><span class="NLM_article-title">Genome-Wide Association Study of Schizophrenia in Japanese Population</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">e20468</span><span class="refDoi"> DOI: 10.1371/journal.pone.0020468</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01857&amp;key=10.1371%2Fjournal.pone.0020468" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2011&pages=e20468&author=K.+Yamadaauthor=Y.+Iwayamaauthor=E.+Hattoriauthor=K.+Iwamotoauthor=T.+Toyotaauthor=T.+Ohnishiauthor=H.+Ohbaauthor=M.+Maekawaauthor=T.+Katoauthor=T.+Yoshikawa&title=Genome-Wide+Association+Study+of+Schizophrenia+in+Japanese+Population&doi=10.1371%2Fjournal.pone.0020468"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0020468&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0020468%26sid%3Dliteratum%253Aachs%26aulast%3DYamada%26aufirst%3DK.%26aulast%3DIwayama%26aufirst%3DY.%26aulast%3DHattori%26aufirst%3DE.%26aulast%3DIwamoto%26aufirst%3DK.%26aulast%3DToyota%26aufirst%3DT.%26aulast%3DOhnishi%26aufirst%3DT.%26aulast%3DOhba%26aufirst%3DH.%26aulast%3DMaekawa%26aufirst%3DM.%26aulast%3DKato%26aufirst%3DT.%26aulast%3DYoshikawa%26aufirst%3DT.%26atitle%3DGenome-Wide%2520Association%2520Study%2520of%2520Schizophrenia%2520in%2520Japanese%2520Population%26jtitle%3DPLoS%2520One%26date%3D2011%26volume%3D6%26spage%3De20468%26doi%3D10.1371%2Fjournal.pone.0020468" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit54"><span><span class="NLM_contrib-group">Farhy Tselnicker, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsemakhovich, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rishal, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kahanovitch, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dessauer, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dascal, N.</span><span> </span><span class="NLM_article-title">Dual Regulation of G Proteins and the G-Protein–Activated K+ Channels by Lithium</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">111</span><span class="NLM_x">, </span> <span class="NLM_fpage">5018</span><span class="NLM_x">–</span> <span class="NLM_lpage">5023</span><span class="refDoi"> DOI: 10.1073/pnas.1316425111</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01857&amp;key=10.1073%2Fpnas.1316425111" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=111&publication_year=2014&pages=5018-5023&author=I.+Farhy+Tselnickerauthor=V.+Tsemakhovichauthor=I.+Rishalauthor=U.+Kahanovitchauthor=C.+W.+Dessauerauthor=N.+Dascal&title=Dual+Regulation+of+G+Proteins+and+the+G-Protein%E2%80%93Activated+K%2B+Channels+by+Lithium&doi=10.1073%2Fpnas.1316425111"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1316425111&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1316425111%26sid%3Dliteratum%253Aachs%26aulast%3DFarhy%2BTselnicker%26aufirst%3DI.%26aulast%3DTsemakhovich%26aufirst%3DV.%26aulast%3DRishal%26aufirst%3DI.%26aulast%3DKahanovitch%26aufirst%3DU.%26aulast%3DDessauer%26aufirst%3DC.%2BW.%26aulast%3DDascal%26aufirst%3DN.%26atitle%3DDual%2520Regulation%2520of%2520G%2520Proteins%2520and%2520the%2520G-Protein%25E2%2580%2593Activated%2520K%252B%2520Channels%2520by%2520Lithium%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2014%26volume%3D111%26spage%3D5018%26epage%3D5023%26doi%3D10.1073%2Fpnas.1316425111" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref55'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="cit55"><span><span class="NLM_contrib-group">Kuzhikandathil, E. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oxford, G. S.</span><span> </span><span class="NLM_article-title">Human Dopamine D3 and D2L Receptors Couple to Inward Rectifier Potassium Channels in Mammalian Cell Lines</span> <span class="citation_source-journal">Mol. Cell. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">390</span><span class="NLM_x">–</span> <span class="NLM_lpage">402</span><span class="refDoi"> DOI: 10.1006/mcne.1998.0722</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01857&amp;key=10.1006%2Fmcne.1998.0722" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01857&amp;key=9888991" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01857&amp;key=1%3ACAS%3A528%3ADyaK1MXmt1Gnuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=1998&pages=390-402&author=E.+V.+Kuzhikandathilauthor=W.+Yuauthor=G.+S.+Oxford&title=Human+Dopamine+D3+and+D2L+Receptors+Couple+to+Inward+Rectifier+Potassium+Channels+in+Mammalian+Cell+Lines&doi=10.1006%2Fmcne.1998.0722"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">Human dopamine D3 and D2L receptors couple to inward rectifier potassium channels in mammalian cell lines</span></div><div class="casAuthors">Kuzhikandathil, Eldo V.; Yu, Weifeng; Oxford, Gerry S.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Neuroscience</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">390-402</span>CODEN:
                <span class="NLM_cas:coden">MOCNED</span>;
        ISSN:<span class="NLM_cas:issn">1044-7431</span>.
    
            (<span class="NLM_cas:orgname">Academic Press</span>)
        </div><div class="casAbstract">The mol. mechanisms coupling the D3 dopamine receptor to downstream effectors have neither been well defined nor well characterized.  Here the authors examine the coupling of the human D3 receptor to G-protein coupled inward rectifier potassium channels (GIRKs) in mammalian cells.  Human D3 receptors couple strongly to homomeric human GIRK2 channels coexpressed in Chinese hamster ovary (CHO) cells, with a coupling efficiency comparable to that of D2L receptors.  The coupling between D3 receptors and native GIRK channels was examd. in an AtT-20 mouse pituitary cell line stably expressing the human D3 receptor.  AtT-20 cells endogenously express somatostatin and muscarinic receptors coupled to GIRK channels.  RT-PCR and Western blot analyses revealed that AtT-20 cells natively express Kir3.1 and Kir3.2 channel isoforms, but not D2 or D3 dopamine receptors.  In D3 receptor expressing AtT-20 cells, application of the D2/D3 receptor agonist, quinpirole, induces pertussis toxin-sensitive inward rectifying K+ currents that are blocked by barium.  Activation of D3 receptors leads to both homologous desensitization of this receptor and an unusual unidirectional heterologous desensitization of somatostatin receptors.  AtT-20 cells may be a good model to examine the functional role of D3 dopamine receptors in regulating neurotransmitter secretion.  (c) 1998 Academic Press.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqqTRDIFIXaNLVg90H21EOLACvtfcHk0lg_yo4IhpjmSg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXmt1Gnuw%253D%253D&md5=5afc4543d838926092dbacb4e06a90a6</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1006%2Fmcne.1998.0722&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fmcne.1998.0722%26sid%3Dliteratum%253Aachs%26aulast%3DKuzhikandathil%26aufirst%3DE.%2BV.%26aulast%3DYu%26aufirst%3DW.%26aulast%3DOxford%26aufirst%3DG.%2BS.%26atitle%3DHuman%2520Dopamine%2520D3%2520and%2520D2L%2520Receptors%2520Couple%2520to%2520Inward%2520Rectifier%2520Potassium%2520Channels%2520in%2520Mammalian%2520Cell%2520Lines%26jtitle%3DMol.%2520Cell.%2520Neurosci.%26date%3D1998%26volume%3D12%26spage%3D390%26epage%3D402%26doi%3D10.1006%2Fmcne.1998.0722" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref56"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref56'); return false;" data-citation="" class="refNumLink">56</a></strong><div class="NLM_citation" id="cit56"><span><span class="NLM_contrib-group">Lavine, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ethier, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oak, J. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pei, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trieu, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rebois, R. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bouvier, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hébert, T. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Tol, H. H. M. G</span><span> </span><span class="NLM_article-title">Protein-Coupled Receptors Form Stable Complexes with Inwardly Rectifying Potassium Channels and Adenylyl Cyclase</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">277</span><span class="NLM_x">, </span> <span class="NLM_fpage">46010</span><span class="NLM_x">–</span> <span class="NLM_lpage">46019</span><span class="refDoi"> DOI: 10.1074/jbc.M205035200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01857&amp;key=10.1074%2Fjbc.M205035200" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=277&publication_year=2002&pages=46010-46019&author=N.+Lavineauthor=N.+Ethierauthor=J.+N.+Oakauthor=L.+Peiauthor=F.+Liuauthor=P.+Trieuauthor=R.+V.+Reboisauthor=M.+Bouvierauthor=T.+E.+H%C3%A9bertauthor=H.+H.+M.+G+Van+Tol&title=Protein-Coupled+Receptors+Form+Stable+Complexes+with+Inwardly+Rectifying+Potassium+Channels+and+Adenylyl+Cyclase&doi=10.1074%2Fjbc.M205035200"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M205035200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M205035200%26sid%3Dliteratum%253Aachs%26aulast%3DLavine%26aufirst%3DN.%26aulast%3DEthier%26aufirst%3DN.%26aulast%3DOak%26aufirst%3DJ.%2BN.%26aulast%3DPei%26aufirst%3DL.%26aulast%3DLiu%26aufirst%3DF.%26aulast%3DTrieu%26aufirst%3DP.%26aulast%3DRebois%26aufirst%3DR.%2BV.%26aulast%3DBouvier%26aufirst%3DM.%26aulast%3DH%25C3%25A9bert%26aufirst%3DT.%2BE.%26aulast%3DVan%2BTol%26aufirst%3DH.%2BH.%2BM.%2BG%26atitle%3DProtein-Coupled%2520Receptors%2520Form%2520Stable%2520Complexes%2520with%2520Inwardly%2520Rectifying%2520Potassium%2520Channels%2520and%2520Adenylyl%2520Cyclase%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2002%26volume%3D277%26spage%3D46010%26epage%3D46019%26doi%3D10.1074%2Fjbc.M205035200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref57"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref57'); return false;" data-citation="" class="refNumLink">57</a></strong><div class="NLM_citation" id="cit57"><span><span class="NLM_contrib-group">Heusler, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newman-Tancredi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castro-Fernandez, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cussac, D.</span><span> </span><span class="NLM_article-title">Differential Agonist and Inverse Agonist Profile of Antipsychotics at D2L Receptors Coupled to GIRK Potassium Channels</span> <span class="citation_source-journal">Neuropharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">1106</span><span class="NLM_x">–</span> <span class="NLM_lpage">1113</span><span class="refDoi"> DOI: 10.1016/j.neuropharm.2006.11.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01857&amp;key=10.1016%2Fj.neuropharm.2006.11.008" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2007&pages=1106-1113&author=P.+Heuslerauthor=A.+Newman-Tancrediauthor=A.+Castro-Fernandezauthor=D.+Cussac&title=Differential+Agonist+and+Inverse+Agonist+Profile+of+Antipsychotics+at+D2L+Receptors+Coupled+to+GIRK+Potassium+Channels&doi=10.1016%2Fj.neuropharm.2006.11.008"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1016%2Fj.neuropharm.2006.11.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuropharm.2006.11.008%26sid%3Dliteratum%253Aachs%26aulast%3DHeusler%26aufirst%3DP.%26aulast%3DNewman-Tancredi%26aufirst%3DA.%26aulast%3DCastro-Fernandez%26aufirst%3DA.%26aulast%3DCussac%26aufirst%3DD.%26atitle%3DDifferential%2520Agonist%2520and%2520Inverse%2520Agonist%2520Profile%2520of%2520Antipsychotics%2520at%2520D2L%2520Receptors%2520Coupled%2520to%2520GIRK%2520Potassium%2520Channels%26jtitle%3DNeuropharmacology%26date%3D2007%26volume%3D52%26spage%3D1106%26epage%3D1113%26doi%3D10.1016%2Fj.neuropharm.2006.11.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref58"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref58'); return false;" data-citation="" class="refNumLink">58</a></strong><div class="NLM_citation" id="cit58"><span><span class="NLM_contrib-group">Shapiro, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Renock, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arrington, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiodo, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, L.-X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sibley, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roth, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mailman, R.</span><span> </span><span class="NLM_article-title">Aripiprazole, a Novel Atypical Antipsychotic Drug with a Unique and Robust Pharmacology</span> <span class="citation_source-journal">Neuropsychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">1400</span><span class="NLM_x">–</span> <span class="NLM_lpage">1411</span><span class="refDoi"> DOI: 10.1038/sj.npp.1300203</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01857&amp;key=10.1038%2Fsj.npp.1300203" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01857&amp;key=12784105" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01857&amp;key=1%3ACAS%3A528%3ADC%252BD3sXls1Slsro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2003&pages=1400-1411&author=D.+A.+Shapiroauthor=S.+Renockauthor=E.+Arringtonauthor=L.+A.+Chiodoauthor=L.-X.+Liuauthor=D.+R.+Sibleyauthor=B.+L.+Rothauthor=R.+Mailman&title=Aripiprazole%2C+a+Novel+Atypical+Antipsychotic+Drug+with+a+Unique+and+Robust+Pharmacology&doi=10.1038%2Fsj.npp.1300203"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">Aripiprazole, a novel atypical antipsychotic drug with a unique and robust pharmacology</span></div><div class="casAuthors">Shapiro, David A.; Renock, Sean; Arrington, Elaine; Chiodo, Louis A.; Liu, Li-Xin; Sibley, David R.; Roth, Bryan L.; Mailman, Richard</div><div class="citationInfo"><span class="NLM_cas:title">Neuropsychopharmacology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1400-1411</span>CODEN:
                <span class="NLM_cas:coden">NEROEW</span>;
        ISSN:<span class="NLM_cas:issn">0893-133X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Atypical antipsychotic drugs have revolutionized the treatment of schizophrenia and related disorders.  The current clin. approved atypical antipsychotic drugs are characterized by having relatively low affinities for D2-dopamine receptors and relatively high affinities for 5-HT2A serotonin receptors (5-HT, 5-hydroxytryptamine (serotonin)).  Aripiprazole (OPC-14597) is a novel atypical antipsychotic drug that is reported to be a high-affinity D2-dopamine receptor partial agonist.  We now provide a comprehensive pharmacol. profile of aripiprazole at a large no. of cloned G protein-coupled receptors, transporters, and ion channels.  These data reveal a no. of interesting and potentially important mol. targets for which aripiprazole has affinity.  Aripiprazole has highest affinity for h5-HT2B-, hD2L-, and hD3-dopamine receptors, but also has significant affinity (5-30 nM) for several other 5-HT receptors (5-HT1A, 5-HT2A, 5-HT7), as well as α1A-adrenergic and hH1-histamine receptors.  Aripiprazole has less affinity (30-200 nM) for other G protein-coupled receptors, including the 5-HT1D, 5-HT2C, α1B-, α2A-, α2B-, α2C-, β1-, and β2-adrenergic, and H3-histamine receptors.  Functionally, aripiprazole is an inverse agonist at 5-HT2B receptors and displays partial agonist actions at 5-HT2A, 5-HT2C, D3, and D4 receptors.  Interestingly, we also discovered that the functional actions of aripiprazole at cloned human D2-dopamine receptors are cell-type selective, and that a range of actions (eg agonism, partial agonism, antagonism) at cloned D2-dopamine receptors are possible depending upon the cell type and function examd.  This mixt. of functional actions at D2-dopamine receptors is consistent with the hypothesis proposed by Lawler et al (1999) that aripiprazole has functionally selective' actions.  Taken together, our results support the hypothesis that the unique actions of aripiprazole in humans are likely a combination of functionally selective' activation of D2 (and possibly D3)-dopamine receptors, coupled with important interactions with selected other biogenic amine receptors-particularly 5-HT receptor subtypes (5-HT1A, 5-HT2A).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrc1m1pKWaDH7Vg90H21EOLACvtfcHk0liRq8FwRG0f4Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXls1Slsro%253D&md5=a90dfc24826c78d9a630ae4831d99cb0</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1038%2Fsj.npp.1300203&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.npp.1300203%26sid%3Dliteratum%253Aachs%26aulast%3DShapiro%26aufirst%3DD.%2BA.%26aulast%3DRenock%26aufirst%3DS.%26aulast%3DArrington%26aufirst%3DE.%26aulast%3DChiodo%26aufirst%3DL.%2BA.%26aulast%3DLiu%26aufirst%3DL.-X.%26aulast%3DSibley%26aufirst%3DD.%2BR.%26aulast%3DRoth%26aufirst%3DB.%2BL.%26aulast%3DMailman%26aufirst%3DR.%26atitle%3DAripiprazole%252C%2520a%2520Novel%2520Atypical%2520Antipsychotic%2520Drug%2520with%2520a%2520Unique%2520and%2520Robust%2520Pharmacology%26jtitle%3DNeuropsychopharmacology%26date%3D2003%26volume%3D28%26spage%3D1400%26epage%3D1411%26doi%3D10.1038%2Fsj.npp.1300203" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref59"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref59'); return false;" data-citation="" class="refNumLink">59</a></strong><div class="NLM_citation" id="cit59"><span><span class="NLM_contrib-group">Klose, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huth, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alzheimer, C.</span><span> </span><span class="NLM_article-title">1-[6-[[(17β)-3-Methoxyestra-1,3,5(10)-Trien-17-Yl]Amino]Hexyl]-1h-Pyrrole-2,5-Dione (U73122) Selectively Inhibits Kir3 and Bk Channels in a Phospholipase C-Independent Fashion</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">74</span><span class="NLM_x">, </span> <span class="NLM_fpage">1203</span><span class="NLM_x">–</span> <span class="NLM_lpage">1214</span><span class="refDoi"> DOI: 10.1124/mol.108.047837</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01857&amp;key=10.1124%2Fmol.108.047837" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=74&publication_year=2008&pages=1203-1214&author=A.+Kloseauthor=T.+Huthauthor=C.+Alzheimer&title=1-%5B6-%5B%5B%2817%CE%B2%29-3-Methoxyestra-1%2C3%2C5%2810%29-Trien-17-Yl%5DAmino%5DHexyl%5D-1h-Pyrrole-2%2C5-Dione+%28U73122%29+Selectively+Inhibits+Kir3+and+Bk+Channels+in+a+Phospholipase+C-Independent+Fashion&doi=10.1124%2Fmol.108.047837"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1124%2Fmol.108.047837&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.108.047837%26sid%3Dliteratum%253Aachs%26aulast%3DKlose%26aufirst%3DA.%26aulast%3DHuth%26aufirst%3DT.%26aulast%3DAlzheimer%26aufirst%3DC.%26atitle%3D1-%255B6-%255B%255B%252817%25CE%25B2%2529-3-Methoxyestra-1%252C3%252C5%252810%2529-Trien-17-Yl%255DAmino%255DHexyl%255D-1h-Pyrrole-2%252C5-Dione%2520%2528U73122%2529%2520Selectively%2520Inhibits%2520Kir3%2520and%2520Bk%2520Channels%2520in%2520a%2520Phospholipase%2520C-Independent%2520Fashion%26jtitle%3DMol.%2520Pharmacol.%26date%3D2008%26volume%3D74%26spage%3D1203%26epage%3D1214%26doi%3D10.1124%2Fmol.108.047837" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref60"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref60'); return false;" data-citation="" class="refNumLink">60</a></strong><div class="NLM_citation" id="cit60"><span><span class="NLM_contrib-group">Liao, Y. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jan, Y. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jan, L. Y.</span><span> </span><span class="NLM_article-title">Heteromultimerization of G-Protein-Gated Inwardly Rectifying K+ Channel Proteins GIRK1 and GIRK2 and Their Altered Expression in Weaver Brain</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">7137</span><span class="NLM_x">–</span> <span class="NLM_lpage">7150</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01857&amp;key=8929423" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01857&amp;key=1%3ACAS%3A528%3ADyaK28XntlegtLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=1996&pages=7137-7150&author=Y.+J.+Liaoauthor=Y.+N.+Janauthor=L.+Y.+Jan&title=Heteromultimerization+of+G-Protein-Gated+Inwardly+Rectifying+K%2B+Channel+Proteins+GIRK1+and+GIRK2+and+Their+Altered+Expression+in+Weaver+Brain"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">Heteromultimerization of G-protein-gated inwardly rectifying K+ channel proteins GIRK1 and GIRK2 and their altered expression in weaver brain</span></div><div class="casAuthors">Liao, Y. Joyce; Jan, Yuh Nung; Jan, Lily Yeh</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">7137-7150</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">The weaver (WV) gene (GIRK2) is a member of the G-protein-gated inwardly rectifying potassium (GIRK) channel family, known effectors in the signal transduction pathway of neurotransmitters such as acetylcholine, dopamine, opioid peptides, and substance P in modulation of neurotransmitter release and neuronal excitability.  GIRK2 immunoreactivity is found in but not limited to brain regions known to be affected in wv mice, such as the cerebellar granule cells and dopaminergic neurons in the substantia nigra pars compacta, cerebral cortex, and thalamus.  GIRK2 and GIRK1, a related family member, have overlapping yet distinct distributions in rat and mouse brains.  In regions where both channel proteins are expressed, such as the cerebral cortex, hippocampus, and cerebellum, they can be co-immunopptd., indicating that they interact to form heteromeric channels in vivo.  In the brain of the wv mouse, GIRK2 expression is decreased dramatically.  In regions where GIRK1 and GIRK2 distributions overlap, both GIRK1 and GIRK2 expressions are severely disrupted, probably because of their co-assembly.  The expression patterns of these GIRK channel subunits provide a basis for consideration of the machinery for neuronal signaling as well as the differential effects of the wv mutation in various neurons.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrG1k2UrVpbH7Vg90H21EOLACvtfcHk0liRq8FwRG0f4Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XntlegtLw%253D&md5=0a0d1710b075acc09f1dbca83008bac0</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLiao%26aufirst%3DY.%2BJ.%26aulast%3DJan%26aufirst%3DY.%2BN.%26aulast%3DJan%26aufirst%3DL.%2BY.%26atitle%3DHeteromultimerization%2520of%2520G-Protein-Gated%2520Inwardly%2520Rectifying%2520K%252B%2520Channel%2520Proteins%2520GIRK1%2520and%2520GIRK2%2520and%2520Their%2520Altered%2520Expression%2520in%2520Weaver%2520Brain%26jtitle%3DJ.%2520Neurosci.%26date%3D1996%26volume%3D16%26spage%3D7137%26epage%3D7150" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref61"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref61'); return false;" data-citation="" class="refNumLink">61</a></strong><div class="NLM_citation" id="cit61"><span><span class="NLM_contrib-group">Tenn, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fletcher, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kapur, S.</span><span> </span><span class="NLM_article-title">A Putative Animal Model of the “Prodromal” State of Schizophrenia</span> <span class="citation_source-journal">Biol. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">586</span><span class="NLM_x">–</span> <span class="NLM_lpage">593</span><span class="refDoi"> DOI: 10.1016/j.biopsych.2004.12.013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01857&amp;key=10.1016%2Fj.biopsych.2004.12.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01857&amp;key=15780845" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01857&amp;key=1%3ACAS%3A528%3ADC%252BD2MXisVWqs7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2005&pages=586-593&author=C.+C.+Tennauthor=P.+J.+Fletcherauthor=S.+Kapur&title=A+Putative+Animal+Model+of+the+%E2%80%9CProdromal%E2%80%9D+State+of+Schizophrenia&doi=10.1016%2Fj.biopsych.2004.12.013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">A putative animal model of the "prodromal" state of schizophrenia</span></div><div class="casAuthors">Tenn, Catherine C.; Fletcher, Paul J.; Kapur, Shitij</div><div class="citationInfo"><span class="NLM_cas:title">Biological Psychiatry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">586-593</span>CODEN:
                <span class="NLM_cas:coden">BIPCBF</span>;
        ISSN:<span class="NLM_cas:issn">0006-3223</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Background: There is growing interest in detecting and treating schizophrenia during the "prodrome," before the symptoms are fully manifested.  The objective of this study was to develop a putative model of the prodrome and study the effects of medications on it.  Methods: Rats were treated with different regimens of amphetamine to produce full sensitization (full syndrome) and partial sensitization (to model the prodromal state) and were then treated with typical and atypical antipsychotics and a D1 antagonist to mimic early intervention.  After several weeks of withdrawal, locomotor activity in response to amphetamine and behavioral deficits (prepulse inhibition [PPI] and latent inhibition [LI]) were examd.  Results: Animals that received the full sensitization showed significant increase in locomotor activity and a disruption in both PPI and LI.  Animals treated with a partial regimen showed only a muted phenotype.  The animals that received "early intervention" did not show progression from the prodromal to the full-blown phenotype.  Conclusions: The partial regimen of amphetamine injections provided a modified phenotype that could be regarded as a representative of the "prodromal" state.  Early intervention, instituted once the prodromal state was already developed, prevented further progression into the full phenotype analogous to schizophrenia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqVEs3CNLEvL7Vg90H21EOLACvtfcHk0lj6zHoGW7OUPA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXisVWqs7o%253D&md5=0bae4c9c1d15831a112003aeeafb534b</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1016%2Fj.biopsych.2004.12.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.biopsych.2004.12.013%26sid%3Dliteratum%253Aachs%26aulast%3DTenn%26aufirst%3DC.%2BC.%26aulast%3DFletcher%26aufirst%3DP.%2BJ.%26aulast%3DKapur%26aufirst%3DS.%26atitle%3DA%2520Putative%2520Animal%2520Model%2520of%2520the%2520%25E2%2580%259CProdromal%25E2%2580%259D%2520State%2520of%2520Schizophrenia%26jtitle%3DBiol.%2520Psychiatry%26date%3D2005%26volume%3D57%26spage%3D586%26epage%3D593%26doi%3D10.1016%2Fj.biopsych.2004.12.013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref62"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref62'); return false;" data-citation="" class="refNumLink">62</a></strong><div class="NLM_citation" id="cit62"><span><span class="NLM_contrib-group">Peleg-Raibstein, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sydekum, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feldon, J.</span><span> </span><span class="NLM_article-title">Differential Effects on Prepulse Inhibition of Withdrawal from Two Different Repeated Administration Schedules of Amphetamine</span> <span class="citation_source-journal">Int. J. Neuropsychopharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">737</span><span class="NLM_x">–</span> <span class="NLM_lpage">749</span><span class="refDoi"> DOI: 10.1017/S1461145706006493</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01857&amp;key=10.1017%2FS1461145706006493" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01857&amp;key=16448582" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01857&amp;key=1%3ACAS%3A528%3ADC%252BD2sXltlShsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2006&pages=737-749&author=D.+Peleg-Raibsteinauthor=E.+Sydekumauthor=J.+Feldon&title=Differential+Effects+on+Prepulse+Inhibition+of+Withdrawal+from+Two+Different+Repeated+Administration+Schedules+of+Amphetamine&doi=10.1017%2FS1461145706006493"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">Differential effects on prepulse inhibition of withdrawal from two different repeated administration schedules of amphetamine</span></div><div class="casAuthors">Peleg-Raibstein, Daria; Sydekum, Esther; Feldon, Joram</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Neuropsychopharmacology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">737-749</span>CODEN:
                <span class="NLM_cas:coden">IJNUFB</span>;
        ISSN:<span class="NLM_cas:issn">1461-1457</span>.
    
            (<span class="NLM_cas:orgname">Cambridge University Press</span>)
        </div><div class="casAbstract">In this study, rats were tested in behavioral paradigms relevant to schizophrenia during withdrawal from two different administration schedules of amphetamine (Amph).  One of the escalating administration schedules, which has been employed in previous studies, consisted of three daily injections for 6 d with increasing dosages from 1 to 5 mg/kg Amph (Esc-5) and was compared to a hitherto never examd. escalating administration schedule [three injections per day for 6 d escalating from 1 to 8 mg/kg Amph (Esc-8)].  Control animals received an equiv. vol. of saline (Sal) injections according to the same schedule.  Whereas rats treated with Esc-5, as reported before, failed to show an effect on prepulse inhibition (PPI), the Esc-8-treated rats exhibited a long-lasting disruption of PPI in a drug-free state on days 6, 13 and 55 of withdrawal.  The Amph-pretreated animals demonstrated a similar magnitude of behavioral sensitization following an Amph challenge on withdrawal day 58 irresp. of the administration schedule.  To evaluate if the withdrawal from the two Amph schedules led to a change in brain monoamine levels, a subgroup of animals was neurochem. examd. in post-mortem for eight parameters in seven brain regions on withdrawal day 55.  Withdrawal from the Esc-8 schedule induced reduced dopamine levels in the caudate putamen.  Only this neurochem. finding and the PPI attenuation differentiated the Esc-8 animals from the Esc-5 and Sal animals.  These data suggest that, based on the endogenous sensitization hypothesis of schizophrenia, the persistent disruption of PPI obsd. in animals withdrawn from Esc-8 can be used as a valid animal model of specific symptoms of schizophrenic patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGotUHeBdTCPNLVg90H21EOLACvtfcHk0lj6zHoGW7OUPA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXltlShsA%253D%253D&md5=2aa3fddb597567f3ce4071737edea14c</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1017%2FS1461145706006493&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1017%252FS1461145706006493%26sid%3Dliteratum%253Aachs%26aulast%3DPeleg-Raibstein%26aufirst%3DD.%26aulast%3DSydekum%26aufirst%3DE.%26aulast%3DFeldon%26aufirst%3DJ.%26atitle%3DDifferential%2520Effects%2520on%2520Prepulse%2520Inhibition%2520of%2520Withdrawal%2520from%2520Two%2520Different%2520Repeated%2520Administration%2520Schedules%2520of%2520Amphetamine%26jtitle%3DInt.%2520J.%2520Neuropsychopharmacol.%26date%3D2006%26volume%3D9%26spage%3D737%26epage%3D749%26doi%3D10.1017%2FS1461145706006493" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref63"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref63'); return false;" data-citation="" class="refNumLink">63</a></strong><div class="NLM_citation" id="cit63"><span><span class="NLM_contrib-group">Cancela, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Basso, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martijena, I. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Capriles, N. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Molina, V. A.</span><span> </span><span class="NLM_article-title">A Dopaminergic Mechanism Is Involved in the ‘Anxiogenic-Like’ Response Induced by Chronic Amphetamine Treatment: A Behavioral and Neurochemical Study</span> <span class="citation_source-journal">Brain Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">909</span><span class="NLM_x">, </span> <span class="NLM_fpage">179</span><span class="NLM_x">–</span> <span class="NLM_lpage">186</span><span class="refDoi"> DOI: 10.1016/S0006-8993(01)02680-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01857&amp;key=10.1016%2FS0006-8993%2801%2902680-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01857&amp;key=11478934" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01857&amp;key=1%3ACAS%3A528%3ADC%252BD3MXls1ejsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=909&publication_year=2001&pages=179-186&author=L.+M.+Cancelaauthor=A.+M.+Bassoauthor=I.+D.+Martijenaauthor=N.+R.+Caprilesauthor=V.+A.+Molina&title=A+Dopaminergic+Mechanism+Is+Involved+in+the+%E2%80%98Anxiogenic-Like%E2%80%99+Response+Induced+by+Chronic+Amphetamine+Treatment%3A+A+Behavioral+and+Neurochemical+Study&doi=10.1016%2FS0006-8993%2801%2902680-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">A dopaminergic mechanism is involved in the 'anxiogenic-like' response induced by chronic amphetamine treatment: a behavioral and neurochemical study</span></div><div class="casAuthors">Cancela, L. M.; Basso, A. M.; Martijena, I. D.; Capriles, N. R.; Molina, V. A.</div><div class="citationInfo"><span class="NLM_cas:title">Brain Research</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">909</span>
        (<span class="NLM_cas:issue">1,2</span>),
    <span class="NLM_cas:pages">179-186</span>CODEN:
                <span class="NLM_cas:coden">BRREAP</span>;
        ISSN:<span class="NLM_cas:issn">0006-8993</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">The purpose of this study was to examine the influence of chronic d-amphetamine (AMPH) treatment (2 mg/kg i.p., for 9 consecutive days) on behavioral and neurochem. responses to a subsequent exposure - 4 days after the last AMPH injection - to the elevated plus-maze (EPM), as well as to det. the involvement of a dopaminergic mechanism in that influence.  Results showed that chronic AMPH treatment induced an 'anxiogenic-like' response when animals were evaluated in the EPM test.  Pretreatment with either haloperidol (HAL, 1 mg/kg i.p., 20 min prior to each injection) or SCH-23390 (0.1 mg/kg i.p., 10 min prior to each injection) completely abolished the chronic AMPH-induced 'anxiogenic-like' effect displayed in the EPM test.  However, sulpiride pretreatment (60 mg/kg i.p., 10 min prior to each AMPH injection) did not modify such effect.  In addn., rats treated with AMPH and subsequently exposed to the EPM, showed a decrease in the maximal GABA-stimulated chloride uptake in cortical microsacs.  HAL pretreatment restored the maximal chloride uptake induced by chronic AMPH.  Altogether, these results suggest that: (1) previous exposure to chronic AMPH treatment induces an increased emotional response following a conflict situation, (2) dopamine D1 receptors are mainly involved in chronic AMPH-induced changes in the behavior displayed in EPM test, and (3) an interaction between GABAergic and dopaminergic mechanisms may be implicated in neurochem. and behavioral changes induced by chronic AMPH treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo0CQeT1MksYLVg90H21EOLACvtfcHk0lj6zHoGW7OUPA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXls1ejsLs%253D&md5=fccb14f4d4ed713d86ee9cb294902bee</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1016%2FS0006-8993%2801%2902680-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0006-8993%252801%252902680-4%26sid%3Dliteratum%253Aachs%26aulast%3DCancela%26aufirst%3DL.%2BM.%26aulast%3DBasso%26aufirst%3DA.%2BM.%26aulast%3DMartijena%26aufirst%3DI.%2BD.%26aulast%3DCapriles%26aufirst%3DN.%2BR.%26aulast%3DMolina%26aufirst%3DV.%2BA.%26atitle%3DA%2520Dopaminergic%2520Mechanism%2520Is%2520Involved%2520in%2520the%2520%25E2%2580%2598Anxiogenic-Like%25E2%2580%2599%2520Response%2520Induced%2520by%2520Chronic%2520Amphetamine%2520Treatment%253A%2520A%2520Behavioral%2520and%2520Neurochemical%2520Study%26jtitle%3DBrain%2520Res.%26date%3D2001%26volume%3D909%26spage%3D179%26epage%3D186%26doi%3D10.1016%2FS0006-8993%2801%2902680-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref64"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref64'); return false;" data-citation="" class="refNumLink">64</a></strong><div class="NLM_citation" id="cit64"><span><span class="NLM_contrib-group">Amato, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pum, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Groos, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lauber, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huston, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carey, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Souza Silva, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Müller, C. P.</span><span> </span><span class="NLM_article-title">Neuropharmacology of Light-Induced Locomotor Activation</span> <span class="citation_source-journal">Neuropharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">95</span><span class="NLM_x">, </span> <span class="NLM_fpage">243</span><span class="NLM_x">–</span> <span class="NLM_lpage">251</span><span class="refDoi"> DOI: 10.1016/j.neuropharm.2015.03.023</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01857&amp;key=10.1016%2Fj.neuropharm.2015.03.023" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=95&publication_year=2015&pages=243-251&author=D.+Amatoauthor=M.+E.+Pumauthor=D.+Groosauthor=A.+C.+Lauberauthor=J.+P.+Hustonauthor=R.+J.+Careyauthor=M.+A.+de+Souza+Silvaauthor=C.+P.+M%C3%BCller&title=Neuropharmacology+of+Light-Induced+Locomotor+Activation&doi=10.1016%2Fj.neuropharm.2015.03.023"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1016%2Fj.neuropharm.2015.03.023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuropharm.2015.03.023%26sid%3Dliteratum%253Aachs%26aulast%3DAmato%26aufirst%3DD.%26aulast%3DPum%26aufirst%3DM.%2BE.%26aulast%3DGroos%26aufirst%3DD.%26aulast%3DLauber%26aufirst%3DA.%2BC.%26aulast%3DHuston%26aufirst%3DJ.%2BP.%26aulast%3DCarey%26aufirst%3DR.%2BJ.%26aulast%3Dde%2BSouza%2BSilva%26aufirst%3DM.%2BA.%26aulast%3DM%25C3%25BCller%26aufirst%3DC.%2BP.%26atitle%3DNeuropharmacology%2520of%2520Light-Induced%2520Locomotor%2520Activation%26jtitle%3DNeuropharmacology%26date%3D2015%26volume%3D95%26spage%3D243%26epage%3D251%26doi%3D10.1016%2Fj.neuropharm.2015.03.023" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref65"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref65'); return false;" data-citation="" class="refNumLink">65</a></strong><div class="NLM_citation" id="cit65"><span><span class="NLM_contrib-group">Pum, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huston, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Müller, C. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Souza Silva, M. A.</span><span> </span><span class="NLM_article-title">Light-Induced Activity in the Activity Box Is Not Aversively Motivated and Does Not Show between-Trial Habituation</span> <span class="citation_source-journal">Physiol. Behav.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">96</span><span class="NLM_x">, </span> <span class="NLM_fpage">434</span><span class="NLM_x">–</span> <span class="NLM_lpage">439</span><span class="refDoi"> DOI: 10.1016/j.physbeh.2008.11.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01857&amp;key=10.1016%2Fj.physbeh.2008.11.006" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=96&publication_year=2009&pages=434-439&author=M.+E.+Pumauthor=J.+P.+Hustonauthor=C.+P.+M%C3%BCllerauthor=M.+A.+De+Souza+Silva&title=Light-Induced+Activity+in+the+Activity+Box+Is+Not+Aversively+Motivated+and+Does+Not+Show+between-Trial+Habituation&doi=10.1016%2Fj.physbeh.2008.11.006"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1016%2Fj.physbeh.2008.11.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.physbeh.2008.11.006%26sid%3Dliteratum%253Aachs%26aulast%3DPum%26aufirst%3DM.%2BE.%26aulast%3DHuston%26aufirst%3DJ.%2BP.%26aulast%3DM%25C3%25BCller%26aufirst%3DC.%2BP.%26aulast%3DDe%2BSouza%2BSilva%26aufirst%3DM.%2BA.%26atitle%3DLight-Induced%2520Activity%2520in%2520the%2520Activity%2520Box%2520Is%2520Not%2520Aversively%2520Motivated%2520and%2520Does%2520Not%2520Show%2520between-Trial%2520Habituation%26jtitle%3DPhysiol.%2520Behav.%26date%3D2009%26volume%3D96%26spage%3D434%26epage%3D439%26doi%3D10.1016%2Fj.physbeh.2008.11.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref66"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref66'); return false;" data-citation="" class="refNumLink">66</a></strong><div class="NLM_citation" id="cit66"><span><span class="NLM_contrib-group">Pum, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huston, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Souza Silva, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Müller, C. P.</span><span> </span><span class="NLM_article-title">Visual Sensory-Motor Gating by Serotonin Activation in the Medial Prefrontal and Occipital, but not in the Rhinal, Cortices in Rats</span> <span class="citation_source-journal">Neuroscience</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">153</span><span class="NLM_x">, </span> <span class="NLM_fpage">361</span><span class="NLM_x">–</span> <span class="NLM_lpage">372</span><span class="refDoi"> DOI: 10.1016/j.neuroscience.2008.02.029</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01857&amp;key=10.1016%2Fj.neuroscience.2008.02.029" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=153&publication_year=2008&pages=361-372&author=M.+E.+Pumauthor=J.+P.+Hustonauthor=M.+A.+De+Souza+Silvaauthor=C.+P.+M%C3%BCller&title=Visual+Sensory-Motor+Gating+by+Serotonin+Activation+in+the+Medial+Prefrontal+and+Occipital%2C+but+not+in+the+Rhinal%2C+Cortices+in+Rats&doi=10.1016%2Fj.neuroscience.2008.02.029"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1016%2Fj.neuroscience.2008.02.029&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuroscience.2008.02.029%26sid%3Dliteratum%253Aachs%26aulast%3DPum%26aufirst%3DM.%2BE.%26aulast%3DHuston%26aufirst%3DJ.%2BP.%26aulast%3DDe%2BSouza%2BSilva%26aufirst%3DM.%2BA.%26aulast%3DM%25C3%25BCller%26aufirst%3DC.%2BP.%26atitle%3DVisual%2520Sensory-Motor%2520Gating%2520by%2520Serotonin%2520Activation%2520in%2520the%2520Medial%2520Prefrontal%2520and%2520Occipital%252C%2520but%2520not%2520in%2520the%2520Rhinal%252C%2520Cortices%2520in%2520Rats%26jtitle%3DNeuroscience%26date%3D2008%26volume%3D153%26spage%3D361%26epage%3D372%26doi%3D10.1016%2Fj.neuroscience.2008.02.029" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref67"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref67'); return false;" data-citation="" class="refNumLink">67</a></strong><div class="NLM_citation" id="cit67"><span><span class="NLM_contrib-group">Featherstone, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kapur, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fletcher, P. J.</span><span> </span><span class="NLM_article-title">The Amphetamine-Induced Sensitized State as a Model of Schizophrenia</span> <span class="citation_source-journal">Prog. Neuro-Psychopharmacol. Biol. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">1556</span><span class="NLM_x">–</span> <span class="NLM_lpage">1571</span><span class="refDoi"> DOI: 10.1016/j.pnpbp.2007.08.025</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01857&amp;key=10.1016%2Fj.pnpbp.2007.08.025" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01857&amp;key=17884274" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01857&amp;key=1%3ACAS%3A528%3ADC%252BD2sXht1amtr7I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2007&pages=1556-1571&author=R.+E.+Featherstoneauthor=S.+Kapurauthor=P.+J.+Fletcher&title=The+Amphetamine-Induced+Sensitized+State+as+a+Model+of+Schizophrenia&doi=10.1016%2Fj.pnpbp.2007.08.025"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit67R"><div class="casContent"><span class="casTitleNuber">67</span><div class="casTitle"><span class="NLM_cas:atitle">The amphetamine-induced sensitized state as a model of schizophrenia</span></div><div class="casAuthors">Featherstone, R. E.; Kapur, S.; Fletcher, P. J.</div><div class="citationInfo"><span class="NLM_cas:title">Progress in Neuro-Psychopharmacology & Biological Psychiatry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1556-1571</span>CODEN:
                <span class="NLM_cas:coden">PNPPD7</span>;
        ISSN:<span class="NLM_cas:issn">0278-5846</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Schizophrenia is a serious psychiatric disorder which impacts a broad range of cognitive, behavioral and emotional domains.  In animals, exposure to an intermittent, escalating dose regimen of amphetamine induces a sensitized state that appears to share a no. of behavioral and neurochem. similarities with schizophrenia.  In humans repeated exposure to amphetamine, or other psychomotor stimulants, can induce sensitization as well as psychosis.  The following paper evaluates the evidence for the amphetamine-induced sensitized state as an animal model of schizophrenia, focussing sep. on the pos., cognitive and neg. symptoms assocd. with this disease.  Current evidence supports the use of amphetamine sensitization as a model of the pos. symptoms obsd. in schizophrenia.  Addnl., there is increasing evidence for long-lasting cognitive deficits in sensitized animals, esp. in the area of attention and/or cognitive flexibility.  Other areas of cognition, such as long-term memory, appear to be unaltered in sensitized animals.  Finally, little evidence currently exists to either support or refute the use of amphetamine sensitization as a model of neg. symptoms.  It is concluded that amphetamine sensitization likely impacts behavior by altering the functioning of mesolimbic dopamine systems and prefrontal cortical function and can serve as a model of certain domains of schizophrenia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqzo0uzz7CfYrVg90H21EOLACvtfcHk0lhiWw_amnHNBw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXht1amtr7I&md5=9a3a77dd280f48015f7dade8bc5a242a</span></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1016%2Fj.pnpbp.2007.08.025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pnpbp.2007.08.025%26sid%3Dliteratum%253Aachs%26aulast%3DFeatherstone%26aufirst%3DR.%2BE.%26aulast%3DKapur%26aufirst%3DS.%26aulast%3DFletcher%26aufirst%3DP.%2BJ.%26atitle%3DThe%2520Amphetamine-Induced%2520Sensitized%2520State%2520as%2520a%2520Model%2520of%2520Schizophrenia%26jtitle%3DProg.%2520Neuro-Psychopharmacol.%2520Biol.%2520Psychiatry%26date%3D2007%26volume%3D31%26spage%3D1556%26epage%3D1571%26doi%3D10.1016%2Fj.pnpbp.2007.08.025" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref68"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref68'); return false;" data-citation="" class="refNumLink">68</a></strong><div class="NLM_citation" id="cit68"><span><span class="NLM_contrib-group">Prut, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Belzung, C.</span><span> </span><span class="NLM_article-title">The Open Field as a Paradigm to Measure the Effects of Drugs on Anxiety-Like Behaviors: A Review</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">463</span><span class="NLM_x">, </span> <span class="NLM_fpage">3</span><span class="NLM_x">–</span> <span class="NLM_lpage">33</span><span class="refDoi"> DOI: 10.1016/S0014-2999(03)01272-X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01857&amp;key=10.1016%2FS0014-2999%2803%2901272-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01857&amp;key=12600700" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01857&amp;key=1%3ACAS%3A528%3ADC%252BD3sXhsVanu70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=463&publication_year=2003&pages=3-33&author=L.+Prutauthor=C.+Belzung&title=The+Open+Field+as+a+Paradigm+to+Measure+the+Effects+of+Drugs+on+Anxiety-Like+Behaviors%3A+A+Review&doi=10.1016%2FS0014-2999%2803%2901272-X"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit68R"><div class="casContent"><span class="casTitleNuber">68</span><div class="casTitle"><span class="NLM_cas:atitle">The open field as a paradigm to measure the effects of drugs on anxiety-like behaviors: a review</span></div><div class="casAuthors">Prut, Laetitia; Belzung, Catherine</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">463</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">3-33</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">A review. The open field is a very popular animal model of anxiety-like behavior.  An overview of the literature on the action elicited by effective or putative anxiolytics in animals subjected to this procedure indicated that classical treatments such as benzodiazepine receptor full agonists or 5-HT1A receptor full or partial agonists elicit an anxiolytic-like effect in this procedure in most cases (approx. 2/3).  However, compds. (triazolobenzodiazepines such as adinazolam and alprazolam, selective serotonin reuptake inhibitors) that have a different spectrum of therapeutic efficacy in anxiety disorders such as panic attacks, generalized anxiety disorder or obsessive-compulsive disorder were poorly effective as anxiolytics in the open field test, suggesting that this paradigm may not model features of anxiety disorders.  The procedure is also relevant to the study of compds. endowed with anxiogenic effects, as such effects were detected after treatments with benzodiazepine receptor inverse agonists or with corticotropin-releasing factor receptor agonists.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpwZxllzNiJdLVg90H21EOLACvtfcHk0lhiWw_amnHNBw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXhsVanu70%253D&md5=8fbb7f106f0e7c28c1c0b83dfe02dcb3</span></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.1016%2FS0014-2999%2803%2901272-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0014-2999%252803%252901272-X%26sid%3Dliteratum%253Aachs%26aulast%3DPrut%26aufirst%3DL.%26aulast%3DBelzung%26aufirst%3DC.%26atitle%3DThe%2520Open%2520Field%2520as%2520a%2520Paradigm%2520to%2520Measure%2520the%2520Effects%2520of%2520Drugs%2520on%2520Anxiety-Like%2520Behaviors%253A%2520A%2520Review%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2003%26volume%3D463%26spage%3D3%26epage%3D33%26doi%3D10.1016%2FS0014-2999%2803%2901272-X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref69"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref69'); return false;" data-citation="" class="refNumLink">69</a></strong><div class="NLM_citation" id="cit69"><span><span class="NLM_contrib-group">Antelman, S. M.; Chiodo, L. A.</span><span> </span><span class="NLM_article-title">Amphetamine as a Stressor</span>. In  <span class="citation_source-book">Stimulants: Neurochemical, Behavioral and Clinical Perspectives</span>, <span class="NLM_contrib-group">Cresse, I.</span>, Ed.; <span class="NLM_publisher-name">Raven Press</span>: <span class="NLM_publisher-loc">New York</span>,<span class="NLM_x"> </span><span class="NLM_year">1983</span><span class="NLM_x">; </span>pp  <span class="NLM_fpage">269</span><span class="NLM_x">–</span> <span class="NLM_lpage">299</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1983&pages=269-299&author=S.+M.+Antelman&author=L.+A.+Chiodoauthor=I.+Cresse&title=Stimulants%3A+Neurochemical%2C+Behavioral+and+Clinical+Perspectives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DAntelman%26aufirst%3DS.%2BM.%26atitle%3DAmphetamine%2520as%2520a%2520Stressor%26btitle%3DStimulants%253A%2520Neurochemical%252C%2520Behavioral%2520and%2520Clinical%2520Perspectives%26aulast%3DCresse%26aufirst%3DI.%26pub%3DRaven%2520Press%26date%3D1983%26spage%3D269%26epage%3D299" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref70"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref70'); return false;" data-citation="" class="refNumLink">70</a></strong><div class="NLM_citation" id="cit70"><span><span class="NLM_contrib-group">Braga, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petrides, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Figueira, I.</span><span> </span><span class="NLM_article-title">Anxiety Disorders in Schizophrenia</span> <span class="citation_source-journal">Compr. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">460</span><span class="NLM_x">–</span> <span class="NLM_lpage">468</span><span class="refDoi"> DOI: 10.1016/j.comppsych.2004.07.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01857&amp;key=10.1016%2Fj.comppsych.2004.07.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01857&amp;key=15526257" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01857&amp;key=1%3ACAS%3A280%3ADC%252BD2crltlagsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2004&pages=460-468&author=R.+J.+Bragaauthor=G.+Petridesauthor=I.+Figueira&title=Anxiety+Disorders+in+Schizophrenia&doi=10.1016%2Fj.comppsych.2004.07.009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit70R"><div class="casContent"><span class="casTitleNuber">70</span><div class="casTitle"><span class="NLM_cas:atitle">Anxiety disorders in schizophrenia</span></div><div class="casAuthors">Braga Raphael J; Petrides Georgios; Figueira Ivan</div><div class="citationInfo"><span class="NLM_cas:title">Comprehensive psychiatry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">460-8</span>
        ISSN:<span class="NLM_cas:issn">0010-440X</span>.
    </div><div class="casAbstract">Data regarding the co-occurrence of anxiety symptoms or syndromes in schizophrenia is scant.  Hierarchical assumptions embedded in diagnostic systems and methodologic difficulties hamper the development of studies on accessory symptomatology outside of the core positive-negative-disorganized symptoms.  Recent studies have repeatedly challenged these assumptions by presenting data on comorbid disorders in schizophrenia.  We review the current knowledge about anxiety comorbidity in schizophrenia, and its relative prevalence, relevance, and treatment.  A computerized search of the literature published from 1966 to July 2003 was conducted on Medline using the word "schizophrenia" and the words from the names of each anxiety disorder listed in DSM-IV, one at a time.  Only studies including exclusively the diagnosis of schizophrenia were included.  Only 15 studies were dedicated to the subject of anxiety comorbidity prevalence in schizophrenia.  The most studied comorbidities were obsessive-compulsive disorder (OCD) and panic disorder, and most reports suggested them to be highly prevalent in schizophrenia.  Posttraumatic stress disorder (PTSD) was the least studied (N = 2).  Except for two pharmacologic studies in OCD, there were no double-blind randomized controlled trials regarding the treatment of anxiety in schizophrenia.  Most case reports and open label trials tried conventional treatment for anxiety disorders with some degree of success.  The literature indicates that anxiety comorbidities are prevalent in schizophrenia and conventional treatment for anxiety can help alleviate the symptoms in those patients.  However, the body of data provided by research so far is still far from allowing evidence-based conclusions.  Large studies with operationalized criteria, as well as comprehensive assessments of treatment response and outcome are needed to clarify the relationship between anxiety disorders and schizophrenia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQUUO1PHpQ9wDW1zwg2yUK5fW6udTcc2ebAWTuF51Qklbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2crltlagsw%253D%253D&md5=fb58df8052db94ccddfea8f504ab0ebe</span></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=10.1016%2Fj.comppsych.2004.07.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.comppsych.2004.07.009%26sid%3Dliteratum%253Aachs%26aulast%3DBraga%26aufirst%3DR.%2BJ.%26aulast%3DPetrides%26aufirst%3DG.%26aulast%3DFigueira%26aufirst%3DI.%26atitle%3DAnxiety%2520Disorders%2520in%2520Schizophrenia%26jtitle%3DCompr.%2520Psychiatry%26date%3D2004%26volume%3D45%26spage%3D460%26epage%3D468%26doi%3D10.1016%2Fj.comppsych.2004.07.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref71"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref71'); return false;" data-citation="" class="refNumLink">71</a></strong><div class="NLM_citation" id="cit71"><span><span class="NLM_contrib-group">Buckley, P. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lehrer, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castle, D. J.</span><span> </span><span class="NLM_article-title">Psychiatric Comorbidities and Schizophrenia</span> <span class="citation_source-journal">Schizophr. Bull.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">35</span><span class="NLM_x">, </span> <span class="NLM_fpage">383</span><span class="NLM_x">–</span> <span class="NLM_lpage">402</span><span class="refDoi"> DOI: 10.1093/schbul/sbn135</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01857&amp;key=10.1093%2Fschbul%2Fsbn135" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01857&amp;key=19011234" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01857&amp;key=1%3ACAS%3A280%3ADC%252BD1M3it1Glug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2009&pages=383-402&author=P.+F.+Buckleyauthor=B.+J.+Millerauthor=D.+S.+Lehrerauthor=D.+J.+Castle&title=Psychiatric+Comorbidities+and+Schizophrenia&doi=10.1093%2Fschbul%2Fsbn135"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit71R"><div class="casContent"><span class="casTitleNuber">71</span><div class="casTitle"><span class="NLM_cas:atitle">Psychiatric comorbidities and schizophrenia</span></div><div class="casAuthors">Buckley Peter F; Miller Brian J; Lehrer Douglas S; Castle David J</div><div class="citationInfo"><span class="NLM_cas:title">Schizophrenia bulletin</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">383-402</span>
        ISSN:<span class="NLM_cas:issn">0586-7614</span>.
    </div><div class="casAbstract">Psychiatric comorbidities are common among patients with schizophrenia.  Substance abuse comorbidity predominates.  Anxiety and depressive symptoms are also very common throughout the course of illness, with an estimated prevalence of 15% for panic disorder, 29% for posttraumatic stress disorder, and 23% for obsessive-compulsive disorder.  It is estimated that comorbid depression occurs in 50% of patients, and perhaps (conservatively) 47% of patients also have a lifetime diagnosis of comorbid substance abuse.  This article chronicles these associations, examining whether these comorbidities are "more than chance" and might represent (distinct) phenotypes of schizophrenia.  Among the anxiety disorders, the evidence at present is most abundant for an association with obsessive-compulsive disorder.  Additional studies in newly diagnosed antipsychotic-naive patients and their first-degree relatives and searches for genetic and environmental risk factors are needed to replicate preliminary findings and further investigate these associations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSUoGXLx_C2lMAKB7Fa-xrUfW6udTcc2ebAWTuF51Qklbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1M3it1Glug%253D%253D&md5=30a317f1a2f977933d5b2a7fa7061208</span></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=10.1093%2Fschbul%2Fsbn135&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fschbul%252Fsbn135%26sid%3Dliteratum%253Aachs%26aulast%3DBuckley%26aufirst%3DP.%2BF.%26aulast%3DMiller%26aufirst%3DB.%2BJ.%26aulast%3DLehrer%26aufirst%3DD.%2BS.%26aulast%3DCastle%26aufirst%3DD.%2BJ.%26atitle%3DPsychiatric%2520Comorbidities%2520and%2520Schizophrenia%26jtitle%3DSchizophr.%2520Bull.%26date%3D2009%26volume%3D35%26spage%3D383%26epage%3D402%26doi%3D10.1093%2Fschbul%2Fsbn135" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref72"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref72'); return false;" data-citation="" class="refNumLink">72</a></strong><div class="NLM_citation" id="cit72"><span><span class="NLM_contrib-group">Shin, H.-W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chung, S. J.</span><span> </span><span class="NLM_article-title">Drug-Induced Parkinsonism</span> <span class="citation_source-journal">J. Clin. Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">15</span><span class="NLM_x">–</span> <span class="NLM_lpage">21</span><span class="refDoi"> DOI: 10.3988/jcn.2012.8.1.15</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01857&amp;key=10.3988%2Fjcn.2012.8.1.15" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01857&amp;key=22523509" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01857&amp;key=1%3ACAS%3A280%3ADC%252BC38rntVarsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2012&pages=15-21&author=H.-W.+Shinauthor=S.+J.+Chung&title=Drug-Induced+Parkinsonism&doi=10.3988%2Fjcn.2012.8.1.15"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit72R"><div class="casContent"><span class="casTitleNuber">72</span><div class="casTitle"><span class="NLM_cas:atitle">Drug-induced parkinsonism</span></div><div class="casAuthors">Shin Hae-Won; Chung Sun Ju</div><div class="citationInfo"><span class="NLM_cas:title">Journal of clinical neurology (Seoul, Korea)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">15-21</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Drug-induced parkinsonism (DIP) is the second-most-common etiology of parkinsonism in the elderly after Parkinson's disease (PD).  Many patients with DIP may be misdiagnosed with PD because the clinical features of these two conditions are indistinguishable.  Moreover, neurological deficits in patients with DIP may be severe enough to affect daily activities and may persist for long periods of time after the cessation of drug taking.  In addition to typical antipsychotics, DIP may be caused by gastrointestinal prokinetics, calcium channel blockers, atypical antipsychotics, and antiepileptic drugs.  The clinical manifestations of DIP are classically described as bilateral and symmetric parkinsonism without tremor at rest.  However, about half of DIP patients show asymmetrical parkinsonism and tremor at rest, making it difficult to differentiate DIP from PD.  The pathophysiology of DIP is related to drug-induced changes in the basal ganglia motor circuit secondary to dopaminergic receptor blockade.  Since these effects are limited to postsynaptic dopaminergic receptors, it is expected that presynaptic dopaminergic neurons in the striatum will be intact.  Dopamine transporter (DAT) imaging is useful for diagnosing presynaptic parkinsonism.  DAT uptake in the striatum is significantly decreased even in the early stage of PD, and this characteristic may help in differentiating PD from DIP.  DIP may have a significant and longstanding effect on patients' daily lives, and so physicians should be cautious when prescribing dopaminergic receptor blockers and should monitor patients' neurological signs, especially for parkinsonism and other movement disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcS3_M1KFAjW5MAKB7Fa-xrUfW6udTcc2ebAWTuF51Qklbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC38rntVarsg%253D%253D&md5=97026b438d04a37dc4bf74c0d05e3fad</span></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=10.3988%2Fjcn.2012.8.1.15&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3988%252Fjcn.2012.8.1.15%26sid%3Dliteratum%253Aachs%26aulast%3DShin%26aufirst%3DH.-W.%26aulast%3DChung%26aufirst%3DS.%2BJ.%26atitle%3DDrug-Induced%2520Parkinsonism%26jtitle%3DJ.%2520Clin.%2520Neurol.%26date%3D2012%26volume%3D8%26spage%3D15%26epage%3D21%26doi%3D10.3988%2Fjcn.2012.8.1.15" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref73"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref73'); return false;" data-citation="" class="refNumLink">73</a></strong><div class="NLM_citation" id="cit73"><span><span class="NLM_contrib-group">Leucht, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wahlbeck, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamann, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kissling, W.</span><span> </span><span class="NLM_article-title">New Generation Antipsychotics Versus Low-Potency Conventional Antipsychotics: A Systematic Review and Meta-Analysis</span> <span class="citation_source-journal">Lancet</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">361</span><span class="NLM_x">, </span> <span class="NLM_fpage">1581</span><span class="NLM_x">–</span> <span class="NLM_lpage">1589</span><span class="refDoi"> DOI: 10.1016/S0140-6736(03)13306-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01857&amp;key=10.1016%2FS0140-6736%2803%2913306-5" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=361&publication_year=2003&pages=1581-1589&author=S.+Leuchtauthor=K.+Wahlbeckauthor=J.+Hamannauthor=W.+Kissling&title=New+Generation+Antipsychotics+Versus+Low-Potency+Conventional+Antipsychotics%3A+A+Systematic+Review+and+Meta-Analysis&doi=10.1016%2FS0140-6736%2803%2913306-5"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=10.1016%2FS0140-6736%2803%2913306-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0140-6736%252803%252913306-5%26sid%3Dliteratum%253Aachs%26aulast%3DLeucht%26aufirst%3DS.%26aulast%3DWahlbeck%26aufirst%3DK.%26aulast%3DHamann%26aufirst%3DJ.%26aulast%3DKissling%26aufirst%3DW.%26atitle%3DNew%2520Generation%2520Antipsychotics%2520Versus%2520Low-Potency%2520Conventional%2520Antipsychotics%253A%2520A%2520Systematic%2520Review%2520and%2520Meta-Analysis%26jtitle%3DLancet%26date%3D2003%26volume%3D361%26spage%3D1581%26epage%3D1589%26doi%3D10.1016%2FS0140-6736%2803%2913306-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref74"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref74'); return false;" data-citation="" class="refNumLink">74</a></strong><div class="NLM_citation" id="cit74"><span><span class="NLM_contrib-group">Robinson, T. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Becker, J. B.</span><span> </span><span class="NLM_article-title">Enduring Changes in Brain and Behavior Produced by Chronic Amphetamine Administration: A Review and Evaluation of Animal Models of Amphetamine Psychosis</span> <span class="citation_source-journal">Brain Res. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1986</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">157</span><span class="NLM_x">–</span> <span class="NLM_lpage">198</span><span class="refDoi"> DOI: 10.1016/0165-0173(86)90002-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01857&amp;key=10.1016%2F0165-0173%2886%2990002-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01857&amp;key=1%3ACAS%3A528%3ADyaL28Xlt1Kmurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=1986&pages=157-198&author=T.+E.+Robinsonauthor=J.+B.+Becker&title=Enduring+Changes+in+Brain+and+Behavior+Produced+by+Chronic+Amphetamine+Administration%3A+A+Review+and+Evaluation+of+Animal+Models+of+Amphetamine+Psychosis&doi=10.1016%2F0165-0173%2886%2990002-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit74R"><div class="casContent"><span class="casTitleNuber">74</span><div class="casTitle"><span class="NLM_cas:atitle">Enduring changes in brain and behavior produced by chronic amphetamine administration:  a review and evaluation of animal models of amphetamine psychosis</span></div><div class="casAuthors">Robinson, Terry E.; Becker, Jill B.</div><div class="citationInfo"><span class="NLM_cas:title">Brain Research Reviews</span>
        (<span class="NLM_cas:date">1986</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">157-98</span>CODEN:
                <span class="NLM_cas:coden">BRERD2</span>;
        ISSN:<span class="NLM_cas:issn">0165-0173</span>.
    </div><div class="casAbstract">A review, with 321 refs., of animal models in and the neuro- and behavioral pharmacol. of amphetamine  [300-62-9]-induced psychosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGouiZQnq9tKMLVg90H21EOLACvtfcHk0liOnffZpkDgKA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL28Xlt1Kmurs%253D&md5=69280fb23b95328aaff8fff3df5e99fe</span></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=10.1016%2F0165-0173%2886%2990002-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0165-0173%252886%252990002-0%26sid%3Dliteratum%253Aachs%26aulast%3DRobinson%26aufirst%3DT.%2BE.%26aulast%3DBecker%26aufirst%3DJ.%2BB.%26atitle%3DEnduring%2520Changes%2520in%2520Brain%2520and%2520Behavior%2520Produced%2520by%2520Chronic%2520Amphetamine%2520Administration%253A%2520A%2520Review%2520and%2520Evaluation%2520of%2520Animal%2520Models%2520of%2520Amphetamine%2520Psychosis%26jtitle%3DBrain%2520Res.%2520Rev.%26date%3D1986%26volume%3D11%26spage%3D157%26epage%3D198%26doi%3D10.1016%2F0165-0173%2886%2990002-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref75"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref75'); return false;" data-citation="" class="refNumLink">75</a></strong><div class="NLM_citation" id="cit75"><span><span class="NLM_contrib-group">Tschammer, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elsner, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goetz, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ehrlich, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schuster, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruberg, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuhhorn, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whistler, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hubner, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gmeiner, P.</span><span> </span><span class="NLM_article-title">Highly Potent 5-Aminotetrahydropyrazolopyridines: Enantioselective Dopamine D3 Receptor Binding, Functional Selectivity, and Analysis of Receptor-Ligand Interactions</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">2477</span><span class="NLM_x">–</span> <span class="NLM_lpage">2491</span><span class="refDoi"> DOI: 10.1021/jm101639t</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm101639t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=2477-2491&author=N.+Tschammerauthor=J.+Elsnerauthor=A.+Goetzauthor=K.+Ehrlichauthor=S.+Schusterauthor=M.+Rubergauthor=J.+Kuhhornauthor=D.+Thompsonauthor=J.+Whistlerauthor=H.+Hubnerauthor=P.+Gmeiner&title=Highly+Potent+5-Aminotetrahydropyrazolopyridines%3A+Enantioselective+Dopamine+D3+Receptor+Binding%2C+Functional+Selectivity%2C+and+Analysis+of+Receptor-Ligand+Interactions&doi=10.1021%2Fjm101639t"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=10.1021%2Fjm101639t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm101639t%26sid%3Dliteratum%253Aachs%26aulast%3DTschammer%26aufirst%3DN.%26aulast%3DElsner%26aufirst%3DJ.%26aulast%3DGoetz%26aufirst%3DA.%26aulast%3DEhrlich%26aufirst%3DK.%26aulast%3DSchuster%26aufirst%3DS.%26aulast%3DRuberg%26aufirst%3DM.%26aulast%3DKuhhorn%26aufirst%3DJ.%26aulast%3DThompson%26aufirst%3DD.%26aulast%3DWhistler%26aufirst%3DJ.%26aulast%3DHubner%26aufirst%3DH.%26aulast%3DGmeiner%26aufirst%3DP.%26atitle%3DHighly%2520Potent%25205-Aminotetrahydropyrazolopyridines%253A%2520Enantioselective%2520Dopamine%2520D3%2520Receptor%2520Binding%252C%2520Functional%2520Selectivity%252C%2520and%2520Analysis%2520of%2520Receptor-Ligand%2520Interactions%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D2477%26epage%3D2491%26doi%3D10.1021%2Fjm101639t" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref76"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref76'); return false;" data-citation="" class="refNumLink">76</a></strong><div class="NLM_citation" id="cit76"><span><span class="NLM_contrib-group">Lowry, O. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosebrough, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farr, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Randall, R. J.</span><span> </span><span class="NLM_article-title">Protein Measurement with the Folin Phenol Reagent</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1951</span><span class="NLM_x">, </span> <span class="NLM_volume">193</span><span class="NLM_x">, </span> <span class="NLM_fpage">265</span><span class="NLM_x">–</span> <span class="NLM_lpage">275</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01857&amp;key=10.1016%2FS0021-9258%2819%2952451-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01857&amp;key=14907713" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01857&amp;key=1%3ACAS%3A528%3ADyaG38XhsVyrsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=193&publication_year=1951&pages=265-275&author=O.+H.+Lowryauthor=N.+J.+Rosebroughauthor=A.+L.+Farrauthor=R.+J.+Randall&title=Protein+Measurement+with+the+Folin+Phenol+Reagent"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit76R"><div class="casContent"><span class="casTitleNuber">76</span><div class="casTitle"><span class="NLM_cas:atitle">Protein measurement with the Folin phenol reagent</span></div><div class="casAuthors">Lowry, Oliver H.; Rosebrough, Nira J.; Farr, A. Lewis; Randall, Rose J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">1951</span>),
    <span class="NLM_cas:volume">193</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">265-75</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    </div><div class="casAbstract">cf. C.A. 41, 1271h.  Proteins were detd. with the Folin phenol reagent after alk. Cu treatment.  The method is as sensitive as with Nessler reagent, yet requires no digestion.  It is 10-20 times more sensitive than detn. of the ultraviolet absorption at λ = 280 mμ and is more specific.  It is several fold more sensitive than the ninhydrin reaction and 100 times more sensitive than the biuret reaction.  Two major disadvantages are: the amt. of color varies with different proteins; the color is not strictly proportional to concn.  Few substances cause serious interference.  Uric acid, guanine, and xanthine react with Folin reagent.  The method is useful for following enzyme fractionation, detg. mixed tissue proteins, detn. of very small amts. of protein, or detg. highly dild. protein, or protein in colored solns. or in the presence of N-contg. material.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrHNRKGd34F8LVg90H21EOLACvtfcHk0liOnffZpkDgKA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaG38XhsVyrsw%253D%253D&md5=19d36395fad7dd87661caa3d2b97640d</span></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=10.1016%2FS0021-9258%2819%2952451-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0021-9258%252819%252952451-6%26sid%3Dliteratum%253Aachs%26aulast%3DLowry%26aufirst%3DO.%2BH.%26aulast%3DRosebrough%26aufirst%3DN.%2BJ.%26aulast%3DFarr%26aufirst%3DA.%2BL.%26aulast%3DRandall%26aufirst%3DR.%2BJ.%26atitle%3DProtein%2520Measurement%2520with%2520the%2520Folin%2520Phenol%2520Reagent%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1951%26volume%3D193%26spage%3D265%26epage%3D275" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref77"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref77'); return false;" data-citation="" class="refNumLink">77</a></strong><div class="NLM_citation" id="cit77"><span><span class="NLM_contrib-group">Hübner, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haubmann, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Utz, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gmeiner, P.</span><span> </span><span class="NLM_article-title">Conjugated Enynes as Nonaromatic Catechol Bioisosteres: Synthesis, Binding Experiments, and Computational Studies of Novel Dopamine Receptor Agonists Recognizing Preferentially the D3 Subtype</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">756</span><span class="NLM_x">–</span> <span class="NLM_lpage">762</span><span class="refDoi"> DOI: 10.1021/jm991098z</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm991098z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01857&amp;key=1%3ACAS%3A528%3ADC%252BD3cXmvV2ntQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2000&pages=756-762&author=H.+H%C3%BCbnerauthor=C.+Haubmannauthor=W.+Utzauthor=P.+Gmeiner&title=Conjugated+Enynes+as+Nonaromatic+Catechol+Bioisosteres%3A+Synthesis%2C+Binding+Experiments%2C+and+Computational+Studies+of+Novel+Dopamine+Receptor+Agonists+Recognizing+Preferentially+the+D3+Subtype&doi=10.1021%2Fjm991098z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit77R"><div class="casContent"><span class="casTitleNuber">77</span><div class="casTitle"><span class="NLM_cas:atitle">Conjugated Enynes as Nonaromatic Catechol Bioisosteres: Synthesis, Binding Experiments, and Computational Studies of Novel Dopamine Receptor Agonists Recognizing Preferentially the D3 Subtype</span></div><div class="casAuthors">Huebner, Harald; Haubmann, Christian; Utz, Wolfgang; Gmeiner, Peter</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">756-762</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">To evaluate nonarom. catechol bioisosteres, the conformationally restrained enynes and enediynes were synthesized via palladium-catalyzed coupling as the key reaction step.  Subsequent receptor binding studies at the dopamine receptor subtypes D1, D2 long, D2 short, D3, and D4 showed highly interesting binding profiles for the enynes when compared to dopamine.  At the guanine nucleotide-sensitive high-affinity binding site of the D3 receptor, the target compd. (Ki = 5.2 nM) was 10-fold more potent than dopamine but less potent at the D2 and D4 subtypes.  In contrast to dopamine the agonists enynes showed strong selectivity for the receptors of the D2 family (D2-D4).  As far as we know, this study represents the first report on nonarom. dopamine agonists.  Comparison of mol. electrostatic potentials, derived from semiempirical MO calcns., and lipophilicity maps was performed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoWheANs3NXRLVg90H21EOLACvtfcHk0liOnffZpkDgKA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXmvV2ntQ%253D%253D&md5=affc96571dd02832d40f990d29786a3a</span></div><a href="/servlet/linkout?suffix=cit77&amp;dbid=16384&amp;doi=10.1021%2Fjm991098z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm991098z%26sid%3Dliteratum%253Aachs%26aulast%3DH%25C3%25BCbner%26aufirst%3DH.%26aulast%3DHaubmann%26aufirst%3DC.%26aulast%3DUtz%26aufirst%3DW.%26aulast%3DGmeiner%26aufirst%3DP.%26atitle%3DConjugated%2520Enynes%2520as%2520Nonaromatic%2520Catechol%2520Bioisosteres%253A%2520Synthesis%252C%2520Binding%2520Experiments%252C%2520and%2520Computational%2520Studies%2520of%2520Novel%2520Dopamine%2520Receptor%2520Agonists%2520Recognizing%2520Preferentially%2520the%2520D3%2520Subtype%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2000%26volume%3D43%26spage%3D756%26epage%3D762%26doi%3D10.1021%2Fjm991098z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref78"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref78'); return false;" data-citation="" class="refNumLink">78</a></strong><div class="NLM_citation" id="cit78"><span><span class="NLM_contrib-group">Cheng, Y.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prusoff, W. H.</span><span> </span><span class="NLM_article-title">Relationship between the Inhibition Constant (Ki) and the Concentration of Inhibitor Which Causes 50 Per Cent Inhibition (I50) of an Enzymatic Reaction</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1973</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">3099</span><span class="NLM_x">–</span> <span class="NLM_lpage">3108</span><span class="refDoi"> DOI: 10.1016/0006-2952(73)90196-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01857&amp;key=10.1016%2F0006-2952%2873%2990196-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01857&amp;key=4202581" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01857&amp;key=1%3ACAS%3A528%3ADyaE2cXhtVGgs7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=1973&pages=3099-3108&author=Y.-C.+Chengauthor=W.+H.+Prusoff&title=Relationship+between+the+Inhibition+Constant+%28Ki%29+and+the+Concentration+of+Inhibitor+Which+Causes+50+Per+Cent+Inhibition+%28I50%29+of+an+Enzymatic+Reaction&doi=10.1016%2F0006-2952%2873%2990196-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit78R"><div class="casContent"><span class="casTitleNuber">78</span><div class="casTitle"><span class="NLM_cas:atitle">Relation between the inhibition constant K1) and the concentration of inhibitor which causes fifty per cent inhibition (I50) of an enzymic reaction</span></div><div class="casAuthors">Cheng, Yung-Chi; Prusoff, William H.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Pharmacology</span>
        (<span class="NLM_cas:date">1973</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">3099-108</span>CODEN:
                <span class="NLM_cas:coden">BCPCA6</span>;
        ISSN:<span class="NLM_cas:issn">0006-2952</span>.
    </div><div class="casAbstract">The Ki and I50 values are equal where the kinetics are non- or uncompetitive, but not where they are competitive.  The relation between the 2 values was analyzed for non- and uncompetitive bi- and monosubstrate reactions and for competitive bisubstrate reactions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqodFY_8msz57Vg90H21EOLACvtfcHk0lhNq-Gb9PKgdg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE2cXhtVGgs7c%253D&md5=fe7175ca300d8f4085df87af37f8656c</span></div><a href="/servlet/linkout?suffix=cit78&amp;dbid=16384&amp;doi=10.1016%2F0006-2952%2873%2990196-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0006-2952%252873%252990196-2%26sid%3Dliteratum%253Aachs%26aulast%3DCheng%26aufirst%3DY.-C.%26aulast%3DPrusoff%26aufirst%3DW.%2BH.%26atitle%3DRelationship%2520between%2520the%2520Inhibition%2520Constant%2520%2528Ki%2529%2520and%2520the%2520Concentration%2520of%2520Inhibitor%2520Which%2520Causes%252050%2520Per%2520Cent%2520Inhibition%2520%2528I50%2529%2520of%2520an%2520Enzymatic%2520Reaction%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D1973%26volume%3D22%26spage%3D3099%26epage%3D3108%26doi%3D10.1016%2F0006-2952%2873%2990196-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref79"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref79'); return false;" data-citation="" class="refNumLink">79</a></strong><div class="NLM_citation" id="cit79"><span><span class="NLM_contrib-group">Namkung, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Radresa, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Armando, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Devost, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beautrait, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le Gouill, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laporte, S. A.</span><span> </span><span class="NLM_article-title">Quantifying Biased Signaling in Gpcrs Using Bret-Based Biosensors</span> <span class="citation_source-journal">Methods</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">92</span><span class="NLM_x">, </span> <span class="NLM_fpage">5</span><span class="NLM_x">–</span> <span class="NLM_lpage">10</span><span class="refDoi"> DOI: 10.1016/j.ymeth.2015.04.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01857&amp;key=10.1016%2Fj.ymeth.2015.04.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01857&amp;key=25890247" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01857&amp;key=1%3ACAS%3A528%3ADC%252BC2MXmslehsLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=92&publication_year=2016&pages=5-10&author=Y.+Namkungauthor=O.+Radresaauthor=S.+Armandoauthor=D.+Devostauthor=A.+Beautraitauthor=C.+Le+Gouillauthor=S.+A.+Laporte&title=Quantifying+Biased+Signaling+in+Gpcrs+Using+Bret-Based+Biosensors&doi=10.1016%2Fj.ymeth.2015.04.010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit79R"><div class="casContent"><span class="casTitleNuber">79</span><div class="casTitle"><span class="NLM_cas:atitle">Quantifying biased signaling in GPCRs using BRET-based biosensors</span></div><div class="casAuthors">Namkung, Yoon; Radresa, Olivier; Armando, Sylvain; Devost, Dominic; Beautrait, Alexandre; Le Gouill, Christian; Laporte, Stephane A.</div><div class="citationInfo"><span class="NLM_cas:title">Methods (Amsterdam, Netherlands)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">92</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">5-10</span>CODEN:
                <span class="NLM_cas:coden">MTHDE9</span>;
        ISSN:<span class="NLM_cas:issn">1046-2023</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">There has been a growing appreciation that G protein-coupled receptor (GPCR) functional selectivity (viz. biased signaling), in particular between G protein- and β-arrestin-dependent signaling, can be achieved with specific ligands, and that such directed signaling represents a promising avenue for improving drug efficacy and therapy.  Thus, for any given GPCRs it is important to define means to pharmacol. characterize and classify drugs for their propensity to bias signaling.  Here we describe an exptl. protocol and step-by-step approach to assess functional selectivity between Gαq and β-arrestin-dependent responses using the prototypical angiotensin II (AngII) type 1 receptor (AT1R) expressed in HEK 293 cells.  The protocol describes the expression of Bioluminescence Resonance Energy Transfer (BRET) sensors for either Gαq or β-arrestin with AT1R, and the use of the operational model of pharmacol. agonism to quantify ligand bias.  Such methods are equally applicable to other GPCRs and their downstream signaling effectors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoisQm2sSQfUbVg90H21EOLACvtfcHk0lhNq-Gb9PKgdg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXmslehsLo%253D&md5=3734d70788ffaa1faeb348d608d2c126</span></div><a href="/servlet/linkout?suffix=cit79&amp;dbid=16384&amp;doi=10.1016%2Fj.ymeth.2015.04.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ymeth.2015.04.010%26sid%3Dliteratum%253Aachs%26aulast%3DNamkung%26aufirst%3DY.%26aulast%3DRadresa%26aufirst%3DO.%26aulast%3DArmando%26aufirst%3DS.%26aulast%3DDevost%26aufirst%3DD.%26aulast%3DBeautrait%26aufirst%3DA.%26aulast%3DLe%2BGouill%26aufirst%3DC.%26aulast%3DLaporte%26aufirst%3DS.%2BA.%26atitle%3DQuantifying%2520Biased%2520Signaling%2520in%2520Gpcrs%2520Using%2520Bret-Based%2520Biosensors%26jtitle%3DMethods%26date%3D2016%26volume%3D92%26spage%3D5%26epage%3D10%26doi%3D10.1016%2Fj.ymeth.2015.04.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref80"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref80'); return false;" data-citation="" class="refNumLink">80</a></strong><div class="NLM_citation" id="cit80"><span><span class="NLM_contrib-group">Amato, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Natesan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yavich, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kapur, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Müller, C. P.</span><span> </span><span class="NLM_article-title">Dynamic Regulation of Dopamine and Serotonin Responses to Salient Stimuli During Chronic Haloperidol Treatment</span> <span class="citation_source-journal">Int. J. Neuropsychopharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">1327</span><span class="NLM_x">–</span> <span class="NLM_lpage">1339</span><span class="refDoi"> DOI: 10.1017/S1461145711000010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01857&amp;key=10.1017%2FS1461145711000010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01857&amp;key=21281560" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01857&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtlKis77M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2011&pages=1327-1339&author=D.+Amatoauthor=S.+Natesanauthor=L.+Yavichauthor=S.+Kapurauthor=C.+P.+M%C3%BCller&title=Dynamic+Regulation+of+Dopamine+and+Serotonin+Responses+to+Salient+Stimuli+During+Chronic+Haloperidol+Treatment&doi=10.1017%2FS1461145711000010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit80R"><div class="casContent"><span class="casTitleNuber">80</span><div class="casTitle"><span class="NLM_cas:atitle">Dynamic regulation of dopamine and serotonin responses to salient stimuli during chronic haloperidol treatment</span></div><div class="casAuthors">Amato, Davide; Natesan, Sridhar; Yavich, Leonid; Kapur, Shitij; Mueller, Christian P.</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Neuropsychopharmacology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1327-1339</span>CODEN:
                <span class="NLM_cas:coden">IJNUFB</span>;
        ISSN:<span class="NLM_cas:issn">1461-1457</span>.
    
            (<span class="NLM_cas:orgname">Cambridge University Press</span>)
        </div><div class="casAbstract">Antipsychotic drugs are the clin. std. for the treatment of schizophrenia.  Although these drugs work initially, many compliant patients relapse due to treatment failure.  The known biomarkers can not sufficiently explain antipsychotic treatment failure.  We, therefore, enquired how the dynamic responses of the neurotransmitters, dopamine and serotonin, change in relation to treatment action and failure.  Rats received either short-term (2-6 d) or long-term (12-14 d) treatment with haloperidol, which resembled human D2 receptor occupancy, using osmotic mini-pumps.  Dopamine and serotonin basal levels and responses to novelty, appetitive food, and to an aversive tail pinch were measured in the prefrontal cortex, nucleus accumbens and caudate putamen using in-vivo microdialysis, and the behavior was recorded.  Subsequently, we used in-vivo voltammetry to measure dopamine overflow in the nucleus accumbens.  Haloperidol decreased dopamine, but not serotonin baseline levels in a time-dependent way.  Salient stimuli induced dopamine and serotonin responses.  Short-term haloperidol treatment attenuated the mesolimbic dopamine responses to aversive stimulation, while the responses to appetitive stimulation were largely preserved.  After long-term treatment, the initial response adaptations were reversed.  Similar changes were also obsd. at the behavioral level.  In-vivo voltammetry showed that nucleus accumbens dopamine adaptations and their reversal were mediated by changes in extracellular dopamine release.  Chronic haloperidol treatment, which resembles human D2 receptor occupancy, modulates dopamine and behavioral responses to aversive and appetitive stimulation depending on the duration of treatment.  Specific changes in dopamine response dynamics and their reversal may be a functional substrate of antipsychotic action and failure resp.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGovrLCzTakKKrVg90H21EOLACvtfcHk0lhNq-Gb9PKgdg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtlKis77M&md5=793c20ed4f723903f5aac12b6d7cfe40</span></div><a href="/servlet/linkout?suffix=cit80&amp;dbid=16384&amp;doi=10.1017%2FS1461145711000010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1017%252FS1461145711000010%26sid%3Dliteratum%253Aachs%26aulast%3DAmato%26aufirst%3DD.%26aulast%3DNatesan%26aufirst%3DS.%26aulast%3DYavich%26aufirst%3DL.%26aulast%3DKapur%26aufirst%3DS.%26aulast%3DM%25C3%25BCller%26aufirst%3DC.%2BP.%26atitle%3DDynamic%2520Regulation%2520of%2520Dopamine%2520and%2520Serotonin%2520Responses%2520to%2520Salient%2520Stimuli%2520During%2520Chronic%2520Haloperidol%2520Treatment%26jtitle%3DInt.%2520J.%2520Neuropsychopharmacol.%26date%3D2011%26volume%3D14%26spage%3D1327%26epage%3D1339%26doi%3D10.1017%2FS1461145711000010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53'],'ref54':['cit54'],'ref55':['cit55'],'ref56':['cit56'],'ref57':['cit57'],'ref58':['cit58'],'ref59':['cit59'],'ref60':['cit60'],'ref61':['cit61'],'ref62':['cit62'],'ref63':['cit63'],'ref64':['cit64'],'ref65':['cit65'],'ref66':['cit66'],'ref67':['cit67'],'ref68':['cit68'],'ref69':['cit69'],'ref70':['cit70'],'ref71':['cit71'],'ref72':['cit72'],'ref73':['cit73'],'ref74':['cit74'],'ref75':['cit75'],'ref76':['cit76'],'ref77':['cit77'],'ref78':['cit78'],'ref79':['cit79'],'ref80':['cit80']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 35 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Ana Mallo-Abreu, Irene Reyes-Resina, Jhonny Azuaje, Rafael Franco, Aitor García-Rey, Maria Majellaro, Darío Miranda-Pastoriza, Xerardo García-Mera, Willem Jespers, Hugo Gutiérrez-de-Terán, Gemma Navarro, <span class="NLM_string-name hlFld-ContribAuthor">Eddy Sotelo</span>. </span><span class="cited-content_cbyCitation_article-title">Potent and Subtype-Selective Dopamine D2 Receptor Biased Partial Agonists Discovered via an Ugi-Based Approach. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (12)
                                     , 8710-8726. <a href="https://doi.org/10.1021/acs.jmedchem.1c00704" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.1c00704</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.1c00704&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.1c00704%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DPotent%252Band%252BSubtype-Selective%252BDopamine%252BD2%252BReceptor%252BBiased%252BPartial%252BAgonists%252BDiscovered%252Bvia%252Ban%252BUgi-Based%252BApproach%26aulast%3DMallo-Abreu%26aufirst%3DAna%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D19042021%26date%3D10062021%26volume%3D64%26issue%3D12%26spage%3D8710%26epage%3D8726" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Katrina M. Mennie, Michael H. Reutershan, Catherine White, Bruce Adams, Bridget Becker, James Deng, Jason D. Katz, Elisabeth LaBlue, Kaila Margrey, <span class="NLM_string-name hlFld-ContribAuthor">Josep Saurí</span>. </span><span class="cited-content_cbyCitation_article-title">Divergent and Regioselective Synthesis of Pyrazolo[1,5-a]pyridines and Imidazo[1,5-a]pyridines. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2021,</strong> <em>23 </em>
                                    (12)
                                     , 4694-4698. <a href="https://doi.org/10.1021/acs.orglett.1c01431" title="DOI URL">https://doi.org/10.1021/acs.orglett.1c01431</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.orglett.1c01431&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.orglett.1c01431%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DDivergent%252Band%252BRegioselective%252BSynthesis%252Bof%252BPyrazolo%25255B1%25252C5-a%25255Dpyridines%252Band%252BImidazo%25255B1%25252C5-a%25255Dpyridines%26aulast%3DMennie%26aufirst%3DKatrina%2BM.%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D26042021%26date%3D26052021%26volume%3D23%26issue%3D12%26spage%3D4694%26epage%3D4698" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Tamara Ullmann, Marie Gienger, Julian Budzinski, Jan Hellmann, Harald Hübner, Peter Gmeiner, <span class="NLM_string-name hlFld-ContribAuthor">Dorothee Weikert</span>. </span><span class="cited-content_cbyCitation_article-title">Homobivalent Dopamine D2 Receptor Ligands Modulate the Dynamic Equilibrium of D2 Monomers and Homo- and Heterodimers. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Biology</span><span> <strong>2021,</strong> <em>16 </em>
                                    (2)
                                     , 371-379. <a href="https://doi.org/10.1021/acschembio.0c00895" title="DOI URL">https://doi.org/10.1021/acschembio.0c00895</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acschembio.0c00895&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facschembio.0c00895%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Biology%26atitle%3DHomobivalent%252BDopamine%252BD2%252BReceptor%252BLigands%252BModulate%252Bthe%252BDynamic%252BEquilibrium%252Bof%252BD2%252BMonomers%252Band%252BHomo-%252Band%252BHeterodimers%26aulast%3DUllmann%26aufirst%3DTamara%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D2020%26date%3D19112020%26date%3D28122020%26date%3D12012021%26volume%3D16%26issue%3D2%26spage%3D371%26epage%3D379" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Amy Hauck Newman, Francisco O. Battiti, <span class="NLM_string-name hlFld-ContribAuthor">Alessandro Bonifazi</span>. </span><span class="cited-content_cbyCitation_article-title">2016 Philip S. Portoghese Medicinal Chemistry Lectureship: Designing Bivalent or Bitopic Molecules for G-Protein Coupled Receptors. The Whole Is Greater Than the Sum of Its Parts. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (5)
                                     , 1779-1797. <a href="https://doi.org/10.1021/acs.jmedchem.9b01105" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b01105</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b01105&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b01105%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3D2016%252BPhilip%252BS.%252BPortoghese%252BMedicinal%252BChemistry%252BLectureship%25253A%252BDesigning%252BBivalent%252Bor%252BBitopic%252BMolecules%252Bfor%252BG-Protein%252BCoupled%252BReceptors.%252BThe%252BWhole%252BIs%252BGreater%252BThan%252Bthe%252BSum%252Bof%252BIts%252BParts%26aulast%3DNewman%26aufirst%3DAmy%2BHauck%26date%3D2020%26date%3D2019%26date%3D2019%26date%3D09072019%26date%3D24092019%26date%3D09092019%26volume%3D63%26issue%3D5%26spage%3D1779%26epage%3D1797" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Anna S. Pirzer, Roman Lasch, Heike Friedrich, Harald Hübner, Peter Gmeiner, <span class="NLM_string-name hlFld-ContribAuthor">Markus R. Heinrich</span>. </span><span class="cited-content_cbyCitation_article-title">Benzyl Phenylsemicarbazides: A Chemistry-Driven Approach Leading to G Protein-Biased Dopamine D4 Receptor Agonists with High Subtype Selectivity. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (21)
                                     , 9658-9679. <a href="https://doi.org/10.1021/acs.jmedchem.9b01085" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b01085</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b01085&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b01085%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DBenzyl%252BPhenylsemicarbazides%25253A%252BA%252BChemistry-Driven%252BApproach%252BLeading%252Bto%252BG%252BProtein-Biased%252BDopamine%252BD4%252BReceptor%252BAgonists%252Bwith%252BHigh%252BSubtype%252BSelectivity%26aulast%3DPirzer%26aufirst%3DAnna%2BS.%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D05072019%26date%3D30102019%26date%3D15102019%26volume%3D62%26issue%3D21%26spage%3D9658%26epage%3D9679" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Michael
L. Martini, Caroline Ray, Xufen Yu, Jing Liu, Vladimir M. Pogorelov, William C. Wetsel, Xi-Ping Huang, John D. McCorvy, Marc G. Caron, <span class="NLM_string-name hlFld-ContribAuthor">Jian Jin</span>. </span><span class="cited-content_cbyCitation_article-title">Designing Functionally Selective Noncatechol Dopamine D1 Receptor Agonists with Potent In Vivo Antiparkinsonian Activity. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Neuroscience</span><span> <strong>2019,</strong> <em>10 </em>
                                    (9)
                                     , 4160-4182. <a href="https://doi.org/10.1021/acschemneuro.9b00410" title="DOI URL">https://doi.org/10.1021/acschemneuro.9b00410</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acschemneuro.9b00410&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facschemneuro.9b00410%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Neuroscience%26atitle%3DDesigning%252BFunctionally%252BSelective%252BNoncatechol%252BDopamine%252BD1%252BReceptor%252BAgonists%252Bwith%252BPotent%252BIn%252BVivo%252BAntiparkinsonian%252BActivity%26aulast%3DMartini%26aufirst%3DMichael%2BL.%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D20072019%26date%3D06082019%26date%3D20082019%26date%3D06082019%26volume%3D10%26issue%3D9%26spage%3D4160%26epage%3D4182" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Yudao Shen, John D. McCorvy, Michael L. Martini, Ramona M. Rodriguiz, Vladimir M. Pogorelov, Karen M. Ward, William C. Wetsel, Jing Liu, Bryan L. Roth, <span class="NLM_string-name hlFld-ContribAuthor">Jian Jin</span>. </span><span class="cited-content_cbyCitation_article-title">D2 Dopamine Receptor G Protein-Biased Partial Agonists Based on Cariprazine. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (9)
                                     , 4755-4771. <a href="https://doi.org/10.1021/acs.jmedchem.9b00508" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b00508</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b00508&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b00508%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DD2%252BDopamine%252BReceptor%252BG%252BProtein-Biased%252BPartial%252BAgonists%252BBased%252Bon%252BCariprazine%26aulast%3DShen%26aufirst%3DYudao%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D22032019%26date%3D18042019%26date%3D09042019%26volume%3D62%26issue%3D9%26spage%3D4755%26epage%3D4771" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Michael
L. Martini, Jing Liu, Caroline Ray, Xufen Yu, Xi-Ping Huang, Aarti Urs, Nikhil Urs, John D. McCorvy, Marc G. Caron, Bryan L. Roth, <span class="NLM_string-name hlFld-ContribAuthor">Jian Jin</span>. </span><span class="cited-content_cbyCitation_article-title">Defining Structure–Functional Selectivity Relationships (SFSR) for a Class of Non-Catechol Dopamine D1 Receptor Agonists. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (7)
                                     , 3753-3772. <a href="https://doi.org/10.1021/acs.jmedchem.9b00351" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b00351</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b00351&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b00351%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDefining%252BStructure%2525E2%252580%252593Functional%252BSelectivity%252BRelationships%252B%252528SFSR%252529%252Bfor%252Ba%252BClass%252Bof%252BNon-Catechol%252BDopamine%252BD1%252BReceptor%252BAgonists%26aulast%3DMartini%26aufirst%3DMichael%2BL.%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D25022019%26date%3D27032019%26date%3D15032019%26volume%3D62%26issue%3D7%26spage%3D3753%26epage%3D3772" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Alessandro Bonifazi, Hideaki Yano, Adrian M. Guerrero, Vivek Kumar, Alexander F. Hoffman, Carl R. Lupica, Lei Shi, <span class="NLM_string-name hlFld-ContribAuthor">Amy Hauck Newman</span>. </span><span class="cited-content_cbyCitation_article-title">Novel and Potent Dopamine D2 Receptor Go-Protein Biased Agonists. </span><span class="cited-content_cbyCitation_journal-name">ACS Pharmacology & Translational Science</span><span> <strong>2019,</strong> <em>2 </em>
                                    (1)
                                     , 52-65. <a href="https://doi.org/10.1021/acsptsci.8b00060" title="DOI URL">https://doi.org/10.1021/acsptsci.8b00060</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsptsci.8b00060&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsptsci.8b00060%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Pharmacology%2520%2526%2520Translational%2520Science%26atitle%3DNovel%252Band%252BPotent%252BDopamine%252BD2%252BReceptor%252BGo-Protein%252BBiased%252BAgonists%26aulast%3DBonifazi%26aufirst%3DAlessandro%26date%3D2019%26date%3D2019%26date%3D2018%26date%3D21122018%26date%3D28012019%26date%3D14012019%26volume%3D2%26issue%3D1%26spage%3D52%26epage%3D65" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Liang Tan, Wenzhong Yan, John D. McCorvy, <span class="NLM_string-name hlFld-ContribAuthor">Jianjun Cheng</span>. </span><span class="cited-content_cbyCitation_article-title">Biased Ligands of G Protein-Coupled Receptors (GPCRs): Structure–Functional Selectivity Relationships (SFSRs) and Therapeutic Potential. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>61 </em>
                                    (22)
                                     , 9841-9878. <a href="https://doi.org/10.1021/acs.jmedchem.8b00435" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b00435</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b00435&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b00435%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DBiased%252BLigands%252Bof%252BG%252BProtein-Coupled%252BReceptors%252B%252528GPCRs%252529%25253A%252BStructure%2525E2%252580%252593Functional%252BSelectivity%252BRelationships%252B%252528SFSRs%252529%252Band%252BTherapeutic%252BPotential%26aulast%3DTan%26aufirst%3DLiang%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D19032018%26date%3D10072018%26date%3D25062018%26volume%3D61%26issue%3D22%26spage%3D9841%26epage%3D9878" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Michel Weïwer, Qihong Xu, Jennifer P. Gale, Michael Lewis, Arthur J. Campbell, Frederick A. Schroeder, Genevieve C. Van de Bittner, Michelle Walk, Aldo Amaya, Ping Su, Luka D̵ordevic, Joshua R. Sacher, Adam Skepner, David Fei, Kelly Dennehy, Shannon Nguyen, Patrick W. Faloon, Jose Perez, Jeffrey R. Cottrell, Fang Liu, Michelle Palmer, Jen Q. Pan, Jacob M. Hooker, Yan-Ling Zhang, Edward Scolnick, Florence F. Wagner, <span class="NLM_string-name hlFld-ContribAuthor">Edward B. Holson</span>. </span><span class="cited-content_cbyCitation_article-title">Functionally Biased D2R Antagonists: Targeting the β-Arrestin Pathway to Improve Antipsychotic Treatment. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Biology</span><span> <strong>2018,</strong> <em>13 </em>
                                    (4)
                                     , 1038-1047. <a href="https://doi.org/10.1021/acschembio.8b00168" title="DOI URL">https://doi.org/10.1021/acschembio.8b00168</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acschembio.8b00168&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facschembio.8b00168%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Biology%26atitle%3DFunctionally%252BBiased%252BD2R%252BAntagonists%25253A%252BTargeting%252Bthe%252B%2525CE%2525B2-Arrestin%252BPathway%252Bto%252BImprove%252BAntipsychotic%252BTreatment%26aulast%3DWe%25C3%25AFwer%26aufirst%3DMichel%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D16022018%26date%3D27022018%26date%3D14032018%26date%3D27022018%26volume%3D13%26issue%3D4%26spage%3D1038%26epage%3D1047" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Inbar  Fish</span>, <span class="hlFld-ContribAuthor ">Anne  Stößel</span>, <span class="hlFld-ContribAuthor ">Katrin  Eitel</span>, <span class="hlFld-ContribAuthor ">Celine  Valant</span>, <span class="hlFld-ContribAuthor ">Sabine  Albold</span>, <span class="hlFld-ContribAuthor ">Harald  Huebner</span>, <span class="hlFld-ContribAuthor ">Dorothee  Möller</span>, <span class="hlFld-ContribAuthor ">Mary J.  Clark</span>, <span class="hlFld-ContribAuthor ">Roger K.  Sunahara</span>, <span class="hlFld-ContribAuthor ">Arthur  Christopoulos</span>, <span class="hlFld-ContribAuthor ">Brian K.  Shoichet</span>, and <span class="hlFld-ContribAuthor ">Peter  Gmeiner</span>  . </span><span class="cited-content_cbyCitation_article-title">Structure-Based Design and Discovery of New M2 Receptor Agonists. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>60 </em>
                                    (22)
                                     , 9239-9250. <a href="https://doi.org/10.1021/acs.jmedchem.7b01113" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b01113</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b01113&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.7b01113%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DStructure-Based%252BDesign%252Band%252BDiscovery%252Bof%252BNew%252BM2%252BReceptor%252BAgonists%26aulast%3DFish%26aufirst%3DInbar%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D03082017%26date%3D13112017%26date%3D22112017%26date%3D02112017%26volume%3D60%26issue%3D22%26spage%3D9239%26epage%3D9250" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Barbara  Männel</span>, <span class="hlFld-ContribAuthor ">Mariama  Jaiteh</span>, <span class="hlFld-ContribAuthor ">Alexey  Zeifman</span>, <span class="hlFld-ContribAuthor ">Alena  Randakova</span>, <span class="hlFld-ContribAuthor ">Dorothee  Möller</span>, <span class="hlFld-ContribAuthor ">Harald  Hübner</span>, <span class="hlFld-ContribAuthor ">Peter  Gmeiner</span>, and <span class="hlFld-ContribAuthor ">Jens  Carlsson</span>  . </span><span class="cited-content_cbyCitation_article-title">Structure-Guided Screening for Functionally Selective D2 Dopamine Receptor Ligands from a Virtual Chemical Library. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Biology</span><span> <strong>2017,</strong> <em>12 </em>
                                    (10)
                                     , 2652-2661. <a href="https://doi.org/10.1021/acschembio.7b00493" title="DOI URL">https://doi.org/10.1021/acschembio.7b00493</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acschembio.7b00493&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facschembio.7b00493%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Biology%26atitle%3DStructure-Guided%252BScreening%252Bfor%252BFunctionally%252BSelective%252BD2%252BDopamine%252BReceptor%252BLigands%252Bfrom%252Ba%252BVirtual%252BChemical%252BLibrary%26aulast%3DM%25C3%25A4nnel%26aufirst%3DBarbara%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D15062017%26date%3D28082017%26date%3D19092017%26date%3D20102017%26date%3D28082017%26volume%3D12%26issue%3D10%26spage%3D2652%26epage%3D2661" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Barbara  Männel</span>, <span class="hlFld-ContribAuthor ">Daniela  Dengler</span>, <span class="hlFld-ContribAuthor ">Jeremy  Shonberg</span>, <span class="hlFld-ContribAuthor ">Harald  Hübner</span>, <span class="hlFld-ContribAuthor ">Dorothee  Möller</span>, and <span class="hlFld-ContribAuthor ">Peter  Gmeiner</span>  . </span><span class="cited-content_cbyCitation_article-title">Hydroxy-Substituted Heteroarylpiperazines: Novel Scaffolds for β-Arrestin-Biased D2R Agonists. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>60 </em>
                                    (11)
                                     , 4693-4713. <a href="https://doi.org/10.1021/acs.jmedchem.7b00363" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b00363</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b00363&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.7b00363%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DHydroxy-Substituted%252BHeteroarylpiperazines%25253A%252BNovel%252BScaffolds%252Bfor%252B%2525CE%2525B2-Arrestin-Biased%252BD2R%252BAgonists%26aulast%3DM%25C3%25A4nnel%26aufirst%3DBarbara%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D07032017%26date%3D18052017%26date%3D08062017%26date%3D10052017%26volume%3D60%26issue%3D11%26spage%3D4693%26epage%3D4713" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Deborah  Wenk</span>, <span class="hlFld-ContribAuthor ">Vladimir  Ignatchenko</span>, <span class="hlFld-ContribAuthor ">Andrew  Macklin</span>, <span class="hlFld-ContribAuthor ">Harald  Hübner</span>, <span class="hlFld-ContribAuthor ">Peter  Gmeiner</span>, <span class="hlFld-ContribAuthor ">Dorothée  Weikert</span>, <span class="hlFld-ContribAuthor ">Monika  Pischetsrieder</span>, <span class="hlFld-ContribAuthor ">Thomas  Kislinger</span>. </span><span class="cited-content_cbyCitation_article-title">Functionally selective activation of the dopamine receptor D2 is mirrored by the protein expression profiles. </span><span class="cited-content_cbyCitation_journal-name">Scientific Reports</span><span> <strong>2021,</strong> <em>11 </em>
                                    (1)
                                     <a href="https://doi.org/10.1038/s41598-021-83038-x" title="DOI URL">https://doi.org/10.1038/s41598-021-83038-x</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41598-021-83038-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41598-021-83038-x%26sid%3Dliteratum%253Aachs%26jtitle%3DScientific%2520Reports%26atitle%3DFunctionally%252Bselective%252Bactivation%252Bof%252Bthe%252Bdopamine%252Breceptor%252BD2%252Bis%252Bmirrored%252Bby%252Bthe%252Bprotein%252Bexpression%252Bprofiles%26aulast%3DWenk%26aufirst%3DDeborah%26date%3D2021%26date%3D2021%26volume%3D11%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiaoling  Pan</span>, <span class="hlFld-ContribAuthor ">Pai  Liu</span>, <span class="hlFld-ContribAuthor ">Xinghui  Wu</span>, <span class="hlFld-ContribAuthor ">Yahui  Zhang</span>, <span class="hlFld-ContribAuthor ">Zhengxu  Cai</span>, <span class="hlFld-ContribAuthor ">Jianbing  Shi</span>, <span class="hlFld-ContribAuthor ">Junge  Zhi</span>, <span class="hlFld-ContribAuthor ">Zi  Li</span>, <span class="hlFld-ContribAuthor ">Dayan  Wang</span>, <span class="hlFld-ContribAuthor ">Bin  Tong</span>, <span class="hlFld-ContribAuthor ">Yuping  Dong</span>. </span><span class="cited-content_cbyCitation_article-title">A “Turn-on” fluorescent bioprobe with aggregation-induced emission characteristics for detection of influenza virus-specific hemagglutinin protein. </span><span class="cited-content_cbyCitation_journal-name">Sensors and Actuators B: Chemical</span><span> <strong>2021,</strong> <em>345 </em>, 130392. <a href="https://doi.org/10.1016/j.snb.2021.130392" title="DOI URL">https://doi.org/10.1016/j.snb.2021.130392</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.snb.2021.130392&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.snb.2021.130392%26sid%3Dliteratum%253Aachs%26jtitle%3DSensors%2520and%2520Actuators%2520B%253A%2520Chemical%26atitle%3DA%252B%2525E2%252580%25259CTurn-on%2525E2%252580%25259D%252Bfluorescent%252Bbioprobe%252Bwith%252Baggregation-induced%252Bemission%252Bcharacteristics%252Bfor%252Bdetection%252Bof%252Binfluenza%252Bvirus-specific%252Bhemagglutinin%252Bprotein%26aulast%3DPan%26aufirst%3DXiaoling%26date%3D2021%26volume%3D345%26spage%3D130392" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Michael  Willmann</span>, <span class="hlFld-ContribAuthor ">Johannes  Ermert</span>, <span class="hlFld-ContribAuthor ">Olaf  Prante</span>, <span class="hlFld-ContribAuthor ">Harald  Hübner</span>, <span class="hlFld-ContribAuthor ">Peter  Gmeiner</span>, <span class="hlFld-ContribAuthor ">Bernd  Neumaier</span>. </span><span class="cited-content_cbyCitation_article-title">Radiosynthesis and evaluation of 18F-labeled dopamine D4-receptor ligands. </span><span class="cited-content_cbyCitation_journal-name">Nuclear Medicine and Biology</span><span> <strong>2021,</strong> <em>92 </em>, 43-52. <a href="https://doi.org/10.1016/j.nucmedbio.2020.07.004" title="DOI URL">https://doi.org/10.1016/j.nucmedbio.2020.07.004</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.nucmedbio.2020.07.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.nucmedbio.2020.07.004%26sid%3Dliteratum%253Aachs%26jtitle%3DNuclear%2520Medicine%2520and%2520Biology%26atitle%3DRadiosynthesis%252Band%252Bevaluation%252Bof%252B18F-labeled%252Bdopamine%252BD4-receptor%252Bligands%26aulast%3DWillmann%26aufirst%3DMichael%26date%3D2021%26volume%3D92%26spage%3D43%26epage%3D52" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Taygun C  Uzuneser</span>, <span class="hlFld-ContribAuthor ">Eva-Maria  Weiss</span>, <span class="hlFld-ContribAuthor ">Jana  Dahlmanns</span>, <span class="hlFld-ContribAuthor ">Liubov S  Kalinichenko</span>, <span class="hlFld-ContribAuthor ">Davide  Amato</span>, <span class="hlFld-ContribAuthor ">Johannes  Kornhuber</span>, <span class="hlFld-ContribAuthor ">Christian  Alzheimer</span>, <span class="hlFld-ContribAuthor ">Jan  Hellmann</span>, <span class="hlFld-ContribAuthor ">Jonas  Kaindl</span>, <span class="hlFld-ContribAuthor ">Harald  Hübner</span>, <span class="hlFld-ContribAuthor ">Stefan  Löber</span>, <span class="hlFld-ContribAuthor ">Peter  Gmeiner</span>, <span class="hlFld-ContribAuthor ">Teja W  Grömer</span>, <span class="hlFld-ContribAuthor ">Christian P  Müller</span>. </span><span class="cited-content_cbyCitation_article-title">Presynaptic vesicular accumulation is required for antipsychotic efficacy in psychotic-like rats. </span><span class="cited-content_cbyCitation_journal-name">Journal of Psychopharmacology</span><span> <strong>2021,</strong> <em>35 </em>
                                    (1)
                                     , 65-77. <a href="https://doi.org/10.1177/0269881120965908" title="DOI URL">https://doi.org/10.1177/0269881120965908</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1177/0269881120965908&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1177%2F0269881120965908%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Psychopharmacology%26atitle%3DPresynaptic%252Bvesicular%252Baccumulation%252Bis%252Brequired%252Bfor%252Bantipsychotic%252Befficacy%252Bin%252Bpsychotic-like%252Brats%26aulast%3DUzuneser%26aufirst%3DTaygun%2BC%26date%3D2021%26date%3D2020%26volume%3D35%26issue%3D1%26spage%3D65%26epage%3D77" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Benjamin E.  Blass</span>. </span><span class="cited-content_cbyCitation_article-title">Classical targets in drug discovery. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2021,</strong>,, 111-183. <a href="https://doi.org/10.1016/B978-0-12-817214-8.00003-8" title="DOI URL">https://doi.org/10.1016/B978-0-12-817214-8.00003-8</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-817214-8.00003-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-817214-8.00003-8%26sid%3Dliteratum%253Aachs%26atitle%3DClassical%252Btargets%252Bin%252Bdrug%252Bdiscovery%26aulast%3DBlass%26aufirst%3DBenjamin%2BE.%26date%3D2021%26spage%3D111%26epage%3D183%26pub%3DElsevier%26atitle%3DBasic%252BPrinciples%252Bof%252BDrug%252BDiscovery%252Band%252BDevelopment%26date%3D2021%26volume%3D5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tomasz Maciej  Stepniewski</span>, <span class="hlFld-ContribAuthor ">Arturo  Mancini</span>, <span class="hlFld-ContribAuthor ">Richard  Ågren</span>, <span class="hlFld-ContribAuthor ">Mariona  Torrens-Fontanals</span>, <span class="hlFld-ContribAuthor ">Meriem  Semache</span>, <span class="hlFld-ContribAuthor ">Michel  Bouvier</span>, <span class="hlFld-ContribAuthor ">Kristoffer  Sahlholm</span>, <span class="hlFld-ContribAuthor ">Billy  Breton</span>, <span class="hlFld-ContribAuthor ">Jana  Selent</span>. </span><span class="cited-content_cbyCitation_article-title">Mechanistic insights into dopaminergic and serotonergic neurotransmission – concerted interactions with helices 5 and 6 drive the functional outcome. </span><span class="cited-content_cbyCitation_journal-name">Chemical Science</span><span> <strong>2021,</strong> <em>291 </em><a href="https://doi.org/10.1039/D1SC00749A" title="DOI URL">https://doi.org/10.1039/D1SC00749A</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D1SC00749A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD1SC00749A%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Science%26atitle%3DMechanistic%252Binsights%252Binto%252Bdopaminergic%252Band%252Bserotonergic%252Bneurotransmission%252B%2525E2%252580%252593%252Bconcerted%252Binteractions%252Bwith%252Bhelices%252B5%252Band%252B6%252Bdrive%252Bthe%252Bfunctional%252Boutcome%26aulast%3DStepniewski%26aufirst%3DTomasz%2BMaciej%26date%3D2021%26date%3D2021%26volume%3D291" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Anni  Allikalt</span>, <span class="hlFld-ContribAuthor ">Nirupam  Purkayastha</span>, <span class="hlFld-ContribAuthor ">Khajidmaa  Flad</span>, <span class="hlFld-ContribAuthor ">Maximilian F.  Schmidt</span>, <span class="hlFld-ContribAuthor ">Alina  Tabor</span>, <span class="hlFld-ContribAuthor ">Peter  Gmeiner</span>, <span class="hlFld-ContribAuthor ">Harald  Hübner</span>, <span class="hlFld-ContribAuthor ">Dorothee  Weikert</span>. </span><span class="cited-content_cbyCitation_article-title">Fluorescent ligands for dopamine D2/D3 receptors. </span><span class="cited-content_cbyCitation_journal-name">Scientific Reports</span><span> <strong>2020,</strong> <em>10 </em>
                                    (1)
                                     <a href="https://doi.org/10.1038/s41598-020-78827-9" title="DOI URL">https://doi.org/10.1038/s41598-020-78827-9</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41598-020-78827-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41598-020-78827-9%26sid%3Dliteratum%253Aachs%26jtitle%3DScientific%2520Reports%26atitle%3DFluorescent%252Bligands%252Bfor%252Bdopamine%252BD2%25252FD3%252Breceptors%26aulast%3DAllikalt%26aufirst%3DAnni%26date%3D2020%26date%3D2020%26volume%3D10%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Viktoriya  Lukasheva</span>, <span class="hlFld-ContribAuthor ">Dominic  Devost</span>, <span class="hlFld-ContribAuthor ">Christian  Le Gouill</span>, <span class="hlFld-ContribAuthor ">Yoon  Namkung</span>, <span class="hlFld-ContribAuthor ">Ryan D.  Martin</span>, <span class="hlFld-ContribAuthor ">Jean-Michel  Longpré</span>, <span class="hlFld-ContribAuthor ">Mohammad  Amraei</span>, <span class="hlFld-ContribAuthor ">Yuji  Shinjo</span>, <span class="hlFld-ContribAuthor ">Mireille  Hogue</span>, <span class="hlFld-ContribAuthor ">Monique  Lagacé</span>, <span class="hlFld-ContribAuthor ">Billy  Breton</span>, <span class="hlFld-ContribAuthor ">Junken  Aoki</span>, <span class="hlFld-ContribAuthor ">Jason C.  Tanny</span>, <span class="hlFld-ContribAuthor ">Stéphane A.  Laporte</span>, <span class="hlFld-ContribAuthor ">Graciela  Pineyro</span>, <span class="hlFld-ContribAuthor ">Asuka  Inoue</span>, <span class="hlFld-ContribAuthor ">Michel  Bouvier</span>, <span class="hlFld-ContribAuthor ">Terence E.  Hébert</span>. </span><span class="cited-content_cbyCitation_article-title">Signal profiling of the β1AR reveals coupling to novel signalling pathways and distinct phenotypic responses mediated by β1AR and β2AR. </span><span class="cited-content_cbyCitation_journal-name">Scientific Reports</span><span> <strong>2020,</strong> <em>10 </em>
                                    (1)
                                     <a href="https://doi.org/10.1038/s41598-020-65636-3" title="DOI URL">https://doi.org/10.1038/s41598-020-65636-3</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41598-020-65636-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41598-020-65636-3%26sid%3Dliteratum%253Aachs%26jtitle%3DScientific%2520Reports%26atitle%3DSignal%252Bprofiling%252Bof%252Bthe%252B%2525CE%2525B21AR%252Breveals%252Bcoupling%252Bto%252Bnovel%252Bsignalling%252Bpathways%252Band%252Bdistinct%252Bphenotypic%252Bresponses%252Bmediated%252Bby%252B%2525CE%2525B21AR%252Band%252B%2525CE%2525B22AR%26aulast%3DLukasheva%26aufirst%3DViktoriya%26date%3D2020%26date%3D2020%26volume%3D10%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Marta  Sanchez-Soto</span>, <span class="hlFld-ContribAuthor ">Ravi Kumar  Verma</span>, <span class="hlFld-ContribAuthor ">Blair K. A.  Willette</span>, <span class="hlFld-ContribAuthor ">Elizabeth C.  Gonye</span>, <span class="hlFld-ContribAuthor ">Annah M.  Moore</span>, <span class="hlFld-ContribAuthor ">Amy E.  Moritz</span>, <span class="hlFld-ContribAuthor ">Comfort A.  Boateng</span>, <span class="hlFld-ContribAuthor ">Hideaki  Yano</span>, <span class="hlFld-ContribAuthor ">R. Benjamin  Free</span>, <span class="hlFld-ContribAuthor ">Lei  Shi</span>, <span class="hlFld-ContribAuthor ">David R.  Sibley</span>. </span><span class="cited-content_cbyCitation_article-title">A structural basis for how ligand binding site changes can allosterically regulate GPCR signaling and engender functional selectivity. </span><span class="cited-content_cbyCitation_journal-name">Science Signaling</span><span> <strong>2020,</strong> <em>13 </em>
                                    (617)
                                     , eaaw5885. <a href="https://doi.org/10.1126/scisignal.aaw5885" title="DOI URL">https://doi.org/10.1126/scisignal.aaw5885</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1126/scisignal.aaw5885&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1126%2Fscisignal.aaw5885%26sid%3Dliteratum%253Aachs%26jtitle%3DScience%2520Signaling%26atitle%3DA%252Bstructural%252Bbasis%252Bfor%252Bhow%252Bligand%252Bbinding%252Bsite%252Bchanges%252Bcan%252Ballosterically%252Bregulate%252BGPCR%252Bsignaling%252Band%252Bengender%252Bfunctional%252Bselectivity%26aulast%3DSanchez-Soto%26aufirst%3DMarta%26date%3D2020%26date%3D2020%26volume%3D13%26issue%3D617%26spage%3Deaaw5885" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Marlene  Jacobson</span>, <span class="hlFld-ContribAuthor ">Wayne  Childers</span>, <span class="hlFld-ContribAuthor ">Magid  Abou‐Gharbia</span>. </span><span class="cited-content_cbyCitation_article-title">Dopamine D
              2
              Partial Agonists – Discovery, Evolution, and Therapeutic Potential. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2019,</strong>,, 83-130. <a href="https://doi.org/10.1002/9783527814695.ch4" title="DOI URL">https://doi.org/10.1002/9783527814695.ch4</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/9783527814695.ch4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F9783527814695.ch4%26sid%3Dliteratum%253Aachs%26atitle%3DDopamine%252BD%252B2%252BPartial%252BAgonists%252B%2525E2%252580%252593%252BDiscovery%25252C%252BEvolution%25252C%252Band%252BTherapeutic%252BPotential%26aulast%3DJacobson%26aufirst%3DMarlene%26date%3D2019%26date%3D2019%26spage%3D83%26epage%3D130%26pub%3DWiley%26atitle%3DSuccessful%252BDrug%252BDiscovery%26aulast%3DFischer%26aufirst%3DJ%25C3%25A1nos%26date%3D2019%26date%3D2019%26volume%3D107" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mohammad  Seyedabadi</span>, <span class="hlFld-ContribAuthor ">Mohammad Hossein  Ghahremani</span>, <span class="hlFld-ContribAuthor ">Paul R.  Albert</span>. </span><span class="cited-content_cbyCitation_article-title">Biased signaling of G protein coupled receptors (GPCRs): Molecular determinants of GPCR/transducer selectivity and therapeutic potential. </span><span class="cited-content_cbyCitation_journal-name">Pharmacology & Therapeutics</span><span> <strong>2019,</strong> <em>200 </em>, 148-178. <a href="https://doi.org/10.1016/j.pharmthera.2019.05.006" title="DOI URL">https://doi.org/10.1016/j.pharmthera.2019.05.006</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.pharmthera.2019.05.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.pharmthera.2019.05.006%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmacology%2520%2526%2520Therapeutics%26atitle%3DBiased%252Bsignaling%252Bof%252BG%252Bprotein%252Bcoupled%252Breceptors%252B%252528GPCRs%252529%25253A%252BMolecular%252Bdeterminants%252Bof%252BGPCR%25252Ftransducer%252Bselectivity%252Band%252Btherapeutic%252Bpotential%26aulast%3DSeyedabadi%26aufirst%3DMohammad%26date%3D2019%26volume%3D200%26spage%3D148%26epage%3D178" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rafaela R.  Silva</span>, <span class="hlFld-ContribAuthor ">Lucas T.  Parreiras-e-Silva</span>, <span class="hlFld-ContribAuthor ">Thais E.T.  Pompeu</span>, <span class="hlFld-ContribAuthor ">Diego A.  Duarte</span>, <span class="hlFld-ContribAuthor ">Carlos A.M.  Fraga</span>, <span class="hlFld-ContribAuthor ">Eliezer J.  Barreiro</span>, <span class="hlFld-ContribAuthor ">Ricardo  Menegatti</span>, <span class="hlFld-ContribAuthor ">Claudio M.  Costa-Neto</span>, <span class="hlFld-ContribAuthor ">François  Noël</span>. </span><span class="cited-content_cbyCitation_article-title">Evaluation of Functional Selectivity of Haloperidol, Clozapine, and LASSBio-579, an Experimental Compound With Antipsychotic-Like Actions in Rodents, at G Protein and Arrestin Signaling Downstream of the Dopamine D2 Receptor. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Pharmacology</span><span> <strong>2019,</strong> <em>10 </em><a href="https://doi.org/10.3389/fphar.2019.00628" title="DOI URL">https://doi.org/10.3389/fphar.2019.00628</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fphar.2019.00628&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffphar.2019.00628%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Pharmacology%26atitle%3DEvaluation%252Bof%252BFunctional%252BSelectivity%252Bof%252BHaloperidol%25252C%252BClozapine%25252C%252Band%252BLASSBio-579%25252C%252Ban%252BExperimental%252BCompound%252BWith%252BAntipsychotic-Like%252BActions%252Bin%252BRodents%25252C%252Bat%252BG%252BProtein%252Band%252BArrestin%252BSignaling%252BDownstream%252Bof%252Bthe%252BDopamine%252BD2%252BReceptor%26aulast%3DSilva%26aufirst%3DRafaela%2BR.%26date%3D2019%26date%3D2019%26volume%3D10" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Taygun C.  Uzuneser</span>, <span class="hlFld-ContribAuthor ">Jil  Speidel</span>, <span class="hlFld-ContribAuthor ">Georgios  Kogias</span>, <span class="hlFld-ContribAuthor ">An-Li  Wang</span>, <span class="hlFld-ContribAuthor ">Maria A.  de Souza Silva</span>, <span class="hlFld-ContribAuthor ">Joseph P.  Huston</span>, <span class="hlFld-ContribAuthor ">Iulia  Zoicas</span>, <span class="hlFld-ContribAuthor ">Stephan  von Hörsten</span>, <span class="hlFld-ContribAuthor ">Johannes  Kornhuber</span>, <span class="hlFld-ContribAuthor ">Carsten  Korth</span>, <span class="hlFld-ContribAuthor ">Christian P.  Müller</span>. </span><span class="cited-content_cbyCitation_article-title">Disrupted-in-Schizophrenia 1 (DISC1) Overexpression and Juvenile Immune Activation Cause Sex-Specific Schizophrenia-Related Psychopathology in Rats. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Psychiatry</span><span> <strong>2019,</strong> <em>10 </em><a href="https://doi.org/10.3389/fpsyt.2019.00222" title="DOI URL">https://doi.org/10.3389/fpsyt.2019.00222</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fpsyt.2019.00222&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffpsyt.2019.00222%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Psychiatry%26atitle%3DDisrupted-in-Schizophrenia%252B1%252B%252528DISC1%252529%252BOverexpression%252Band%252BJuvenile%252BImmune%252BActivation%252BCause%252BSex-Specific%252BSchizophrenia-Related%252BPsychopathology%252Bin%252BRats%26aulast%3DUzuneser%26aufirst%3DTaygun%2BC.%26date%3D2019%26date%3D2019%26volume%3D10" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Terry  Kenakin</span>, . </span><span class="cited-content_cbyCitation_article-title">Biased Receptor Signaling in Drug Discovery. </span><span class="cited-content_cbyCitation_journal-name">Pharmacological Reviews</span><span> <strong>2019,</strong> <em>71 </em>
                                    (2)
                                     , 267-315. <a href="https://doi.org/10.1124/pr.118.016790" title="DOI URL">https://doi.org/10.1124/pr.118.016790</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1124/pr.118.016790&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1124%2Fpr.118.016790%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmacological%2520Reviews%26atitle%3DBiased%252BReceptor%252BSignaling%252Bin%252BDrug%252BDiscovery%26aulast%3DKenakin%26aufirst%3DTerry%26date%3D2019%26date%3D2019%26volume%3D71%26issue%3D2%26spage%3D267%26epage%3D315" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Taygun C.  Uzuneser</span>, <span class="hlFld-ContribAuthor ">Magnus  Schindehütte</span>, <span class="hlFld-ContribAuthor ">Ekrem  Dere</span>, <span class="hlFld-ContribAuthor ">Stephan  von Hörsten</span>, <span class="hlFld-ContribAuthor ">Johannes  Kornhuber</span>, <span class="hlFld-ContribAuthor ">Teja W.  Grömer</span>, <span class="hlFld-ContribAuthor ">Christian P.  Müller</span>. </span><span class="cited-content_cbyCitation_article-title">Schizophrenia dimension-specific antipsychotic drug action and failure in amphetamine-sensitized psychotic-like rats. </span><span class="cited-content_cbyCitation_journal-name">European Neuropsychopharmacology</span><span> <strong>2018,</strong> <em>28 </em>
                                    (12)
                                     , 1382-1393. <a href="https://doi.org/10.1016/j.euroneuro.2018.09.005" title="DOI URL">https://doi.org/10.1016/j.euroneuro.2018.09.005</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.euroneuro.2018.09.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.euroneuro.2018.09.005%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Neuropsychopharmacology%26atitle%3DSchizophrenia%252Bdimension-specific%252Bantipsychotic%252Bdrug%252Baction%252Band%252Bfailure%252Bin%252Bamphetamine-sensitized%252Bpsychotic-like%252Brats%26aulast%3DUzuneser%26aufirst%3DTaygun%2BC.%26date%3D2018%26volume%3D28%26issue%3D12%26spage%3D1382%26epage%3D1393" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sladjana-Kostic  Rajacic</span>, <span class="hlFld-ContribAuthor ">Gerhard  Schwall</span>, <span class="hlFld-ContribAuthor ">Jelena  Penjisevic</span>, <span class="hlFld-ContribAuthor ">Deana  Andric</span>, <span class="hlFld-ContribAuthor ">Vladimir  Sukalovic</span>, <span class="hlFld-ContribAuthor ">Vukic  Soskic</span>. </span><span class="cited-content_cbyCitation_article-title">Identification of NQO1 and ferrochelatase as interaction partners for neuroprotective
              N
              -{[2-(4-phenyl-piperazin-1-yl)-ethyl]-phenyl}-arylamides. </span><span class="cited-content_cbyCitation_journal-name">Chemical Biology & Drug Design</span><span> <strong>2018,</strong> <em>92 </em>
                                    (1)
                                     , 1393-1397. <a href="https://doi.org/10.1111/cbdd.13193" title="DOI URL">https://doi.org/10.1111/cbdd.13193</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/cbdd.13193&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fcbdd.13193%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Biology%2520%2526%2520Drug%2520Design%26atitle%3DIdentification%252Bof%252BNQO1%252Band%252Bferrochelatase%252Bas%252Binteraction%252Bpartners%252Bfor%252Bneuroprotective%252BN%252B-%25257B%25255B2-%2525284-phenyl-piperazin-1-yl%252529-ethyl%25255D-phenyl%25257D-arylamides%26aulast%3DRajacic%26aufirst%3DSladjana-Kostic%26date%3D2018%26date%3D2018%26volume%3D92%26issue%3D1%26spage%3D1393%26epage%3D1397" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Peiling  Yan</span>, <span class="hlFld-ContribAuthor ">Guiyun  Duan</span>, <span class="hlFld-ContribAuthor ">Ruixue  Ji</span>, <span class="hlFld-ContribAuthor ">Yanqing  Ge</span>. </span><span class="cited-content_cbyCitation_article-title">A simple and efficient synthesis of new fluorophore 4-hydroxy pyrazolo[1,5-a]pyridines through a tandem reaction. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron Letters</span><span> <strong>2018,</strong> <em>59 </em>
                                    (25)
                                     , 2426-2429. <a href="https://doi.org/10.1016/j.tetlet.2018.05.022" title="DOI URL">https://doi.org/10.1016/j.tetlet.2018.05.022</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tetlet.2018.05.022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tetlet.2018.05.022%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%2520Letters%26atitle%3DA%252Bsimple%252Band%252Befficient%252Bsynthesis%252Bof%252Bnew%252Bfluorophore%252B4-hydroxy%252Bpyrazolo%25255B1%25252C5-a%25255Dpyridines%252Bthrough%252Ba%252Btandem%252Breaction%26aulast%3DYan%26aufirst%3DPeiling%26date%3D2018%26volume%3D59%26issue%3D25%26spage%3D2426%26epage%3D2429" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lani S.  Chun</span>, <span class="hlFld-ContribAuthor ">Rakesh H.  Vekariya</span>, <span class="hlFld-ContribAuthor ">R. Benjamin  Free</span>, <span class="hlFld-ContribAuthor ">Yun  Li</span>, <span class="hlFld-ContribAuthor ">Da-Ting  Lin</span>, <span class="hlFld-ContribAuthor ">Ping  Su</span>, <span class="hlFld-ContribAuthor ">Fang  Liu</span>, <span class="hlFld-ContribAuthor ">Yoon  Namkung</span>, <span class="hlFld-ContribAuthor ">Stephane A.  Laporte</span>, <span class="hlFld-ContribAuthor ">Amy E.  Moritz</span>, <span class="hlFld-ContribAuthor ">Jeffrey  Aubé</span>, <span class="hlFld-ContribAuthor ">Kevin J.  Frankowski</span>, <span class="hlFld-ContribAuthor ">David R.  Sibley</span>. </span><span class="cited-content_cbyCitation_article-title">Structure-Activity Investigation of a G Protein-Biased Agonist Reveals Molecular Determinants for Biased Signaling of the D2 Dopamine Receptor. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Synaptic Neuroscience</span><span> <strong>2018,</strong> <em>10 </em><a href="https://doi.org/10.3389/fnsyn.2018.00002" title="DOI URL">https://doi.org/10.3389/fnsyn.2018.00002</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fnsyn.2018.00002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffnsyn.2018.00002%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Synaptic%2520Neuroscience%26atitle%3DStructure-Activity%252BInvestigation%252Bof%252Ba%252BG%252BProtein-Biased%252BAgonist%252BReveals%252BMolecular%252BDeterminants%252Bfor%252BBiased%252BSignaling%252Bof%252Bthe%252BD2%252BDopamine%252BReceptor%26aulast%3DChun%26aufirst%3DLani%2BS.%26date%3D2018%26date%3D2018%26volume%3D10" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ping  Zhang</span>, <span class="hlFld-ContribAuthor ">Huaying  Lv</span>, <span class="hlFld-ContribAuthor ">Guiyun  Duan</span>, <span class="hlFld-ContribAuthor ">Jian  Dong</span>, <span class="hlFld-ContribAuthor ">Yanqing  Ge</span>. </span><span class="cited-content_cbyCitation_article-title">A novel pyrazolo[1,5-
              a
              ]pyridine fluorophore and its application to detect pH in cells. </span><span class="cited-content_cbyCitation_journal-name">RSC Advances</span><span> <strong>2018,</strong> <em>8 </em>
                                    (54)
                                     , 30732-30735. <a href="https://doi.org/10.1039/C8RA06191B" title="DOI URL">https://doi.org/10.1039/C8RA06191B</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C8RA06191B&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC8RA06191B%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Advances%26atitle%3DA%252Bnovel%252Bpyrazolo%25255B1%25252C5-%252Ba%252B%25255Dpyridine%252Bfluorophore%252Band%252Bits%252Bapplication%252Bto%252Bdetect%252BpH%252Bin%252Bcells%26aulast%3DZhang%26aufirst%3DPing%26date%3D2018%26date%3D2018%26volume%3D8%26issue%3D54%26spage%3D30732%26epage%3D30735" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alina  Tabor</span>, <span class="hlFld-ContribAuthor ">Dorothee  Möller</span>, <span class="hlFld-ContribAuthor ">Harald  Hübner</span>, <span class="hlFld-ContribAuthor ">Johannes  Kornhuber</span>, <span class="hlFld-ContribAuthor ">Peter  Gmeiner</span>. </span><span class="cited-content_cbyCitation_article-title">Visualization of ligand-induced dopamine D2S and D2L receptor internalization by TIRF microscopy. </span><span class="cited-content_cbyCitation_journal-name">Scientific Reports</span><span> <strong>2017,</strong> <em>7 </em>
                                    (1)
                                     <a href="https://doi.org/10.1038/s41598-017-11436-1" title="DOI URL">https://doi.org/10.1038/s41598-017-11436-1</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41598-017-11436-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41598-017-11436-1%26sid%3Dliteratum%253Aachs%26jtitle%3DScientific%2520Reports%26atitle%3DVisualization%252Bof%252Bligand-induced%252Bdopamine%252BD2S%252Band%252BD2L%252Breceptor%252Binternalization%252Bby%252BTIRF%252Bmicroscopy%26aulast%3DTabor%26aufirst%3DAlina%26date%3D2017%26date%3D2017%26volume%3D7%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Barbara  Männel</span>, <span class="hlFld-ContribAuthor ">Harald  Hübner</span>, <span class="hlFld-ContribAuthor ">Dorothée  Möller</span>, <span class="hlFld-ContribAuthor ">Peter  Gmeiner</span>. </span><span class="cited-content_cbyCitation_article-title">β-Arrestin biased dopamine D2 receptor partial agonists: Synthesis and pharmacological evaluation. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2017,</strong> <em>25 </em>
                                    (20)
                                     , 5613-5628. <a href="https://doi.org/10.1016/j.bmc.2017.08.037" title="DOI URL">https://doi.org/10.1016/j.bmc.2017.08.037</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2017.08.037&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2017.08.037%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3D%2525CE%2525B2-Arrestin%252Bbiased%252Bdopamine%252BD2%252Breceptor%252Bpartial%252Bagonists%25253A%252BSynthesis%252Band%252Bpharmacological%252Bevaluation%26aulast%3DM%25C3%25A4nnel%26aufirst%3DBarbara%26date%3D2017%26volume%3D25%26issue%3D20%26spage%3D5613%26epage%3D5628" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01857/20170407/images/medium/jm-2016-01857v_0011.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01857/20170407/images/large/jm-2016-01857v_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01857&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01857/20170407/images/medium/jm-2016-01857v_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01857/20170407/images/large/jm-2016-01857v_0001.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Chemical structure of type I compounds (1,4-DAP) consisting of an aromatic core structure (π<sub>1</sub>), a basic amine unit, a linker region, and a second, mostly lipophilic system (π<sub>2</sub>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01857/20170407/images/large/jm-2016-01857v_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01857&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01857/20170407/images/medium/jm-2016-01857v_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01857/20170407/images/large/jm-2016-01857v_0002.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Chemical structures of approved antipsychotics drugs <b>1a</b>–<b>1c</b> and recently described functionally selective dopamine receptor partial agonists (<b>2a</b>–<b>2c</b>) bearing a 1,4-DAP as orthosteric headgroup.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01857/20170407/images/large/jm-2016-01857v_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01857&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01857/20170407/images/medium/jm-2016-01857v_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01857/20170407/images/large/jm-2016-01857v_0006.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. <sup>a</sup>Synthesis of Pyrazolo[1,5-<i>a</i>]pyridine-Derived Dopaminergics Containing an Amide Linker</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01857/20170407/images/large/jm-2016-01857v_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01857&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) methyl 4-bromobutyrate, TEA, DMF, rt, 24 h (88–98%); (b) 1 M NaOH, MeOH, 65 °C, 6 h (93–94%); (c) 5-aminopyrazolo[1,5-<i>a</i>]pyridine, HATU, DIPEA, DMF/CH<sub>2</sub>Cl<sub>2</sub>, 24h, rt (68–95%); (d) POCl<sub>3</sub>, DMF, 0 °C to rt, 1 h (58–59%); (e) hydroxylamine·HCl, EtOH/H<sub>2</sub>O, reflux, 2 h (77–83%); (f) for <b>9a</b> TCT, DMF, rt, 5 h (75%); and (g) for <b>9b</b> Ac<sub>2</sub>O, reflux, 6 h (12%).</p></p></figure><figure data-id="sch2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01857/20170407/images/medium/jm-2016-01857v_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01857/20170407/images/large/jm-2016-01857v_0007.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. <sup>a</sup>Synthesis of Prazolo[1,5-<i>a</i>]pyridine-Derived Dopaminergics Containing a Butoxy-Linker</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01857/20170407/images/large/jm-2016-01857v_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01857&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) HBr 48%, reflux, 16 h; (b) KI, DIPEA or TEA, ACN, 85 °C, 6–16 h, (19–89%); (c) LiAlH<sub>4</sub>, Et<sub>2</sub>O, 0 °C to rt, 1 h (74%); (d) MnO<sub>2</sub>, CH<sub>2</sub>Cl<sub>2</sub>, rt, 14 h (97%); (e) hydroxylamine hydrochloride, EtOH/H<sub>2</sub>O, reflux, 2 h (85%); (f) TCT, DMF, rt, 7 h (54%); (g) POCl<sub>3</sub>, DMF, 0 °C to rt, 1 h (79–98%); (h) hydroxylamine·HCl, EtOH/H<sub>2</sub>O, reflux, 2 h (35–89%); and (i) Ac<sub>2</sub>O, reflux, 6 h (79%).</p></p></figure><figure data-id="fig3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01857/20170407/images/medium/jm-2016-01857v_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01857/20170407/images/large/jm-2016-01857v_0003.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Functional properties of pyrazolo[1,5-<i>a</i>]pyridines <b>16c</b>, (<i>S</i>)-<b>13b</b>, and (<i>R</i>)-<b>13b</b> in comparison to the full agonist quinpirole and the reference antipsychotic <b>1a</b> at D<sub>2S</sub>R. Activation of Gα<sub>oA</sub> (a and c) and Gα<sub>i2</sub> (b and d) was determined either by (a and b) [<sup>35</sup>S]GTPγS binding or by (c and d) BRET changes occurring upon separation of RLucII-Gα<sub>i/o</sub> from GFP10-Gγ<sub>2</sub>. Ligand-stimulated recruitment of β-arrestin-2 was determined employing (e) the PathHunter assay or (f) an approach based on bystander BRET. Data were normalized relative to the response of quinpirole (100%) and vehicle (0%) and represent mean ± SEM from three to ten independent experiments, each performed at least in duplicate.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01857/20170407/images/large/jm-2016-01857v_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01857&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01857/20170407/images/medium/jm-2016-01857v_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01857/20170407/images/large/jm-2016-01857v_0004.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Ligand-induced activation of GIRK1/2 channels. When HEK293T cells expressing D<sub>2L</sub>R and GIRK1/2 cells were stimulated with (a) 10 μM dopamine, (b) 1 μM <b>1a</b>, or (c) 1 μM <b>16c</b>, a robust K<sup>+</sup> current is induced at the holding potential of −70 mV in high K<sup>+</sup> external solution. Currents are completely inhibited by subsequent addition of a 2 mM BaCl<sub>2</sub> into the bath solution. (d) Quantification of D<sub>2L</sub>R activation from ramp currents shows a partial response is elicited by <b>1a</b> and <b>16c</b> compared to the endogenous agonist dopamine. (e) In HEK293T cells expressing D<sub>3</sub>R and GIRK1/2, only dopamine, but not 1 μM solutions of <b>1a</b> or <b>16c</b>, evoke a significant K<sup>+</sup> current. Data represent mean ± SEM from 9 to 30 individual cells, VEH = vehicle, **<i>p</i> < 0.01, ***<i>p</i> < 0.001, one-way ANOVA.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01857/20170407/images/large/jm-2016-01857v_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01857&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01857/20170407/images/medium/jm-2016-01857v_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01857/20170407/images/large/jm-2016-01857v_0005.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Effects of <b>16c</b> compared to <b>1a</b> on schizophrenia-like behavior in rats. Animals received i.p. injections of amphetamine (AMPH) with a sensitization regimen or saline (SAL). Subsequently, the animals were continuously treated with <b>1a</b> (1.5 mg/kg/day), <b>16c</b> (1.5 mg/kg/day), or vehicle (VEH) for 7 days. Baseline activity: (a) baseline horizontal locomotion, (b) rearing, and (c) center duration in the open field on treatment day 7 are shown for SAL/VEH (<i>n</i> = 11), AMPH/VEH (<i>n</i> = 12), AMPH/<b>1a</b> (<i>n</i> = 12), and AMPH/<b>16c</b> (<i>n</i> = 9) groups as a 20 min total activity. AMPH-induced activity: the effects of a challenge AMPH injection (1.5 mg/kg) on (d) horizontal locomotion, (e) rearing, and (f) center duration are shown in 5 min intervals and as the area under the curve (AUC) total activity (g, h, i, respectively). AMPH-induced behaviors are calculated as Δ baseline (vs last 5 min of baseline). Values are shown as mean ± SEM, *<i>p</i> < 0.05, **<i>p</i> < 0.01, and ***<i>p</i> < 0.001 compared to SAL/VEH. #<i>p</i> < 0.05, ##<i>p</i> < 0.01, and ###<i>p</i> < 0.001 compared to AMPH/VEH.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01857/20170407/images/large/jm-2016-01857v_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01857&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i61">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_53323" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_53323" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 80 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Welsch, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Snyder, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stockwell, B. R.</span><span> </span><span class="NLM_article-title">Privileged Scaffolds for Library Design and Drug Discovery</span> <span class="citation_source-journal">Curr. Opin. Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">347</span><span class="NLM_x">–</span> <span class="NLM_lpage">361</span><span class="refDoi"> DOI: 10.1016/j.cbpa.2010.02.018</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01857&amp;key=10.1016%2Fj.cbpa.2010.02.018" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01857&amp;key=20303320" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01857&amp;key=1%3ACAS%3A528%3ADC%252BC3cXmvVWqsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2010&pages=347-361&author=M.+E.+Welschauthor=S.+A.+Snyderauthor=B.+R.+Stockwell&title=Privileged+Scaffolds+for+Library+Design+and+Drug+Discovery&doi=10.1016%2Fj.cbpa.2010.02.018"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Privileged scaffolds for library design and drug discovery</span></div><div class="casAuthors">Welsch, Matthew E.; Snyder, Scott A.; Stockwell, Brent R.</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Chemical Biology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">347-361</span>CODEN:
                <span class="NLM_cas:coden">COCBF4</span>;
        ISSN:<span class="NLM_cas:issn">1367-5931</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">This review explores the concept of using privileged scaffolds to identify biol. active compds. through building chem. libraries.  We hope to accomplish three main objectives: to provide one of the most comprehensive listings of privileged scaffolds; to reveal through four selected examples the present state of the art in privileged scaffold library synthesis (in hopes of inspiring new and even more creative approaches); and also to offer some thoughts on how new privileged scaffolds might be identified and exploited.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqWQPxdsWawiLVg90H21EOLACvtfcHk0ljOen9vlJWvgQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXmvVWqsLs%253D&md5=fd0c2a642f063fd6f42f2c34fd186f8a</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1016%2Fj.cbpa.2010.02.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cbpa.2010.02.018%26sid%3Dliteratum%253Aachs%26aulast%3DWelsch%26aufirst%3DM.%2BE.%26aulast%3DSnyder%26aufirst%3DS.%2BA.%26aulast%3DStockwell%26aufirst%3DB.%2BR.%26atitle%3DPrivileged%2520Scaffolds%2520for%2520Library%2520Design%2520and%2520Drug%2520Discovery%26jtitle%3DCurr.%2520Opin.%2520Chem.%2520Biol.%26date%3D2010%26volume%3D14%26spage%3D347%26epage%3D361%26doi%3D10.1016%2Fj.cbpa.2010.02.018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Löber, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hübner, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tschammer, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gmeiner, P.</span><span> </span><span class="NLM_article-title">Recent Advances in the Search for D3- and D4-Selective Drugs: Probes, Models and Candidates</span> <span class="citation_source-journal">Trends Pharmacol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">148</span><span class="NLM_x">–</span> <span class="NLM_lpage">157</span><span class="refDoi"> DOI: 10.1016/j.tips.2010.12.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01857&amp;key=10.1016%2Fj.tips.2010.12.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01857&amp;key=21232805" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01857&amp;key=1%3ACAS%3A280%3ADC%252BC3M3ktVWnsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2011&pages=148-157&author=S.+L%C3%B6berauthor=H.+H%C3%BCbnerauthor=N.+Tschammerauthor=P.+Gmeiner&title=Recent+Advances+in+the+Search+for+D3-+and+D4-Selective+Drugs%3A+Probes%2C+Models+and+Candidates&doi=10.1016%2Fj.tips.2010.12.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Recent advances in the search for D3- and D4-selective drugs: probes, models and candidates</span></div><div class="casAuthors">Lober Stefan; Hubner Harald; Tschammer Nuska; Gmeiner Peter</div><div class="citationInfo"><span class="NLM_cas:title">Trends in pharmacological sciences</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">148-57</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Dopamine D(2)-like receptors (including D(2), D(3) and D(4)) belong to the 'rhodopsin-like' family of G protein-coupled receptors (GPCRs), which represent the largest group of targets for bioactive molecules.  Due to their high sequence similarity, the design of subtype-selective ligands requires rational and effective strategies.  The general formula of 1,4-disubstituted aromatic piperidines and piperazines (1,4-DAPs) was extracted from classical dopaminergic drugs.  The biological properties of this compound family are encoded by an aromatic head group that controls intrinsic activity, an amine moiety and a lipophilic appendage.  D(3)- and D(4)-selective molecular probes and drug candidates were generated from the general formula of 1,4-DAP.  Formal structural rearrangement led to investigational drugs beyond the 1,4-DAP structure.  The very recent publication of the X-ray crystal structure of D(3) should facilitate efficient discovery of unprecedented chemotypes.  However, the development of D(3)-selective agonists, functionally selective ligands and the exploitation of homo- and heteromers remain challenging.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSJYDidIFGFwMjl5L8hwNX0fW6udTcc2eZeXKufGOQoGLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3M3ktVWnsg%253D%253D&md5=9b688525eaa75c6d965b634617c16d70</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1016%2Fj.tips.2010.12.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tips.2010.12.003%26sid%3Dliteratum%253Aachs%26aulast%3DL%25C3%25B6ber%26aufirst%3DS.%26aulast%3DH%25C3%25BCbner%26aufirst%3DH.%26aulast%3DTschammer%26aufirst%3DN.%26aulast%3DGmeiner%26aufirst%3DP.%26atitle%3DRecent%2520Advances%2520in%2520the%2520Search%2520for%2520D3-%2520and%2520D4-Selective%2520Drugs%253A%2520Probes%252C%2520Models%2520and%2520Candidates%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D2011%26volume%3D32%26spage%3D148%26epage%3D157%26doi%3D10.1016%2Fj.tips.2010.12.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Szabo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klein Herenbrink, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christopoulos, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lane, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Capuano, B.</span><span> </span><span class="NLM_article-title">Structure–Activity Relationships of Privileged Structures Lead to the Discovery of Novel Biased Ligands at the Dopamine D2 Receptor</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">4924</span><span class="NLM_x">–</span> <span class="NLM_lpage">4939</span><span class="refDoi"> DOI: 10.1021/jm500457x</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm500457x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=4924-4939&author=M.+Szaboauthor=C.+Klein+Herenbrinkauthor=A.+Christopoulosauthor=J.+R.+Laneauthor=B.+Capuano&title=Structure%E2%80%93Activity+Relationships+of+Privileged+Structures+Lead+to+the+Discovery+of+Novel+Biased+Ligands+at+the+Dopamine+D2+Receptor&doi=10.1021%2Fjm500457x"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1021%2Fjm500457x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm500457x%26sid%3Dliteratum%253Aachs%26aulast%3DSzabo%26aufirst%3DM.%26aulast%3DKlein%2BHerenbrink%26aufirst%3DC.%26aulast%3DChristopoulos%26aufirst%3DA.%26aulast%3DLane%26aufirst%3DJ.%2BR.%26aulast%3DCapuano%26aufirst%3DB.%26atitle%3DStructure%25E2%2580%2593Activity%2520Relationships%2520of%2520Privileged%2520Structures%2520Lead%2520to%2520the%2520Discovery%2520of%2520Novel%2520Biased%2520Ligands%2520at%2520the%2520Dopamine%2520D2%2520Receptor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D4924%26epage%3D4939%26doi%3D10.1021%2Fjm500457x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Newman, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beuming, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Banala, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Donthamsetti, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pongetti, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LaBounty, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levy, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cao, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Michino, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luedtke, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Javitch, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, L.</span><span> </span><span class="NLM_article-title">Molecular Determinants of Selectivity and Efficacy at the Dopamine D3 Receptor</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">6689</span><span class="NLM_x">–</span> <span class="NLM_lpage">6699</span><span class="refDoi"> DOI: 10.1021/jm300482h</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm300482h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01857&amp;key=1%3ACAS%3A528%3ADC%252BC38XnsFCkt7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=6689-6699&author=A.+H.+Newmanauthor=T.+Beumingauthor=A.+K.+Banalaauthor=P.+Donthamsettiauthor=K.+Pongettiauthor=A.+LaBountyauthor=B.+Levyauthor=J.+Caoauthor=M.+Michinoauthor=R.+R.+Luedtkeauthor=J.+A.+Javitchauthor=L.+Shi&title=Molecular+Determinants+of+Selectivity+and+Efficacy+at+the+Dopamine+D3+Receptor&doi=10.1021%2Fjm300482h"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular Determinants of Selectivity and Efficacy at the Dopamine D3 Receptor</span></div><div class="casAuthors">Newman, Amy Hauck; Beuming, Thijs; Banala, Ashwini K.; Donthamsetti, Prashant; Pongetti, Katherine; LaBounty, Alex; Levy, Benjamin; Cao, Jianjing; Michino, Mayako; Luedtke, Robert R.; Javitch, Jonathan A.; Shi, Lei</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">6689-6699</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The dopamine D3 receptor (D3R) has been implicated in substance abuse and other neuropsychiatric disorders.  The high sequence homol. between the D3R and D2R, esp. within the orthosteric binding site (OBS) that binds dopamine, has made the development of D3R-selective compds. challenging.  Here, we deconstruct into pharmacophoric elements a series of D3R-selective substituted-4-phenylpiperazine compds. and use computational simulations and binding and activation studies to dissect the structural bases for D3R selectivity and efficacy.  We find that selectivity arises from divergent interactions within a second binding pocket (SBP) sep. from the OBS, whereas efficacy depends on the binding mode in the OBS.  Our findings reveal structural features of the receptor that are crit. to selectivity and efficacy that can be used to design highly D3R-selective ligands with targeted efficacies.  These findings are generalizable to other GPCRs in which the SBP can be targeted by bitopic or allosteric ligands.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqmBJU7uyvVg7Vg90H21EOLACvtfcHk0lg1RKMRU-_PWw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XnsFCkt7c%253D&md5=033dd49282723650828a3ec0a31211e5</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1021%2Fjm300482h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300482h%26sid%3Dliteratum%253Aachs%26aulast%3DNewman%26aufirst%3DA.%2BH.%26aulast%3DBeuming%26aufirst%3DT.%26aulast%3DBanala%26aufirst%3DA.%2BK.%26aulast%3DDonthamsetti%26aufirst%3DP.%26aulast%3DPongetti%26aufirst%3DK.%26aulast%3DLaBounty%26aufirst%3DA.%26aulast%3DLevy%26aufirst%3DB.%26aulast%3DCao%26aufirst%3DJ.%26aulast%3DMichino%26aufirst%3DM.%26aulast%3DLuedtke%26aufirst%3DR.%2BR.%26aulast%3DJavitch%26aufirst%3DJ.%2BA.%26aulast%3DShi%26aufirst%3DL.%26atitle%3DMolecular%2520Determinants%2520of%2520Selectivity%2520and%2520Efficacy%2520at%2520the%2520Dopamine%2520D3%2520Receptor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D6689%26epage%3D6699%26doi%3D10.1021%2Fjm300482h" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Ehrlich, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Götz, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bollinger, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tschammer, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bettinetti, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Härterich, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hübner, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lanig, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gmeiner, P.</span><span> </span><span class="NLM_article-title">Dopamine D2, D3, and D4 Selective Phenylpiperazines as Molecular Probes to Explore the Origins of Subtype Specific Receptor Binding</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">4923</span><span class="NLM_x">–</span> <span class="NLM_lpage">4935</span><span class="refDoi"> DOI: 10.1021/jm900690y</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm900690y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01857&amp;key=1%3ACAS%3A528%3ADC%252BD1MXos1ehtLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=4923-4935&author=K.+Ehrlichauthor=A.+G%C3%B6tzauthor=S.+Bollingerauthor=N.+Tschammerauthor=L.+Bettinettiauthor=S.+H%C3%A4rterichauthor=H.+H%C3%BCbnerauthor=H.+Lanigauthor=P.+Gmeiner&title=Dopamine+D2%2C+D3%2C+and+D4+Selective+Phenylpiperazines+as+Molecular+Probes+to+Explore+the+Origins+of+Subtype+Specific+Receptor+Binding&doi=10.1021%2Fjm900690y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Dopamine D2, D3, and D4 Selective Phenylpiperazines as Molecular Probes To Explore the Origins of Subtype Specific Receptor Binding</span></div><div class="casAuthors">Ehrlich, Katharina; Gotz, Angela; Bollinger, Stefan; Tschammer, Nuska; Bettinetti, Laura; Harterich, Steffen; Hubner, Harald; Lanig, Harald; Gmeiner, Peter</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">4923-4935</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Assembling phenylpiperazines with 7a-azaindole via different spacer elements, we developed subtype selective dopamine receptor ligands, e.g. I, preferentially interacting with D4, D2, and D3, resp.  To complete this set, the methylthio analogs exceeding the affinity of methoxy derivs. by one order of magnitude and a structural intermediate II were synthesized.  These chem. similar but biol. divergent target compds. served as mol. probes for radioligand displacement expts., mutagenesis, and docking studies on homol. models based on the recent crystal structure of the β2-adrenergic receptor.  Specific interactions with the highly conserved amino acids Asp3.32 and His6.55 and less conserved residues at positions 2.61, 2.64, 3.28, and 3.29 were identified.  Inclusion of a carefully modeled extracellular loop 2 displayed two nonconserved residues in EL2 that differently contribute to ligand binding.  Obviously, subtype selectivity is caused by nonconserved but frequently mediated by conserved amino acids.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpX2fsUqpFTIbVg90H21EOLACvtfcHk0ljuVojc9SlcOg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXos1ehtLk%253D&md5=99880da2621063e269f8b7f765e09d55</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1021%2Fjm900690y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm900690y%26sid%3Dliteratum%253Aachs%26aulast%3DEhrlich%26aufirst%3DK.%26aulast%3DG%25C3%25B6tz%26aufirst%3DA.%26aulast%3DBollinger%26aufirst%3DS.%26aulast%3DTschammer%26aufirst%3DN.%26aulast%3DBettinetti%26aufirst%3DL.%26aulast%3DH%25C3%25A4rterich%26aufirst%3DS.%26aulast%3DH%25C3%25BCbner%26aufirst%3DH.%26aulast%3DLanig%26aufirst%3DH.%26aulast%3DGmeiner%26aufirst%3DP.%26atitle%3DDopamine%2520D2%252C%2520D3%252C%2520and%2520D4%2520Selective%2520Phenylpiperazines%2520as%2520Molecular%2520Probes%2520to%2520Explore%2520the%2520Origins%2520of%2520Subtype%2520Specific%2520Receptor%2520Binding%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D4923%26epage%3D4935%26doi%3D10.1021%2Fjm900690y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Burris, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Molski, T. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ryan, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tottori, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kikuchi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yocca, F. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Molinoff, P. B.</span><span> </span><span class="NLM_article-title">Aripiprazole, a Novel Antipsychotic, Is a High-Affinity Partial Agonist at Human Dopamine D2 Receptors</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">302</span><span class="NLM_x">, </span> <span class="NLM_fpage">381</span><span class="NLM_x">–</span> <span class="NLM_lpage">389</span><span class="refDoi"> DOI: 10.1124/jpet.102.033175</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01857&amp;key=10.1124%2Fjpet.102.033175" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01857&amp;key=12065741" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01857&amp;key=1%3ACAS%3A528%3ADC%252BD38Xlt1SnsLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=302&publication_year=2002&pages=381-389&author=K.+D.+Burrisauthor=T.+F.+Molskiauthor=C.+Xuauthor=E.+Ryanauthor=K.+Tottoriauthor=T.+Kikuchiauthor=F.+D.+Yoccaauthor=P.+B.+Molinoff&title=Aripiprazole%2C+a+Novel+Antipsychotic%2C+Is+a+High-Affinity+Partial+Agonist+at+Human+Dopamine+D2+Receptors&doi=10.1124%2Fjpet.102.033175"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Aripiprazole, a novel antipsychotic, is a high-affinity partial agonist at human dopamine D2 receptors</span></div><div class="casAuthors">Burris, Kevin D.; Molski, Thaddeus F.; Xu, Cen; Ryan, Elaine; Tottori, Katsura; Kikuchi, Tetsuro; Yocca, Frank D.; Molinoff, Perry B.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">302</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">381-389</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Aripiprazole is the first next-generation atypical antipsychotic with a mechanism of action that differs from currently marketed typical and atypical antipsychotics.  Aripiprazole displays properties of an agonist and antagonist in animal models of dopaminergic hypoactivity and hyperactivity, resp.  This study examd. the interactions of aripiprazole with a single population of human D2 receptors to clarify further its pharmacol. properties.  In membranes prepd. from Chinese hamster ovary cells that express recombinant D2L receptors, aripiprazole bound with high affinity to both the G protein-coupled and uncoupled states of receptors.  Aripiprazole potently activated D2 receptor-mediated inhibition of cAMP accumulation.  Partial receptor inactivation using the alkylating agent N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ) significantly reduced the max. effect of aripiprazole on inhibition of cAMP accumulation.  This effect was seen with concns. of EEDQ that did not alter the maximal inhibitory effect of dopamine.  Consistent with the expected effects of a partial agonist, increasing concns. of aripiprazole blocked the action of dopamine with maximal blockade equal to the agonist effect of aripiprazole alone.  The efficacy of aripiprazole relative to that of dopamine varied from 25% in cells that lacked spare receptors for dopamine to 90% in cells with receptor reserve.  These results, together with previous studies demonstrating partial agonist activity at serotonin 5-hydroxytryptamine (5-HT)1A receptors and antagonist activity at 5-HT2A receptors, support the identification of aripiprazole as a dopamine-serotonin system stabilizer.  The receptor activity profile may underlie the unique activity of aripiprazole in animals and its antipsychotic activity in humans.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqu--oNCiWjJ7Vg90H21EOLACvtfcHk0ljuVojc9SlcOg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xlt1SnsLY%253D&md5=907bbba92bdfb6c4d2ee703f289c32f6</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1124%2Fjpet.102.033175&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.102.033175%26sid%3Dliteratum%253Aachs%26aulast%3DBurris%26aufirst%3DK.%2BD.%26aulast%3DMolski%26aufirst%3DT.%2BF.%26aulast%3DXu%26aufirst%3DC.%26aulast%3DRyan%26aufirst%3DE.%26aulast%3DTottori%26aufirst%3DK.%26aulast%3DKikuchi%26aufirst%3DT.%26aulast%3DYocca%26aufirst%3DF.%2BD.%26aulast%3DMolinoff%26aufirst%3DP.%2BB.%26atitle%3DAripiprazole%252C%2520a%2520Novel%2520Antipsychotic%252C%2520Is%2520a%2520High-Affinity%2520Partial%2520Agonist%2520at%2520Human%2520Dopamine%2520D2%2520Receptors%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2002%26volume%3D302%26spage%3D381%26epage%3D389%26doi%3D10.1124%2Fjpet.102.033175" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Kiss, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Horvath, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nemethy, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laszlovszky, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bugovics, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fazekas, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hornok, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orosz, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gyertyan, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Agai-Csongor, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Domany, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tihanyi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adham, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Szombathelyi, Z.</span><span> </span><span class="NLM_article-title">Cariprazine (RGH-188), a Dopamine D3 Receptor-Preferring, D3/D2 Dopamine Receptor Antagonist-Partial Agonist Antipsychotic Candidate: In Vitro and Neurochemical Profile</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">333</span><span class="NLM_x">, </span> <span class="NLM_fpage">328</span><span class="NLM_x">–</span> <span class="NLM_lpage">340</span><span class="refDoi"> DOI: 10.1124/jpet.109.160432</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01857&amp;key=10.1124%2Fjpet.109.160432" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01857&amp;key=20093397" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01857&amp;key=1%3ACAS%3A528%3ADC%252BC3cXkvFGktLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=333&publication_year=2010&pages=328-340&author=B.+Kissauthor=A.+Horvathauthor=Z.+Nemethyauthor=E.+Schmidtauthor=I.+Laszlovszkyauthor=G.+Bugovicsauthor=K.+Fazekasauthor=K.+Hornokauthor=S.+Oroszauthor=I.+Gyertyanauthor=E.+Agai-Csongorauthor=G.+Domanyauthor=K.+Tihanyiauthor=N.+Adhamauthor=Z.+Szombathelyi&title=Cariprazine+%28RGH-188%29%2C+a+Dopamine+D3+Receptor-Preferring%2C+D3%2FD2+Dopamine+Receptor+Antagonist-Partial+Agonist+Antipsychotic+Candidate%3A+In+Vitro+and+Neurochemical+Profile&doi=10.1124%2Fjpet.109.160432"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Cariprazine (RGH-188), a dopamine D3 receptor-preferring, D3/D2 dopamine receptor antagonist-partial agonist antipsychotic candidate: in vitro and neurochemical profile</span></div><div class="casAuthors">Kiss, Bela; Horvath, Attila; Nemethy, Zsolt; Schmidt, Eva; Laszlovszky, Istvan; Bugovics, Gyula; Fazekas, Karoly; Hornok, Katalin; Orosz, Szabolcs; Gyertyan, Istvan; Agai-Csongor, Eva; Domany, Gyorgy; Tihanyi, Karoly; Adham, Nika; Szombathelyi, Zsolt</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">333</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">328-340</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Cariprazine {RGH-188; trans-N-[4-[2-[4-(2,3-dichlorophenyl)piperazin-1-yl]ethyl]cyclohexyl]-N',N'-dimethylurea hydrochloride}, a novel candidate antipsychotic, demonstrated approx. 10-fold higher affinity for human D3 vs. human D2L and human D2S receptors (pKi 10.07, 9.16, and 9.31, resp.).  It displayed high affinity at human serotonin (5-HT) type 2B receptors (pKi 9.24) with pure antagonism.  Cariprazine had lower affinity at human and rat hippocampal 5-HT1A receptors (pKi 8.59 and 8.34, resp.) and demonstrated low intrinsic efficacy.  Cariprazine displayed low affinity at human 5-HT2A receptors (pKi 7.73).  Moderate or low affinity for histamine H1 and 5-HT2C receptors (pKi 7.63 and 6.87, resp.) suggest cariprazine's reduced propensity for adverse events related to these receptors.  Cariprazine demonstrated different functional profiles at dopamine receptors depending on the assay system.  It displayed D2 and D3 antagonism in [35S]GTPγS binding assays, but stimulated inositol phosphate (IP) prodn. (pEC50 8.50, Emax 30%) and antagonized (±)-quinpirole-induced IP accumulation (pKb 9.22) in murine cells expressing human D2L receptors.  It had partial agonist activity (pEC50 8.58, Emax 71%) by inhibiting cAMP accumulation in Chinese hamster ovary cells expressing human D3 receptors and potently antagonized R(+)-2-dipropylamino-7-hydroxy-1,2,3,4-tetrahydronaphthalene HBr (7-OH-DPAT)-induced suppression of cAMP formation (pKb 9.57).  In these functional assays, cariprazine showed similar (D2) or higher (D3) antagonist-partial agonist affinity and greater (3- to 10-fold) D3 vs. D2 selectivity compared with aripiprazole.  In in vivo turnover and biosynthesis expts., cariprazine demonstrated D2-related partial agonist and antagonist properties, depending on actual dopaminergic tone.  The antagonist-partial agonist properties of cariprazine at D3 and D2 receptors, with very high and preferential affinity to D3 receptors, make it a candidate antipsychotic with a unique pharmacol. profile among known antipsychotics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrk5eSWEiD1ibVg90H21EOLACvtfcHk0ljuVojc9SlcOg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXkvFGktLs%253D&md5=3a949dfc5f907c0a72f24b61af2a944e</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1124%2Fjpet.109.160432&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.109.160432%26sid%3Dliteratum%253Aachs%26aulast%3DKiss%26aufirst%3DB.%26aulast%3DHorvath%26aufirst%3DA.%26aulast%3DNemethy%26aufirst%3DZ.%26aulast%3DSchmidt%26aufirst%3DE.%26aulast%3DLaszlovszky%26aufirst%3DI.%26aulast%3DBugovics%26aufirst%3DG.%26aulast%3DFazekas%26aufirst%3DK.%26aulast%3DHornok%26aufirst%3DK.%26aulast%3DOrosz%26aufirst%3DS.%26aulast%3DGyertyan%26aufirst%3DI.%26aulast%3DAgai-Csongor%26aufirst%3DE.%26aulast%3DDomany%26aufirst%3DG.%26aulast%3DTihanyi%26aufirst%3DK.%26aulast%3DAdham%26aufirst%3DN.%26aulast%3DSzombathelyi%26aufirst%3DZ.%26atitle%3DCariprazine%2520%2528RGH-188%2529%252C%2520a%2520Dopamine%2520D3%2520Receptor-Preferring%252C%2520D3%252FD2%2520Dopamine%2520Receptor%2520Antagonist-Partial%2520Agonist%2520Antipsychotic%2520Candidate%253A%2520In%2520Vitro%2520and%2520Neurochemical%2520Profile%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2010%26volume%3D333%26spage%3D328%26epage%3D340%26doi%3D10.1124%2Fjpet.109.160432" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Maeda, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sugino, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akazawa, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amada, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shimada, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Futamura, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamashita, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ito, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McQuade, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mørk, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pehrson, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hentzer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nielsen, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bundgaard, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arnt, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stensbøl, T. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kikuchi, T.</span><span> </span><span class="NLM_article-title">Brexpiprazole I: In Vitro and in Vivo Characterization of a Novel Serotonin-Dopamine Activity Modulator</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">350</span><span class="NLM_x">, </span> <span class="NLM_fpage">589</span><span class="refDoi"> DOI: 10.1124/jpet.114.213793</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01857&amp;key=10.1124%2Fjpet.114.213793" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01857&amp;key=24947465" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01857&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhs1artLrI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=350&publication_year=2014&pages=589&author=K.+Maedaauthor=H.+Suginoauthor=H.+Akazawaauthor=N.+Amadaauthor=J.+Shimadaauthor=T.+Futamuraauthor=H.+Yamashitaauthor=N.+Itoauthor=R.+D.+McQuadeauthor=A.+M%C3%B8rkauthor=A.+L.+Pehrsonauthor=M.+Hentzerauthor=V.+Nielsenauthor=C.+Bundgaardauthor=J.+Arntauthor=T.+B.+Stensb%C3%B8lauthor=T.+Kikuchi&title=Brexpiprazole+I%3A+In+Vitro+and+in+Vivo+Characterization+of+a+Novel+Serotonin-Dopamine+Activity+Modulator&doi=10.1124%2Fjpet.114.213793"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Brexpiprazole I: in vitro and in vivo characterization of a novel serotonin-dopamine activity modulator</span></div><div class="casAuthors">Maeda, Kenji; Sugino, Haruhiko; Akazawa, Hitomi; Amada, Naoki; Shimada, Jun; Futamura, Takashi; Yamashita, Hiroshi; Ito, Nobuaki; McQuade, Robert D.; Moerk, Arne; Pehrson, Alan L.; Hentzer, Morten; Nielsen, Vibeke; Bundgaard, Christoffer; Arnt, Joern; Stensboel, Tine Bryan; Kikuchi, Tetsuro</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">350</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">589-604, 16 pp.</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">1521-0103</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Brexpiprazole (OPC-34712, 7-{4-[4-(1-benzothiophen-4-yl) piperazin-1-yl]butoxy}quinolin-2(1H)-one) is a novel drug candidate in clin. development for psychiatric disorders with high affinity for serotonin, dopamine, and noradrenaline receptors.  In particular, it bound with high affinity (Ki < 1 nM) to human serotonin 1A (h5-HT1A)-, h5-HT2A-, long form of human D2(hD2L)-, hα1B-, and hα2C-adrenergic receptors.  It displayed partial agonism at h5-HT1A and hD2 receptors in cloned receptor systems and potent antagonism of h5-HT2A receptors and hα1B/2C-adrenoceptors.  Brexpiprazole also had affinity (Ki < 5 nM) for hD3-, h5-HT2B-, h5-HT7-, hα1A-, and hα1D-adrenergic receptors, moderate affinity for hH1 (Ki = 19 nM), and low affinity for hM1 receptors (K1 > 1000 nM).  Brexpiprazole potently bound to rat 5-HT2A and D2 receptors in vivo, and ex vivo binding studies further confirmed high 5-HT1A receptor binding potency.  Brexpiprazole inhibited DOI (2,5-dimethoxy-4-iodoamphetamine)-induced head twitches in rats, suggestive of 5-HT2A antagonism.  Furthermore, in vivo D2 partial agonist activity of brexpiprazole was confirmed by its inhibitory effect on reserpine-induced DOPA accumulation in rats.  In rat microdialysis studies, brexpiprazole slightly reduced extracellular dopamine in nucleus accumbens but not in prefrontal cortex, whereas moderate increases of the dopamine metabolites, homovanillic acid and DOPAC (3,4-dihydroxy-phenyl-acetic acid), in these areas also suggested in vivo D2 partial agonist activity.  In particular, based on a lower intrinsic activity at D2 receptors and higher binding affinities for 5-HT1A/2A receptors than aripiprazole, brexpiprazole would have a favorable antipsychotic potential without D2 receptor agonist- and antagonist-related adverse effects.  In conclusion, brexpiprazole is a serotonin-dopamine activity modulator with a unique pharmacol., which may offer novel treatment options across a broad spectrum of central nervous system disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqOd8uBhM0Ua7Vg90H21EOLACvtfcHk0lg8XHtJ92valg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhs1artLrI&md5=9e0436e35bbb10762bc42b3552a33341</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1124%2Fjpet.114.213793&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.114.213793%26sid%3Dliteratum%253Aachs%26aulast%3DMaeda%26aufirst%3DK.%26aulast%3DSugino%26aufirst%3DH.%26aulast%3DAkazawa%26aufirst%3DH.%26aulast%3DAmada%26aufirst%3DN.%26aulast%3DShimada%26aufirst%3DJ.%26aulast%3DFutamura%26aufirst%3DT.%26aulast%3DYamashita%26aufirst%3DH.%26aulast%3DIto%26aufirst%3DN.%26aulast%3DMcQuade%26aufirst%3DR.%2BD.%26aulast%3DM%25C3%25B8rk%26aufirst%3DA.%26aulast%3DPehrson%26aufirst%3DA.%2BL.%26aulast%3DHentzer%26aufirst%3DM.%26aulast%3DNielsen%26aufirst%3DV.%26aulast%3DBundgaard%26aufirst%3DC.%26aulast%3DArnt%26aufirst%3DJ.%26aulast%3DStensb%25C3%25B8l%26aufirst%3DT.%2BB.%26aulast%3DKikuchi%26aufirst%3DT.%26atitle%3DBrexpiprazole%2520I%253A%2520In%2520Vitro%2520and%2520in%2520Vivo%2520Characterization%2520of%2520a%2520Novel%2520Serotonin-Dopamine%2520Activity%2520Modulator%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2014%26volume%3D350%26spage%3D589%26doi%3D10.1124%2Fjpet.114.213793" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Citrome, L.</span><span> </span><span class="NLM_article-title">The ABC’s of Dopamine Receptor Partial Agonists – Aripiprazole, Brexpiprazole and Cariprazine: The 15-min Challenge to Sort These Agents Out</span> <span class="citation_source-journal">Int. J. Clin. Pract.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">69</span><span class="NLM_x">, </span> <span class="NLM_fpage">1211</span><span class="NLM_x">–</span> <span class="NLM_lpage">1220</span><span class="refDoi"> DOI: 10.1111/ijcp.12752</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01857&amp;key=10.1111%2Fijcp.12752" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01857&amp;key=26477545" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01857&amp;key=1%3ACAS%3A280%3ADC%252BC28zivVOruw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2015&pages=1211-1220&author=L.+Citrome&title=The+ABC%E2%80%99s+of+Dopamine+Receptor+Partial+Agonists+%E2%80%93+Aripiprazole%2C+Brexpiprazole+and+Cariprazine%3A+The+15-min+Challenge+to+Sort+These+Agents+Out&doi=10.1111%2Fijcp.12752"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">The ABC's of dopamine receptor partial agonists - aripiprazole, brexpiprazole and cariprazine: the 15-min challenge to sort these agents out</span></div><div class="casAuthors">Citrome L</div><div class="citationInfo"><span class="NLM_cas:title">International journal of clinical practice</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">69</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1211-20</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcR5dufhzNPDzckU0YCbOU3EfW6udTcc2eZxng3TEhWuMLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC28zivVOruw%253D%253D&md5=ed3806f83eb24513241153fcb0bc65e0</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1111%2Fijcp.12752&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fijcp.12752%26sid%3Dliteratum%253Aachs%26aulast%3DCitrome%26aufirst%3DL.%26atitle%3DThe%2520ABC%25E2%2580%2599s%2520of%2520Dopamine%2520Receptor%2520Partial%2520Agonists%2520%25E2%2580%2593%2520Aripiprazole%252C%2520Brexpiprazole%2520and%2520Cariprazine%253A%2520The%252015-min%2520Challenge%2520to%2520Sort%2520These%2520Agents%2520Out%26jtitle%3DInt.%2520J.%2520Clin.%2520Pract.%26date%3D2015%26volume%3D69%26spage%3D1211%26epage%3D1220%26doi%3D10.1111%2Fijcp.12752" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Möller, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kling, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skultety, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leuner, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hübner, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gmeiner, P.</span><span> </span><span class="NLM_article-title">Functionally Selective Dopamine D2, D3 Receptor Partial Agonists</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">4861</span><span class="NLM_x">–</span> <span class="NLM_lpage">4875</span><span class="refDoi"> DOI: 10.1021/jm5004039</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm5004039" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=4861-4875&author=D.+M%C3%B6llerauthor=R.+C.+Klingauthor=M.+Skultetyauthor=K.+Leunerauthor=H.+H%C3%BCbnerauthor=P.+Gmeiner&title=Functionally+Selective+Dopamine+D2%2C+D3+Receptor+Partial+Agonists&doi=10.1021%2Fjm5004039"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1021%2Fjm5004039&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm5004039%26sid%3Dliteratum%253Aachs%26aulast%3DM%25C3%25B6ller%26aufirst%3DD.%26aulast%3DKling%26aufirst%3DR.%2BC.%26aulast%3DSkultety%26aufirst%3DM.%26aulast%3DLeuner%26aufirst%3DK.%26aulast%3DH%25C3%25BCbner%26aufirst%3DH.%26aulast%3DGmeiner%26aufirst%3DP.%26atitle%3DFunctionally%2520Selective%2520Dopamine%2520D2%252C%2520D3%2520Receptor%2520Partial%2520Agonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D4861%26epage%3D4875%26doi%3D10.1021%2Fjm5004039" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Allen, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yost, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Setola, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sassano, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peterson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yadav, P. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, X. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feng, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jensen, N. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Che, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bai, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frye, S. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wetsel, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caron, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Javitch, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roth, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jin, J.</span><span> </span><span class="NLM_article-title">Discovery of Beta-Arrestin-Biased Dopamine D2 Ligands for Probing Signal Transduction Pathways Essential for Antipsychotic Efficacy</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">108</span><span class="NLM_x">, </span> <span class="NLM_fpage">18488</span><span class="NLM_x">–</span> <span class="NLM_lpage">18493</span><span class="refDoi"> DOI: 10.1073/pnas.1104807108</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01857&amp;key=10.1073%2Fpnas.1104807108" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01857&amp;key=22025698" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01857&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsFymtLzK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=108&publication_year=2011&pages=18488-18493&author=J.+A.+Allenauthor=J.+M.+Yostauthor=V.+Setolaauthor=X.+Chenauthor=M.+F.+Sassanoauthor=M.+Chenauthor=S.+Petersonauthor=P.+N.+Yadavauthor=X.+P.+Huangauthor=B.+Fengauthor=N.+H.+Jensenauthor=X.+Cheauthor=X.+Baiauthor=S.+V.+Fryeauthor=W.+C.+Wetselauthor=M.+G.+Caronauthor=J.+A.+Javitchauthor=B.+L.+Rothauthor=J.+Jin&title=Discovery+of+Beta-Arrestin-Biased+Dopamine+D2+Ligands+for+Probing+Signal+Transduction+Pathways+Essential+for+Antipsychotic+Efficacy&doi=10.1073%2Fpnas.1104807108"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of β-arrestin-biased dopamine D2 ligands for probing signal transduction pathways essential for antipsychotic efficacy</span></div><div class="casAuthors">Allen, John A.; Yost, Julianne M.; Setola, Vincent; Chen, Xin; Sassano, Maria F.; Chen, Meng; Peterson, Sean; Yadav, Prem N.; Huang, Xi-Ping; Feng, Bo; Jensen, Niels H.; Che, Xin; Bai, Xu; Frye, Stephen V.; Wetsel, William C.; Caron, Marc G.; Javitch, Jonathan A.; Roth, Bryan L.; Jin, Jian</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">108</span>
        (<span class="NLM_cas:issue">45</span>),
    <span class="NLM_cas:pages">18488-18493, S18488/1-S18488/15</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Elucidating the key signal transduction pathways essential for both antipsychotic efficacy and side-effect profiles is essential for developing safer and more effective therapies.  Recent work has highlighted noncanonical modes of dopamine D2 receptor (D2R) signaling via β-arrestins as being important for the therapeutic actions of both antipsychotic and antimanic agents.  We thus sought to create unique D2R agonists that display signaling bias via β-arrestinergic signaling.  Through a robust diversity-oriented modification of the scaffold represented by aripiprazole (1), we discovered UNC9975 (2), UNC0006 (3); and UNC9994 (4) as unprecedented β-arrestin-biased D2R ligands.  These compds. also represent unprecedented β-arrestin-biased ligands for a Gi-coupled G protein-coupled receptor (GPCR).  Significantly, UNC9975, UNC0006, and UNC9994 are simultaneously antagonists of Gi-regulated cAMP prodn. and partial agonists for D2R/β-arrestin-2 interactions.  Importantly, VNC9975 displayed potent antipsychotic-like activity without inducing motoric side effects in inbred C57BL/6 mice in vivo.  Genetic deletion of β-arrestin-2 simultaneously attenuated the antipsychotic actions of UNC9975 and transformed it into a typical antipsychotic .drug with a high propensity to induce catalepsy.  Similarly, the antipsychotic-like activity displayed by UNC9994, an extremely β-arrestin-biased D2R agonist, in wild-type mice was completely abolished in β-arrestin-2 knockout mice.  Taken together, our results suggest that β-arrestin signaling and recruitment can be simultaneously a significant contributor to antipsychotic efficacy and protective against motoric side effects.  These functionally selective, β-arrestin-biased D2R ligands represent valuable chem. probes for further investigations of D2R signaling in health and disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr87mjP6jm447Vg90H21EOLACvtfcHk0lg8XHtJ92valg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsFymtLzK&md5=d5b06e4ac4d2cc4cd04fd1de760ec628</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1104807108&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1104807108%26sid%3Dliteratum%253Aachs%26aulast%3DAllen%26aufirst%3DJ.%2BA.%26aulast%3DYost%26aufirst%3DJ.%2BM.%26aulast%3DSetola%26aufirst%3DV.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DSassano%26aufirst%3DM.%2BF.%26aulast%3DChen%26aufirst%3DM.%26aulast%3DPeterson%26aufirst%3DS.%26aulast%3DYadav%26aufirst%3DP.%2BN.%26aulast%3DHuang%26aufirst%3DX.%2BP.%26aulast%3DFeng%26aufirst%3DB.%26aulast%3DJensen%26aufirst%3DN.%2BH.%26aulast%3DChe%26aufirst%3DX.%26aulast%3DBai%26aufirst%3DX.%26aulast%3DFrye%26aufirst%3DS.%2BV.%26aulast%3DWetsel%26aufirst%3DW.%2BC.%26aulast%3DCaron%26aufirst%3DM.%2BG.%26aulast%3DJavitch%26aufirst%3DJ.%2BA.%26aulast%3DRoth%26aufirst%3DB.%2BL.%26aulast%3DJin%26aufirst%3DJ.%26atitle%3DDiscovery%2520of%2520Beta-Arrestin-Biased%2520Dopamine%2520D2%2520Ligands%2520for%2520Probing%2520Signal%2520Transduction%2520Pathways%2520Essential%2520for%2520Antipsychotic%2520Efficacy%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2011%26volume%3D108%26spage%3D18488%26epage%3D18493%26doi%3D10.1073%2Fpnas.1104807108" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Chen, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCorvy, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fischer, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Butler, K. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roth, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jin, J.</span><span> </span><span class="NLM_article-title">Discovery of G Protein-Biased D2 Dopamine Receptor Partial Agonists</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">10601</span><span class="NLM_x">–</span> <span class="NLM_lpage">10618</span><span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b01208</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b01208" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01857&amp;key=1%3ACAS%3A528%3ADC%252BC28XhslOqs7vK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=10601-10618&author=X.+Chenauthor=J.+D.+McCorvyauthor=M.+G.+Fischerauthor=K.+V.+Butlerauthor=Y.+Shenauthor=B.+L.+Rothauthor=J.+Jin&title=Discovery+of+G+Protein-Biased+D2+Dopamine+Receptor+Partial+Agonists&doi=10.1021%2Facs.jmedchem.6b01208"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of G Protein-Biased D2 Dopamine Receptor Partial Agonists</span></div><div class="casAuthors">Chen, Xin; McCorvy, John D.; Fischer, Matthew G.; Butler, Kyle V.; Shen, Yudao; Roth, Bryan L.; Jin, Jian</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">10601-10618</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Biased ligands (also known as functionally selective ligands) of G protein-coupled receptors are valuable tools for dissecting the roles of G protein-dependent and independent signaling pathways in health and disease.  Biased ligands have also been increasingly pursued by the biomedical community as promising therapeutics with improved efficacy and reduced side effects compared with unbiased ligands.  The authors previously discovered first-in-class β-arrestin-biased agonists of dopamine D2 receptor (D2R) by extensively exploring multiple regions of aripiprazole, a balanced D2R agonist.  In the authors' continuing efforts to identify biased agonists of D2R, the authors unexpectedly discovered a G protein-biased agonist of D2R, compd. 1 (5-(4-(4-(2,3-dichlorophenyl)piperazin-1-yl)butoxy)-2-methylbenzo[d]thiazole), which is the first G protein-biased D2R agonist from the aripiprazole scaffold.  The authors designed and synthesized novel analogs to explore two regions of 1 and conducted structure-functional selectivity relationship (SFSR) studies.  Here the authors report the discovery of 1, findings from the authors' SFSR studies, and characterization of novel G protein-biased D2R agonists.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoeKlhGCqSPxLVg90H21EOLACvtfcHk0ljQtWzlFTbarQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhslOqs7vK&md5=81b1435b1ae82438aa3f270f7ee4f853</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b01208&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b01208%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DX.%26aulast%3DMcCorvy%26aufirst%3DJ.%2BD.%26aulast%3DFischer%26aufirst%3DM.%2BG.%26aulast%3DButler%26aufirst%3DK.%2BV.%26aulast%3DShen%26aufirst%3DY.%26aulast%3DRoth%26aufirst%3DB.%2BL.%26aulast%3DJin%26aufirst%3DJ.%26atitle%3DDiscovery%2520of%2520G%2520Protein-Biased%2520D2%2520Dopamine%2520Receptor%2520Partial%2520Agonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D10601%26epage%3D10618%26doi%3D10.1021%2Facs.jmedchem.6b01208" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Chen, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sassano, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zheng, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Setola, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bai, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frye, S. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wetsel, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roth, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jin, J.</span><span> </span><span class="NLM_article-title">Structure-Functional Selectivity Relationship Studies of Beta-Arrestin-Biased Dopamine D2 Receptor Agonists</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">7141</span><span class="NLM_x">–</span> <span class="NLM_lpage">7153</span><span class="refDoi"> DOI: 10.1021/jm300603y</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm300603y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=7141-7153&author=X.+Chenauthor=M.+F.+Sassanoauthor=L.+Zhengauthor=V.+Setolaauthor=M.+Chenauthor=X.+Baiauthor=S.+V.+Fryeauthor=W.+C.+Wetselauthor=B.+L.+Rothauthor=J.+Jin&title=Structure-Functional+Selectivity+Relationship+Studies+of+Beta-Arrestin-Biased+Dopamine+D2+Receptor+Agonists&doi=10.1021%2Fjm300603y"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1021%2Fjm300603y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300603y%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DX.%26aulast%3DSassano%26aufirst%3DM.%2BF.%26aulast%3DZheng%26aufirst%3DL.%26aulast%3DSetola%26aufirst%3DV.%26aulast%3DChen%26aufirst%3DM.%26aulast%3DBai%26aufirst%3DX.%26aulast%3DFrye%26aufirst%3DS.%2BV.%26aulast%3DWetsel%26aufirst%3DW.%2BC.%26aulast%3DRoth%26aufirst%3DB.%2BL.%26aulast%3DJin%26aufirst%3DJ.%26atitle%3DStructure-Functional%2520Selectivity%2520Relationship%2520Studies%2520of%2520Beta-Arrestin-Biased%2520Dopamine%2520D2%2520Receptor%2520Agonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D7141%26epage%3D7153%26doi%3D10.1021%2Fjm300603y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Shonberg, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herenbrink, C. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lopez, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christopoulos, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scammells, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Capuano, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lane, J. R.</span><span> </span><span class="NLM_article-title">A Structure-Activity Analysis of Biased Agonism at the Dopamine D2 Receptor</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">9199</span><span class="NLM_x">–</span> <span class="NLM_lpage">9221</span><span class="refDoi"> DOI: 10.1021/jm401318w</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm401318w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01857&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhs1CktrbJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=9199-9221&author=J.+Shonbergauthor=C.+K.+Herenbrinkauthor=L.+Lopezauthor=A.+Christopoulosauthor=P.+J.+Scammellsauthor=B.+Capuanoauthor=J.+R.+Lane&title=A+Structure-Activity+Analysis+of+Biased+Agonism+at+the+Dopamine+D2+Receptor&doi=10.1021%2Fjm401318w"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">A Structure-Activity Analysis of Biased Agonism at the Dopamine D2 Receptor</span></div><div class="casAuthors">Shonberg, Jeremy; Herenbrink, Carmen Klein; Lopez, Laura; Christopoulos, Arthur; Scammells, Peter J.; Capuano, Ben; Lane, J. Robert</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">9199-9221</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Biased agonism offers an opportunity for the medicinal chemist to discover pathway-selective ligands for GPCRs.  A no. of studies have suggested that biased agonism at the dopamine D2 receptor (D2R) may be advantageous for the treatment of neuropsychiatric disorders, including schizophrenia.  As such, it is of great importance to gain insight into the SAR of biased agonism at this receptor.  The authors have generated SAR based on a novel D2R partial agonist, tert-Bu (trans-4-(2-(3,4-dihydroisoquinolin-2-(1H)-yl)-ethyl)-cyclohexyl)-carbamate.  This ligand shares structural similarity to cariprazine, a drug awaiting FDA approval for the treatment of schizophrenia, yet displays a distinct bias toward two different signaling end points.  The authors synthesized a no. of derivs. of tert-Bu (trans-4-(2-(3,4-dihydroisoquinolin-2-(1H)-yl)-ethyl)-cyclohexyl)-carbamate with subtle structural modifications, including incorporation of cariprazine fragments.  By combining pharmacol. profiling with anal. methodol. to identify and to quantify bias, the authors have demonstrated that efficacy and biased agonism can be finely tuned by minor structural modifications to the head group contg. the tertiary amine, a tail group that extends away from this moiety, and the orientation and length of a spacer region between these two moieties.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGocktbsOBHWB7Vg90H21EOLACvtfcHk0ljQtWzlFTbarQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhs1CktrbJ&md5=124b940132336819740ec30d2962a3a3</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1021%2Fjm401318w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm401318w%26sid%3Dliteratum%253Aachs%26aulast%3DShonberg%26aufirst%3DJ.%26aulast%3DHerenbrink%26aufirst%3DC.%2BK.%26aulast%3DLopez%26aufirst%3DL.%26aulast%3DChristopoulos%26aufirst%3DA.%26aulast%3DScammells%26aufirst%3DP.%2BJ.%26aulast%3DCapuano%26aufirst%3DB.%26aulast%3DLane%26aufirst%3DJ.%2BR.%26atitle%3DA%2520Structure-Activity%2520Analysis%2520of%2520Biased%2520Agonism%2520at%2520the%2520Dopamine%2520D2%2520Receptor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D9199%26epage%3D9221%26doi%3D10.1021%2Fjm401318w" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Costa-Neto, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parreiras-e-Silva, L. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bouvier, M.</span><span> </span><span class="NLM_article-title">A Pluridimensional View of Biased Agonism</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">90</span><span class="NLM_x">, </span> <span class="NLM_fpage">587</span><span class="NLM_x">–</span> <span class="NLM_lpage">595</span><span class="refDoi"> DOI: 10.1124/mol.116.105940</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01857&amp;key=10.1124%2Fmol.116.105940" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01857&amp;key=27638872" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01857&amp;key=1%3ACAS%3A528%3ADC%252BC2sXitVaktbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=90&publication_year=2016&pages=587-595&author=C.+M.+Costa-Netoauthor=L.+T.+Parreiras-e-Silvaauthor=M.+Bouvier&title=A+Pluridimensional+View+of+Biased+Agonism&doi=10.1124%2Fmol.116.105940"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">A pluridimensional view of biased agonism</span></div><div class="casAuthors">Costa-Neto, Claudio M.; Parreiras-e-Silva, Lucas T.; Bouvier, Michel</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmacology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">90</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">587-595</span>CODEN:
                <span class="NLM_cas:coden">MOPMA3</span>;
        ISSN:<span class="NLM_cas:issn">1521-0111</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">A review.  When studying G protein-coupled receptor (GPCR) signaling and ligand-biased agonism, at least three dimensional spaces must be considered, as follows: (1) the distinct conformations that can be stabilized by different ligands promoting the engagement of different signaling effectors and accessory regulators; (2) the distinct subcellular trafficking that can be conferred by different ligands, which results in spatially distinct signals; and (3) the differential binding kinetics that maintain the receptor in specific conformation and/or subcellular localization for different periods of time, allowing for the engagement of distinct signaling effector subsets.  These three pluridimensional aspects of signaling contribute to different faces of functional selectivity and provide a complex, interconnected way to define the signaling profile of each individual ligand acting at GPCRs.  In this review, we discuss how each of these aspects may contribute to the diversity of signaling, but also how they shed light on the complexity of data analyses and interpretation.  The impact of phenotype variability as a source of signaling diversity, and the influence of novel and more sensitive assays in the detection and anal. of signaling pluridimensionality, is also discussed.  Finally, we discuss perspectives for the use of the concept of pluridimensional signaling in drug discovery, in which we highlight future predictive tools that may facilitate the identification of compds. with optimal therapeutic and safety properties based on the signaling signatures of drug candidates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo1fNh8j-db6LVg90H21EOLACvtfcHk0li3VAjbuS1fMg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXitVaktbc%253D&md5=959701333007f859e11126cc6629336e</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1124%2Fmol.116.105940&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.116.105940%26sid%3Dliteratum%253Aachs%26aulast%3DCosta-Neto%26aufirst%3DC.%2BM.%26aulast%3DParreiras-e-Silva%26aufirst%3DL.%2BT.%26aulast%3DBouvier%26aufirst%3DM.%26atitle%3DA%2520Pluridimensional%2520View%2520of%2520Biased%2520Agonism%26jtitle%3DMol.%2520Pharmacol.%26date%3D2016%26volume%3D90%26spage%3D587%26epage%3D595%26doi%3D10.1124%2Fmol.116.105940" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Galandrin, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oligny-Longpré, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bouvier, M.</span><span> </span><span class="NLM_article-title">The Evasive Nature of Drug Efficacy: Implications for Drug Discovery</span> <span class="citation_source-journal">Trends Pharmacol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">423</span><span class="NLM_x">–</span> <span class="NLM_lpage">430</span><span class="refDoi"> DOI: 10.1016/j.tips.2007.06.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01857&amp;key=10.1016%2Fj.tips.2007.06.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01857&amp;key=17659355" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01857&amp;key=1%3ACAS%3A528%3ADC%252BD2sXotlWltb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2007&pages=423-430&author=S.+Galandrinauthor=G.+Oligny-Longpr%C3%A9author=M.+Bouvier&title=The+Evasive+Nature+of+Drug+Efficacy%3A+Implications+for+Drug+Discovery&doi=10.1016%2Fj.tips.2007.06.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">The evasive nature of drug efficacy: implications for drug discovery</span></div><div class="casAuthors">Galandrin, Segolene; Oligny-Longpre, Genevieve; Bouvier, Michel</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Pharmacological Sciences</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">423-430</span>CODEN:
                <span class="NLM_cas:coden">TPHSDY</span>;
        ISSN:<span class="NLM_cas:issn">0165-6147</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  The efficacy of a drug is generally detd. by the drug's ability to promote a quantifiable biol. response.  In the context of the classical receptor-occupancy theory, the efficacy is considered an intrinsic property of the ligand/receptor pair, and it is often assumed to be the same for all the responses evoked by this pair.  The recognition that a single receptor can engage different signaling pathways and that various drugs binding to this receptor might differentially influence each of these pathways led to the reassessment of the efficacy concept.  Of particular notice is the fact that ligands that behave as agonists toward a given signaling pathway can act, through the same receptor, as antagonists or even inverse agonists on a different pathway in the same cell.  These observations, variously referred to as 'ligand-directed trafficking of receptor signaling' (LDTRS), functional selectivity', 'biased agonism', 'ligand-biased efficacy', 'collateral efficacy' or 'pluridimensional efficacy', have important implications for the mol. definition of efficacy and the process of drug discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrY1ZaH2DyMSrVg90H21EOLACvtfcHk0li3VAjbuS1fMg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXotlWltb4%253D&md5=d0db88b9a041d115cd9f739854a5d480</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1016%2Fj.tips.2007.06.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tips.2007.06.005%26sid%3Dliteratum%253Aachs%26aulast%3DGalandrin%26aufirst%3DS.%26aulast%3DOligny-Longpr%25C3%25A9%26aufirst%3DG.%26aulast%3DBouvier%26aufirst%3DM.%26atitle%3DThe%2520Evasive%2520Nature%2520of%2520Drug%2520Efficacy%253A%2520Implications%2520for%2520Drug%2520Discovery%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D2007%26volume%3D28%26spage%3D423%26epage%3D430%26doi%3D10.1016%2Fj.tips.2007.06.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Bock, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kostenis, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tränkle, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lohse, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mohr, K.</span><span> </span><span class="NLM_article-title">Pilot the Pulse: Controlling the Multiplicity of Receptor Dynamics</span> <span class="citation_source-journal">Trends Pharmacol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">35</span><span class="NLM_x">, </span> <span class="NLM_fpage">630</span><span class="NLM_x">–</span> <span class="NLM_lpage">638</span><span class="refDoi"> DOI: 10.1016/j.tips.2014.10.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01857&amp;key=10.1016%2Fj.tips.2014.10.002" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2014&pages=630-638&author=A.+Bockauthor=E.+Kostenisauthor=C.+Tr%C3%A4nkleauthor=M.+J.+Lohseauthor=K.+Mohr&title=Pilot+the+Pulse%3A+Controlling+the+Multiplicity+of+Receptor+Dynamics&doi=10.1016%2Fj.tips.2014.10.002"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1016%2Fj.tips.2014.10.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tips.2014.10.002%26sid%3Dliteratum%253Aachs%26aulast%3DBock%26aufirst%3DA.%26aulast%3DKostenis%26aufirst%3DE.%26aulast%3DTr%25C3%25A4nkle%26aufirst%3DC.%26aulast%3DLohse%26aufirst%3DM.%2BJ.%26aulast%3DMohr%26aufirst%3DK.%26atitle%3DPilot%2520the%2520Pulse%253A%2520Controlling%2520the%2520Multiplicity%2520of%2520Receptor%2520Dynamics%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D2014%26volume%3D35%26spage%3D630%26epage%3D638%26doi%3D10.1016%2Fj.tips.2014.10.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Lane, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Donthamsetti, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shonberg, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Draper-Joyce, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dentry, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Michino, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">López, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scammells, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Capuano, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sexton, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Javitch, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christopoulos, A.</span><span> </span><span class="NLM_article-title">A New Mechanism of Allostery in a G Protein–Coupled Receptor Dimer</span> <span class="citation_source-journal">Nat. Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">745</span><span class="NLM_x">–</span> <span class="NLM_lpage">752</span><span class="refDoi"> DOI: 10.1038/nchembio.1593</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01857&amp;key=10.1038%2Fnchembio.1593" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01857&amp;key=25108820" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01857&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtlahurrL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2014&pages=745-752&author=J.+R.+Laneauthor=P.+Donthamsettiauthor=J.+Shonbergauthor=C.+J.+Draper-Joyceauthor=S.+Dentryauthor=M.+Michinoauthor=L.+Shiauthor=L.+L%C3%B3pezauthor=P.+J.+Scammellsauthor=B.+Capuanoauthor=P.+M.+Sextonauthor=J.+A.+Javitchauthor=A.+Christopoulos&title=A+New+Mechanism+of+Allostery+in+a+G+Protein%E2%80%93Coupled+Receptor+Dimer&doi=10.1038%2Fnchembio.1593"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">A new mechanism of allostery in a G protein-coupled receptor dimer</span></div><div class="casAuthors">Lane, J. Robert; Donthamsetti, Prashant; Shonberg, Jeremy; Draper-Joyce, Christopher J.; Dentry, Samuel; Michino, Mayako; Shi, Lei; Lopez, Laura; Scammells, Peter J.; Capuano, Ben; Sexton, Patrick M.; Javitch, Jonathan A.; Christopoulos, Arthur</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">745-752</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">SB269652 is to our knowledge the first drug-like allosteric modulator of the dopamine D2 receptor (D2R), but it contains structural features assocd. with orthosteric D2R antagonists.  Using a functional complementation system to control the identity of individual protomers within a dimeric D2R complex, we converted the pharmacol. of the interaction between SB269652 and dopamine from allosteric to competitive by impairing ligand binding to one of the protomers, indicating that the allostery requires D2R dimers.  Addnl. expts. identified a 'bitopic' pose for SB269652 extending from the orthosteric site into a secondary pocket at the extracellular end of the transmembrane (TM) domain, involving TM2 and TM7.  Engagement of this secondary pocket was a requirement for the allosteric pharmacol. of SB269652.  This suggests a new mechanism whereby a bitopic ligand binds in an extended pose on one G protein-coupled receptor protomer to allosterically modulate the binding of a ligand to the orthosteric site of a second protomer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpBF9SXb0jATLVg90H21EOLACvtfcHk0li3VAjbuS1fMg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtlahurrL&md5=ececb5fc0e3e9b803807f700dc2c2cad</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.1593&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.1593%26sid%3Dliteratum%253Aachs%26aulast%3DLane%26aufirst%3DJ.%2BR.%26aulast%3DDonthamsetti%26aufirst%3DP.%26aulast%3DShonberg%26aufirst%3DJ.%26aulast%3DDraper-Joyce%26aufirst%3DC.%2BJ.%26aulast%3DDentry%26aufirst%3DS.%26aulast%3DMichino%26aufirst%3DM.%26aulast%3DShi%26aufirst%3DL.%26aulast%3DL%25C3%25B3pez%26aufirst%3DL.%26aulast%3DScammells%26aufirst%3DP.%2BJ.%26aulast%3DCapuano%26aufirst%3DB.%26aulast%3DSexton%26aufirst%3DP.%2BM.%26aulast%3DJavitch%26aufirst%3DJ.%2BA.%26aulast%3DChristopoulos%26aufirst%3DA.%26atitle%3DA%2520New%2520Mechanism%2520of%2520Allostery%2520in%2520a%2520G%2520Protein%25E2%2580%2593Coupled%2520Receptor%2520Dimer%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2014%26volume%3D10%26spage%3D745%26epage%3D752%26doi%3D10.1038%2Fnchembio.1593" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Weichert, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Banerjee, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hiller, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kling, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hübner, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gmeiner, P.</span><span> </span><span class="NLM_article-title">Molecular Determinants of Biased Agonism at the Dopamine D2 Receptor</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">2703</span><span class="NLM_x">–</span> <span class="NLM_lpage">2717</span><span class="refDoi"> DOI: 10.1021/jm501889t</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm501889t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01857&amp;key=1%3ACAS%3A528%3ADC%252BC2MXjslelsrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=2703-2717&author=D.+Weichertauthor=A.+Banerjeeauthor=C.+Hillerauthor=R.+C.+Klingauthor=H.+H%C3%BCbnerauthor=P.+Gmeiner&title=Molecular+Determinants+of+Biased+Agonism+at+the+Dopamine+D2+Receptor&doi=10.1021%2Fjm501889t"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular Determinants of Biased Agonism at the Dopamine D2 Receptor</span></div><div class="casAuthors">Weichert, Dietmar; Banerjee, Ashutosh; Hiller, Christine; Kling, Ralf C.; Huebner, Harald; Gmeiner, Peter</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2703-2717</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The development of biased (functionally selective) ligands provides a formidable challenge in medicinal chem.  In an effort to learn to design functionally selective mol. tools for the highly therapeutically relevant dopamine D2 receptor, we synthesized a collection of agonists based on structurally distinct head groups derived from canonical or atypical dopaminergic pharmacophores.  The test compds. feature a long lipophilic appendage that was shown to mediate biased signaling.  By employing functional assays and mol. dynamics simulations, we could show that atypical dopamine surrogates of type 1 and 2 promote biased signaling, while ligands built from classical dopaminergic head groups (type 3 and 4) typically elicit more balanced signaling profiles.  Besides this, we found a strong influence of the stereochem. of type 4 aminotetraline-derived agonists on functional selectivity at D2 receptors.  Whereas the (S)-enantiomer behaved as a full agonist, the biased ligand (R)-4 induced poor G protein coupling but substantial β-arrestin recruitment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqLUr0k5gvdy7Vg90H21EOLACvtfcHk0lhvBtsC7e5hog"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXjslelsrc%253D&md5=cdf8f3ed9dff5f14ae06dbbc227fb14a</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Fjm501889t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm501889t%26sid%3Dliteratum%253Aachs%26aulast%3DWeichert%26aufirst%3DD.%26aulast%3DBanerjee%26aufirst%3DA.%26aulast%3DHiller%26aufirst%3DC.%26aulast%3DKling%26aufirst%3DR.%2BC.%26aulast%3DH%25C3%25BCbner%26aufirst%3DH.%26aulast%3DGmeiner%26aufirst%3DP.%26atitle%3DMolecular%2520Determinants%2520of%2520Biased%2520Agonism%2520at%2520the%2520Dopamine%2520D2%2520Receptor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D2703%26epage%3D2717%26doi%3D10.1021%2Fjm501889t" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Cannon, J. G.</span><span> </span><span class="NLM_article-title">Structure-Activity Relationships of Dopamine Agonists</span> <span class="citation_source-journal">Annu. Rev. Pharmacol. Toxicol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1983</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">103</span><span class="NLM_x">–</span> <span class="NLM_lpage">129</span><span class="refDoi"> DOI: 10.1146/annurev.pa.23.040183.000535</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01857&amp;key=10.1146%2Fannurev.pa.23.040183.000535" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=1983&pages=103-129&author=J.+G.+Cannon&title=Structure-Activity+Relationships+of+Dopamine+Agonists&doi=10.1146%2Fannurev.pa.23.040183.000535"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1146%2Fannurev.pa.23.040183.000535&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev.pa.23.040183.000535%26sid%3Dliteratum%253Aachs%26aulast%3DCannon%26aufirst%3DJ.%2BG.%26atitle%3DStructure-Activity%2520Relationships%2520of%2520Dopamine%2520Agonists%26jtitle%3DAnnu.%2520Rev.%2520Pharmacol.%2520Toxicol.%26date%3D1983%26volume%3D23%26spage%3D103%26epage%3D129%26doi%3D10.1146%2Fannurev.pa.23.040183.000535" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Masri, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salahpour, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Didriksen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghisi, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beaulieu, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gainetdinov, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caron, M. G.</span><span> </span><span class="NLM_article-title">Antagonism of Dopamine D2 Receptor/Beta-Arrestin 2 Interaction Is a Common Property of Clinically Effective Antipsychotics</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">105</span><span class="NLM_x">, </span> <span class="NLM_fpage">13656</span><span class="NLM_x">–</span> <span class="NLM_lpage">13661</span><span class="refDoi"> DOI: 10.1073/pnas.0803522105</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01857&amp;key=10.1073%2Fpnas.0803522105" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=105&publication_year=2008&pages=13656-13661&author=B.+Masriauthor=A.+Salahpourauthor=M.+Didriksenauthor=V.+Ghisiauthor=J.+M.+Beaulieuauthor=R.+R.+Gainetdinovauthor=M.+G.+Caron&title=Antagonism+of+Dopamine+D2+Receptor%2FBeta-Arrestin+2+Interaction+Is+a+Common+Property+of+Clinically+Effective+Antipsychotics&doi=10.1073%2Fpnas.0803522105"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0803522105&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0803522105%26sid%3Dliteratum%253Aachs%26aulast%3DMasri%26aufirst%3DB.%26aulast%3DSalahpour%26aufirst%3DA.%26aulast%3DDidriksen%26aufirst%3DM.%26aulast%3DGhisi%26aufirst%3DV.%26aulast%3DBeaulieu%26aufirst%3DJ.%2BM.%26aulast%3DGainetdinov%26aufirst%3DR.%2BR.%26aulast%3DCaron%26aufirst%3DM.%2BG.%26atitle%3DAntagonism%2520of%2520Dopamine%2520D2%2520Receptor%252FBeta-Arrestin%25202%2520Interaction%2520Is%2520a%2520Common%2520Property%2520of%2520Clinically%2520Effective%2520Antipsychotics%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2008%26volume%3D105%26spage%3D13656%26epage%3D13661%26doi%3D10.1073%2Fpnas.0803522105" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Sandanayaka, V.; Singh, J.; Zhou, L.-M.; Gurney, M. E.</span><span> </span><span class="NLM_article-title">Biaryl Nitrogen-Heterocycle Inhibitors of LTA4H for Treating Inflammation</span>. U.S. Patent 2007/0149544A1,<span class="NLM_x"> </span><span class="NLM_year">2007</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2007&author=V.+Sandanayaka&author=J.+Singh&author=L.-M.+Zhou&author=M.+E.+Gurney&title=Biaryl+Nitrogen-Heterocycle+Inhibitors+of+LTA4H+for+Treating+Inflammation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DSandanayaka%26aufirst%3DV.%26atitle%3DBiaryl%2520Nitrogen-Heterocycle%2520Inhibitors%2520of%2520LTA4H%2520for%2520Treating%2520Inflammation%26date%3D2007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Möller, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salama, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kling, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hübner, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gmeiner, P.</span><span> </span><span class="NLM_article-title">1,4-Disubstituted Aromatic Piperazines with High 5-HT2a/D2 Selectivity: Quantitative Structure-Selectivity Investigations, Docking, Synthesis and Biological Evaluation</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">6195</span><span class="NLM_x">–</span> <span class="NLM_lpage">6209</span><span class="refDoi"> DOI: 10.1016/j.bmc.2015.07.050</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01857&amp;key=10.1016%2Fj.bmc.2015.07.050" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2015&pages=6195-6209&author=D.+M%C3%B6llerauthor=I.+Salamaauthor=R.+C.+Klingauthor=H.+H%C3%BCbnerauthor=P.+Gmeiner&title=1%2C4-Disubstituted+Aromatic+Piperazines+with+High+5-HT2a%2FD2+Selectivity%3A+Quantitative+Structure-Selectivity+Investigations%2C+Docking%2C+Synthesis+and+Biological+Evaluation&doi=10.1016%2Fj.bmc.2015.07.050"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2015.07.050&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2015.07.050%26sid%3Dliteratum%253Aachs%26aulast%3DM%25C3%25B6ller%26aufirst%3DD.%26aulast%3DSalama%26aufirst%3DI.%26aulast%3DKling%26aufirst%3DR.%2BC.%26aulast%3DH%25C3%25BCbner%26aufirst%3DH.%26aulast%3DGmeiner%26aufirst%3DP.%26atitle%3D1%252C4-Disubstituted%2520Aromatic%2520Piperazines%2520with%2520High%25205-HT2a%252FD2%2520Selectivity%253A%2520Quantitative%2520Structure-Selectivity%2520Investigations%252C%2520Docking%252C%2520Synthesis%2520and%2520Biological%2520Evaluation%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2015%26volume%3D23%26spage%3D6195%26epage%3D6209%26doi%3D10.1016%2Fj.bmc.2015.07.050" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Kendall, J. D.; Marshall, A. J.</span><span> </span><span class="NLM_article-title">Pyrazolo[1,5-<i>a</i>]Pyridine Derivatives as PI3 Kinase Inhibitors and Their Preparation, Pharmaceutical Compositions and Use in the Treatment of Cancers</span>. Patent WO2009008748A1,<span class="NLM_x"> </span><span class="NLM_year">2009</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&author=J.+D.+Kendall&author=A.+J.+Marshall&title=Pyrazolo%5B1%2C5-a%5DPyridine+Derivatives+as+PI3+Kinase+Inhibitors+and+Their+Preparation%2C+Pharmaceutical+Compositions+and+Use+in+the+Treatment+of+Cancers"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DKendall%26aufirst%3DJ.%2BD.%26atitle%3DPyrazolo%255B1%252C5-a%255DPyridine%2520Derivatives%2520as%2520PI3%2520Kinase%2520Inhibitors%2520and%2520Their%2520Preparation%252C%2520Pharmaceutical%2520Compositions%2520and%2520Use%2520in%2520the%2520Treatment%2520of%2520Cancers%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Gmeiner, P.; Huebner, H.; Skultety, M.</span><span> </span><span class="NLM_article-title">Preparation of Indolizines and Aza-Analog Derivatives Thereof as CNS Active Compounds</span>. Patent WO2008113559A2,<span class="NLM_x"> </span><span class="NLM_year">2008</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&author=P.+Gmeiner&author=H.+Huebner&author=M.+Skultety&title=Preparation+of+Indolizines+and+Aza-Analog+Derivatives+Thereof+as+CNS+Active+Compounds"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DGmeiner%26aufirst%3DP.%26atitle%3DPreparation%2520of%2520Indolizines%2520and%2520Aza-Analog%2520Derivatives%2520Thereof%2520as%2520CNS%2520Active%2520Compounds%26date%3D2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Boeckler, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohnmacht, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lehmann, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Utz, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hübner, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gmeiner, P.</span><span> </span><span class="NLM_article-title">COMFA and COMSIA Investigations Revealing Novel Insights into the Binding Modes of Dopamine D3 Receptor Agonists</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">2493</span><span class="NLM_x">–</span> <span class="NLM_lpage">2508</span><span class="refDoi"> DOI: 10.1021/jm049269+</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm049269%2B" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=2493-2508&author=F.+Boecklerauthor=U.+Ohnmachtauthor=T.+Lehmannauthor=W.+Utzauthor=H.+H%C3%BCbnerauthor=P.+Gmeiner&title=COMFA+and+COMSIA+Investigations+Revealing+Novel+Insights+into+the+Binding+Modes+of+Dopamine+D3+Receptor+Agonists&doi=10.1021%2Fjm049269%2B"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1021%2Fjm049269%2B&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm049269%252B%26sid%3Dliteratum%253Aachs%26aulast%3DBoeckler%26aufirst%3DF.%26aulast%3DOhnmacht%26aufirst%3DU.%26aulast%3DLehmann%26aufirst%3DT.%26aulast%3DUtz%26aufirst%3DW.%26aulast%3DH%25C3%25BCbner%26aufirst%3DH.%26aulast%3DGmeiner%26aufirst%3DP.%26atitle%3DCOMFA%2520and%2520COMSIA%2520Investigations%2520Revealing%2520Novel%2520Insights%2520into%2520the%2520Binding%2520Modes%2520of%2520Dopamine%2520D3%2520Receptor%2520Agonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D2493%26epage%3D2508%26doi%3D10.1021%2Fjm049269%2B" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Moffett, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hanze, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seay, P. H.</span><span> </span><span class="NLM_article-title">Central Nervous System Depressants. V. Polyhydroxy and Methoxyphenyl Ketones, Carbinols, and Derivatives</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1964</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">178</span><span class="NLM_x">–</span> <span class="NLM_lpage">186</span><span class="refDoi"> DOI: 10.1021/jm00332a013</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm00332a013" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=1964&pages=178-186&author=R.+B.+Moffettauthor=A.+R.+Hanzeauthor=P.+H.+Seay&title=Central+Nervous+System+Depressants.+V.+Polyhydroxy+and+Methoxyphenyl+Ketones%2C+Carbinols%2C+and+Derivatives&doi=10.1021%2Fjm00332a013"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1021%2Fjm00332a013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00332a013%26sid%3Dliteratum%253Aachs%26aulast%3DMoffett%26aufirst%3DR.%2BB.%26aulast%3DHanze%26aufirst%3DA.%2BR.%26aulast%3DSeay%26aufirst%3DP.%2BH.%26atitle%3DCentral%2520Nervous%2520System%2520Depressants.%2520V.%2520Polyhydroxy%2520and%2520Methoxyphenyl%2520Ketones%252C%2520Carbinols%252C%2520and%2520Derivatives%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1964%26volume%3D7%26spage%3D178%26epage%3D186%26doi%3D10.1021%2Fjm00332a013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">De Luca, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giacomelli, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Porcheddu, A.</span><span> </span><span class="NLM_article-title">Beckmann Rearrangement of Oximes under Very Mild Conditions</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">67</span><span class="NLM_x">, </span> <span class="NLM_fpage">6272</span><span class="NLM_x">–</span> <span class="NLM_lpage">6274</span><span class="refDoi"> DOI: 10.1021/jo025960d</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo025960d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01857&amp;key=1%3ACAS%3A528%3ADC%252BD38XlsFals78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2002&pages=6272-6274&author=L.+De+Lucaauthor=G.+Giacomelliauthor=A.+Porcheddu&title=Beckmann+Rearrangement+of+Oximes+under+Very+Mild+Conditions&doi=10.1021%2Fjo025960d"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Beckmann Rearrangement of Oximes under Very Mild Conditions</span></div><div class="casAuthors">De Luca, Lidia; Giacomelli, Giampaolo; Porcheddu, Andrea</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">6272-6274</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A variety of ketoximes, easily prepd. from the corresponding ketones, undergo the Beckmann rearrangement upon treatment with 2,4,6-trichloro[1,3,5]triazine in DMF at room temp. in excellent yields.  This procedure can be applied to aldoximes for obtaining the corresponding nitriles.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqHuyV4LhDjT7Vg90H21EOLACvtfcHk0lj49ERuBKcf5Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XlsFals78%253D&md5=ca020b2ef4bd9a3880baed63e669e442</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1021%2Fjo025960d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo025960d%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BLuca%26aufirst%3DL.%26aulast%3DGiacomelli%26aufirst%3DG.%26aulast%3DPorcheddu%26aufirst%3DA.%26atitle%3DBeckmann%2520Rearrangement%2520of%2520Oximes%2520under%2520Very%2520Mild%2520Conditions%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2002%26volume%3D67%26spage%3D6272%26epage%3D6274%26doi%3D10.1021%2Fjo025960d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Dulcere, J. P.</span><span> </span><span class="NLM_article-title">Vilsmeier Reagent for a High-Yield Conversion of Aldoximes to Nitriles</span> <span class="citation_source-journal">Tetrahedron Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1981</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">1599</span><span class="NLM_x">–</span> <span class="NLM_lpage">1600</span><span class="refDoi"> DOI: 10.1016/S0040-4039(01)90387-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01857&amp;key=10.1016%2FS0040-4039%2801%2990387-9" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=1981&pages=1599-1600&author=J.+P.+Dulcere&title=Vilsmeier+Reagent+for+a+High-Yield+Conversion+of+Aldoximes+to+Nitriles&doi=10.1016%2FS0040-4039%2801%2990387-9"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1016%2FS0040-4039%2801%2990387-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0040-4039%252801%252990387-9%26sid%3Dliteratum%253Aachs%26aulast%3DDulcere%26aufirst%3DJ.%2BP.%26atitle%3DVilsmeier%2520Reagent%2520for%2520a%2520High-Yield%2520Conversion%2520of%2520Aldoximes%2520to%2520Nitriles%26jtitle%3DTetrahedron%2520Lett.%26date%3D1981%26volume%3D22%26spage%3D1599%26epage%3D1600%26doi%3D10.1016%2FS0040-4039%2801%2990387-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Lane, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Powney, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wise, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rees, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milligan, G. G.</span><span> </span><span class="NLM_article-title">Protein Coupling and Ligand Selectivity of the D2L and D3 Dopamine Receptors</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">325</span><span class="NLM_x">, </span> <span class="NLM_fpage">319</span><span class="NLM_x">–</span> <span class="NLM_lpage">330</span><span class="refDoi"> DOI: 10.1124/jpet.107.134296</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01857&amp;key=10.1124%2Fjpet.107.134296" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01857&amp;key=18218829" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01857&amp;key=1%3ACAS%3A528%3ADC%252BD1cXktFGjur0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=325&publication_year=2008&pages=319-330&author=J.+R.+Laneauthor=B.+Powneyauthor=A.+Wiseauthor=S.+Reesauthor=G.+G.+Milligan&title=Protein+Coupling+and+Ligand+Selectivity+of+the+D2L+and+D3+Dopamine+Receptors&doi=10.1124%2Fjpet.107.134296"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">G protein coupling and ligand selectivity of the D2L and D3 dopamine receptors</span></div><div class="casAuthors">Lane, J. Robert; Powney, Ben; Wise, Alan; Rees, Stephen; Milligan, Graeme</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">325</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">319-330</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The human dopamine D2L receptor couples promiscuously to multiple members of the Gαi/o subfamily.  Despite the high homol. of the D2L and D3 receptors, the G protein coupling specificity of the human D3 receptor is less clearly characterized.  The primary aim of this study, then, was the parallel characterization of the G protein coupling specificity of the D2L and D3 receptors.  By using both receptor-G protein fusion proteins and stable cell lines in which pertussis toxin-resistant mutants of individual Gαi-family G proteins were expressed in an inducible fashion, we demonstrated highly selective coupling of the D3 receptor to Gαo1.  Furthermore, by using the fusion proteins to ensure identical stoichiometry of receptor to G protein for each pairing, a range of ligands displayed higher potency and, for partial agonists, higher efficacy at the D3 receptor when coupled to Gαo1 compared with the D2L receptor.  The second aim of this study was to investigate the mol. basis of the above differential G protein coupling specificity.  The importance of a 12-amino acid sequence from the C-terminal end of the third intracellular loop of the D2L receptor in providing promiscuity in G protein coupling was demonstrated using a chimeric D3/D2 receptor in which the equiv. region of the D3 receptor was exchanged for this sequence.  This chimera displayed D3-like affinity for [3H]spiperone and potency for agonists but gained D2-like ability to couple to each of Gαi1-3 as well as Gαo1.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqxa1ewwkwA2bVg90H21EOLACvtfcHk0lj49ERuBKcf5Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXktFGjur0%253D&md5=dd55e53f17554e5fdf1740b788b9028c</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1124%2Fjpet.107.134296&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.107.134296%26sid%3Dliteratum%253Aachs%26aulast%3DLane%26aufirst%3DJ.%2BR.%26aulast%3DPowney%26aufirst%3DB.%26aulast%3DWise%26aufirst%3DA.%26aulast%3DRees%26aufirst%3DS.%26aulast%3DMilligan%26aufirst%3DG.%2BG.%26atitle%3DProtein%2520Coupling%2520and%2520Ligand%2520Selectivity%2520of%2520the%2520D2L%2520and%2520D3%2520Dopamine%2520Receptors%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2008%26volume%3D325%26spage%3D319%26epage%3D330%26doi%3D10.1124%2Fjpet.107.134296" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Gazi, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strange, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nickolls, S. A.</span><span> </span><span class="NLM_article-title">Functional Coupling of the Human Dopamine D2 Receptor with Galphai1, Galphai2, Galphai3, and Galphao G Proteins: Evidence for Agonist Regulation of G Protein Selectivity</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">138</span><span class="NLM_x">, </span> <span class="NLM_fpage">775</span><span class="NLM_x">–</span> <span class="NLM_lpage">786</span><span class="refDoi"> DOI: 10.1038/sj.bjp.0705116</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01857&amp;key=10.1038%2Fsj.bjp.0705116" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01857&amp;key=12642378" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01857&amp;key=1%3ACAS%3A528%3ADC%252BD3sXisFegs7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=138&publication_year=2003&pages=775-786&author=L.+Gaziauthor=P.+G.+Strangeauthor=S.+A.+Nickolls&title=Functional+Coupling+of+the+Human+Dopamine+D2+Receptor+with+Galphai1%2C+Galphai2%2C+Galphai3%2C+and+Galphao+G+Proteins%3A+Evidence+for+Agonist+Regulation+of+G+Protein+Selectivity&doi=10.1038%2Fsj.bjp.0705116"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Functional coupling of the human dopamine D2 receptor with Gαi1, Gαi2, Gαi3 and Gαo G proteins: Evidence for agonist regulation of G protein selectivity</span></div><div class="casAuthors">Gazi, Lucien; Nickolls, Sarah A.; Strange, Philip G.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">138</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">775-786</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The human dopamine D2long (D2L) receptor was expressed with four different G proteins in Sf9 cells using the baculovirus expression system.  When co-expressed with Gi/Go G proteins (Gi1α, Gi2α, Gi3α, or Goα, plus Gβ1 and Gγ2), the receptor displayed a high-affinity binding site for the agonists (dopamine and NPA), which was sensitive to GTP (100 μM), demonstrating interaction between the receptor and the different G proteins.  The receptor to G protein ratio (R:G ratio) was evaluated using [3H]-spiperone satn. binding (R) and [35S]-GTPγS satn. binding (G).  R:G ratios of 1:12, 1:3, 1:14 and 1:5 were found for Gi1, Gi2, Gi3, and Go prepns., resp.  However, when R:G ratios of 1:2 and 1:12 were compared for Gi2 and Go, no difference was found for the stimulation of [35S]-GTPγS binding.  Several agonists were tested for their ability to stimulate [35S]-GTPγS binding to membranes co-expressing the receptor and various G proteins.  All the compds. tested showed agonist activity in prepns. expressing Gi3 and Go.  However, for Gi2 and Gi1 prepns., compds. such as S-(-)-3-PPP and p-tyramine were unable to stimulate [35S]-GTPγS binding.  Most of the compds. showed higher relative efficacies (compared to dopamine) and higher potencies in the prepn. expressing Go.  Comparison of the effects of different agonists in the different prepns. showed that each agonist differentially activates the four G proteins.  We conclude that the degree of selectivity of G protein activation by the D2L receptor can depend on the conformation of the receptor stabilized by an agonist.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpSCewgdeU6SbVg90H21EOLACvtfcHk0lj49ERuBKcf5Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXisFegs7s%253D&md5=f0417b2243b11377ab4df51a98aebaff</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjp.0705116&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjp.0705116%26sid%3Dliteratum%253Aachs%26aulast%3DGazi%26aufirst%3DL.%26aulast%3DStrange%26aufirst%3DP.%2BG.%26aulast%3DNickolls%26aufirst%3DS.%2BA.%26atitle%3DFunctional%2520Coupling%2520of%2520the%2520Human%2520Dopamine%2520D2%2520Receptor%2520with%2520Galphai1%252C%2520Galphai2%252C%2520Galphai3%252C%2520and%2520Galphao%2520G%2520Proteins%253A%2520Evidence%2520for%2520Agonist%2520Regulation%2520of%2520G%2520Protein%2520Selectivity%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2003%26volume%3D138%26spage%3D775%26epage%3D786%26doi%3D10.1038%2Fsj.bjp.0705116" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Ahlgren-Beckendorf, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levant, B.</span><span> </span><span class="NLM_article-title">Signaling Mechanisms of the D3 Dopamine Receptor</span> <span class="citation_source-journal">J. Recept. Signal Transduction Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">117</span><span class="NLM_x">–</span> <span class="NLM_lpage">130</span><span class="refDoi"> DOI: 10.1081/RRS-200029953</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01857&amp;key=10.1081%2FRRS-200029953" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01857&amp;key=15521358" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01857&amp;key=1%3ACAS%3A528%3ADC%252BD2cXnvVKhs7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2004&pages=117-130&author=J.+A.+Ahlgren-Beckendorfauthor=B.+Levant&title=Signaling+Mechanisms+of+the+D3+Dopamine+Receptor&doi=10.1081%2FRRS-200029953"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Signaling Mechanisms of the D3 Dopamine Receptor</span></div><div class="casAuthors">Ahlgren-Beckendorf, Joy A.; Levant, Beth</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Receptors and Signal Transduction</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">117-130</span>CODEN:
                <span class="NLM_cas:coden">JRSTCT</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    
            (<span class="NLM_cas:orgname">Marcel Dekker, Inc.</span>)
        </div><div class="casAbstract">A review.  A substantial body of evidence shows the capacity of the dopamine D3 receptor to couple functionally to G proteins when expressed in an appropriate milieu in heterologous expression systems.  In these systems, activation of D3 receptors inhibits adenylate cyclase, modulates ion flow through potassium and calcium channels, and activates kinases, most notably mitogen-activated protein kinase.  Coupling to Gi/Go is implicated in many of these effects, but other G proteins may contribute.  Studies with chimeric receptors implicate the 3rd intracellular loop in the mediation of agonist-induced signal transduction.  Finally, D3-preferring drugs modulate expression of c-fos in neuronal cultures and brain.  Signaling mechanisms of the D3 receptor in brain, however, remain to be definitively detd.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpOl-65wNzGh7Vg90H21EOLACvtfcHk0lg3adsatUVq-w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXnvVKhs7w%253D&md5=30ff8f18d95ab96ae90c078458ff4dc6</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1081%2FRRS-200029953&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1081%252FRRS-200029953%26sid%3Dliteratum%253Aachs%26aulast%3DAhlgren-Beckendorf%26aufirst%3DJ.%2BA.%26aulast%3DLevant%26aufirst%3DB.%26atitle%3DSignaling%2520Mechanisms%2520of%2520the%2520D3%2520Dopamine%2520Receptor%26jtitle%3DJ.%2520Recept.%2520Signal%2520Transduction%2520Res.%26date%3D2004%26volume%3D24%26spage%3D117%26epage%3D130%26doi%3D10.1081%2FRRS-200029953" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Jiang, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spicher, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boulay, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Birnbaumer, L.</span><span> </span><span class="NLM_article-title">Most Central Nervous System D2 Dopamine Receptors Are Coupled to Their Effectors by Go</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">98</span><span class="NLM_x">, </span> <span class="NLM_fpage">3577</span><span class="NLM_x">–</span> <span class="NLM_lpage">3582</span><span class="refDoi"> DOI: 10.1073/pnas.051632598</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01857&amp;key=10.1073%2Fpnas.051632598" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=98&publication_year=2001&pages=3577-3582&author=M.+Jiangauthor=K.+Spicherauthor=G.+Boulayauthor=Y.+Wangauthor=L.+Birnbaumer&title=Most+Central+Nervous+System+D2+Dopamine+Receptors+Are+Coupled+to+Their+Effectors+by+Go&doi=10.1073%2Fpnas.051632598"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1073%2Fpnas.051632598&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.051632598%26sid%3Dliteratum%253Aachs%26aulast%3DJiang%26aufirst%3DM.%26aulast%3DSpicher%26aufirst%3DK.%26aulast%3DBoulay%26aufirst%3DG.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DBirnbaumer%26aufirst%3DL.%26atitle%3DMost%2520Central%2520Nervous%2520System%2520D2%2520Dopamine%2520Receptors%2520Are%2520Coupled%2520to%2520Their%2520Effectors%2520by%2520Go%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2001%26volume%3D98%26spage%3D3577%26epage%3D3582%26doi%3D10.1073%2Fpnas.051632598" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Asano, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morishita, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Semba, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Itoh, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaziro, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kato, K.</span><span> </span><span class="NLM_article-title">Identification of Lung Major Gtp-Binding Protein as Gi2 and Its Distribution in Various Rat-Tissues Determined by Immunoassay</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1989</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">4749</span><span class="NLM_x">–</span> <span class="NLM_lpage">4754</span><span class="refDoi"> DOI: 10.1021/bi00437a035</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi00437a035" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=1989&pages=4749-4754&author=T.+Asanoauthor=R.+Morishitaauthor=R.+Sembaauthor=H.+Itohauthor=Y.+Kaziroauthor=K.+Kato&title=Identification+of+Lung+Major+Gtp-Binding+Protein+as+Gi2+and+Its+Distribution+in+Various+Rat-Tissues+Determined+by+Immunoassay&doi=10.1021%2Fbi00437a035"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1021%2Fbi00437a035&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi00437a035%26sid%3Dliteratum%253Aachs%26aulast%3DAsano%26aufirst%3DT.%26aulast%3DMorishita%26aufirst%3DR.%26aulast%3DSemba%26aufirst%3DR.%26aulast%3DItoh%26aufirst%3DH.%26aulast%3DKaziro%26aufirst%3DY.%26aulast%3DKato%26aufirst%3DK.%26atitle%3DIdentification%2520of%2520Lung%2520Major%2520Gtp-Binding%2520Protein%2520as%2520Gi2%2520and%2520Its%2520Distribution%2520in%2520Various%2520Rat-Tissues%2520Determined%2520by%2520Immunoassay%26jtitle%3DBiochemistry%26date%3D1989%26volume%3D28%26spage%3D4749%26epage%3D4754%26doi%3D10.1021%2Fbi00437a035" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group">Strange, P. G.</span><span> </span><span class="NLM_article-title">Use of the Gtpgammas Binding Assay for Analysis of Ligand Potency and Efficacy at G Protein-Coupled Receptors</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">161</span><span class="NLM_x">, </span> <span class="NLM_fpage">1238</span><span class="NLM_x">–</span> <span class="NLM_lpage">1249</span><span class="refDoi"> DOI: 10.1111/j.1476-5381.2010.00963.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01857&amp;key=10.1111%2Fj.1476-5381.2010.00963.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01857&amp;key=20662841" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01857&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsFWhsr3K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=161&publication_year=2010&pages=1238-1249&author=P.+G.+Strange&title=Use+of+the+Gtpgammas+Binding+Assay+for+Analysis+of+Ligand+Potency+and+Efficacy+at+G+Protein-Coupled+Receptors&doi=10.1111%2Fj.1476-5381.2010.00963.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Use of the GTPγS ([35S]GTPγS and Eu-GTPγS) binding assay for analysis of ligand potency and efficacy at G protein-coupled receptors</span></div><div class="casAuthors">Strange, Philip G.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">161</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1238-1249</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">1476-5381</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  In this review I consider assays for G protein-coupled receptor (GPCR) activity based on the binding of labeled analogs of GTPγS ([35S]GTPγS or Eu-GTPγS) to G proteins in tissues (GTPγS binding assays).  Such assays provide convenient measures of GPCR activity close to the receptor in the signaling cascade.  In order to set up a GTPγS binding assay, the requirements of the assay must be considered.  These are tissue source, GTPγS analog, G protein, GDP, Mg2+/Na+ ions, saponin, incubation time.  The assay, once optimized, can be used to generate concn./response curves for GPCRs signaling via Gi/o proteins (or to other G proteins with a modified assay) and actions of agonists, inverse agonists and antagonists may, in principle, be assessed.  For agonists and inverse agonists, data for the maximal agonist effect, the concn. of ligand giving a half-maximal response and the Hill coeff. may be derived.  For antagonists, data for the equil. dissocn. const. can be obtained.  The mechanistic basis of the assay is considered.  Although the assay can be used to profile ligands, under the conditions it is used, it may not be measuring the same event that dets. GPCR action in cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGonpFh81URvabVg90H21EOLACvtfcHk0lg3adsatUVq-w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsFWhsr3K&md5=8fa11a4e869eec381bae3880f4051dc2</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1111%2Fj.1476-5381.2010.00963.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1476-5381.2010.00963.x%26sid%3Dliteratum%253Aachs%26aulast%3DStrange%26aufirst%3DP.%2BG.%26atitle%3DUse%2520of%2520the%2520Gtpgammas%2520Binding%2520Assay%2520for%2520Analysis%2520of%2520Ligand%2520Potency%2520and%2520Efficacy%2520at%2520G%2520Protein-Coupled%2520Receptors%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2010%26volume%3D161%26spage%3D1238%26epage%3D1249%26doi%3D10.1111%2Fj.1476-5381.2010.00963.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group">Harrison, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Traynor, J. R.</span><span> </span><span class="NLM_article-title">The [35s]Gtpγs Binding Assay: Approaches and Applications in Pharmacology</span> <span class="citation_source-journal">Life Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">74</span><span class="NLM_x">, </span> <span class="NLM_fpage">489</span><span class="NLM_x">–</span> <span class="NLM_lpage">508</span><span class="refDoi"> DOI: 10.1016/j.lfs.2003.07.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01857&amp;key=10.1016%2Fj.lfs.2003.07.005" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=74&publication_year=2003&pages=489-508&author=C.+Harrisonauthor=J.+R.+Traynor&title=The+%5B35s%5DGtp%CE%B3s+Binding+Assay%3A+Approaches+and+Applications+in+Pharmacology&doi=10.1016%2Fj.lfs.2003.07.005"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1016%2Fj.lfs.2003.07.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.lfs.2003.07.005%26sid%3Dliteratum%253Aachs%26aulast%3DHarrison%26aufirst%3DC.%26aulast%3DTraynor%26aufirst%3DJ.%2BR.%26atitle%3DThe%2520%255B35s%255DGtp%25CE%25B3s%2520Binding%2520Assay%253A%2520Approaches%2520and%2520Applications%2520in%2520Pharmacology%26jtitle%3DLife%2520Sci.%26date%3D2003%26volume%3D74%26spage%3D489%26epage%3D508%26doi%3D10.1016%2Fj.lfs.2003.07.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span>In  <span class="citation_source-book">Assay Guidance Manual</span>; <span class="NLM_contrib-group">Sittampalam, G. S.; Coussens, N. P.; Nelson, H.; Arkin, M.; Auld, D.; Austin, C.; Bejcek, B.; Glicksman, M.; Inglese, J.; Iversen, P. W.; Li, Z.; McGee, J.; McManus, O.; Minor, L.; Napper, A.; Peltier, J. M.; Riss, T.; Trask, O. J.,  Jr.; Weidner, J.</span>, Eds.; <span class="NLM_publisher-name">Eli Lilly & Company and the National Center for Advancing Translational Sciences</span>: <span class="NLM_publisher-loc">Bethesda, MD</span>,<span class="NLM_x"> </span><span class="NLM_year">2004</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2004&author=G.+S.+Sittampalam&author=N.+P.+Coussens&author=H.+Nelson&author=M.+Arkin&author=D.+Auld&author=C.+Austin&author=B.+Bejcek&author=M.+Glicksman&author=J.+Inglese&author=P.+W.+Iversen&author=Z.+Li&author=J.+McGee&author=O.+McManus&author=L.+Minor&author=A.+Napper&author=J.+M.+Peltier&author=T.+Riss&author=O.+J.+Trask&author=J.+Weidner&title=Assay+Guidance+Manual"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26btitle%3DAssay%2520Guidance%2520Manual%26aulast%3DSittampalam%26aufirst%3DG.%2BS.%26pub%3DEli%2520Lilly%2520%2526%2520Company%2520and%2520the%2520National%2520Center%2520for%2520Advancing%2520Translational%2520Sciences%26date%3D2004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group">Klein Herenbrink, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sykes, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Donthamsetti, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Canals, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coudrat, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shonberg, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scammells, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Capuano, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sexton, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Charlton, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Javitch, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christopoulos, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lane, J. R.</span><span> </span><span class="NLM_article-title">The Role of Kinetic Context in Apparent Biased Agonism at GPCRs</span> <span class="citation_source-journal">Nat. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">10842</span><span class="refDoi"> DOI: 10.1038/ncomms10842</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01857&amp;key=10.1038%2Fncomms10842" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01857&amp;key=26905976" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01857&amp;key=1%3ACAS%3A528%3ADC%252BC28Xjt1emtbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=10842&author=C.+Klein+Herenbrinkauthor=D.+A.+Sykesauthor=P.+Donthamsettiauthor=M.+Canalsauthor=T.+Coudratauthor=J.+Shonbergauthor=P.+J.+Scammellsauthor=B.+Capuanoauthor=P.+M.+Sextonauthor=S.+J.+Charltonauthor=J.+A.+Javitchauthor=A.+Christopoulosauthor=J.+R.+Lane&title=The+Role+of+Kinetic+Context+in+Apparent+Biased+Agonism+at+GPCRs&doi=10.1038%2Fncomms10842"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">The role of kinetic context in apparent biased agonism at GPCRs</span></div><div class="casAuthors">Klein Herenbrink, Carmen; Sykes, David A.; Donthamsetti, Prashant; Canals, Meritxell; Coudrat, Thomas; Shonberg, Jeremy; Scammells, Peter J.; Capuano, Ben; Sexton, Patrick M.; Charlton, Steven J.; Javitch, Jonathan A.; Christopoulos, Arthur; Lane, J. Robert</div><div class="citationInfo"><span class="NLM_cas:title">Nature Communications</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">10842</span>CODEN:
                <span class="NLM_cas:coden">NCAOBW</span>;
        ISSN:<span class="NLM_cas:issn">2041-1723</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Biased agonism describes the ability of ligands to stabilize different conformations of a GPCR linked to distinct functional outcomes and offers the prospect of designing pathway-specific drugs that avoid on-target side effects.  This mechanism is usually inferred from pharmacol. data with the assumption that the confounding influences of observational (i.e., assay dependent) and system (i.e., cell background dependent) bias are excluded by exptl. design and anal.  Here we reveal that 'kinetic context', as detd. by ligand-binding kinetics and the temporal pattern of receptor-signalling processes, can have a profound influence on the apparent bias of a series of agonists for the dopamine D2 receptor and can even lead to reversals in the direction of bias.  We propose that kinetic context must be acknowledged in the design and interpretation of studies of biased agonism.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoboe6-_23rF7Vg90H21EOLACvtfcHk0lj59ommoBphng"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xjt1emtbk%253D&md5=3afdebd5ad1c8a8b1db93478e9b2c7d4</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1038%2Fncomms10842&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncomms10842%26sid%3Dliteratum%253Aachs%26aulast%3DKlein%2BHerenbrink%26aufirst%3DC.%26aulast%3DSykes%26aufirst%3DD.%2BA.%26aulast%3DDonthamsetti%26aufirst%3DP.%26aulast%3DCanals%26aufirst%3DM.%26aulast%3DCoudrat%26aufirst%3DT.%26aulast%3DShonberg%26aufirst%3DJ.%26aulast%3DScammells%26aufirst%3DP.%2BJ.%26aulast%3DCapuano%26aufirst%3DB.%26aulast%3DSexton%26aufirst%3DP.%2BM.%26aulast%3DCharlton%26aufirst%3DS.%2BJ.%26aulast%3DJavitch%26aufirst%3DJ.%2BA.%26aulast%3DChristopoulos%26aufirst%3DA.%26aulast%3DLane%26aufirst%3DJ.%2BR.%26atitle%3DThe%2520Role%2520of%2520Kinetic%2520Context%2520in%2520Apparent%2520Biased%2520Agonism%2520at%2520GPCRs%26jtitle%3DNat.%2520Commun.%26date%3D2016%26volume%3D7%26spage%3D10842%26doi%3D10.1038%2Fncomms10842" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group">Gales, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rebois, R. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hogue, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trieu, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Breit, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hebert, T. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bouvier, M.</span><span> </span><span class="NLM_article-title">Real-Time Monitoring of Receptor and G-Protein Interactions in Living Cells</span> <span class="citation_source-journal">Nat. Methods</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">177</span><span class="NLM_x">–</span> <span class="NLM_lpage">184</span><span class="refDoi"> DOI: 10.1038/nmeth743</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01857&amp;key=10.1038%2Fnmeth743" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01857&amp;key=15782186" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01857&amp;key=1%3ACAS%3A528%3ADC%252BD2MXisVGisrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2005&pages=177-184&author=C.+Galesauthor=R.+V.+Reboisauthor=M.+Hogueauthor=P.+Trieuauthor=A.+Breitauthor=T.+E.+Hebertauthor=M.+Bouvier&title=Real-Time+Monitoring+of+Receptor+and+G-Protein+Interactions+in+Living+Cells&doi=10.1038%2Fnmeth743"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Real-time monitoring of receptor and G-protein interactions in living cells</span></div><div class="casAuthors">Gales, Celine; Rebois, R. Victor; Hogue, Mireille; Trieu, Phan; Breit, Andreas; Hebert, Terence E.; Bouvier, Michel</div><div class="citationInfo"><span class="NLM_cas:title">Nature Methods</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">177-184</span>CODEN:
                <span class="NLM_cas:coden">NMAEA3</span>;
        ISSN:<span class="NLM_cas:issn">1548-7091</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">G protein-coupled receptors (GPCRs) represent the largest family of proteins involved in signal transduction.  Here we present a bioLuminescence resonance energy transfer (BRET) assay that directly monitors in real time the early interactions between human GPCRs and their cognate G-protein subunits in living human cells.  In addn. to detecting basal precoupling of the receptors to Gα-, Gβ- and Gγ-subunits, BRET measured very rapid ligand-induced increases in the interaction between receptor and Gαβγ-complexes (t1/2 ∼ 300 ms) followed by a slower (several minutes) decrease, reflecting receptor desensitization.  The agonist-promoted increase in GPCR-Gβγ interaction was highly dependent on the identity of the Gα-subunit present in the complex.  Therefore, this G protein- activity biosensor provides a novel tool to directly probe the dynamics and selectivity of receptor-mediated, G-protein activation-deactivation cycles that could be advantageously used to identify ligands for orphan GPCRs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpz1sC3NFz4krVg90H21EOLACvtfcHk0lj59ommoBphng"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXisVGisrk%253D&md5=257987f332dee95f8df83bd0343190f5</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1038%2Fnmeth743&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnmeth743%26sid%3Dliteratum%253Aachs%26aulast%3DGales%26aufirst%3DC.%26aulast%3DRebois%26aufirst%3DR.%2BV.%26aulast%3DHogue%26aufirst%3DM.%26aulast%3DTrieu%26aufirst%3DP.%26aulast%3DBreit%26aufirst%3DA.%26aulast%3DHebert%26aufirst%3DT.%2BE.%26aulast%3DBouvier%26aufirst%3DM.%26atitle%3DReal-Time%2520Monitoring%2520of%2520Receptor%2520and%2520G-Protein%2520Interactions%2520in%2520Living%2520Cells%26jtitle%3DNat.%2520Methods%26date%3D2005%26volume%3D2%26spage%3D177%26epage%3D184%26doi%3D10.1038%2Fnmeth743" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group">Richard-Lalonde, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nagi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Audet, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sleno, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amraei, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hogue, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balboni, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schiller, P. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bouvier, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hébert, T. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pineyro, G.</span><span> </span><span class="NLM_article-title">Conformational Dynamics of Kir3.1/Kir3.2 Channel Activation Via δ-Opioid Receptors</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">83</span><span class="NLM_x">, </span> <span class="NLM_fpage">416</span><span class="NLM_x">–</span> <span class="NLM_lpage">428</span><span class="refDoi"> DOI: 10.1124/mol.112.081950</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01857&amp;key=10.1124%2Fmol.112.081950" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=83&publication_year=2013&pages=416-428&author=M.+Richard-Lalondeauthor=K.+Nagiauthor=N.+Audetauthor=R.+Slenoauthor=M.+Amraeiauthor=M.+Hogueauthor=G.+Balboniauthor=P.+W.+Schillerauthor=M.+Bouvierauthor=T.+E.+H%C3%A9bertauthor=G.+Pineyro&title=Conformational+Dynamics+of+Kir3.1%2FKir3.2+Channel+Activation+Via+%CE%B4-Opioid+Receptors&doi=10.1124%2Fmol.112.081950"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1124%2Fmol.112.081950&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.112.081950%26sid%3Dliteratum%253Aachs%26aulast%3DRichard-Lalonde%26aufirst%3DM.%26aulast%3DNagi%26aufirst%3DK.%26aulast%3DAudet%26aufirst%3DN.%26aulast%3DSleno%26aufirst%3DR.%26aulast%3DAmraei%26aufirst%3DM.%26aulast%3DHogue%26aufirst%3DM.%26aulast%3DBalboni%26aufirst%3DG.%26aulast%3DSchiller%26aufirst%3DP.%2BW.%26aulast%3DBouvier%26aufirst%3DM.%26aulast%3DH%25C3%25A9bert%26aufirst%3DT.%2BE.%26aulast%3DPineyro%26aufirst%3DG.%26atitle%3DConformational%2520Dynamics%2520of%2520Kir3.1%252FKir3.2%2520Channel%2520Activation%2520Via%2520%25CE%25B4-Opioid%2520Receptors%26jtitle%3DMol.%2520Pharmacol.%26date%3D2013%26volume%3D83%26spage%3D416%26epage%3D428%26doi%3D10.1124%2Fmol.112.081950" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group">Quoyer, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janz, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ren, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Armando, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lukashova, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benovic, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carlson, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hunt, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bouvier, M.</span><span> </span><span class="NLM_article-title">Pepducin Targeting the C-X-C Chemokine Receptor Type 4 Acts as a Biased Agonist Favoring Activation of the Inhibitory G Protein</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">110</span><span class="NLM_x">, </span> <span class="NLM_fpage">E5088</span><span class="NLM_x">–</span> <span class="NLM_lpage">E5097</span><span class="refDoi"> DOI: 10.1073/pnas.1312515110</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01857&amp;key=10.1073%2Fpnas.1312515110" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01857&amp;key=24309376" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01857&amp;key=1%3ACAS%3A528%3ADC%252BC2cXns1SjtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=110&publication_year=2013&pages=E5088-E5097&author=J.+Quoyerauthor=J.+M.+Janzauthor=J.+Luoauthor=Y.+Renauthor=S.+Armandoauthor=V.+Lukashovaauthor=J.+L.+Benovicauthor=K.+E.+Carlsonauthor=S.+W.+Huntauthor=M.+Bouvier&title=Pepducin+Targeting+the+C-X-C+Chemokine+Receptor+Type+4+Acts+as+a+Biased+Agonist+Favoring+Activation+of+the+Inhibitory+G+Protein&doi=10.1073%2Fpnas.1312515110"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Pepducin targeting the C-X-C chemokine receptor type 4 acts as a biased agonist favoring activation of the inhibitory G protein</span></div><div class="casAuthors">Quoyer, Julie; Janz, Jay M.; Luo, Jiansong; Ren, Yong; Armando, Sylvain; Lukashova, Viktoria; Benovic, Jeffrey L.; Carlson, Kenneth E.; Hunt, Stephen W., III; Bouvier, Michel</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">110</span>
        (<span class="NLM_cas:issue">52</span>),
    <span class="NLM_cas:pages">E5088-E5097,SE5088/1-SE5088/6</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Short lipidated peptide sequences derived from various intracellular loop regions of G protein-coupled receptors (GPCRs) are named pepducins and act as allosteric modulators of a no. of GPCRs.  Recently, a pepducin selectively targeting the C-X-C chemokine receptor type 4 (CXCR4) was found to be an allosteric agonist, active in both cell-based assays and in vivo.  However, the precise mechanism of action of this class of ligands remains poorly understood.  In particular, given the diversity of signaling effectors that can be engaged by a given receptor, it is not clear whether pepducins can show biased signaling leading to functional selectivity.  To explore the ligand-biased potential of pepducins, the authors assessed the effect of the CXCR4 selective pepducin, ATI-2341, on the ability of the receptor to engage the inhibitory G proteins (Gi1, Gi2 and Gi3), G13, and β-arrestins.  Using bioluminescence resonance energy transfer-based biosensors, the authors found that, in contrast to the natural CXCR4 ligand, stromal cell-derived factor-1α, which promotes the engagement of the three Gi subtypes, G13 and the two β-arrestins, ATI-2341 leads to the engagement of the Gi subtypes but not G13 or the β-arrestins.  Calcn. of the transduction ratio for each pathway revealed a strong neg. bias of ATI-2341 toward G13 and β-arrestins, revealing functional selectivity for the Gi pathways.  The neg. bias toward β-arrestins results from the reduced ability of the pepducin to promote GPCR kinase-mediated phosphorylation of the receptor.  In addn. to revealing ligand-biased signaling of pepducins, these findings shed some light on the mechanism of action of a unique class of allosteric regulators.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoBOvGh6qLDbLVg90H21EOLACvtfcHk0lj59ommoBphng"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXns1SjtQ%253D%253D&md5=748ab512167787aa3fe31642f7c244b1</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1312515110&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1312515110%26sid%3Dliteratum%253Aachs%26aulast%3DQuoyer%26aufirst%3DJ.%26aulast%3DJanz%26aufirst%3DJ.%2BM.%26aulast%3DLuo%26aufirst%3DJ.%26aulast%3DRen%26aufirst%3DY.%26aulast%3DArmando%26aufirst%3DS.%26aulast%3DLukashova%26aufirst%3DV.%26aulast%3DBenovic%26aufirst%3DJ.%2BL.%26aulast%3DCarlson%26aufirst%3DK.%2BE.%26aulast%3DHunt%26aufirst%3DS.%2BW.%26aulast%3DBouvier%26aufirst%3DM.%26atitle%3DPepducin%2520Targeting%2520the%2520C-X-C%2520Chemokine%2520Receptor%2520Type%25204%2520Acts%2520as%2520a%2520Biased%2520Agonist%2520Favoring%2520Activation%2520of%2520the%2520Inhibitory%2520G%2520Protein%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2013%26volume%3D110%26spage%3DE5088%26epage%3DE5097%26doi%3D10.1073%2Fpnas.1312515110" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group">Gales, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Durm, J. J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schaak, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pontier, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Percherancier, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Audet, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paris, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bouvier, M.</span><span> </span><span class="NLM_article-title">Probing the Activation-Promoted Structural Rearrangements in Preassembled Receptor-G Protein Complexes</span> <span class="citation_source-journal">Nat. Struct. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">778</span><span class="NLM_x">–</span> <span class="NLM_lpage">786</span><span class="refDoi"> DOI: 10.1038/nsmb1134</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01857&amp;key=10.1038%2Fnsmb1134" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01857&amp;key=16906158" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01857&amp;key=1%3ACAS%3A528%3ADC%252BD28XptFWitbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2006&pages=778-786&author=C.+Galesauthor=J.+J.+J.+Van+Durmauthor=S.+Schaakauthor=S.+Pontierauthor=Y.+Percherancierauthor=M.+Audetauthor=H.+Parisauthor=M.+Bouvier&title=Probing+the+Activation-Promoted+Structural+Rearrangements+in+Preassembled+Receptor-G+Protein+Complexes&doi=10.1038%2Fnsmb1134"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Probing the activation-promoted structural rearrangements in preassembled receptor-G protein complexes</span></div><div class="casAuthors">Gales, Celine; Van Durm, Joost J. J.; Schaak, Stephane; Pontier, Stephanie; Percherancier, Yann; Audet, Martin; Paris, Herve; Bouvier, Michel</div><div class="citationInfo"><span class="NLM_cas:title">Nature Structural & Molecular Biology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">778-786</span>CODEN:
                <span class="NLM_cas:coden">NSMBCU</span>;
        ISSN:<span class="NLM_cas:issn">1545-9993</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Activation of heterotrimeric G proteins by their cognate seven transmembrane domain receptors is believed to involve conformational changes propagated from the receptor to the G proteins.  However, the nature of these changes remains unknown.  We monitored the conformational rearrangements at the interfaces between receptors and G proteins and between G protein subunits by measuring bioluminescence resonance energy transfer (BRET) between probes inserted at multiple sites in receptor-G protein complexes.  Using the data obtained for the α2AAR-Gαi1β1γ2 complex and the available crystal structures of Gαi1β1γ2, we propose a model wherein agonist binding induces conformational reorganization of a preexisting receptor-G protein complex, leading the Gα-Gβγ interface to open but not dissoc.  This conformational change may represent the movement required to allow nucleotide exit from the Gα subunit, thus reflecting the initial activation event.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGocRdOHDSfyEbVg90H21EOLACvtfcHk0lgy_fYxEhnVOQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XptFWitbg%253D&md5=a060403bc8d77ebf07dd76cd1d0c87fc</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1038%2Fnsmb1134&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnsmb1134%26sid%3Dliteratum%253Aachs%26aulast%3DGales%26aufirst%3DC.%26aulast%3DVan%2BDurm%26aufirst%3DJ.%2BJ.%2BJ.%26aulast%3DSchaak%26aufirst%3DS.%26aulast%3DPontier%26aufirst%3DS.%26aulast%3DPercherancier%26aufirst%3DY.%26aulast%3DAudet%26aufirst%3DM.%26aulast%3DParis%26aufirst%3DH.%26aulast%3DBouvier%26aufirst%3DM.%26atitle%3DProbing%2520the%2520Activation-Promoted%2520Structural%2520Rearrangements%2520in%2520Preassembled%2520Receptor-G%2520Protein%2520Complexes%26jtitle%3DNat.%2520Struct.%2520Mol.%2520Biol.%26date%3D2006%26volume%3D13%26spage%3D778%26epage%3D786%26doi%3D10.1038%2Fnsmb1134" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group">Black, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leff, P.</span><span> </span><span class="NLM_article-title">Operational Models of Pharmacological Agonism</span> <span class="citation_source-journal">Proc. R. Soc. London, Ser. B</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1983</span><span class="NLM_x">, </span> <span class="NLM_volume">220</span><span class="NLM_x">, </span> <span class="NLM_fpage">141</span><span class="NLM_x">–</span> <span class="NLM_lpage">162</span><span class="refDoi"> DOI: 10.1098/rspb.1983.0093</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01857&amp;key=10.1098%2Frspb.1983.0093" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01857&amp;key=6141562" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01857&amp;key=1%3ACAS%3A528%3ADyaL2cXmtFaqtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=220&publication_year=1983&pages=141-162&author=J.+W.+Blackauthor=P.+Leff&title=Operational+Models+of+Pharmacological+Agonism&doi=10.1098%2Frspb.1983.0093"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Operational models of pharmacological agonism</span></div><div class="casAuthors">Black, J. W.; Leff, P.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the Royal Society of London, Series B:  Biological Sciences</span>
        (<span class="NLM_cas:date">1983</span>),
    <span class="NLM_cas:volume">220</span>
        (<span class="NLM_cas:issue">1219</span>),
    <span class="NLM_cas:pages">141-62</span>CODEN:
                <span class="NLM_cas:coden">PRLBA4</span>;
        ISSN:<span class="NLM_cas:issn">0080-4649</span>.
    </div><div class="casAbstract">A general, operational model is presented which explicitly describes pharmacol. agonism in terms of 3 parameters: an agonist-receptor dissocn. const., the total receptor concn. [Ro], and a parameter (KE) which defines the transduction of the agonist-receptor complex into pharmacol. effect.  The ratio RO/KE, the transducer ratio (τ), is a logical definition for the efficacy of an agonist in a system.  The model provides a chem. definition of intrinsic efficacy, making this parameter exptl. accessible in principle.  Alternate models are compared and contrasted with regard to their practical and conceptual utilities in exptl. pharmacol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGonpXVldFQ_nbVg90H21EOLACvtfcHk0lgy_fYxEhnVOQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2cXmtFaqtA%253D%253D&md5=a0421df9c56495d48d076010acf44b65</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1098%2Frspb.1983.0093&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1098%252Frspb.1983.0093%26sid%3Dliteratum%253Aachs%26aulast%3DBlack%26aufirst%3DJ.%2BW.%26aulast%3DLeff%26aufirst%3DP.%26atitle%3DOperational%2520Models%2520of%2520Pharmacological%2520Agonism%26jtitle%3DProc.%2520R.%2520Soc.%2520London%252C%2520Ser.%2520B%26date%3D1983%26volume%3D220%26spage%3D141%26epage%3D162%26doi%3D10.1098%2Frspb.1983.0093" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group">Kenakin, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watson, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muniz-Medina, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christopoulos, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Novick, S.</span><span> </span><span class="NLM_article-title">A Simple Method for Quantifying Functional Selectivity and Agonist Bias</span> <span class="citation_source-journal">ACS Chem. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">193</span><span class="NLM_x">–</span> <span class="NLM_lpage">203</span><span class="refDoi"> DOI: 10.1021/cn200111m</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cn200111m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01857&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhs1ChtLvN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2012&pages=193-203&author=T.+Kenakinauthor=C.+Watsonauthor=V.+Muniz-Medinaauthor=A.+Christopoulosauthor=S.+Novick&title=A+Simple+Method+for+Quantifying+Functional+Selectivity+and+Agonist+Bias&doi=10.1021%2Fcn200111m"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">A Simple Method for Quantifying Functional Selectivity and Agonist Bias</span></div><div class="casAuthors">Kenakin, Terry; Watson, Christian; Muniz-Medina, Vanessa; Christopoulos, Arthur; Novick, Steven</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">193-203</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Activation of seven-transmembrane (7TM) receptors by agonists does not always lead to uniform activation of all signaling pathways mediated by a given receptor.  Relative to other ligands, many agonists are "biased" toward producing subsets of receptor behaviors.  A hallmark of such "functional selectivity" is cell type dependence; this poses a particular problem for the profiling of agonists in whole cell test systems removed from the therapeutic one(s).  Such response-specific cell-based variability makes it difficult to guide medicinal chem. efforts aimed at identifying and optimizing therapeutically meaningful agonist bias.  For this reason, we present a scale, based on the Black and Leff operational model, that contains the key elements required to describe 7TM agonism, namely, affinity (KA-1) for the receptor and efficacy (τ) in activating a particular signaling pathway.  Utilizing a "transduction coeff." term, log(τ/KA), this scale can statistically evaluate selective agonist effects in a manner that can theor. inform structure-activity studies and/or drug candidate selection matrixes.  The bias of four chemokines for CCR5-mediated inositol phosphate prodn. vs. internalization is quantified to illustrate the practical application of this method.  The independence of this method with respect to receptor d. and the calcn. of statistical ests. of confidence of differences are specifically discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoxSkELs1bHQLVg90H21EOLACvtfcHk0lgy_fYxEhnVOQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhs1ChtLvN&md5=270841d11f9720caaf3e59a6fe0aee74</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1021%2Fcn200111m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcn200111m%26sid%3Dliteratum%253Aachs%26aulast%3DKenakin%26aufirst%3DT.%26aulast%3DWatson%26aufirst%3DC.%26aulast%3DMuniz-Medina%26aufirst%3DV.%26aulast%3DChristopoulos%26aufirst%3DA.%26aulast%3DNovick%26aufirst%3DS.%26atitle%3DA%2520Simple%2520Method%2520for%2520Quantifying%2520Functional%2520Selectivity%2520and%2520Agonist%2520Bias%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2012%26volume%3D3%26spage%3D193%26epage%3D203%26doi%3D10.1021%2Fcn200111m" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group">van der Westhuizen, E. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Breton, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christopoulos, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bouvier, M.</span><span> </span><span class="NLM_article-title">Quantification of Ligand Bias for Clinically Relevant B2-Adrenergic Receptor Ligands: Implications for Drug Taxonomy</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">85</span><span class="NLM_x">, </span> <span class="NLM_fpage">492</span><span class="NLM_x">–</span> <span class="NLM_lpage">509</span><span class="refDoi"> DOI: 10.1124/mol.113.088880</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01857&amp;key=10.1124%2Fmol.113.088880" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=85&publication_year=2014&pages=492-509&author=E.+T.+van+der+Westhuizenauthor=B.+Bretonauthor=A.+Christopoulosauthor=M.+Bouvier&title=Quantification+of+Ligand+Bias+for+Clinically+Relevant+B2-Adrenergic+Receptor+Ligands%3A+Implications+for+Drug+Taxonomy&doi=10.1124%2Fmol.113.088880"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1124%2Fmol.113.088880&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.113.088880%26sid%3Dliteratum%253Aachs%26aulast%3Dvan%2Bder%2BWesthuizen%26aufirst%3DE.%2BT.%26aulast%3DBreton%26aufirst%3DB.%26aulast%3DChristopoulos%26aufirst%3DA.%26aulast%3DBouvier%26aufirst%3DM.%26atitle%3DQuantification%2520of%2520Ligand%2520Bias%2520for%2520Clinically%2520Relevant%2520B2-Adrenergic%2520Receptor%2520Ligands%253A%2520Implications%2520for%2520Drug%2520Taxonomy%26jtitle%3DMol.%2520Pharmacol.%26date%3D2014%26volume%3D85%26spage%3D492%26epage%3D509%26doi%3D10.1124%2Fmol.113.088880" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group">Shonberg, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lopez, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scammells, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christopoulos, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Capuano, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lane, J. R.</span><span> </span><span class="NLM_article-title">Biased Agonism at G Protein-Coupled Receptors: The Promise and the Challenges - a Medicinal Chemistry Perspective</span> <span class="citation_source-journal">Med. Res. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">1286</span><span class="NLM_x">–</span> <span class="NLM_lpage">330</span><span class="refDoi"> DOI: 10.1002/med.21318</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01857&amp;key=10.1002%2Fmed.21318" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01857&amp;key=24796277" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01857&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhslalu7rJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2014&pages=1286-330&author=J.+Shonbergauthor=L.+Lopezauthor=P.+J.+Scammellsauthor=A.+Christopoulosauthor=B.+Capuanoauthor=J.+R.+Lane&title=Biased+Agonism+at+G+Protein-Coupled+Receptors%3A+The+Promise+and+the+Challenges+-+a+Medicinal+Chemistry+Perspective&doi=10.1002%2Fmed.21318"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Biased Agonism at G Protein-Coupled Receptors: The Promise and the Challenges-A Medicinal Chemistry Perspective</span></div><div class="casAuthors">Shonberg, Jeremy; Lopez, Laura; Scammells, Peter J.; Christopoulos, Arthur; Capuano, Ben; Lane, J. Robert</div><div class="citationInfo"><span class="NLM_cas:title">Medicinal Research Reviews</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1286-1330</span>CODEN:
                <span class="NLM_cas:coden">MRREDD</span>;
        ISSN:<span class="NLM_cas:issn">0198-6325</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">Historically, detn. of G protein-coupled receptor (GPCR) ligand efficacy has often been restricted to identifying the ligand as an agonist or antagonist at a given signaling pathway.  This classification was deemed sufficient to predict compd. efficacy at all signaling endpoints, including the therapeutically relevant one(s).  However, it is now apparent that ligands acting at the same GPCR can stabilize multiple, distinct, receptor conformations linked to different functional outcomes.  This phenomenon, known as biased agonism, stimulus bias, or functional selectivity offers the opportunity to sep. on-target therapeutic effects from side effects through the design of drugs that show pathway selectivity.  However, the medicinal chemist faces numerous challenges to develop biased ligands, including the detection and quantification of biased agonism.  This review summarizes the current state of the field of research into biased agonism at GPCRs, with a particular focus on efforts to relate biased agonism to ligand structure.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpg-egFZpSKvbVg90H21EOLACvtfcHk0ljg7PS3yo0k1A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhslalu7rJ&md5=85a5b385750d21856ae044391c46ee75</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1002%2Fmed.21318&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fmed.21318%26sid%3Dliteratum%253Aachs%26aulast%3DShonberg%26aufirst%3DJ.%26aulast%3DLopez%26aufirst%3DL.%26aulast%3DScammells%26aufirst%3DP.%2BJ.%26aulast%3DChristopoulos%26aufirst%3DA.%26aulast%3DCapuano%26aufirst%3DB.%26aulast%3DLane%26aufirst%3DJ.%2BR.%26atitle%3DBiased%2520Agonism%2520at%2520G%2520Protein-Coupled%2520Receptors%253A%2520The%2520Promise%2520and%2520the%2520Challenges%2520-%2520a%2520Medicinal%2520Chemistry%2520Perspective%26jtitle%3DMed.%2520Res.%2520Rev.%26date%3D2014%26volume%3D34%26spage%3D1286%26epage%3D330%26doi%3D10.1002%2Fmed.21318" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group">Kenakin, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christopoulos, A.</span><span> </span><span class="NLM_article-title">Signalling Bias in New Drug Discovery: Detection, Quantification and Therapeutic Impact</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">205</span><span class="NLM_x">–</span> <span class="NLM_lpage">216</span><span class="refDoi"> DOI: 10.1038/nrd3954</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01857&amp;key=10.1038%2Fnrd3954" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01857&amp;key=23411724" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2012&pages=205-216&author=T.+Kenakinauthor=A.+Christopoulos&title=Signalling+Bias+in+New+Drug+Discovery%3A+Detection%2C+Quantification+and+Therapeutic+Impact&doi=10.1038%2Fnrd3954"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1038%2Fnrd3954&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd3954%26sid%3Dliteratum%253Aachs%26aulast%3DKenakin%26aufirst%3DT.%26aulast%3DChristopoulos%26aufirst%3DA.%26atitle%3DSignalling%2520Bias%2520in%2520New%2520Drug%2520Discovery%253A%2520Detection%252C%2520Quantification%2520and%2520Therapeutic%2520Impact%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2012%26volume%3D12%26spage%3D205%26epage%3D216%26doi%3D10.1038%2Fnrd3954" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group">Namkung, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le Gouill, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lukashova, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kobayashi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hogue, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khoury, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Song, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bouvier, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laporte, S. A.</span><span> </span><span class="NLM_article-title">Monitoring G Protein-Coupled Receptor and Beta-Arrestin Trafficking in Live Cells Using Enhanced Bystander Bret</span> <span class="citation_source-journal">Nat. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">12178</span><span class="refDoi"> DOI: 10.1038/ncomms12178</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01857&amp;key=10.1038%2Fncomms12178" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01857&amp;key=27397672" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01857&amp;key=1%3ACAS%3A280%3ADC%252BC2s7psVKjtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=12178&author=Y.+Namkungauthor=C.+Le+Gouillauthor=V.+Lukashovaauthor=H.+Kobayashiauthor=M.+Hogueauthor=E.+Khouryauthor=M.+Songauthor=M.+Bouvierauthor=S.+A.+Laporte&title=Monitoring+G+Protein-Coupled+Receptor+and+Beta-Arrestin+Trafficking+in+Live+Cells+Using+Enhanced+Bystander+Bret&doi=10.1038%2Fncomms12178"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Monitoring G protein-coupled receptor and β-arrestin trafficking in live cells using enhanced bystander BRET</span></div><div class="casAuthors">Namkung Yoon; Khoury Etienne; Song Mideum; Laporte Stephane A; Le Gouill Christian; Lukashova Viktoria; Kobayashi Hiroyuki; Hogue Mireille; Bouvier Michel; Laporte Stephane A; Laporte Stephane A</div><div class="citationInfo"><span class="NLM_cas:title">Nature communications</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">12178</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Endocytosis and intracellular trafficking of receptors are pivotal to maintain physiological functions and drug action; however, robust quantitative approaches are lacking to study such processes in live cells.  Here we present new bioluminescence resonance energy transfer (BRET) sensors to quantitatively monitor G protein-coupled receptors (GPCRs) and β-arrestin trafficking.  These sensors are based on bystander BRET and use the naturally interacting chromophores luciferase (RLuc) and green fluorescent protein (rGFP) from Renilla.  The versatility and robustness of this approach are exemplified by anchoring rGFP at the plasma membrane or in endosomes to generate high dynamic spectrometric BRET signals on ligand-promoted recruitment or sequestration of RLuc-tagged proteins to, or from, specific cell compartments, as well as sensitive subcellular BRET imaging for protein translocation visualization.  These sensors are scalable to high-throughput formats and allow quantitative pharmacological studies of GPCR trafficking in real time, in live cells, revealing ligand-dependent biased trafficking of receptor/β-arrestin complexes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRxqtzvqqnir4qdXsLcGTEUfW6udTcc2eZx1HgyvVj8H7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2s7psVKjtA%253D%253D&md5=db78058cbea3a04028c8b15f93810a17</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1038%2Fncomms12178&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncomms12178%26sid%3Dliteratum%253Aachs%26aulast%3DNamkung%26aufirst%3DY.%26aulast%3DLe%2BGouill%26aufirst%3DC.%26aulast%3DLukashova%26aufirst%3DV.%26aulast%3DKobayashi%26aufirst%3DH.%26aulast%3DHogue%26aufirst%3DM.%26aulast%3DKhoury%26aufirst%3DE.%26aulast%3DSong%26aufirst%3DM.%26aulast%3DBouvier%26aufirst%3DM.%26aulast%3DLaporte%26aufirst%3DS.%2BA.%26atitle%3DMonitoring%2520G%2520Protein-Coupled%2520Receptor%2520and%2520Beta-Arrestin%2520Trafficking%2520in%2520Live%2520Cells%2520Using%2520Enhanced%2520Bystander%2520Bret%26jtitle%3DNat.%2520Commun.%26date%3D2016%26volume%3D7%26spage%3D12178%26doi%3D10.1038%2Fncomms12178" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group">Luján, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marron Fernandez de Velasco, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aguado, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wickman, K.</span><span> </span><span class="NLM_article-title">New Insights into the Therapeutic Potential of Girk Channels</span> <span class="citation_source-journal">Trends Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x">, </span> <span class="NLM_fpage">20</span><span class="NLM_x">–</span> <span class="NLM_lpage">29</span><span class="refDoi"> DOI: 10.1016/j.tins.2013.10.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01857&amp;key=10.1016%2Fj.tins.2013.10.006" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2014&pages=20-29&author=R.+Luj%C3%A1nauthor=E.+Marron+Fernandez+de+Velascoauthor=C.+Aguadoauthor=K.+Wickman&title=New+Insights+into+the+Therapeutic+Potential+of+Girk+Channels&doi=10.1016%2Fj.tins.2013.10.006"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1016%2Fj.tins.2013.10.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tins.2013.10.006%26sid%3Dliteratum%253Aachs%26aulast%3DLuj%25C3%25A1n%26aufirst%3DR.%26aulast%3DMarron%2BFernandez%2Bde%2BVelasco%26aufirst%3DE.%26aulast%3DAguado%26aufirst%3DC.%26aulast%3DWickman%26aufirst%3DK.%26atitle%3DNew%2520Insights%2520into%2520the%2520Therapeutic%2520Potential%2520of%2520Girk%2520Channels%26jtitle%3DTrends%2520Neurosci.%26date%3D2014%26volume%3D37%26spage%3D20%26epage%3D29%26doi%3D10.1016%2Fj.tins.2013.10.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group">Lüscher, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Slesinger, P. A.</span><span> </span><span class="NLM_article-title">Emerging Concepts for G Protein-Gated Inwardly Rectifying Potassium (GIRK) Channels in Health and Disease</span> <span class="citation_source-journal">Nat. Rev. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">301</span><span class="NLM_x">–</span> <span class="NLM_lpage">315</span><span class="refDoi"> DOI: 10.1038/nrn2834</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01857&amp;key=10.1038%2Fnrn2834" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01857&amp;key=20389305" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01857&amp;key=1%3ACAS%3A280%3ADC%252BC3c3ntlWlug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2010&pages=301-315&author=C.+L%C3%BCscherauthor=P.+A.+Slesinger&title=Emerging+Concepts+for+G+Protein-Gated+Inwardly+Rectifying+Potassium+%28GIRK%29+Channels+in+Health+and+Disease&doi=10.1038%2Fnrn2834"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Emerging roles for G protein-gated inwardly rectifying potassium (GIRK) channels in health and disease</span></div><div class="casAuthors">Luscher Christian; Slesinger Paul A</div><div class="citationInfo"><span class="NLM_cas:title">Nature reviews. Neuroscience</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">301-15</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">G protein-gated inwardly rectifying potassium (GIRK) channels hyperpolarize neurons in response to activation of many different G protein-coupled receptors and thus control the excitability of neurons through GIRK-mediated self-inhibition, slow synaptic potentials and volume transmission.  GIRK channel function and trafficking are highly dependent on the channel subunit composition.  Pharmacological investigations of GIRK channels and studies in animal models suggest that GIRK activity has an important role in physiological responses, including pain perception and memory modulation.  Moreover, abnormal GIRK function has been implicated in altering neuronal excitability and cell death, which may be important in the pathophysiology of diseases such as epilepsy, Down's syndrome, Parkinson's disease and drug addiction.  GIRK channels may therefore prove to be a valuable new therapeutic target.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRaDoT2N_WTNS6Ufuk_1xoTfW6udTcc2eZu_JzX683rx7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3c3ntlWlug%253D%253D&md5=087130f9aa185e685d39911042294672</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1038%2Fnrn2834&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrn2834%26sid%3Dliteratum%253Aachs%26aulast%3DL%25C3%25BCscher%26aufirst%3DC.%26aulast%3DSlesinger%26aufirst%3DP.%2BA.%26atitle%3DEmerging%2520Concepts%2520for%2520G%2520Protein-Gated%2520Inwardly%2520Rectifying%2520Potassium%2520%2528GIRK%2529%2520Channels%2520in%2520Health%2520and%2520Disease%26jtitle%3DNat.%2520Rev.%2520Neurosci.%26date%3D2010%26volume%3D11%26spage%3D301%26epage%3D315%26doi%3D10.1038%2Fnrn2834" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group">Whorton, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MacKinnon, R.</span><span> </span><span class="NLM_article-title">X-Ray Structure of the Mammalian GIRK2-Beta Gamma G-Protein Complex</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">498</span><span class="NLM_x">, </span> <span class="NLM_fpage">190</span><span class="NLM_x">–</span> <span class="NLM_lpage">197</span><span class="refDoi"> DOI: 10.1038/nature12241</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01857&amp;key=10.1038%2Fnature12241" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=498&publication_year=2013&pages=190-197&author=M.+R.+Whortonauthor=R.+MacKinnon&title=X-Ray+Structure+of+the+Mammalian+GIRK2-Beta+Gamma+G-Protein+Complex&doi=10.1038%2Fnature12241"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1038%2Fnature12241&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature12241%26sid%3Dliteratum%253Aachs%26aulast%3DWhorton%26aufirst%3DM.%2BR.%26aulast%3DMacKinnon%26aufirst%3DR.%26atitle%3DX-Ray%2520Structure%2520of%2520the%2520Mammalian%2520GIRK2-Beta%2520Gamma%2520G-Protein%2520Complex%26jtitle%3DNature%26date%3D2013%26volume%3D498%26spage%3D190%26epage%3D197%26doi%3D10.1038%2Fnature12241" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group">Yamada, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iwayama, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toyota, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohnishi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohba, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maekawa, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshikawa, T.</span><span> </span><span class="NLM_article-title">Association Study of the Kcnj3 Gene as a Susceptibility Candidate for Schizophrenia in the Chinese Population</span> <span class="citation_source-journal">Hum. Genet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">131</span><span class="NLM_x">, </span> <span class="NLM_fpage">443</span><span class="NLM_x">–</span> <span class="NLM_lpage">451</span><span class="refDoi"> DOI: 10.1007/s00439-011-1089-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01857&amp;key=10.1007%2Fs00439-011-1089-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01857&amp;key=21927946" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01857&amp;key=1%3ACAS%3A528%3ADC%252BC38XitlGisr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=131&publication_year=2012&pages=443-451&author=K.+Yamadaauthor=Y.+Iwayamaauthor=T.+Toyotaauthor=T.+Ohnishiauthor=H.+Ohbaauthor=M.+Maekawaauthor=T.+Yoshikawa&title=Association+Study+of+the+Kcnj3+Gene+as+a+Susceptibility+Candidate+for+Schizophrenia+in+the+Chinese+Population&doi=10.1007%2Fs00439-011-1089-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Association study of the KCNJ3 gene as a susceptibility candidate for schizophrenia in the Chinese population</span></div><div class="casAuthors">Yamada, Kazuo; Iwayama, Yoshimi; Toyota, Tomoko; Ohnishi, Tetsuo; Ohba, Hisako; Maekawa, Motoko; Yoshikawa, Takeo</div><div class="citationInfo"><span class="NLM_cas:title">Human Genetics</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">131</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">443-451</span>CODEN:
                <span class="NLM_cas:coden">HUGEDQ</span>;
        ISSN:<span class="NLM_cas:issn">0340-6717</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">We recently reported the results of a genome-wide assocn. study (GWAS) of schizophrenia in the Japanese population.  In that study, a single nucleotide polymorphism (SNP) (rs3106653) in the KCNJ3 (potassium inwardly rectifying channel, subfamily J, member 3) gene located at 2q24.1 showed assocn. with schizophrenia in two independent sample sets.  KCNJ3, also termed GIRK1 or Kir3.1, is a member of the G protein-activated inwardly rectifying K+ channel (GIRK) group.  GIRKs are widely distributed in the brain and play an important role in regulating neural excitability through the activation of various G protein-coupled receptors.  In this study, we set out to examine this assocn. using a different population.  We first performed a gene-centric assocn. study of the KCNJ3 gene, by genotyping 38 tagSNPs in the Chinese population.  We detected nine SNPs that displayed significant assocn. with schizophrenia (lowest P = 0.0016 for rs3106658, Global significance = 0.036).  The initial marker SNP (rs3106653) examd. in our prior GWAS in the Japanese population also showed nominally significant assocn. in the Chinese population (P = 0.028).  Next, we analyzed transcript levels in the dorsolateral prefrontal cortex of postmortem brains from patients with schizophrenia and bipolar disorder and from healthy controls, using real-time quant. RT-PCR.  We found significantly lower KCNJ3 expression in postmortem brains from schizophrenic and bipolar patients compared with controls.  These data suggest that the KCNJ3 gene is genetically assocd. with schizophrenia in Asian populations and add further evidence to the "channelopathy theory of psychiatric illnesses".</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGofPx0Jz3BOkbVg90H21EOLACvtfcHk0ljBiyRMLO2KMQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XitlGisr4%253D&md5=dc03299798c57ac86f3801941dbf6ce9</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1007%2Fs00439-011-1089-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00439-011-1089-3%26sid%3Dliteratum%253Aachs%26aulast%3DYamada%26aufirst%3DK.%26aulast%3DIwayama%26aufirst%3DY.%26aulast%3DToyota%26aufirst%3DT.%26aulast%3DOhnishi%26aufirst%3DT.%26aulast%3DOhba%26aufirst%3DH.%26aulast%3DMaekawa%26aufirst%3DM.%26aulast%3DYoshikawa%26aufirst%3DT.%26atitle%3DAssociation%2520Study%2520of%2520the%2520Kcnj3%2520Gene%2520as%2520a%2520Susceptibility%2520Candidate%2520for%2520Schizophrenia%2520in%2520the%2520Chinese%2520Population%26jtitle%3DHum.%2520Genet.%26date%3D2012%26volume%3D131%26spage%3D443%26epage%3D451%26doi%3D10.1007%2Fs00439-011-1089-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group">Yamada, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iwayama, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hattori, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iwamoto, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toyota, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohnishi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohba, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maekawa, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kato, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshikawa, T.</span><span> </span><span class="NLM_article-title">Genome-Wide Association Study of Schizophrenia in Japanese Population</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">e20468</span><span class="refDoi"> DOI: 10.1371/journal.pone.0020468</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01857&amp;key=10.1371%2Fjournal.pone.0020468" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2011&pages=e20468&author=K.+Yamadaauthor=Y.+Iwayamaauthor=E.+Hattoriauthor=K.+Iwamotoauthor=T.+Toyotaauthor=T.+Ohnishiauthor=H.+Ohbaauthor=M.+Maekawaauthor=T.+Katoauthor=T.+Yoshikawa&title=Genome-Wide+Association+Study+of+Schizophrenia+in+Japanese+Population&doi=10.1371%2Fjournal.pone.0020468"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0020468&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0020468%26sid%3Dliteratum%253Aachs%26aulast%3DYamada%26aufirst%3DK.%26aulast%3DIwayama%26aufirst%3DY.%26aulast%3DHattori%26aufirst%3DE.%26aulast%3DIwamoto%26aufirst%3DK.%26aulast%3DToyota%26aufirst%3DT.%26aulast%3DOhnishi%26aufirst%3DT.%26aulast%3DOhba%26aufirst%3DH.%26aulast%3DMaekawa%26aufirst%3DM.%26aulast%3DKato%26aufirst%3DT.%26aulast%3DYoshikawa%26aufirst%3DT.%26atitle%3DGenome-Wide%2520Association%2520Study%2520of%2520Schizophrenia%2520in%2520Japanese%2520Population%26jtitle%3DPLoS%2520One%26date%3D2011%26volume%3D6%26spage%3De20468%26doi%3D10.1371%2Fjournal.pone.0020468" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit54"><span><span class="NLM_contrib-group">Farhy Tselnicker, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsemakhovich, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rishal, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kahanovitch, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dessauer, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dascal, N.</span><span> </span><span class="NLM_article-title">Dual Regulation of G Proteins and the G-Protein–Activated K+ Channels by Lithium</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">111</span><span class="NLM_x">, </span> <span class="NLM_fpage">5018</span><span class="NLM_x">–</span> <span class="NLM_lpage">5023</span><span class="refDoi"> DOI: 10.1073/pnas.1316425111</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01857&amp;key=10.1073%2Fpnas.1316425111" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=111&publication_year=2014&pages=5018-5023&author=I.+Farhy+Tselnickerauthor=V.+Tsemakhovichauthor=I.+Rishalauthor=U.+Kahanovitchauthor=C.+W.+Dessauerauthor=N.+Dascal&title=Dual+Regulation+of+G+Proteins+and+the+G-Protein%E2%80%93Activated+K%2B+Channels+by+Lithium&doi=10.1073%2Fpnas.1316425111"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1316425111&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1316425111%26sid%3Dliteratum%253Aachs%26aulast%3DFarhy%2BTselnicker%26aufirst%3DI.%26aulast%3DTsemakhovich%26aufirst%3DV.%26aulast%3DRishal%26aufirst%3DI.%26aulast%3DKahanovitch%26aufirst%3DU.%26aulast%3DDessauer%26aufirst%3DC.%2BW.%26aulast%3DDascal%26aufirst%3DN.%26atitle%3DDual%2520Regulation%2520of%2520G%2520Proteins%2520and%2520the%2520G-Protein%25E2%2580%2593Activated%2520K%252B%2520Channels%2520by%2520Lithium%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2014%26volume%3D111%26spage%3D5018%26epage%3D5023%26doi%3D10.1073%2Fpnas.1316425111" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref55"><div class="reference"><strong class="refLabel"><a href="#ref55" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-cit55"><span><span class="NLM_contrib-group">Kuzhikandathil, E. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oxford, G. S.</span><span> </span><span class="NLM_article-title">Human Dopamine D3 and D2L Receptors Couple to Inward Rectifier Potassium Channels in Mammalian Cell Lines</span> <span class="citation_source-journal">Mol. Cell. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">390</span><span class="NLM_x">–</span> <span class="NLM_lpage">402</span><span class="refDoi"> DOI: 10.1006/mcne.1998.0722</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01857&amp;key=10.1006%2Fmcne.1998.0722" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01857&amp;key=9888991" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01857&amp;key=1%3ACAS%3A528%3ADyaK1MXmt1Gnuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=1998&pages=390-402&author=E.+V.+Kuzhikandathilauthor=W.+Yuauthor=G.+S.+Oxford&title=Human+Dopamine+D3+and+D2L+Receptors+Couple+to+Inward+Rectifier+Potassium+Channels+in+Mammalian+Cell+Lines&doi=10.1006%2Fmcne.1998.0722"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">Human dopamine D3 and D2L receptors couple to inward rectifier potassium channels in mammalian cell lines</span></div><div class="casAuthors">Kuzhikandathil, Eldo V.; Yu, Weifeng; Oxford, Gerry S.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Neuroscience</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">390-402</span>CODEN:
                <span class="NLM_cas:coden">MOCNED</span>;
        ISSN:<span class="NLM_cas:issn">1044-7431</span>.
    
            (<span class="NLM_cas:orgname">Academic Press</span>)
        </div><div class="casAbstract">The mol. mechanisms coupling the D3 dopamine receptor to downstream effectors have neither been well defined nor well characterized.  Here the authors examine the coupling of the human D3 receptor to G-protein coupled inward rectifier potassium channels (GIRKs) in mammalian cells.  Human D3 receptors couple strongly to homomeric human GIRK2 channels coexpressed in Chinese hamster ovary (CHO) cells, with a coupling efficiency comparable to that of D2L receptors.  The coupling between D3 receptors and native GIRK channels was examd. in an AtT-20 mouse pituitary cell line stably expressing the human D3 receptor.  AtT-20 cells endogenously express somatostatin and muscarinic receptors coupled to GIRK channels.  RT-PCR and Western blot analyses revealed that AtT-20 cells natively express Kir3.1 and Kir3.2 channel isoforms, but not D2 or D3 dopamine receptors.  In D3 receptor expressing AtT-20 cells, application of the D2/D3 receptor agonist, quinpirole, induces pertussis toxin-sensitive inward rectifying K+ currents that are blocked by barium.  Activation of D3 receptors leads to both homologous desensitization of this receptor and an unusual unidirectional heterologous desensitization of somatostatin receptors.  AtT-20 cells may be a good model to examine the functional role of D3 dopamine receptors in regulating neurotransmitter secretion.  (c) 1998 Academic Press.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqqTRDIFIXaNLVg90H21EOLACvtfcHk0ljBiyRMLO2KMQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXmt1Gnuw%253D%253D&md5=5afc4543d838926092dbacb4e06a90a6</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1006%2Fmcne.1998.0722&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fmcne.1998.0722%26sid%3Dliteratum%253Aachs%26aulast%3DKuzhikandathil%26aufirst%3DE.%2BV.%26aulast%3DYu%26aufirst%3DW.%26aulast%3DOxford%26aufirst%3DG.%2BS.%26atitle%3DHuman%2520Dopamine%2520D3%2520and%2520D2L%2520Receptors%2520Couple%2520to%2520Inward%2520Rectifier%2520Potassium%2520Channels%2520in%2520Mammalian%2520Cell%2520Lines%26jtitle%3DMol.%2520Cell.%2520Neurosci.%26date%3D1998%26volume%3D12%26spage%3D390%26epage%3D402%26doi%3D10.1006%2Fmcne.1998.0722" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref56"><div class="reference"><strong class="refLabel"><a href="#ref56" class="rightTabRefNumLink">56</a></strong><div class="NLM_citation" id="rightTab-cit56"><span><span class="NLM_contrib-group">Lavine, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ethier, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oak, J. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pei, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trieu, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rebois, R. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bouvier, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hébert, T. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Tol, H. H. M. G</span><span> </span><span class="NLM_article-title">Protein-Coupled Receptors Form Stable Complexes with Inwardly Rectifying Potassium Channels and Adenylyl Cyclase</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">277</span><span class="NLM_x">, </span> <span class="NLM_fpage">46010</span><span class="NLM_x">–</span> <span class="NLM_lpage">46019</span><span class="refDoi"> DOI: 10.1074/jbc.M205035200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01857&amp;key=10.1074%2Fjbc.M205035200" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=277&publication_year=2002&pages=46010-46019&author=N.+Lavineauthor=N.+Ethierauthor=J.+N.+Oakauthor=L.+Peiauthor=F.+Liuauthor=P.+Trieuauthor=R.+V.+Reboisauthor=M.+Bouvierauthor=T.+E.+H%C3%A9bertauthor=H.+H.+M.+G+Van+Tol&title=Protein-Coupled+Receptors+Form+Stable+Complexes+with+Inwardly+Rectifying+Potassium+Channels+and+Adenylyl+Cyclase&doi=10.1074%2Fjbc.M205035200"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M205035200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M205035200%26sid%3Dliteratum%253Aachs%26aulast%3DLavine%26aufirst%3DN.%26aulast%3DEthier%26aufirst%3DN.%26aulast%3DOak%26aufirst%3DJ.%2BN.%26aulast%3DPei%26aufirst%3DL.%26aulast%3DLiu%26aufirst%3DF.%26aulast%3DTrieu%26aufirst%3DP.%26aulast%3DRebois%26aufirst%3DR.%2BV.%26aulast%3DBouvier%26aufirst%3DM.%26aulast%3DH%25C3%25A9bert%26aufirst%3DT.%2BE.%26aulast%3DVan%2BTol%26aufirst%3DH.%2BH.%2BM.%2BG%26atitle%3DProtein-Coupled%2520Receptors%2520Form%2520Stable%2520Complexes%2520with%2520Inwardly%2520Rectifying%2520Potassium%2520Channels%2520and%2520Adenylyl%2520Cyclase%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2002%26volume%3D277%26spage%3D46010%26epage%3D46019%26doi%3D10.1074%2Fjbc.M205035200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref57"><div class="reference"><strong class="refLabel"><a href="#ref57" class="rightTabRefNumLink">57</a></strong><div class="NLM_citation" id="rightTab-cit57"><span><span class="NLM_contrib-group">Heusler, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newman-Tancredi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castro-Fernandez, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cussac, D.</span><span> </span><span class="NLM_article-title">Differential Agonist and Inverse Agonist Profile of Antipsychotics at D2L Receptors Coupled to GIRK Potassium Channels</span> <span class="citation_source-journal">Neuropharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">1106</span><span class="NLM_x">–</span> <span class="NLM_lpage">1113</span><span class="refDoi"> DOI: 10.1016/j.neuropharm.2006.11.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01857&amp;key=10.1016%2Fj.neuropharm.2006.11.008" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2007&pages=1106-1113&author=P.+Heuslerauthor=A.+Newman-Tancrediauthor=A.+Castro-Fernandezauthor=D.+Cussac&title=Differential+Agonist+and+Inverse+Agonist+Profile+of+Antipsychotics+at+D2L+Receptors+Coupled+to+GIRK+Potassium+Channels&doi=10.1016%2Fj.neuropharm.2006.11.008"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1016%2Fj.neuropharm.2006.11.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuropharm.2006.11.008%26sid%3Dliteratum%253Aachs%26aulast%3DHeusler%26aufirst%3DP.%26aulast%3DNewman-Tancredi%26aufirst%3DA.%26aulast%3DCastro-Fernandez%26aufirst%3DA.%26aulast%3DCussac%26aufirst%3DD.%26atitle%3DDifferential%2520Agonist%2520and%2520Inverse%2520Agonist%2520Profile%2520of%2520Antipsychotics%2520at%2520D2L%2520Receptors%2520Coupled%2520to%2520GIRK%2520Potassium%2520Channels%26jtitle%3DNeuropharmacology%26date%3D2007%26volume%3D52%26spage%3D1106%26epage%3D1113%26doi%3D10.1016%2Fj.neuropharm.2006.11.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref58"><div class="reference"><strong class="refLabel"><a href="#ref58" class="rightTabRefNumLink">58</a></strong><div class="NLM_citation" id="rightTab-cit58"><span><span class="NLM_contrib-group">Shapiro, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Renock, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arrington, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiodo, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, L.-X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sibley, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roth, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mailman, R.</span><span> </span><span class="NLM_article-title">Aripiprazole, a Novel Atypical Antipsychotic Drug with a Unique and Robust Pharmacology</span> <span class="citation_source-journal">Neuropsychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">1400</span><span class="NLM_x">–</span> <span class="NLM_lpage">1411</span><span class="refDoi"> DOI: 10.1038/sj.npp.1300203</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01857&amp;key=10.1038%2Fsj.npp.1300203" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01857&amp;key=12784105" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01857&amp;key=1%3ACAS%3A528%3ADC%252BD3sXls1Slsro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2003&pages=1400-1411&author=D.+A.+Shapiroauthor=S.+Renockauthor=E.+Arringtonauthor=L.+A.+Chiodoauthor=L.-X.+Liuauthor=D.+R.+Sibleyauthor=B.+L.+Rothauthor=R.+Mailman&title=Aripiprazole%2C+a+Novel+Atypical+Antipsychotic+Drug+with+a+Unique+and+Robust+Pharmacology&doi=10.1038%2Fsj.npp.1300203"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">Aripiprazole, a novel atypical antipsychotic drug with a unique and robust pharmacology</span></div><div class="casAuthors">Shapiro, David A.; Renock, Sean; Arrington, Elaine; Chiodo, Louis A.; Liu, Li-Xin; Sibley, David R.; Roth, Bryan L.; Mailman, Richard</div><div class="citationInfo"><span class="NLM_cas:title">Neuropsychopharmacology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1400-1411</span>CODEN:
                <span class="NLM_cas:coden">NEROEW</span>;
        ISSN:<span class="NLM_cas:issn">0893-133X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Atypical antipsychotic drugs have revolutionized the treatment of schizophrenia and related disorders.  The current clin. approved atypical antipsychotic drugs are characterized by having relatively low affinities for D2-dopamine receptors and relatively high affinities for 5-HT2A serotonin receptors (5-HT, 5-hydroxytryptamine (serotonin)).  Aripiprazole (OPC-14597) is a novel atypical antipsychotic drug that is reported to be a high-affinity D2-dopamine receptor partial agonist.  We now provide a comprehensive pharmacol. profile of aripiprazole at a large no. of cloned G protein-coupled receptors, transporters, and ion channels.  These data reveal a no. of interesting and potentially important mol. targets for which aripiprazole has affinity.  Aripiprazole has highest affinity for h5-HT2B-, hD2L-, and hD3-dopamine receptors, but also has significant affinity (5-30 nM) for several other 5-HT receptors (5-HT1A, 5-HT2A, 5-HT7), as well as α1A-adrenergic and hH1-histamine receptors.  Aripiprazole has less affinity (30-200 nM) for other G protein-coupled receptors, including the 5-HT1D, 5-HT2C, α1B-, α2A-, α2B-, α2C-, β1-, and β2-adrenergic, and H3-histamine receptors.  Functionally, aripiprazole is an inverse agonist at 5-HT2B receptors and displays partial agonist actions at 5-HT2A, 5-HT2C, D3, and D4 receptors.  Interestingly, we also discovered that the functional actions of aripiprazole at cloned human D2-dopamine receptors are cell-type selective, and that a range of actions (eg agonism, partial agonism, antagonism) at cloned D2-dopamine receptors are possible depending upon the cell type and function examd.  This mixt. of functional actions at D2-dopamine receptors is consistent with the hypothesis proposed by Lawler et al (1999) that aripiprazole has functionally selective' actions.  Taken together, our results support the hypothesis that the unique actions of aripiprazole in humans are likely a combination of functionally selective' activation of D2 (and possibly D3)-dopamine receptors, coupled with important interactions with selected other biogenic amine receptors-particularly 5-HT receptor subtypes (5-HT1A, 5-HT2A).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrc1m1pKWaDH7Vg90H21EOLACvtfcHk0lha4o5KmZwuyg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXls1Slsro%253D&md5=a90dfc24826c78d9a630ae4831d99cb0</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1038%2Fsj.npp.1300203&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.npp.1300203%26sid%3Dliteratum%253Aachs%26aulast%3DShapiro%26aufirst%3DD.%2BA.%26aulast%3DRenock%26aufirst%3DS.%26aulast%3DArrington%26aufirst%3DE.%26aulast%3DChiodo%26aufirst%3DL.%2BA.%26aulast%3DLiu%26aufirst%3DL.-X.%26aulast%3DSibley%26aufirst%3DD.%2BR.%26aulast%3DRoth%26aufirst%3DB.%2BL.%26aulast%3DMailman%26aufirst%3DR.%26atitle%3DAripiprazole%252C%2520a%2520Novel%2520Atypical%2520Antipsychotic%2520Drug%2520with%2520a%2520Unique%2520and%2520Robust%2520Pharmacology%26jtitle%3DNeuropsychopharmacology%26date%3D2003%26volume%3D28%26spage%3D1400%26epage%3D1411%26doi%3D10.1038%2Fsj.npp.1300203" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref59"><div class="reference"><strong class="refLabel"><a href="#ref59" class="rightTabRefNumLink">59</a></strong><div class="NLM_citation" id="rightTab-cit59"><span><span class="NLM_contrib-group">Klose, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huth, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alzheimer, C.</span><span> </span><span class="NLM_article-title">1-[6-[[(17β)-3-Methoxyestra-1,3,5(10)-Trien-17-Yl]Amino]Hexyl]-1h-Pyrrole-2,5-Dione (U73122) Selectively Inhibits Kir3 and Bk Channels in a Phospholipase C-Independent Fashion</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">74</span><span class="NLM_x">, </span> <span class="NLM_fpage">1203</span><span class="NLM_x">–</span> <span class="NLM_lpage">1214</span><span class="refDoi"> DOI: 10.1124/mol.108.047837</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01857&amp;key=10.1124%2Fmol.108.047837" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=74&publication_year=2008&pages=1203-1214&author=A.+Kloseauthor=T.+Huthauthor=C.+Alzheimer&title=1-%5B6-%5B%5B%2817%CE%B2%29-3-Methoxyestra-1%2C3%2C5%2810%29-Trien-17-Yl%5DAmino%5DHexyl%5D-1h-Pyrrole-2%2C5-Dione+%28U73122%29+Selectively+Inhibits+Kir3+and+Bk+Channels+in+a+Phospholipase+C-Independent+Fashion&doi=10.1124%2Fmol.108.047837"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1124%2Fmol.108.047837&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.108.047837%26sid%3Dliteratum%253Aachs%26aulast%3DKlose%26aufirst%3DA.%26aulast%3DHuth%26aufirst%3DT.%26aulast%3DAlzheimer%26aufirst%3DC.%26atitle%3D1-%255B6-%255B%255B%252817%25CE%25B2%2529-3-Methoxyestra-1%252C3%252C5%252810%2529-Trien-17-Yl%255DAmino%255DHexyl%255D-1h-Pyrrole-2%252C5-Dione%2520%2528U73122%2529%2520Selectively%2520Inhibits%2520Kir3%2520and%2520Bk%2520Channels%2520in%2520a%2520Phospholipase%2520C-Independent%2520Fashion%26jtitle%3DMol.%2520Pharmacol.%26date%3D2008%26volume%3D74%26spage%3D1203%26epage%3D1214%26doi%3D10.1124%2Fmol.108.047837" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref60"><div class="reference"><strong class="refLabel"><a href="#ref60" class="rightTabRefNumLink">60</a></strong><div class="NLM_citation" id="rightTab-cit60"><span><span class="NLM_contrib-group">Liao, Y. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jan, Y. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jan, L. Y.</span><span> </span><span class="NLM_article-title">Heteromultimerization of G-Protein-Gated Inwardly Rectifying K+ Channel Proteins GIRK1 and GIRK2 and Their Altered Expression in Weaver Brain</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">7137</span><span class="NLM_x">–</span> <span class="NLM_lpage">7150</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01857&amp;key=8929423" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01857&amp;key=1%3ACAS%3A528%3ADyaK28XntlegtLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=1996&pages=7137-7150&author=Y.+J.+Liaoauthor=Y.+N.+Janauthor=L.+Y.+Jan&title=Heteromultimerization+of+G-Protein-Gated+Inwardly+Rectifying+K%2B+Channel+Proteins+GIRK1+and+GIRK2+and+Their+Altered+Expression+in+Weaver+Brain"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">Heteromultimerization of G-protein-gated inwardly rectifying K+ channel proteins GIRK1 and GIRK2 and their altered expression in weaver brain</span></div><div class="casAuthors">Liao, Y. Joyce; Jan, Yuh Nung; Jan, Lily Yeh</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">7137-7150</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">The weaver (WV) gene (GIRK2) is a member of the G-protein-gated inwardly rectifying potassium (GIRK) channel family, known effectors in the signal transduction pathway of neurotransmitters such as acetylcholine, dopamine, opioid peptides, and substance P in modulation of neurotransmitter release and neuronal excitability.  GIRK2 immunoreactivity is found in but not limited to brain regions known to be affected in wv mice, such as the cerebellar granule cells and dopaminergic neurons in the substantia nigra pars compacta, cerebral cortex, and thalamus.  GIRK2 and GIRK1, a related family member, have overlapping yet distinct distributions in rat and mouse brains.  In regions where both channel proteins are expressed, such as the cerebral cortex, hippocampus, and cerebellum, they can be co-immunopptd., indicating that they interact to form heteromeric channels in vivo.  In the brain of the wv mouse, GIRK2 expression is decreased dramatically.  In regions where GIRK1 and GIRK2 distributions overlap, both GIRK1 and GIRK2 expressions are severely disrupted, probably because of their co-assembly.  The expression patterns of these GIRK channel subunits provide a basis for consideration of the machinery for neuronal signaling as well as the differential effects of the wv mutation in various neurons.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrG1k2UrVpbH7Vg90H21EOLACvtfcHk0lha4o5KmZwuyg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XntlegtLw%253D&md5=0a0d1710b075acc09f1dbca83008bac0</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLiao%26aufirst%3DY.%2BJ.%26aulast%3DJan%26aufirst%3DY.%2BN.%26aulast%3DJan%26aufirst%3DL.%2BY.%26atitle%3DHeteromultimerization%2520of%2520G-Protein-Gated%2520Inwardly%2520Rectifying%2520K%252B%2520Channel%2520Proteins%2520GIRK1%2520and%2520GIRK2%2520and%2520Their%2520Altered%2520Expression%2520in%2520Weaver%2520Brain%26jtitle%3DJ.%2520Neurosci.%26date%3D1996%26volume%3D16%26spage%3D7137%26epage%3D7150" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref61"><div class="reference"><strong class="refLabel"><a href="#ref61" class="rightTabRefNumLink">61</a></strong><div class="NLM_citation" id="rightTab-cit61"><span><span class="NLM_contrib-group">Tenn, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fletcher, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kapur, S.</span><span> </span><span class="NLM_article-title">A Putative Animal Model of the “Prodromal” State of Schizophrenia</span> <span class="citation_source-journal">Biol. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">586</span><span class="NLM_x">–</span> <span class="NLM_lpage">593</span><span class="refDoi"> DOI: 10.1016/j.biopsych.2004.12.013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01857&amp;key=10.1016%2Fj.biopsych.2004.12.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01857&amp;key=15780845" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01857&amp;key=1%3ACAS%3A528%3ADC%252BD2MXisVWqs7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2005&pages=586-593&author=C.+C.+Tennauthor=P.+J.+Fletcherauthor=S.+Kapur&title=A+Putative+Animal+Model+of+the+%E2%80%9CProdromal%E2%80%9D+State+of+Schizophrenia&doi=10.1016%2Fj.biopsych.2004.12.013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">A putative animal model of the "prodromal" state of schizophrenia</span></div><div class="casAuthors">Tenn, Catherine C.; Fletcher, Paul J.; Kapur, Shitij</div><div class="citationInfo"><span class="NLM_cas:title">Biological Psychiatry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">586-593</span>CODEN:
                <span class="NLM_cas:coden">BIPCBF</span>;
        ISSN:<span class="NLM_cas:issn">0006-3223</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Background: There is growing interest in detecting and treating schizophrenia during the "prodrome," before the symptoms are fully manifested.  The objective of this study was to develop a putative model of the prodrome and study the effects of medications on it.  Methods: Rats were treated with different regimens of amphetamine to produce full sensitization (full syndrome) and partial sensitization (to model the prodromal state) and were then treated with typical and atypical antipsychotics and a D1 antagonist to mimic early intervention.  After several weeks of withdrawal, locomotor activity in response to amphetamine and behavioral deficits (prepulse inhibition [PPI] and latent inhibition [LI]) were examd.  Results: Animals that received the full sensitization showed significant increase in locomotor activity and a disruption in both PPI and LI.  Animals treated with a partial regimen showed only a muted phenotype.  The animals that received "early intervention" did not show progression from the prodromal to the full-blown phenotype.  Conclusions: The partial regimen of amphetamine injections provided a modified phenotype that could be regarded as a representative of the "prodromal" state.  Early intervention, instituted once the prodromal state was already developed, prevented further progression into the full phenotype analogous to schizophrenia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqVEs3CNLEvL7Vg90H21EOLACvtfcHk0ljID3Lx4PWZ9A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXisVWqs7o%253D&md5=0bae4c9c1d15831a112003aeeafb534b</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1016%2Fj.biopsych.2004.12.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.biopsych.2004.12.013%26sid%3Dliteratum%253Aachs%26aulast%3DTenn%26aufirst%3DC.%2BC.%26aulast%3DFletcher%26aufirst%3DP.%2BJ.%26aulast%3DKapur%26aufirst%3DS.%26atitle%3DA%2520Putative%2520Animal%2520Model%2520of%2520the%2520%25E2%2580%259CProdromal%25E2%2580%259D%2520State%2520of%2520Schizophrenia%26jtitle%3DBiol.%2520Psychiatry%26date%3D2005%26volume%3D57%26spage%3D586%26epage%3D593%26doi%3D10.1016%2Fj.biopsych.2004.12.013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref62"><div class="reference"><strong class="refLabel"><a href="#ref62" class="rightTabRefNumLink">62</a></strong><div class="NLM_citation" id="rightTab-cit62"><span><span class="NLM_contrib-group">Peleg-Raibstein, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sydekum, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feldon, J.</span><span> </span><span class="NLM_article-title">Differential Effects on Prepulse Inhibition of Withdrawal from Two Different Repeated Administration Schedules of Amphetamine</span> <span class="citation_source-journal">Int. J. Neuropsychopharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">737</span><span class="NLM_x">–</span> <span class="NLM_lpage">749</span><span class="refDoi"> DOI: 10.1017/S1461145706006493</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01857&amp;key=10.1017%2FS1461145706006493" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01857&amp;key=16448582" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01857&amp;key=1%3ACAS%3A528%3ADC%252BD2sXltlShsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2006&pages=737-749&author=D.+Peleg-Raibsteinauthor=E.+Sydekumauthor=J.+Feldon&title=Differential+Effects+on+Prepulse+Inhibition+of+Withdrawal+from+Two+Different+Repeated+Administration+Schedules+of+Amphetamine&doi=10.1017%2FS1461145706006493"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">Differential effects on prepulse inhibition of withdrawal from two different repeated administration schedules of amphetamine</span></div><div class="casAuthors">Peleg-Raibstein, Daria; Sydekum, Esther; Feldon, Joram</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Neuropsychopharmacology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">737-749</span>CODEN:
                <span class="NLM_cas:coden">IJNUFB</span>;
        ISSN:<span class="NLM_cas:issn">1461-1457</span>.
    
            (<span class="NLM_cas:orgname">Cambridge University Press</span>)
        </div><div class="casAbstract">In this study, rats were tested in behavioral paradigms relevant to schizophrenia during withdrawal from two different administration schedules of amphetamine (Amph).  One of the escalating administration schedules, which has been employed in previous studies, consisted of three daily injections for 6 d with increasing dosages from 1 to 5 mg/kg Amph (Esc-5) and was compared to a hitherto never examd. escalating administration schedule [three injections per day for 6 d escalating from 1 to 8 mg/kg Amph (Esc-8)].  Control animals received an equiv. vol. of saline (Sal) injections according to the same schedule.  Whereas rats treated with Esc-5, as reported before, failed to show an effect on prepulse inhibition (PPI), the Esc-8-treated rats exhibited a long-lasting disruption of PPI in a drug-free state on days 6, 13 and 55 of withdrawal.  The Amph-pretreated animals demonstrated a similar magnitude of behavioral sensitization following an Amph challenge on withdrawal day 58 irresp. of the administration schedule.  To evaluate if the withdrawal from the two Amph schedules led to a change in brain monoamine levels, a subgroup of animals was neurochem. examd. in post-mortem for eight parameters in seven brain regions on withdrawal day 55.  Withdrawal from the Esc-8 schedule induced reduced dopamine levels in the caudate putamen.  Only this neurochem. finding and the PPI attenuation differentiated the Esc-8 animals from the Esc-5 and Sal animals.  These data suggest that, based on the endogenous sensitization hypothesis of schizophrenia, the persistent disruption of PPI obsd. in animals withdrawn from Esc-8 can be used as a valid animal model of specific symptoms of schizophrenic patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGotUHeBdTCPNLVg90H21EOLACvtfcHk0ljID3Lx4PWZ9A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXltlShsA%253D%253D&md5=2aa3fddb597567f3ce4071737edea14c</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1017%2FS1461145706006493&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1017%252FS1461145706006493%26sid%3Dliteratum%253Aachs%26aulast%3DPeleg-Raibstein%26aufirst%3DD.%26aulast%3DSydekum%26aufirst%3DE.%26aulast%3DFeldon%26aufirst%3DJ.%26atitle%3DDifferential%2520Effects%2520on%2520Prepulse%2520Inhibition%2520of%2520Withdrawal%2520from%2520Two%2520Different%2520Repeated%2520Administration%2520Schedules%2520of%2520Amphetamine%26jtitle%3DInt.%2520J.%2520Neuropsychopharmacol.%26date%3D2006%26volume%3D9%26spage%3D737%26epage%3D749%26doi%3D10.1017%2FS1461145706006493" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref63"><div class="reference"><strong class="refLabel"><a href="#ref63" class="rightTabRefNumLink">63</a></strong><div class="NLM_citation" id="rightTab-cit63"><span><span class="NLM_contrib-group">Cancela, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Basso, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martijena, I. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Capriles, N. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Molina, V. A.</span><span> </span><span class="NLM_article-title">A Dopaminergic Mechanism Is Involved in the ‘Anxiogenic-Like’ Response Induced by Chronic Amphetamine Treatment: A Behavioral and Neurochemical Study</span> <span class="citation_source-journal">Brain Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">909</span><span class="NLM_x">, </span> <span class="NLM_fpage">179</span><span class="NLM_x">–</span> <span class="NLM_lpage">186</span><span class="refDoi"> DOI: 10.1016/S0006-8993(01)02680-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01857&amp;key=10.1016%2FS0006-8993%2801%2902680-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01857&amp;key=11478934" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01857&amp;key=1%3ACAS%3A528%3ADC%252BD3MXls1ejsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=909&publication_year=2001&pages=179-186&author=L.+M.+Cancelaauthor=A.+M.+Bassoauthor=I.+D.+Martijenaauthor=N.+R.+Caprilesauthor=V.+A.+Molina&title=A+Dopaminergic+Mechanism+Is+Involved+in+the+%E2%80%98Anxiogenic-Like%E2%80%99+Response+Induced+by+Chronic+Amphetamine+Treatment%3A+A+Behavioral+and+Neurochemical+Study&doi=10.1016%2FS0006-8993%2801%2902680-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">A dopaminergic mechanism is involved in the 'anxiogenic-like' response induced by chronic amphetamine treatment: a behavioral and neurochemical study</span></div><div class="casAuthors">Cancela, L. M.; Basso, A. M.; Martijena, I. D.; Capriles, N. R.; Molina, V. A.</div><div class="citationInfo"><span class="NLM_cas:title">Brain Research</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">909</span>
        (<span class="NLM_cas:issue">1,2</span>),
    <span class="NLM_cas:pages">179-186</span>CODEN:
                <span class="NLM_cas:coden">BRREAP</span>;
        ISSN:<span class="NLM_cas:issn">0006-8993</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">The purpose of this study was to examine the influence of chronic d-amphetamine (AMPH) treatment (2 mg/kg i.p., for 9 consecutive days) on behavioral and neurochem. responses to a subsequent exposure - 4 days after the last AMPH injection - to the elevated plus-maze (EPM), as well as to det. the involvement of a dopaminergic mechanism in that influence.  Results showed that chronic AMPH treatment induced an 'anxiogenic-like' response when animals were evaluated in the EPM test.  Pretreatment with either haloperidol (HAL, 1 mg/kg i.p., 20 min prior to each injection) or SCH-23390 (0.1 mg/kg i.p., 10 min prior to each injection) completely abolished the chronic AMPH-induced 'anxiogenic-like' effect displayed in the EPM test.  However, sulpiride pretreatment (60 mg/kg i.p., 10 min prior to each AMPH injection) did not modify such effect.  In addn., rats treated with AMPH and subsequently exposed to the EPM, showed a decrease in the maximal GABA-stimulated chloride uptake in cortical microsacs.  HAL pretreatment restored the maximal chloride uptake induced by chronic AMPH.  Altogether, these results suggest that: (1) previous exposure to chronic AMPH treatment induces an increased emotional response following a conflict situation, (2) dopamine D1 receptors are mainly involved in chronic AMPH-induced changes in the behavior displayed in EPM test, and (3) an interaction between GABAergic and dopaminergic mechanisms may be implicated in neurochem. and behavioral changes induced by chronic AMPH treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo0CQeT1MksYLVg90H21EOLACvtfcHk0ljID3Lx4PWZ9A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXls1ejsLs%253D&md5=fccb14f4d4ed713d86ee9cb294902bee</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1016%2FS0006-8993%2801%2902680-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0006-8993%252801%252902680-4%26sid%3Dliteratum%253Aachs%26aulast%3DCancela%26aufirst%3DL.%2BM.%26aulast%3DBasso%26aufirst%3DA.%2BM.%26aulast%3DMartijena%26aufirst%3DI.%2BD.%26aulast%3DCapriles%26aufirst%3DN.%2BR.%26aulast%3DMolina%26aufirst%3DV.%2BA.%26atitle%3DA%2520Dopaminergic%2520Mechanism%2520Is%2520Involved%2520in%2520the%2520%25E2%2580%2598Anxiogenic-Like%25E2%2580%2599%2520Response%2520Induced%2520by%2520Chronic%2520Amphetamine%2520Treatment%253A%2520A%2520Behavioral%2520and%2520Neurochemical%2520Study%26jtitle%3DBrain%2520Res.%26date%3D2001%26volume%3D909%26spage%3D179%26epage%3D186%26doi%3D10.1016%2FS0006-8993%2801%2902680-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref64"><div class="reference"><strong class="refLabel"><a href="#ref64" class="rightTabRefNumLink">64</a></strong><div class="NLM_citation" id="rightTab-cit64"><span><span class="NLM_contrib-group">Amato, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pum, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Groos, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lauber, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huston, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carey, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Souza Silva, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Müller, C. P.</span><span> </span><span class="NLM_article-title">Neuropharmacology of Light-Induced Locomotor Activation</span> <span class="citation_source-journal">Neuropharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">95</span><span class="NLM_x">, </span> <span class="NLM_fpage">243</span><span class="NLM_x">–</span> <span class="NLM_lpage">251</span><span class="refDoi"> DOI: 10.1016/j.neuropharm.2015.03.023</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01857&amp;key=10.1016%2Fj.neuropharm.2015.03.023" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=95&publication_year=2015&pages=243-251&author=D.+Amatoauthor=M.+E.+Pumauthor=D.+Groosauthor=A.+C.+Lauberauthor=J.+P.+Hustonauthor=R.+J.+Careyauthor=M.+A.+de+Souza+Silvaauthor=C.+P.+M%C3%BCller&title=Neuropharmacology+of+Light-Induced+Locomotor+Activation&doi=10.1016%2Fj.neuropharm.2015.03.023"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1016%2Fj.neuropharm.2015.03.023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuropharm.2015.03.023%26sid%3Dliteratum%253Aachs%26aulast%3DAmato%26aufirst%3DD.%26aulast%3DPum%26aufirst%3DM.%2BE.%26aulast%3DGroos%26aufirst%3DD.%26aulast%3DLauber%26aufirst%3DA.%2BC.%26aulast%3DHuston%26aufirst%3DJ.%2BP.%26aulast%3DCarey%26aufirst%3DR.%2BJ.%26aulast%3Dde%2BSouza%2BSilva%26aufirst%3DM.%2BA.%26aulast%3DM%25C3%25BCller%26aufirst%3DC.%2BP.%26atitle%3DNeuropharmacology%2520of%2520Light-Induced%2520Locomotor%2520Activation%26jtitle%3DNeuropharmacology%26date%3D2015%26volume%3D95%26spage%3D243%26epage%3D251%26doi%3D10.1016%2Fj.neuropharm.2015.03.023" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref65"><div class="reference"><strong class="refLabel"><a href="#ref65" class="rightTabRefNumLink">65</a></strong><div class="NLM_citation" id="rightTab-cit65"><span><span class="NLM_contrib-group">Pum, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huston, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Müller, C. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Souza Silva, M. A.</span><span> </span><span class="NLM_article-title">Light-Induced Activity in the Activity Box Is Not Aversively Motivated and Does Not Show between-Trial Habituation</span> <span class="citation_source-journal">Physiol. Behav.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">96</span><span class="NLM_x">, </span> <span class="NLM_fpage">434</span><span class="NLM_x">–</span> <span class="NLM_lpage">439</span><span class="refDoi"> DOI: 10.1016/j.physbeh.2008.11.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01857&amp;key=10.1016%2Fj.physbeh.2008.11.006" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=96&publication_year=2009&pages=434-439&author=M.+E.+Pumauthor=J.+P.+Hustonauthor=C.+P.+M%C3%BCllerauthor=M.+A.+De+Souza+Silva&title=Light-Induced+Activity+in+the+Activity+Box+Is+Not+Aversively+Motivated+and+Does+Not+Show+between-Trial+Habituation&doi=10.1016%2Fj.physbeh.2008.11.006"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1016%2Fj.physbeh.2008.11.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.physbeh.2008.11.006%26sid%3Dliteratum%253Aachs%26aulast%3DPum%26aufirst%3DM.%2BE.%26aulast%3DHuston%26aufirst%3DJ.%2BP.%26aulast%3DM%25C3%25BCller%26aufirst%3DC.%2BP.%26aulast%3DDe%2BSouza%2BSilva%26aufirst%3DM.%2BA.%26atitle%3DLight-Induced%2520Activity%2520in%2520the%2520Activity%2520Box%2520Is%2520Not%2520Aversively%2520Motivated%2520and%2520Does%2520Not%2520Show%2520between-Trial%2520Habituation%26jtitle%3DPhysiol.%2520Behav.%26date%3D2009%26volume%3D96%26spage%3D434%26epage%3D439%26doi%3D10.1016%2Fj.physbeh.2008.11.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref66"><div class="reference"><strong class="refLabel"><a href="#ref66" class="rightTabRefNumLink">66</a></strong><div class="NLM_citation" id="rightTab-cit66"><span><span class="NLM_contrib-group">Pum, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huston, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Souza Silva, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Müller, C. P.</span><span> </span><span class="NLM_article-title">Visual Sensory-Motor Gating by Serotonin Activation in the Medial Prefrontal and Occipital, but not in the Rhinal, Cortices in Rats</span> <span class="citation_source-journal">Neuroscience</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">153</span><span class="NLM_x">, </span> <span class="NLM_fpage">361</span><span class="NLM_x">–</span> <span class="NLM_lpage">372</span><span class="refDoi"> DOI: 10.1016/j.neuroscience.2008.02.029</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01857&amp;key=10.1016%2Fj.neuroscience.2008.02.029" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=153&publication_year=2008&pages=361-372&author=M.+E.+Pumauthor=J.+P.+Hustonauthor=M.+A.+De+Souza+Silvaauthor=C.+P.+M%C3%BCller&title=Visual+Sensory-Motor+Gating+by+Serotonin+Activation+in+the+Medial+Prefrontal+and+Occipital%2C+but+not+in+the+Rhinal%2C+Cortices+in+Rats&doi=10.1016%2Fj.neuroscience.2008.02.029"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1016%2Fj.neuroscience.2008.02.029&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuroscience.2008.02.029%26sid%3Dliteratum%253Aachs%26aulast%3DPum%26aufirst%3DM.%2BE.%26aulast%3DHuston%26aufirst%3DJ.%2BP.%26aulast%3DDe%2BSouza%2BSilva%26aufirst%3DM.%2BA.%26aulast%3DM%25C3%25BCller%26aufirst%3DC.%2BP.%26atitle%3DVisual%2520Sensory-Motor%2520Gating%2520by%2520Serotonin%2520Activation%2520in%2520the%2520Medial%2520Prefrontal%2520and%2520Occipital%252C%2520but%2520not%2520in%2520the%2520Rhinal%252C%2520Cortices%2520in%2520Rats%26jtitle%3DNeuroscience%26date%3D2008%26volume%3D153%26spage%3D361%26epage%3D372%26doi%3D10.1016%2Fj.neuroscience.2008.02.029" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref67"><div class="reference"><strong class="refLabel"><a href="#ref67" class="rightTabRefNumLink">67</a></strong><div class="NLM_citation" id="rightTab-cit67"><span><span class="NLM_contrib-group">Featherstone, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kapur, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fletcher, P. J.</span><span> </span><span class="NLM_article-title">The Amphetamine-Induced Sensitized State as a Model of Schizophrenia</span> <span class="citation_source-journal">Prog. Neuro-Psychopharmacol. Biol. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">1556</span><span class="NLM_x">–</span> <span class="NLM_lpage">1571</span><span class="refDoi"> DOI: 10.1016/j.pnpbp.2007.08.025</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01857&amp;key=10.1016%2Fj.pnpbp.2007.08.025" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01857&amp;key=17884274" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01857&amp;key=1%3ACAS%3A528%3ADC%252BD2sXht1amtr7I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2007&pages=1556-1571&author=R.+E.+Featherstoneauthor=S.+Kapurauthor=P.+J.+Fletcher&title=The+Amphetamine-Induced+Sensitized+State+as+a+Model+of+Schizophrenia&doi=10.1016%2Fj.pnpbp.2007.08.025"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit67R"><div class="casContent"><span class="casTitleNuber">67</span><div class="casTitle"><span class="NLM_cas:atitle">The amphetamine-induced sensitized state as a model of schizophrenia</span></div><div class="casAuthors">Featherstone, R. E.; Kapur, S.; Fletcher, P. J.</div><div class="citationInfo"><span class="NLM_cas:title">Progress in Neuro-Psychopharmacology & Biological Psychiatry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1556-1571</span>CODEN:
                <span class="NLM_cas:coden">PNPPD7</span>;
        ISSN:<span class="NLM_cas:issn">0278-5846</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Schizophrenia is a serious psychiatric disorder which impacts a broad range of cognitive, behavioral and emotional domains.  In animals, exposure to an intermittent, escalating dose regimen of amphetamine induces a sensitized state that appears to share a no. of behavioral and neurochem. similarities with schizophrenia.  In humans repeated exposure to amphetamine, or other psychomotor stimulants, can induce sensitization as well as psychosis.  The following paper evaluates the evidence for the amphetamine-induced sensitized state as an animal model of schizophrenia, focussing sep. on the pos., cognitive and neg. symptoms assocd. with this disease.  Current evidence supports the use of amphetamine sensitization as a model of the pos. symptoms obsd. in schizophrenia.  Addnl., there is increasing evidence for long-lasting cognitive deficits in sensitized animals, esp. in the area of attention and/or cognitive flexibility.  Other areas of cognition, such as long-term memory, appear to be unaltered in sensitized animals.  Finally, little evidence currently exists to either support or refute the use of amphetamine sensitization as a model of neg. symptoms.  It is concluded that amphetamine sensitization likely impacts behavior by altering the functioning of mesolimbic dopamine systems and prefrontal cortical function and can serve as a model of certain domains of schizophrenia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqzo0uzz7CfYrVg90H21EOLACvtfcHk0ljsyd0h2awLOQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXht1amtr7I&md5=9a3a77dd280f48015f7dade8bc5a242a</span></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1016%2Fj.pnpbp.2007.08.025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pnpbp.2007.08.025%26sid%3Dliteratum%253Aachs%26aulast%3DFeatherstone%26aufirst%3DR.%2BE.%26aulast%3DKapur%26aufirst%3DS.%26aulast%3DFletcher%26aufirst%3DP.%2BJ.%26atitle%3DThe%2520Amphetamine-Induced%2520Sensitized%2520State%2520as%2520a%2520Model%2520of%2520Schizophrenia%26jtitle%3DProg.%2520Neuro-Psychopharmacol.%2520Biol.%2520Psychiatry%26date%3D2007%26volume%3D31%26spage%3D1556%26epage%3D1571%26doi%3D10.1016%2Fj.pnpbp.2007.08.025" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref68"><div class="reference"><strong class="refLabel"><a href="#ref68" class="rightTabRefNumLink">68</a></strong><div class="NLM_citation" id="rightTab-cit68"><span><span class="NLM_contrib-group">Prut, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Belzung, C.</span><span> </span><span class="NLM_article-title">The Open Field as a Paradigm to Measure the Effects of Drugs on Anxiety-Like Behaviors: A Review</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">463</span><span class="NLM_x">, </span> <span class="NLM_fpage">3</span><span class="NLM_x">–</span> <span class="NLM_lpage">33</span><span class="refDoi"> DOI: 10.1016/S0014-2999(03)01272-X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01857&amp;key=10.1016%2FS0014-2999%2803%2901272-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01857&amp;key=12600700" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01857&amp;key=1%3ACAS%3A528%3ADC%252BD3sXhsVanu70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=463&publication_year=2003&pages=3-33&author=L.+Prutauthor=C.+Belzung&title=The+Open+Field+as+a+Paradigm+to+Measure+the+Effects+of+Drugs+on+Anxiety-Like+Behaviors%3A+A+Review&doi=10.1016%2FS0014-2999%2803%2901272-X"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit68R"><div class="casContent"><span class="casTitleNuber">68</span><div class="casTitle"><span class="NLM_cas:atitle">The open field as a paradigm to measure the effects of drugs on anxiety-like behaviors: a review</span></div><div class="casAuthors">Prut, Laetitia; Belzung, Catherine</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">463</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">3-33</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">A review. The open field is a very popular animal model of anxiety-like behavior.  An overview of the literature on the action elicited by effective or putative anxiolytics in animals subjected to this procedure indicated that classical treatments such as benzodiazepine receptor full agonists or 5-HT1A receptor full or partial agonists elicit an anxiolytic-like effect in this procedure in most cases (approx. 2/3).  However, compds. (triazolobenzodiazepines such as adinazolam and alprazolam, selective serotonin reuptake inhibitors) that have a different spectrum of therapeutic efficacy in anxiety disorders such as panic attacks, generalized anxiety disorder or obsessive-compulsive disorder were poorly effective as anxiolytics in the open field test, suggesting that this paradigm may not model features of anxiety disorders.  The procedure is also relevant to the study of compds. endowed with anxiogenic effects, as such effects were detected after treatments with benzodiazepine receptor inverse agonists or with corticotropin-releasing factor receptor agonists.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpwZxllzNiJdLVg90H21EOLACvtfcHk0ljsyd0h2awLOQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXhsVanu70%253D&md5=8fbb7f106f0e7c28c1c0b83dfe02dcb3</span></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.1016%2FS0014-2999%2803%2901272-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0014-2999%252803%252901272-X%26sid%3Dliteratum%253Aachs%26aulast%3DPrut%26aufirst%3DL.%26aulast%3DBelzung%26aufirst%3DC.%26atitle%3DThe%2520Open%2520Field%2520as%2520a%2520Paradigm%2520to%2520Measure%2520the%2520Effects%2520of%2520Drugs%2520on%2520Anxiety-Like%2520Behaviors%253A%2520A%2520Review%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2003%26volume%3D463%26spage%3D3%26epage%3D33%26doi%3D10.1016%2FS0014-2999%2803%2901272-X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref69"><div class="reference"><strong class="refLabel"><a href="#ref69" class="rightTabRefNumLink">69</a></strong><div class="NLM_citation" id="rightTab-cit69"><span><span class="NLM_contrib-group">Antelman, S. M.; Chiodo, L. A.</span><span> </span><span class="NLM_article-title">Amphetamine as a Stressor</span>. In  <span class="citation_source-book">Stimulants: Neurochemical, Behavioral and Clinical Perspectives</span>, <span class="NLM_contrib-group">Cresse, I.</span>, Ed.; <span class="NLM_publisher-name">Raven Press</span>: <span class="NLM_publisher-loc">New York</span>,<span class="NLM_x"> </span><span class="NLM_year">1983</span><span class="NLM_x">; </span>pp  <span class="NLM_fpage">269</span><span class="NLM_x">–</span> <span class="NLM_lpage">299</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1983&pages=269-299&author=S.+M.+Antelman&author=L.+A.+Chiodoauthor=I.+Cresse&title=Stimulants%3A+Neurochemical%2C+Behavioral+and+Clinical+Perspectives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DAntelman%26aufirst%3DS.%2BM.%26atitle%3DAmphetamine%2520as%2520a%2520Stressor%26btitle%3DStimulants%253A%2520Neurochemical%252C%2520Behavioral%2520and%2520Clinical%2520Perspectives%26aulast%3DCresse%26aufirst%3DI.%26pub%3DRaven%2520Press%26date%3D1983%26spage%3D269%26epage%3D299" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref70"><div class="reference"><strong class="refLabel"><a href="#ref70" class="rightTabRefNumLink">70</a></strong><div class="NLM_citation" id="rightTab-cit70"><span><span class="NLM_contrib-group">Braga, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petrides, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Figueira, I.</span><span> </span><span class="NLM_article-title">Anxiety Disorders in Schizophrenia</span> <span class="citation_source-journal">Compr. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">460</span><span class="NLM_x">–</span> <span class="NLM_lpage">468</span><span class="refDoi"> DOI: 10.1016/j.comppsych.2004.07.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01857&amp;key=10.1016%2Fj.comppsych.2004.07.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01857&amp;key=15526257" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01857&amp;key=1%3ACAS%3A280%3ADC%252BD2crltlagsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2004&pages=460-468&author=R.+J.+Bragaauthor=G.+Petridesauthor=I.+Figueira&title=Anxiety+Disorders+in+Schizophrenia&doi=10.1016%2Fj.comppsych.2004.07.009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit70R"><div class="casContent"><span class="casTitleNuber">70</span><div class="casTitle"><span class="NLM_cas:atitle">Anxiety disorders in schizophrenia</span></div><div class="casAuthors">Braga Raphael J; Petrides Georgios; Figueira Ivan</div><div class="citationInfo"><span class="NLM_cas:title">Comprehensive psychiatry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">460-8</span>
        ISSN:<span class="NLM_cas:issn">0010-440X</span>.
    </div><div class="casAbstract">Data regarding the co-occurrence of anxiety symptoms or syndromes in schizophrenia is scant.  Hierarchical assumptions embedded in diagnostic systems and methodologic difficulties hamper the development of studies on accessory symptomatology outside of the core positive-negative-disorganized symptoms.  Recent studies have repeatedly challenged these assumptions by presenting data on comorbid disorders in schizophrenia.  We review the current knowledge about anxiety comorbidity in schizophrenia, and its relative prevalence, relevance, and treatment.  A computerized search of the literature published from 1966 to July 2003 was conducted on Medline using the word "schizophrenia" and the words from the names of each anxiety disorder listed in DSM-IV, one at a time.  Only studies including exclusively the diagnosis of schizophrenia were included.  Only 15 studies were dedicated to the subject of anxiety comorbidity prevalence in schizophrenia.  The most studied comorbidities were obsessive-compulsive disorder (OCD) and panic disorder, and most reports suggested them to be highly prevalent in schizophrenia.  Posttraumatic stress disorder (PTSD) was the least studied (N = 2).  Except for two pharmacologic studies in OCD, there were no double-blind randomized controlled trials regarding the treatment of anxiety in schizophrenia.  Most case reports and open label trials tried conventional treatment for anxiety disorders with some degree of success.  The literature indicates that anxiety comorbidities are prevalent in schizophrenia and conventional treatment for anxiety can help alleviate the symptoms in those patients.  However, the body of data provided by research so far is still far from allowing evidence-based conclusions.  Large studies with operationalized criteria, as well as comprehensive assessments of treatment response and outcome are needed to clarify the relationship between anxiety disorders and schizophrenia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQUUO1PHpQ9wDW1zwg2yUK5fW6udTcc2eYsY73OTI0SF7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2crltlagsw%253D%253D&md5=fb58df8052db94ccddfea8f504ab0ebe</span></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=10.1016%2Fj.comppsych.2004.07.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.comppsych.2004.07.009%26sid%3Dliteratum%253Aachs%26aulast%3DBraga%26aufirst%3DR.%2BJ.%26aulast%3DPetrides%26aufirst%3DG.%26aulast%3DFigueira%26aufirst%3DI.%26atitle%3DAnxiety%2520Disorders%2520in%2520Schizophrenia%26jtitle%3DCompr.%2520Psychiatry%26date%3D2004%26volume%3D45%26spage%3D460%26epage%3D468%26doi%3D10.1016%2Fj.comppsych.2004.07.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref71"><div class="reference"><strong class="refLabel"><a href="#ref71" class="rightTabRefNumLink">71</a></strong><div class="NLM_citation" id="rightTab-cit71"><span><span class="NLM_contrib-group">Buckley, P. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lehrer, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castle, D. J.</span><span> </span><span class="NLM_article-title">Psychiatric Comorbidities and Schizophrenia</span> <span class="citation_source-journal">Schizophr. Bull.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">35</span><span class="NLM_x">, </span> <span class="NLM_fpage">383</span><span class="NLM_x">–</span> <span class="NLM_lpage">402</span><span class="refDoi"> DOI: 10.1093/schbul/sbn135</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01857&amp;key=10.1093%2Fschbul%2Fsbn135" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01857&amp;key=19011234" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01857&amp;key=1%3ACAS%3A280%3ADC%252BD1M3it1Glug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2009&pages=383-402&author=P.+F.+Buckleyauthor=B.+J.+Millerauthor=D.+S.+Lehrerauthor=D.+J.+Castle&title=Psychiatric+Comorbidities+and+Schizophrenia&doi=10.1093%2Fschbul%2Fsbn135"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit71R"><div class="casContent"><span class="casTitleNuber">71</span><div class="casTitle"><span class="NLM_cas:atitle">Psychiatric comorbidities and schizophrenia</span></div><div class="casAuthors">Buckley Peter F; Miller Brian J; Lehrer Douglas S; Castle David J</div><div class="citationInfo"><span class="NLM_cas:title">Schizophrenia bulletin</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">383-402</span>
        ISSN:<span class="NLM_cas:issn">0586-7614</span>.
    </div><div class="casAbstract">Psychiatric comorbidities are common among patients with schizophrenia.  Substance abuse comorbidity predominates.  Anxiety and depressive symptoms are also very common throughout the course of illness, with an estimated prevalence of 15% for panic disorder, 29% for posttraumatic stress disorder, and 23% for obsessive-compulsive disorder.  It is estimated that comorbid depression occurs in 50% of patients, and perhaps (conservatively) 47% of patients also have a lifetime diagnosis of comorbid substance abuse.  This article chronicles these associations, examining whether these comorbidities are "more than chance" and might represent (distinct) phenotypes of schizophrenia.  Among the anxiety disorders, the evidence at present is most abundant for an association with obsessive-compulsive disorder.  Additional studies in newly diagnosed antipsychotic-naive patients and their first-degree relatives and searches for genetic and environmental risk factors are needed to replicate preliminary findings and further investigate these associations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSUoGXLx_C2lMAKB7Fa-xrUfW6udTcc2eYsY73OTI0SF7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1M3it1Glug%253D%253D&md5=30a317f1a2f977933d5b2a7fa7061208</span></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=10.1093%2Fschbul%2Fsbn135&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fschbul%252Fsbn135%26sid%3Dliteratum%253Aachs%26aulast%3DBuckley%26aufirst%3DP.%2BF.%26aulast%3DMiller%26aufirst%3DB.%2BJ.%26aulast%3DLehrer%26aufirst%3DD.%2BS.%26aulast%3DCastle%26aufirst%3DD.%2BJ.%26atitle%3DPsychiatric%2520Comorbidities%2520and%2520Schizophrenia%26jtitle%3DSchizophr.%2520Bull.%26date%3D2009%26volume%3D35%26spage%3D383%26epage%3D402%26doi%3D10.1093%2Fschbul%2Fsbn135" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref72"><div class="reference"><strong class="refLabel"><a href="#ref72" class="rightTabRefNumLink">72</a></strong><div class="NLM_citation" id="rightTab-cit72"><span><span class="NLM_contrib-group">Shin, H.-W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chung, S. J.</span><span> </span><span class="NLM_article-title">Drug-Induced Parkinsonism</span> <span class="citation_source-journal">J. Clin. Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">15</span><span class="NLM_x">–</span> <span class="NLM_lpage">21</span><span class="refDoi"> DOI: 10.3988/jcn.2012.8.1.15</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01857&amp;key=10.3988%2Fjcn.2012.8.1.15" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01857&amp;key=22523509" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01857&amp;key=1%3ACAS%3A280%3ADC%252BC38rntVarsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2012&pages=15-21&author=H.-W.+Shinauthor=S.+J.+Chung&title=Drug-Induced+Parkinsonism&doi=10.3988%2Fjcn.2012.8.1.15"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit72R"><div class="casContent"><span class="casTitleNuber">72</span><div class="casTitle"><span class="NLM_cas:atitle">Drug-induced parkinsonism</span></div><div class="casAuthors">Shin Hae-Won; Chung Sun Ju</div><div class="citationInfo"><span class="NLM_cas:title">Journal of clinical neurology (Seoul, Korea)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">15-21</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Drug-induced parkinsonism (DIP) is the second-most-common etiology of parkinsonism in the elderly after Parkinson's disease (PD).  Many patients with DIP may be misdiagnosed with PD because the clinical features of these two conditions are indistinguishable.  Moreover, neurological deficits in patients with DIP may be severe enough to affect daily activities and may persist for long periods of time after the cessation of drug taking.  In addition to typical antipsychotics, DIP may be caused by gastrointestinal prokinetics, calcium channel blockers, atypical antipsychotics, and antiepileptic drugs.  The clinical manifestations of DIP are classically described as bilateral and symmetric parkinsonism without tremor at rest.  However, about half of DIP patients show asymmetrical parkinsonism and tremor at rest, making it difficult to differentiate DIP from PD.  The pathophysiology of DIP is related to drug-induced changes in the basal ganglia motor circuit secondary to dopaminergic receptor blockade.  Since these effects are limited to postsynaptic dopaminergic receptors, it is expected that presynaptic dopaminergic neurons in the striatum will be intact.  Dopamine transporter (DAT) imaging is useful for diagnosing presynaptic parkinsonism.  DAT uptake in the striatum is significantly decreased even in the early stage of PD, and this characteristic may help in differentiating PD from DIP.  DIP may have a significant and longstanding effect on patients' daily lives, and so physicians should be cautious when prescribing dopaminergic receptor blockers and should monitor patients' neurological signs, especially for parkinsonism and other movement disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcS3_M1KFAjW5MAKB7Fa-xrUfW6udTcc2eYsY73OTI0SF7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC38rntVarsg%253D%253D&md5=97026b438d04a37dc4bf74c0d05e3fad</span></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=10.3988%2Fjcn.2012.8.1.15&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3988%252Fjcn.2012.8.1.15%26sid%3Dliteratum%253Aachs%26aulast%3DShin%26aufirst%3DH.-W.%26aulast%3DChung%26aufirst%3DS.%2BJ.%26atitle%3DDrug-Induced%2520Parkinsonism%26jtitle%3DJ.%2520Clin.%2520Neurol.%26date%3D2012%26volume%3D8%26spage%3D15%26epage%3D21%26doi%3D10.3988%2Fjcn.2012.8.1.15" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref73"><div class="reference"><strong class="refLabel"><a href="#ref73" class="rightTabRefNumLink">73</a></strong><div class="NLM_citation" id="rightTab-cit73"><span><span class="NLM_contrib-group">Leucht, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wahlbeck, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamann, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kissling, W.</span><span> </span><span class="NLM_article-title">New Generation Antipsychotics Versus Low-Potency Conventional Antipsychotics: A Systematic Review and Meta-Analysis</span> <span class="citation_source-journal">Lancet</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">361</span><span class="NLM_x">, </span> <span class="NLM_fpage">1581</span><span class="NLM_x">–</span> <span class="NLM_lpage">1589</span><span class="refDoi"> DOI: 10.1016/S0140-6736(03)13306-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01857&amp;key=10.1016%2FS0140-6736%2803%2913306-5" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=361&publication_year=2003&pages=1581-1589&author=S.+Leuchtauthor=K.+Wahlbeckauthor=J.+Hamannauthor=W.+Kissling&title=New+Generation+Antipsychotics+Versus+Low-Potency+Conventional+Antipsychotics%3A+A+Systematic+Review+and+Meta-Analysis&doi=10.1016%2FS0140-6736%2803%2913306-5"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=10.1016%2FS0140-6736%2803%2913306-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0140-6736%252803%252913306-5%26sid%3Dliteratum%253Aachs%26aulast%3DLeucht%26aufirst%3DS.%26aulast%3DWahlbeck%26aufirst%3DK.%26aulast%3DHamann%26aufirst%3DJ.%26aulast%3DKissling%26aufirst%3DW.%26atitle%3DNew%2520Generation%2520Antipsychotics%2520Versus%2520Low-Potency%2520Conventional%2520Antipsychotics%253A%2520A%2520Systematic%2520Review%2520and%2520Meta-Analysis%26jtitle%3DLancet%26date%3D2003%26volume%3D361%26spage%3D1581%26epage%3D1589%26doi%3D10.1016%2FS0140-6736%2803%2913306-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref74"><div class="reference"><strong class="refLabel"><a href="#ref74" class="rightTabRefNumLink">74</a></strong><div class="NLM_citation" id="rightTab-cit74"><span><span class="NLM_contrib-group">Robinson, T. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Becker, J. B.</span><span> </span><span class="NLM_article-title">Enduring Changes in Brain and Behavior Produced by Chronic Amphetamine Administration: A Review and Evaluation of Animal Models of Amphetamine Psychosis</span> <span class="citation_source-journal">Brain Res. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1986</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">157</span><span class="NLM_x">–</span> <span class="NLM_lpage">198</span><span class="refDoi"> DOI: 10.1016/0165-0173(86)90002-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01857&amp;key=10.1016%2F0165-0173%2886%2990002-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01857&amp;key=1%3ACAS%3A528%3ADyaL28Xlt1Kmurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=1986&pages=157-198&author=T.+E.+Robinsonauthor=J.+B.+Becker&title=Enduring+Changes+in+Brain+and+Behavior+Produced+by+Chronic+Amphetamine+Administration%3A+A+Review+and+Evaluation+of+Animal+Models+of+Amphetamine+Psychosis&doi=10.1016%2F0165-0173%2886%2990002-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit74R"><div class="casContent"><span class="casTitleNuber">74</span><div class="casTitle"><span class="NLM_cas:atitle">Enduring changes in brain and behavior produced by chronic amphetamine administration:  a review and evaluation of animal models of amphetamine psychosis</span></div><div class="casAuthors">Robinson, Terry E.; Becker, Jill B.</div><div class="citationInfo"><span class="NLM_cas:title">Brain Research Reviews</span>
        (<span class="NLM_cas:date">1986</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">157-98</span>CODEN:
                <span class="NLM_cas:coden">BRERD2</span>;
        ISSN:<span class="NLM_cas:issn">0165-0173</span>.
    </div><div class="casAbstract">A review, with 321 refs., of animal models in and the neuro- and behavioral pharmacol. of amphetamine  [300-62-9]-induced psychosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGouiZQnq9tKMLVg90H21EOLACvtfcHk0liEg1NGlXc8ng"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL28Xlt1Kmurs%253D&md5=69280fb23b95328aaff8fff3df5e99fe</span></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=10.1016%2F0165-0173%2886%2990002-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0165-0173%252886%252990002-0%26sid%3Dliteratum%253Aachs%26aulast%3DRobinson%26aufirst%3DT.%2BE.%26aulast%3DBecker%26aufirst%3DJ.%2BB.%26atitle%3DEnduring%2520Changes%2520in%2520Brain%2520and%2520Behavior%2520Produced%2520by%2520Chronic%2520Amphetamine%2520Administration%253A%2520A%2520Review%2520and%2520Evaluation%2520of%2520Animal%2520Models%2520of%2520Amphetamine%2520Psychosis%26jtitle%3DBrain%2520Res.%2520Rev.%26date%3D1986%26volume%3D11%26spage%3D157%26epage%3D198%26doi%3D10.1016%2F0165-0173%2886%2990002-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref75"><div class="reference"><strong class="refLabel"><a href="#ref75" class="rightTabRefNumLink">75</a></strong><div class="NLM_citation" id="rightTab-cit75"><span><span class="NLM_contrib-group">Tschammer, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elsner, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goetz, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ehrlich, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schuster, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruberg, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuhhorn, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whistler, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hubner, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gmeiner, P.</span><span> </span><span class="NLM_article-title">Highly Potent 5-Aminotetrahydropyrazolopyridines: Enantioselective Dopamine D3 Receptor Binding, Functional Selectivity, and Analysis of Receptor-Ligand Interactions</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">2477</span><span class="NLM_x">–</span> <span class="NLM_lpage">2491</span><span class="refDoi"> DOI: 10.1021/jm101639t</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm101639t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=2477-2491&author=N.+Tschammerauthor=J.+Elsnerauthor=A.+Goetzauthor=K.+Ehrlichauthor=S.+Schusterauthor=M.+Rubergauthor=J.+Kuhhornauthor=D.+Thompsonauthor=J.+Whistlerauthor=H.+Hubnerauthor=P.+Gmeiner&title=Highly+Potent+5-Aminotetrahydropyrazolopyridines%3A+Enantioselective+Dopamine+D3+Receptor+Binding%2C+Functional+Selectivity%2C+and+Analysis+of+Receptor-Ligand+Interactions&doi=10.1021%2Fjm101639t"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=10.1021%2Fjm101639t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm101639t%26sid%3Dliteratum%253Aachs%26aulast%3DTschammer%26aufirst%3DN.%26aulast%3DElsner%26aufirst%3DJ.%26aulast%3DGoetz%26aufirst%3DA.%26aulast%3DEhrlich%26aufirst%3DK.%26aulast%3DSchuster%26aufirst%3DS.%26aulast%3DRuberg%26aufirst%3DM.%26aulast%3DKuhhorn%26aufirst%3DJ.%26aulast%3DThompson%26aufirst%3DD.%26aulast%3DWhistler%26aufirst%3DJ.%26aulast%3DHubner%26aufirst%3DH.%26aulast%3DGmeiner%26aufirst%3DP.%26atitle%3DHighly%2520Potent%25205-Aminotetrahydropyrazolopyridines%253A%2520Enantioselective%2520Dopamine%2520D3%2520Receptor%2520Binding%252C%2520Functional%2520Selectivity%252C%2520and%2520Analysis%2520of%2520Receptor-Ligand%2520Interactions%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D2477%26epage%3D2491%26doi%3D10.1021%2Fjm101639t" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref76"><div class="reference"><strong class="refLabel"><a href="#ref76" class="rightTabRefNumLink">76</a></strong><div class="NLM_citation" id="rightTab-cit76"><span><span class="NLM_contrib-group">Lowry, O. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosebrough, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farr, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Randall, R. J.</span><span> </span><span class="NLM_article-title">Protein Measurement with the Folin Phenol Reagent</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1951</span><span class="NLM_x">, </span> <span class="NLM_volume">193</span><span class="NLM_x">, </span> <span class="NLM_fpage">265</span><span class="NLM_x">–</span> <span class="NLM_lpage">275</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01857&amp;key=10.1016%2FS0021-9258%2819%2952451-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01857&amp;key=14907713" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01857&amp;key=1%3ACAS%3A528%3ADyaG38XhsVyrsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=193&publication_year=1951&pages=265-275&author=O.+H.+Lowryauthor=N.+J.+Rosebroughauthor=A.+L.+Farrauthor=R.+J.+Randall&title=Protein+Measurement+with+the+Folin+Phenol+Reagent"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit76R"><div class="casContent"><span class="casTitleNuber">76</span><div class="casTitle"><span class="NLM_cas:atitle">Protein measurement with the Folin phenol reagent</span></div><div class="casAuthors">Lowry, Oliver H.; Rosebrough, Nira J.; Farr, A. Lewis; Randall, Rose J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">1951</span>),
    <span class="NLM_cas:volume">193</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">265-75</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    </div><div class="casAbstract">cf. C.A. 41, 1271h.  Proteins were detd. with the Folin phenol reagent after alk. Cu treatment.  The method is as sensitive as with Nessler reagent, yet requires no digestion.  It is 10-20 times more sensitive than detn. of the ultraviolet absorption at λ = 280 mμ and is more specific.  It is several fold more sensitive than the ninhydrin reaction and 100 times more sensitive than the biuret reaction.  Two major disadvantages are: the amt. of color varies with different proteins; the color is not strictly proportional to concn.  Few substances cause serious interference.  Uric acid, guanine, and xanthine react with Folin reagent.  The method is useful for following enzyme fractionation, detg. mixed tissue proteins, detn. of very small amts. of protein, or detg. highly dild. protein, or protein in colored solns. or in the presence of N-contg. material.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrHNRKGd34F8LVg90H21EOLACvtfcHk0liEg1NGlXc8ng"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaG38XhsVyrsw%253D%253D&md5=19d36395fad7dd87661caa3d2b97640d</span></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=10.1016%2FS0021-9258%2819%2952451-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0021-9258%252819%252952451-6%26sid%3Dliteratum%253Aachs%26aulast%3DLowry%26aufirst%3DO.%2BH.%26aulast%3DRosebrough%26aufirst%3DN.%2BJ.%26aulast%3DFarr%26aufirst%3DA.%2BL.%26aulast%3DRandall%26aufirst%3DR.%2BJ.%26atitle%3DProtein%2520Measurement%2520with%2520the%2520Folin%2520Phenol%2520Reagent%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1951%26volume%3D193%26spage%3D265%26epage%3D275" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref77"><div class="reference"><strong class="refLabel"><a href="#ref77" class="rightTabRefNumLink">77</a></strong><div class="NLM_citation" id="rightTab-cit77"><span><span class="NLM_contrib-group">Hübner, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haubmann, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Utz, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gmeiner, P.</span><span> </span><span class="NLM_article-title">Conjugated Enynes as Nonaromatic Catechol Bioisosteres: Synthesis, Binding Experiments, and Computational Studies of Novel Dopamine Receptor Agonists Recognizing Preferentially the D3 Subtype</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">756</span><span class="NLM_x">–</span> <span class="NLM_lpage">762</span><span class="refDoi"> DOI: 10.1021/jm991098z</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm991098z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01857&amp;key=1%3ACAS%3A528%3ADC%252BD3cXmvV2ntQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2000&pages=756-762&author=H.+H%C3%BCbnerauthor=C.+Haubmannauthor=W.+Utzauthor=P.+Gmeiner&title=Conjugated+Enynes+as+Nonaromatic+Catechol+Bioisosteres%3A+Synthesis%2C+Binding+Experiments%2C+and+Computational+Studies+of+Novel+Dopamine+Receptor+Agonists+Recognizing+Preferentially+the+D3+Subtype&doi=10.1021%2Fjm991098z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit77R"><div class="casContent"><span class="casTitleNuber">77</span><div class="casTitle"><span class="NLM_cas:atitle">Conjugated Enynes as Nonaromatic Catechol Bioisosteres: Synthesis, Binding Experiments, and Computational Studies of Novel Dopamine Receptor Agonists Recognizing Preferentially the D3 Subtype</span></div><div class="casAuthors">Huebner, Harald; Haubmann, Christian; Utz, Wolfgang; Gmeiner, Peter</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">756-762</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">To evaluate nonarom. catechol bioisosteres, the conformationally restrained enynes and enediynes were synthesized via palladium-catalyzed coupling as the key reaction step.  Subsequent receptor binding studies at the dopamine receptor subtypes D1, D2 long, D2 short, D3, and D4 showed highly interesting binding profiles for the enynes when compared to dopamine.  At the guanine nucleotide-sensitive high-affinity binding site of the D3 receptor, the target compd. (Ki = 5.2 nM) was 10-fold more potent than dopamine but less potent at the D2 and D4 subtypes.  In contrast to dopamine the agonists enynes showed strong selectivity for the receptors of the D2 family (D2-D4).  As far as we know, this study represents the first report on nonarom. dopamine agonists.  Comparison of mol. electrostatic potentials, derived from semiempirical MO calcns., and lipophilicity maps was performed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoWheANs3NXRLVg90H21EOLACvtfcHk0liEg1NGlXc8ng"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXmvV2ntQ%253D%253D&md5=affc96571dd02832d40f990d29786a3a</span></div><a href="/servlet/linkout?suffix=cit77&amp;dbid=16384&amp;doi=10.1021%2Fjm991098z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm991098z%26sid%3Dliteratum%253Aachs%26aulast%3DH%25C3%25BCbner%26aufirst%3DH.%26aulast%3DHaubmann%26aufirst%3DC.%26aulast%3DUtz%26aufirst%3DW.%26aulast%3DGmeiner%26aufirst%3DP.%26atitle%3DConjugated%2520Enynes%2520as%2520Nonaromatic%2520Catechol%2520Bioisosteres%253A%2520Synthesis%252C%2520Binding%2520Experiments%252C%2520and%2520Computational%2520Studies%2520of%2520Novel%2520Dopamine%2520Receptor%2520Agonists%2520Recognizing%2520Preferentially%2520the%2520D3%2520Subtype%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2000%26volume%3D43%26spage%3D756%26epage%3D762%26doi%3D10.1021%2Fjm991098z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref78"><div class="reference"><strong class="refLabel"><a href="#ref78" class="rightTabRefNumLink">78</a></strong><div class="NLM_citation" id="rightTab-cit78"><span><span class="NLM_contrib-group">Cheng, Y.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prusoff, W. H.</span><span> </span><span class="NLM_article-title">Relationship between the Inhibition Constant (Ki) and the Concentration of Inhibitor Which Causes 50 Per Cent Inhibition (I50) of an Enzymatic Reaction</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1973</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">3099</span><span class="NLM_x">–</span> <span class="NLM_lpage">3108</span><span class="refDoi"> DOI: 10.1016/0006-2952(73)90196-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01857&amp;key=10.1016%2F0006-2952%2873%2990196-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01857&amp;key=4202581" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01857&amp;key=1%3ACAS%3A528%3ADyaE2cXhtVGgs7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=1973&pages=3099-3108&author=Y.-C.+Chengauthor=W.+H.+Prusoff&title=Relationship+between+the+Inhibition+Constant+%28Ki%29+and+the+Concentration+of+Inhibitor+Which+Causes+50+Per+Cent+Inhibition+%28I50%29+of+an+Enzymatic+Reaction&doi=10.1016%2F0006-2952%2873%2990196-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit78R"><div class="casContent"><span class="casTitleNuber">78</span><div class="casTitle"><span class="NLM_cas:atitle">Relation between the inhibition constant K1) and the concentration of inhibitor which causes fifty per cent inhibition (I50) of an enzymic reaction</span></div><div class="casAuthors">Cheng, Yung-Chi; Prusoff, William H.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Pharmacology</span>
        (<span class="NLM_cas:date">1973</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">3099-108</span>CODEN:
                <span class="NLM_cas:coden">BCPCA6</span>;
        ISSN:<span class="NLM_cas:issn">0006-2952</span>.
    </div><div class="casAbstract">The Ki and I50 values are equal where the kinetics are non- or uncompetitive, but not where they are competitive.  The relation between the 2 values was analyzed for non- and uncompetitive bi- and monosubstrate reactions and for competitive bisubstrate reactions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqodFY_8msz57Vg90H21EOLACvtfcHk0liJWL8eBaspqA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE2cXhtVGgs7c%253D&md5=fe7175ca300d8f4085df87af37f8656c</span></div><a href="/servlet/linkout?suffix=cit78&amp;dbid=16384&amp;doi=10.1016%2F0006-2952%2873%2990196-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0006-2952%252873%252990196-2%26sid%3Dliteratum%253Aachs%26aulast%3DCheng%26aufirst%3DY.-C.%26aulast%3DPrusoff%26aufirst%3DW.%2BH.%26atitle%3DRelationship%2520between%2520the%2520Inhibition%2520Constant%2520%2528Ki%2529%2520and%2520the%2520Concentration%2520of%2520Inhibitor%2520Which%2520Causes%252050%2520Per%2520Cent%2520Inhibition%2520%2528I50%2529%2520of%2520an%2520Enzymatic%2520Reaction%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D1973%26volume%3D22%26spage%3D3099%26epage%3D3108%26doi%3D10.1016%2F0006-2952%2873%2990196-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref79"><div class="reference"><strong class="refLabel"><a href="#ref79" class="rightTabRefNumLink">79</a></strong><div class="NLM_citation" id="rightTab-cit79"><span><span class="NLM_contrib-group">Namkung, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Radresa, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Armando, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Devost, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beautrait, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le Gouill, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laporte, S. A.</span><span> </span><span class="NLM_article-title">Quantifying Biased Signaling in Gpcrs Using Bret-Based Biosensors</span> <span class="citation_source-journal">Methods</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">92</span><span class="NLM_x">, </span> <span class="NLM_fpage">5</span><span class="NLM_x">–</span> <span class="NLM_lpage">10</span><span class="refDoi"> DOI: 10.1016/j.ymeth.2015.04.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01857&amp;key=10.1016%2Fj.ymeth.2015.04.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01857&amp;key=25890247" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01857&amp;key=1%3ACAS%3A528%3ADC%252BC2MXmslehsLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=92&publication_year=2016&pages=5-10&author=Y.+Namkungauthor=O.+Radresaauthor=S.+Armandoauthor=D.+Devostauthor=A.+Beautraitauthor=C.+Le+Gouillauthor=S.+A.+Laporte&title=Quantifying+Biased+Signaling+in+Gpcrs+Using+Bret-Based+Biosensors&doi=10.1016%2Fj.ymeth.2015.04.010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit79R"><div class="casContent"><span class="casTitleNuber">79</span><div class="casTitle"><span class="NLM_cas:atitle">Quantifying biased signaling in GPCRs using BRET-based biosensors</span></div><div class="casAuthors">Namkung, Yoon; Radresa, Olivier; Armando, Sylvain; Devost, Dominic; Beautrait, Alexandre; Le Gouill, Christian; Laporte, Stephane A.</div><div class="citationInfo"><span class="NLM_cas:title">Methods (Amsterdam, Netherlands)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">92</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">5-10</span>CODEN:
                <span class="NLM_cas:coden">MTHDE9</span>;
        ISSN:<span class="NLM_cas:issn">1046-2023</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">There has been a growing appreciation that G protein-coupled receptor (GPCR) functional selectivity (viz. biased signaling), in particular between G protein- and β-arrestin-dependent signaling, can be achieved with specific ligands, and that such directed signaling represents a promising avenue for improving drug efficacy and therapy.  Thus, for any given GPCRs it is important to define means to pharmacol. characterize and classify drugs for their propensity to bias signaling.  Here we describe an exptl. protocol and step-by-step approach to assess functional selectivity between Gαq and β-arrestin-dependent responses using the prototypical angiotensin II (AngII) type 1 receptor (AT1R) expressed in HEK 293 cells.  The protocol describes the expression of Bioluminescence Resonance Energy Transfer (BRET) sensors for either Gαq or β-arrestin with AT1R, and the use of the operational model of pharmacol. agonism to quantify ligand bias.  Such methods are equally applicable to other GPCRs and their downstream signaling effectors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoisQm2sSQfUbVg90H21EOLACvtfcHk0liJWL8eBaspqA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXmslehsLo%253D&md5=3734d70788ffaa1faeb348d608d2c126</span></div><a href="/servlet/linkout?suffix=cit79&amp;dbid=16384&amp;doi=10.1016%2Fj.ymeth.2015.04.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ymeth.2015.04.010%26sid%3Dliteratum%253Aachs%26aulast%3DNamkung%26aufirst%3DY.%26aulast%3DRadresa%26aufirst%3DO.%26aulast%3DArmando%26aufirst%3DS.%26aulast%3DDevost%26aufirst%3DD.%26aulast%3DBeautrait%26aufirst%3DA.%26aulast%3DLe%2BGouill%26aufirst%3DC.%26aulast%3DLaporte%26aufirst%3DS.%2BA.%26atitle%3DQuantifying%2520Biased%2520Signaling%2520in%2520Gpcrs%2520Using%2520Bret-Based%2520Biosensors%26jtitle%3DMethods%26date%3D2016%26volume%3D92%26spage%3D5%26epage%3D10%26doi%3D10.1016%2Fj.ymeth.2015.04.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref80"><div class="reference"><strong class="refLabel"><a href="#ref80" class="rightTabRefNumLink">80</a></strong><div class="NLM_citation" id="rightTab-cit80"><span><span class="NLM_contrib-group">Amato, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Natesan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yavich, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kapur, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Müller, C. P.</span><span> </span><span class="NLM_article-title">Dynamic Regulation of Dopamine and Serotonin Responses to Salient Stimuli During Chronic Haloperidol Treatment</span> <span class="citation_source-journal">Int. J. Neuropsychopharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">1327</span><span class="NLM_x">–</span> <span class="NLM_lpage">1339</span><span class="refDoi"> DOI: 10.1017/S1461145711000010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01857&amp;key=10.1017%2FS1461145711000010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01857&amp;key=21281560" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01857&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtlKis77M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2011&pages=1327-1339&author=D.+Amatoauthor=S.+Natesanauthor=L.+Yavichauthor=S.+Kapurauthor=C.+P.+M%C3%BCller&title=Dynamic+Regulation+of+Dopamine+and+Serotonin+Responses+to+Salient+Stimuli+During+Chronic+Haloperidol+Treatment&doi=10.1017%2FS1461145711000010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit80R"><div class="casContent"><span class="casTitleNuber">80</span><div class="casTitle"><span class="NLM_cas:atitle">Dynamic regulation of dopamine and serotonin responses to salient stimuli during chronic haloperidol treatment</span></div><div class="casAuthors">Amato, Davide; Natesan, Sridhar; Yavich, Leonid; Kapur, Shitij; Mueller, Christian P.</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Neuropsychopharmacology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1327-1339</span>CODEN:
                <span class="NLM_cas:coden">IJNUFB</span>;
        ISSN:<span class="NLM_cas:issn">1461-1457</span>.
    
            (<span class="NLM_cas:orgname">Cambridge University Press</span>)
        </div><div class="casAbstract">Antipsychotic drugs are the clin. std. for the treatment of schizophrenia.  Although these drugs work initially, many compliant patients relapse due to treatment failure.  The known biomarkers can not sufficiently explain antipsychotic treatment failure.  We, therefore, enquired how the dynamic responses of the neurotransmitters, dopamine and serotonin, change in relation to treatment action and failure.  Rats received either short-term (2-6 d) or long-term (12-14 d) treatment with haloperidol, which resembled human D2 receptor occupancy, using osmotic mini-pumps.  Dopamine and serotonin basal levels and responses to novelty, appetitive food, and to an aversive tail pinch were measured in the prefrontal cortex, nucleus accumbens and caudate putamen using in-vivo microdialysis, and the behavior was recorded.  Subsequently, we used in-vivo voltammetry to measure dopamine overflow in the nucleus accumbens.  Haloperidol decreased dopamine, but not serotonin baseline levels in a time-dependent way.  Salient stimuli induced dopamine and serotonin responses.  Short-term haloperidol treatment attenuated the mesolimbic dopamine responses to aversive stimulation, while the responses to appetitive stimulation were largely preserved.  After long-term treatment, the initial response adaptations were reversed.  Similar changes were also obsd. at the behavioral level.  In-vivo voltammetry showed that nucleus accumbens dopamine adaptations and their reversal were mediated by changes in extracellular dopamine release.  Chronic haloperidol treatment, which resembles human D2 receptor occupancy, modulates dopamine and behavioral responses to aversive and appetitive stimulation depending on the duration of treatment.  Specific changes in dopamine response dynamics and their reversal may be a functional substrate of antipsychotic action and failure resp.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGovrLCzTakKKrVg90H21EOLACvtfcHk0liJWL8eBaspqA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtlKis77M&md5=793c20ed4f723903f5aac12b6d7cfe40</span></div><a href="/servlet/linkout?suffix=cit80&amp;dbid=16384&amp;doi=10.1017%2FS1461145711000010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1017%252FS1461145711000010%26sid%3Dliteratum%253Aachs%26aulast%3DAmato%26aufirst%3DD.%26aulast%3DNatesan%26aufirst%3DS.%26aulast%3DYavich%26aufirst%3DL.%26aulast%3DKapur%26aufirst%3DS.%26aulast%3DM%25C3%25BCller%26aufirst%3DC.%2BP.%26atitle%3DDynamic%2520Regulation%2520of%2520Dopamine%2520and%2520Serotonin%2520Responses%2520to%2520Salient%2520Stimuli%2520During%2520Chronic%2520Haloperidol%2520Treatment%26jtitle%3DInt.%2520J.%2520Neuropsychopharmacol.%26date%3D2011%26volume%3D14%26spage%3D1327%26epage%3D1339%26doi%3D10.1017%2FS1461145711000010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i57"><a href="/doi/suppl/10.1021/acs.jmedchem.6b01857">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_54614"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.6b01857">10.1021/acs.jmedchem.6b01857</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Supplementary figures, supplementary results of functional assays and in vivo characterization, and <sup>1</sup>H and <sup>13</sup>C NMR spectra (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.6b01857/suppl_file/jm6b01857_si_001.pdf">PDF</a>)</p></li><li><p class="inline">Molecular formula strings (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.6b01857/suppl_file/jm6b01857_si_002.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.6b01857/suppl_file/jm6b01857_si_001.pdf">jm6b01857_si_001.pdf (2.46 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.6b01857/suppl_file/jm6b01857_si_002.csv">jm6b01857_si_002.csv (3.09 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.6b01857&amp;pbContext=%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.6b01857%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2017.60.issue-7" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.6b01857" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                2MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"677abf50f98fd93e","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
